Who are YECO's closest competitors?

The closest Biotechnology peers to EV Biologics (YECO) are VRTX, REGN, MRNA. Compare valuation, margins, growth, and insider activity side by side.

How does YECO compare to Biotechnology peers?

Side-by-side comparison of EV Biologics (YECO) against industry peers — P/E, ROE, margins, growth rates, and smart-money positioning.

Which Biotechnology stocks have the highest insider activity?

Rank Biotechnology peers by recent insider buying, congressional activity, and hedge-fund accumulation.

YECO vs VRTX, REGN, MRNA

$0.00

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $723 mcap · 7M float · 0.027% daily turnover · Short 84% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

#989 of 1064

Biotechnology

Healthcare · Micro Cap · 1558 peers

Technical Signal Map

204 Bullish

98 Neutral

1257 Bearish

0 Bullish

2 Neutral

19 Bearish

504 Bullish

254 Neutral

2897 Bearish

Peer Comparison

Symbol	Mkt Cap	P/E	ROE %	ROIC %	Net Mgn %	Rev Grw %	Piotroski	Signal	1Y Ret %
YECO EV Biologics, Inc.	—	-0.0	4.7	15.0	18.6	347.3	6	BEARISH	-99.9
ABSI Absci Corporation	$1.9B	-13.8	-57.7	-213.1	-10443.4	-62.3	5	BULLISH	253.7
ABSI Absci Corporation	$1.9B	-13.8	-57.7	-213.1	-10443.4	-62.3	5	BULLISH	253.7
PMVP PMV Pharmaceuticals, Inc.	$100M	-1.3	-70.9	815.8	—	—	2	BULLISH	31.6
PMVP PMV Pharmaceuticals, Inc.	$100M	-1.3	-70.9	815.8	—	—	2	BULLISH	31.6
ICU SeaStar Medical Holding Corporation	$10M	-1.2	-356.9	415.0	-606.5	123.6	4	BULLISH	-24.8
ICU SeaStar Medical Holding Corporation	$10M	-1.2	-356.9	415.0	-606.5	123.6	4	BULLISH	-24.8
FTRE Fortrea Holdings Inc.	$1.9B	-21.5	-15.3	0.6	-1.9	-2.1	6	BULLISH	110.1
FTRE Fortrea Holdings Inc.	$1.9B	-21.5	-15.3	0.6	-1.9	-2.1	6	BULLISH	110.1
NVAX Novavax, Inc.	$1.7B	-6.9	323.7	29.2	-94.2	-61.6	2	BULLISH	10.1
NVAX Novavax, Inc.	$1.7B	-6.9	323.7	29.2	-94.2	-61.6	2	BULLISH	10.1
SEER Seer, Inc.	$120M	-1.8	-26.4	-58.8	-544.8	-13.3	3	BULLISH	2.3
SEER Seer, Inc.	$120M	-1.8	-26.4	-58.8	-544.8	-13.3	3	BULLISH	2.3
NAUT Nautilus Biotechnolgy, Inc.	$250M	-4.4	-36.2	-66.2	-7615.3	—	3	BULLISH	134.7
NAUT Nautilus Biotechnolgy, Inc.	$250M	-4.4	-36.2	-66.2	-7615.3	—	3	BULLISH	134.7
TLSA Tiziana Life Sciences Ltd	$70M	-4.1	-1250.8	978.2	—	—	1	BULLISH	-42.6
TLSA Tiziana Life Sciences Ltd	$70M	-4.1	-1250.8	978.2	—	—	1	BULLISH	-42.6
AGEN Agenus Inc.	$350M	3.1	-33.2	-20.4	-1.6	30.5	6	BULLISH	114.4
AGEN Agenus Inc.	$350M	3.1	-33.2	-20.4	-1.6	30.5	6	BULLISH	114.4
DNA Ginkgo Bioworks Holdings, Inc.	$810M	-2.5	-56.3	-44.0	-231.7	-51.5	2	BULLISH	-15.9
DNA Ginkgo Bioworks Holdings, Inc.	$810M	-2.5	-56.3	-44.0	-231.7	-51.5	2	BULLISH	-15.9
YDES YD Bio Limited Ordinary Shares	$570M	—	—	—	—	—	—	BULLISH	-54.7
YDES YD Bio Limited Ordinary Shares	$570M	—	—	—	—	—	—	BULLISH	-54.7
DMAC DiaMedica Therapeutics Inc.	$440M	-11.4	-114.6	616.3	—	—	2	BULLISH	20.0
DMAC DiaMedica Therapeutics Inc.	$440M	-11.4	-114.6	616.3	—	—	2	BULLISH	20.0
SRZN Surrozen, Inc.	$220M	-0.7	387.2	11.1	1003.5	-8.8	2	BULLISH	114.6
SRZN Surrozen, Inc.	$220M	-0.7	387.2	11.1	1003.5	-8.8	2	BULLISH	114.6
MREO Mereo BioPharma Group plc	$60M	-2.1	-67.8	6194.3	—	-100.0	2	BULLISH	-81.5
MREO Mereo BioPharma Group plc	$60M	-2.1	-67.8	6194.3	—	-100.0	2	BULLISH	-81.5
CVM CEL-SCI Corporation	$20M	-0.9	-252.5	-142.9	—	-100.0	4	BULLISH	-76.8
CVM CEL-SCI Corporation	$20M	-0.9	-252.5	-142.9	—	-100.0	4	BULLISH	-76.8
SXTP 60 Degrees Pharmaceuticals, Inc.	—	-0.2	-321.8	-390.2	-1089.2	68.0	3	BULLISH	-5.4
SXTP 60 Degrees Pharmaceuticals, Inc.	—	-0.2	-321.8	-390.2	-1089.2	68.0	3	BULLISH	-5.4
SPHRF Starpharma Holdings Limited	$240M	-46.8	-83.3	-941.6	-725.1	50.8	5	BULLISH	480.0
SPHRF Starpharma Holdings Limited	$240M	-46.8	-83.3	-941.6	-725.1	50.8	5	BULLISH	480.0
INKT MiNK Therapeutics, Inc.	$60M	-5.2	57.9	42.8	—	—	3	BULLISH	-14.1
INKT MiNK Therapeutics, Inc.	$60M	-5.2	57.9	42.8	—	—	3	BULLISH	-14.1
CRVO CervoMed Inc.	$30M	-0.9	-107.6	1244.8	—	—	2	BULLISH	-62.4
CRVO CervoMed Inc.	$30M	-0.9	-107.6	1244.8	—	—	2	BULLISH	-62.4
YDESW YD Bio Limited Warrants	—	—	—	—	—	—	—	BULLISH	-60.5
YDESW YD Bio Limited Warrants	—	—	—	—	—	—	—	BULLISH	-60.5
BCTXZ BriaCell Therapeutics Corp. Warrant	—	-0.3	-168.1	-2016.9	—	—	1	BULLISH	39.8
BCTXZ BriaCell Therapeutics Corp. Warrant	—	-0.3	-168.1	-2016.9	—	—	1	BULLISH	39.8
MBXBF Microbix Biosystems Inc.	$30M	-8.5	-16.4	-14.6	-19.9	-27.1	3	BULLISH	18.5
MBXBF Microbix Biosystems Inc.	$30M	-8.5	-16.4	-14.6	-19.9	-27.1	3	BULLISH	18.5
ZIVO ZIVO Bioscience, Inc.	$20M	-2.9	185.9	147.5	—	-62.5	2	BULLISH	-67.5
ZIVO ZIVO Bioscience, Inc.	$20M	-2.9	185.9	147.5	—	-62.5	2	BULLISH	-67.5
SLGL Sol-Gel Technologies Ltd.	$240M	-12.8	-35.9	-228.0	36.4	282.9	3	BULLISH	144.1
SLGL Sol-Gel Technologies Ltd.	$240M	-12.8	-35.9	-228.0	36.4	282.9	3	BULLISH	144.1
BYSI BeyondSpring Inc.	$30M	-4.8	20.3	15.7	—	100.0	2	BULLISH	-56.0
BYSI BeyondSpring Inc.	$30M	-4.8	20.3	15.7	—	100.0	2	BULLISH	-56.0
PULM Pulmatrix, Inc.	$10M	-1.4	-98.3	-835.1	—	-100.0	3	BULLISH	-68.0
PULM Pulmatrix, Inc.	$10M	-1.4	-98.3	-835.1	—	-100.0	3	BULLISH	-68.0
DRTSW Alpha Tau Medical Ltd.	$1.6B	-14.2	-141.7	-17.1	—	—	3	BULLISH	1253.3
DRTSW Alpha Tau Medical Ltd.	$1.6B	-14.2	-141.7	-17.1	—	—	3	BULLISH	1253.3
TTRX Turn Therapeutics Inc.	$400M	-45.7	-952.4	115.0	—	—	2	BULLISH	—
TTRX Turn Therapeutics Inc.	$400M	-45.7	-952.4	115.0	—	—	2	BULLISH	—
OBIO Orchestra BioMed Holdings, Inc.	$360M	-6.0	-397.3	468.3	-26994.3	986.1	4	BULLISH	133.3
OBIO Orchestra BioMed Holdings, Inc.	$360M	-6.0	-397.3	468.3	-26994.3	986.1	4	BULLISH	133.3
NTRB Nutriband Inc.	$90M	-12.7	-100.7	-264.9	-201.3	-37.3	3	BULLISH	0.1
NTRB Nutriband Inc.	$90M	-12.7	-100.7	-264.9	-201.3	-37.3	3	BULLISH	0.1
ATGGF Actinogen Medical Limited	$220M	-11.2	-146.7	-361.2	—	-63.0	1	BULLISH	140.0
ATGGF Actinogen Medical Limited	$220M	-11.2	-146.7	-361.2	—	-63.0	1	BULLISH	140.0
DMTRF 3-D Matrix, Ltd.	$350M	13.8	92.3	29.3	50.9	56.9	5	BULLISH	80.0
DMTRF 3-D Matrix, Ltd.	$350M	13.8	92.3	29.3	50.9	56.9	5	BULLISH	80.0
LITS Lite Strategy, Inc.	$50M	-0.2	-170.9	-28.2	—	—	2	BULLISH	-46.1
LITS Lite Strategy, Inc.	$50M	-0.2	-170.9	-28.2	—	—	2	BULLISH	-46.1
GRDX GridAI Technologies Corp.	$30M	-0.9	-55.6	-51.7	-14927.4	67.4	2	BULLISH	-11.2
GRDX GridAI Technologies Corp.	$30M	-0.9	-55.6	-51.7	-14927.4	67.4	2	BULLISH	-11.2
LKFT Lakefront Biotherapeutics N.V.	$1.9B	—	—	—	—	—	—	BULLISH	—
LKFT Lakefront Biotherapeutics N.V.	$1.9B	—	—	—	—	—	—	BULLISH	—
XERS Xeris Biopharma Holdings, Inc.	$1.6B	-93.5	118.2	18.3	-33.8	36.3	6	BULLISH	13.4
XERS Xeris Biopharma Holdings, Inc.	$1.6B	-93.5	118.2	18.3	-33.8	36.3	6	BULLISH	13.4
RIGL Rigel Pharmaceuticals, Inc.	$870M	2.7	126.9	88.5	22.0	3.3	4	BULLISH	67.4
RIGL Rigel Pharmaceuticals, Inc.	$870M	2.7	126.9	88.5	22.0	3.3	4	BULLISH	67.4
GYRE Gyre Therapeutics, Inc.	$790M	-35.7	-15.6	-22.3	-36.4	16.8	3	BULLISH	-6.2
GYRE Gyre Therapeutics, Inc.	$790M	-35.7	-15.6	-22.3	-36.4	16.8	3	BULLISH	-6.2
ENGN enGene Holdings Inc.	$130M	-6.9	-2.3	134.1	—	-100.0	2	BULLISH	-74.5
ENGN enGene Holdings Inc.	$130M	-6.9	-2.3	134.1	—	-100.0	2	BULLISH	-74.5
RLYB Rallybio Corporation	$90M	2.2	64.9	-1399.7	—	-15.1	6	BULLISH	3191.6
RLYB Rallybio Corporation	$90M	2.2	64.9	-1399.7	—	-15.1	6	BULLISH	3191.6
NRXS NeurAxis, Inc.	$90M	-9.2	-143.2	464.1	-118.1	65.2	6	BULLISH	128.6
NRXS NeurAxis, Inc.	$90M	-9.2	-143.2	464.1	-118.1	65.2	6	BULLISH	128.6
ABPO Abpro Holdings, Inc.	—	—	—	—	—	—	—	BULLISH	—
ABPO Abpro Holdings, Inc.	—	—	—	—	—	—	—	BULLISH	—
NMAD NOMAD Power Solutions, Inc.	$50M	—	—	—	—	—	—	BULLISH	—
NMAD NOMAD Power Solutions, Inc.	$50M	—	—	—	—	—	—	BULLISH	—
PPTDF PeptiDream Inc.	$940M	-38.3	-7.1	-9.6	-25.7	47.8	4	BULLISH	-34.3
PPTDF PeptiDream Inc.	$940M	-38.3	-7.1	-9.6	-25.7	47.8	4	BULLISH	-34.3
CELU Celularity Inc.	$50M	-0.6	349.7	-195.2	17.6	-62.8	2	BULLISH	-21.6
CELU Celularity Inc.	$50M	-0.6	349.7	-195.2	17.6	-62.8	2	BULLISH	-21.6
ANTX AN2 Therapeutics, Inc.	$210M	-5.3	-50.1	1243.3	—	—	2	BULLISH	342.6
ANTX AN2 Therapeutics, Inc.	$210M	-5.3	-50.1	1243.3	—	—	2	BULLISH	342.6
CASBF CanSino Biologics Inc.	$1.6B	523.4	0.8	-1.2	11.0	32.5	7	BULLISH	-29.6
CASBF CanSino Biologics Inc.	$1.6B	523.4	0.8	-1.2	11.0	32.5	7	BULLISH	-29.6
HRGN Harvard Apparatus Regenerative Technology Inc.	$40M	-5.5	239.0	256.6	-409.4	—	2	BULLISH	—
HRGN Harvard Apparatus Regenerative Technology Inc.	$40M	-5.5	239.0	256.6	-409.4	—	2	BULLISH	—
FLNA Filana Therapeutics, Inc.	$40M	-1.1	-13.5	38.9	—	—	2	BULLISH	—
FLNA Filana Therapeutics, Inc.	$40M	-1.1	-13.5	38.9	—	—	2	BULLISH	—
INAB IN8bio, Inc.	$10M	-0.7	-111.1	-576.1	—	—	4	BULLISH	-39.4
INAB IN8bio, Inc.	$10M	-0.7	-111.1	-576.1	—	—	4	BULLISH	-39.4
HEPA Hepion Pharmaceuticals, Inc.	—	-0.3	-125.6	710.2	—	—	3	BULLISH	76.1
HEPA Hepion Pharmaceuticals, Inc.	—	-0.3	-125.6	710.2	—	—	3	BULLISH	76.1
VCNX Vaccinex, Inc.	—	-0.5	776.6	414.6	-1584.0	226.6	3	BULLISH	62.9
VCNX Vaccinex, Inc.	—	-0.5	776.6	414.6	-1584.0	226.6	3	BULLISH	62.9
PDSB PDS Biotechnology Corporation	$40M	-1.2	-544.0	456.9	—	—	1	BULLISH	-26.6
PDSB PDS Biotechnology Corporation	$40M	-1.2	-544.0	456.9	—	—	1	BULLISH	-26.6
BCTX BriaCell Therapeutics Corp.	$40M	-0.3	-179.9	-2435.2	—	—	2	BULLISH	-67.9
BCTX BriaCell Therapeutics Corp.	$40M	-0.3	-179.9	-2435.2	—	—	2	BULLISH	-67.9
KROS Keros Therapeutics, Inc.	$230M	-3.1	-17.2	-392.2	—	-93.6	3	BULLISH	-25.6
KROS Keros Therapeutics, Inc.	$230M	-3.1	-17.2	-392.2	—	-93.6	3	BULLISH	-25.6
EVAX Evaxion Biotech A/S	$20M	-0.5	-109.8	-260.4	—	135.9	6	BULLISH	-27.9
EVAX Evaxion Biotech A/S	$20M	-0.5	-109.8	-260.4	—	135.9	6	BULLISH	-27.9
BMNDF Biomind Labs Inc.	$40M	-24.5	85.8	101.7	—	—	2	BULLISH	2811.4
BMNDF Biomind Labs Inc.	$40M	-24.5	85.8	101.7	—	—	2	BULLISH	2811.4
DRTS Alpha Tau Medical Ltd	$1.3B	-14.2	-141.7	-17.1	—	—	3	BULLISH	238.0
DRTS Alpha Tau Medical Ltd	$1.3B	-14.2	-141.7	-17.1	—	—	3	BULLISH	238.0
BITRF Biotron Limited	$20M	-3.6	-137.4	-107.4	-113.4	-24.0	3	BULLISH	219.2
BITRF Biotron Limited	$20M	-3.6	-137.4	-107.4	-113.4	-24.0	3	BULLISH	219.2
CURX Curanex Pharmaceuticals Inc Common Stock	$10M	-0.6	-218.7	-392.2	—	—	1	BULLISH	-69.5
CURX Curanex Pharmaceuticals Inc Common Stock	$10M	-0.6	-218.7	-392.2	—	—	1	BULLISH	-69.5
QPTFF Quest PharmaTech Inc.	$10M	1.6	3.9	-1.7	—	—	4	BULLISH	125.6
QPTFF Quest PharmaTech Inc.	$10M	1.6	3.9	-1.7	—	—	4	BULLISH	125.6
ADAPY Adaptimmune Therapeutics plc	$10M	-0.1	-1341.1	268.4	-221.8	-54.0	0	BULLISH	-69.5
ADAPY Adaptimmune Therapeutics plc	$10M	-0.1	-1341.1	268.4	-221.8	-54.0	0	BULLISH	-69.5
NKGN NKGen Biotech, Inc.	—	-0.0	150.9	—	-4511.3	—	3	BULLISH	-90.0
NKGN NKGen Biotech, Inc.	—	-0.0	150.9	—	-4511.3	—	3	BULLISH	-90.0
TRVN Trevena, Inc.	—	-0.0	344.3	-3198.4	-1745.2	-82.9	3	BULLISH	0.0
TRVN Trevena, Inc.	—	-0.0	344.3	-3198.4	-1745.2	-82.9	3	BULLISH	0.0
HALB Halberd Corporation	—	-31.8	11.6	12.4	—	-52.1	1	BULLISH	-13.0
HALB Halberd Corporation	—	-31.8	11.6	12.4	—	-52.1	1	BULLISH	-13.0
STTK Shattuck Labs, Inc.	$610M	-13.2	-39.2	-29.3	—	-66.6	4	BULLISH	182.8
STTK Shattuck Labs, Inc.	$610M	-13.2	-39.2	-29.3	—	-66.6	4	BULLISH	182.8
ACIU AC Immune S.A.	$280M	-5.2	-78.5	96.7	12.4	-39.5	2	BULLISH	-10.2
ACIU AC Immune S.A.	$280M	-5.2	-78.5	96.7	12.4	-39.5	2	BULLISH	-10.2
LIANY LianMedical	$10M	1.3	74.7	-612.1	—	—	6	BULLISH	7.9
LIANY LianMedical	$10M	1.3	74.7	-612.1	—	—	6	BULLISH	7.9
ANIX Anixa Biosciences, Inc.	$100M	-9.7	-67.1	-1110.2	—	—	3	BULLISH	-13.0
ANIX Anixa Biosciences, Inc.	$100M	-9.7	-67.1	-1110.2	—	—	3	BULLISH	-13.0
TXTM ProText Mobility, Inc.	$10M	58.0	-0.4	-0.3	—	-100.0	1	BULLISH	87.1
TXTM ProText Mobility, Inc.	$10M	58.0	-0.4	-0.3	—	-100.0	1	BULLISH	87.1
PBM Psyence Biomedical Ltd.	—	—	—	—	—	—	—	BULLISH	75.1
PBM Psyence Biomedical Ltd.	—	—	—	—	—	—	—	BULLISH	75.1
NTLA Intellia Therapeutics, Inc.	$1.7B	-3.6	-55.4	-92.1	-1392.3	12.6	4	LEAN BULL	-34.6
NTLA Intellia Therapeutics, Inc.	$1.7B	-3.6	-55.4	-92.1	-1392.3	12.6	4	LEAN BULL	-34.6
ENTA Enanta Pharmaceuticals, Inc.	$380M	-5.4	-70.1	141.5	-135.8	0.7	4	LEAN BULL	22.1
ENTA Enanta Pharmaceuticals, Inc.	$380M	-5.4	-70.1	141.5	-135.8	0.7	4	LEAN BULL	22.1
PLX Protalix BioTherapeutics, Inc.	$220M	11.2	31.2	47.1	19.0	30.1	5	LEAN BULL	14.8
PLX Protalix BioTherapeutics, Inc.	$220M	11.2	31.2	47.1	19.0	30.1	5	LEAN BULL	14.8
CBUS Cibus, Inc.	$130M	-1.0	-225.9	-157.2	-2227.9	-10.3	2	LEAN BULL	27.6
CBUS Cibus, Inc.	$130M	-1.0	-225.9	-157.2	-2227.9	-10.3	2	LEAN BULL	27.6
HOWL Werewolf Therapeutics, Inc.	$50M	-1.3	-119.9	354.7	17.5	—	4	LEAN BULL	-52.4
HOWL Werewolf Therapeutics, Inc.	$50M	-1.3	-119.9	354.7	17.5	—	4	LEAN BULL	-52.4
ACOG Alpha Cognition Inc	$140M	-8.3	-55.3	-198.4	-144.3	232.7	2	LEAN BULL	14.8
ACOG Alpha Cognition Inc	$140M	-8.3	-55.3	-198.4	-144.3	232.7	2	LEAN BULL	14.8
ZHCLF Zenith Capital Corp.	$20M	-0.0	35107.2	37766.2	-360.0	—	3	LEAN BULL	42.9
ZHCLF Zenith Capital Corp.	$20M	-0.0	35107.2	37766.2	-360.0	—	3	LEAN BULL	42.9
GLWLF Glow Lifetech Corp.	$10M	-50.0	-11.1	-21.1	-26.6	59.2	5	LEAN BULL	-5.3
GLWLF Glow Lifetech Corp.	$10M	-50.0	-11.1	-21.1	-26.6	59.2	5	LEAN BULL	-5.3
VIR Vir Biotechnology, Inc.	$1.9B	-6.0	-26.1	-38.9	33.5	1495.9	4	LEAN BULL	96.0
VIR Vir Biotechnology, Inc.	$1.9B	-6.0	-26.1	-38.9	33.5	1495.9	4	LEAN BULL	96.0
NYMXF Nymox Pharmaceutical Corporation	—	-0.7	193.9	89.4	—	—	2	LEAN BULL	-44.4
NYMXF Nymox Pharmaceutical Corporation	—	-0.7	193.9	89.4	—	—	2	LEAN BULL	-44.4
NNVC NanoViricides, Inc.	$30M	-3.1	-189.3	-0.0	—	—	2	LEAN BULL	-11.1
NNVC NanoViricides, Inc.	$30M	-3.1	-189.3	-0.0	—	—	2	LEAN BULL	-11.1
PHRRF PharmaTher Holdings Ltd.	—	-8.3	-125.3	309.7	—	—	2	LEAN BULL	-71.8
PHRRF PharmaTher Holdings Ltd.	—	-8.3	-125.3	309.7	—	—	2	LEAN BULL	-71.8
KRSA Korsana Biosciences, Inc.	$140M	—	—	—	—	—	—	LEAN BULL	—
KRSA Korsana Biosciences, Inc.	$140M	—	—	—	—	—	—	LEAN BULL	—
MNKD MannKind Corporation	$1.2B	-27.2	71.4	4.0	-17.4	30.5	2	LEAN BULL	-29.4
MNKD MannKind Corporation	$1.2B	-27.2	71.4	4.0	-17.4	30.5	2	LEAN BULL	-29.4
ATNM Actinium Pharmaceuticals, Inc.	$40M	3.2	45.9	-197.8	79.7	—	3	LEAN BULL	-26.9
ATNM Actinium Pharmaceuticals, Inc.	$40M	3.2	45.9	-197.8	79.7	—	3	LEAN BULL	-26.9
TRAW Traws Pharma, Inc.	$10M	-1.1	35.4	225.5	—	606.3	3	LEAN BULL	-69.9
TRAW Traws Pharma, Inc.	$10M	-1.1	35.4	225.5	—	606.3	3	LEAN BULL	-69.9
VTGN VistaGen Therapeutics, Inc.	$10M	-0.2	-131.6	644.6	-3499.8	161.3	2	LEAN BULL	-92.1
VTGN VistaGen Therapeutics, Inc.	$10M	-0.2	-131.6	644.6	-3499.8	161.3	2	LEAN BULL	-92.1
NMTRQ 9 Meters Biopharma, Inc.	—	—	—	—	—	—	—	LEAN BULL	0.0
NMTRQ 9 Meters Biopharma, Inc.	—	—	—	—	—	—	—	LEAN BULL	0.0
ASBP Aspire Biopharma Holdings, Inc.	—	-1.1	-1032.1	1368.4	-2009.6	—	6	LEAN BULL	-96.6
ASBP Aspire Biopharma Holdings, Inc.	—	-1.1	-1032.1	1368.4	-2009.6	—	6	LEAN BULL	-96.6
HYFT MindWalk Holdings Corp.	$60M	-5.2	-78.4	-298.7	-93.9	-16.9	5	LEAN BULL	-24.7
HYFT MindWalk Holdings Corp.	$60M	-5.2	-78.4	-298.7	-93.9	-16.9	5	LEAN BULL	-24.7
VERU Veru Inc.	$40M	-4.2	-62.3	-211.2	—	-100.0	3	LEAN BULL	-35.5
VERU Veru Inc.	$40M	-4.2	-62.3	-211.2	—	-100.0	3	LEAN BULL	-35.5
CNSP CNS Pharmaceuticals, Inc.	$10M	-0.2	-106.6	748.6	—	—	3	LEAN BULL	-38.9
CNSP CNS Pharmaceuticals, Inc.	$10M	-0.2	-106.6	748.6	—	—	3	LEAN BULL	-38.9
CUBT Curative Biotechnology, Inc.	$10M	-2.3	31.0	15.3	—	—	4	LEAN BULL	-27.4
CUBT Curative Biotechnology, Inc.	$10M	-2.3	31.0	15.3	—	—	4	LEAN BULL	-27.4
APUS Apimeds Pharmaceuticals US, Inc	—	-0.1	-100.1	-12.6	—	—	2	LEAN BULL	-81.2
APUS Apimeds Pharmaceuticals US, Inc	—	-0.1	-100.1	-12.6	—	—	2	LEAN BULL	-81.2
GNLX Genelux Corporation	$110M	-2.9	-168.9	20537.7	—	—	2	LEAN BULL	-41.8
GNLX Genelux Corporation	$110M	-2.9	-168.9	20537.7	—	—	2	LEAN BULL	-41.8
HSTC HST Global, Inc.	$100M	-27.8	-5.0	-2.1	2.7	—	3	LEAN BULL	349900.0
HSTC HST Global, Inc.	$100M	-27.8	-5.0	-2.1	2.7	—	3	LEAN BULL	349900.0
RNTX Rein Therapeutics Inc.	$20M	-0.4	-753.6	53.9	—	—	3	LEAN BULL	-32.1
RNTX Rein Therapeutics Inc.	$20M	-0.4	-753.6	53.9	—	—	3	LEAN BULL	-32.1
BRAXF Braxia Scientific Corp.	—	-0.1	-254.6	-2393.3	-184.2	27.6	3	LEAN BULL	-92.2
BRAXF Braxia Scientific Corp.	—	-0.1	-254.6	-2393.3	-184.2	27.6	3	LEAN BULL	-92.2
NMLSF Restart Life Sciences Corp.	—	-1.8	-214.3	-153.9	-307.0	—	2	LEAN BULL	83.8
NMLSF Restart Life Sciences Corp.	—	-1.8	-214.3	-153.9	-307.0	—	2	LEAN BULL	83.8
BIXT Bioxytran, Inc.	—	-0.7	92.2	68.7	—	—	4	LEAN BULL	-66.3
BIXT Bioxytran, Inc.	—	-0.7	92.2	68.7	—	—	4	LEAN BULL	-66.3
HRTX Heron Therapeutics, Inc.	$70M	-1.9	334.6	-7.6	-14.6	1.0	3	LEAN BULL	-72.2
HRTX Heron Therapeutics, Inc.	$70M	-1.9	334.6	-7.6	-14.6	1.0	3	LEAN BULL	-72.2
MAZE Maze Therapeutics, Inc.	$1.5B	-9.6	-37.3	-112.3	—	—	3	NEUTRAL	2.4
MAZE Maze Therapeutics, Inc.	$1.5B	-9.6	-37.3	-112.3	—	—	3	NEUTRAL	2.4
SPRO Spero Therapeutics, Inc.	$70M	8.5	19.2	-128.5	—	-7.0	7	NEUTRAL	-39.3
SPRO Spero Therapeutics, Inc.	$70M	8.5	19.2	-128.5	—	-7.0	7	NEUTRAL	-39.3
AEON AEON Biopharma, Inc.	$10M	-0.1	350.0	98.0	—	—	2	NEUTRAL	-67.1
AEON AEON Biopharma, Inc.	$10M	-0.1	350.0	98.0	—	—	2	NEUTRAL	-67.1
ORGS Orgenesis Inc.	$10M	-0.3	764.3	1083.0	2628.2	-192.0	1	NEUTRAL	-26.6
ORGS Orgenesis Inc.	$10M	-0.3	764.3	1083.0	2628.2	-192.0	1	NEUTRAL	-26.6
CPMV Mosaic ImmunoEngineering Inc.	—	-1.2	9.2	7.5	—	—	2	NEUTRAL	-84.9
CPMV Mosaic ImmunoEngineering Inc.	—	-1.2	9.2	7.5	—	—	2	NEUTRAL	-84.9
CAPR Capricor Therapeutics, Inc.	$510M	-3.7	-73.7	-107.5	—	-100.0	3	NEUTRAL	14.4
CAPR Capricor Therapeutics, Inc.	$510M	-3.7	-73.7	-107.5	—	-100.0	3	NEUTRAL	14.4
PBYI Puma Biotechnology, Inc.	$480M	17.7	22.0	52.8	14.5	-2.9	6	NEUTRAL	80.5
PBYI Puma Biotechnology, Inc.	$480M	17.7	22.0	52.8	14.5	-2.9	6	NEUTRAL	80.5
DARE Dare Bioscience, Inc.	$10M	-1.1	165.3	136.8	-1590.4	7816.7	3	NEUTRAL	-60.8
DARE Dare Bioscience, Inc.	$10M	-1.1	165.3	136.8	-1590.4	7816.7	3	NEUTRAL	-60.8
KPRX Kiora Pharmaceuticals, Inc.	$10M	-1.0	-56.4	-2884.1	—	—	2	NEUTRAL	-9.5
KPRX Kiora Pharmaceuticals, Inc.	$10M	-1.0	-56.4	-2884.1	—	—	2	NEUTRAL	-9.5
COYA Coya Therapeutics, Inc.	$110M	-4.5	-0.1	-18.8	-2723.4	1793.8	3	NEUTRAL	-17.8
COYA Coya Therapeutics, Inc.	$110M	-4.5	-0.1	-18.8	-2723.4	1793.8	3	NEUTRAL	-17.8
AFMDQ Affimed N.V.	—	—	—	—	—	—	—	NEUTRAL	—
AFMDQ Affimed N.V.	—	—	—	—	—	—	—	NEUTRAL	—
ANL Adlai Nortye Ltd.	$800M	-7.7	-22.4	-317.5	-36.3	223.4	4	NEUTRAL	738.3
ANL Adlai Nortye Ltd.	$800M	-7.7	-22.4	-317.5	-36.3	223.4	4	NEUTRAL	738.3
CDIO Cardio Diagnostics Holdings, Inc.	$10M	-0.7	-75.4	-230.9	-28012.5	-25.9	3	NEUTRAL	-54.0
CDIO Cardio Diagnostics Holdings, Inc.	$10M	-0.7	-75.4	-230.9	-28012.5	-25.9	3	NEUTRAL	-54.0
CLGN CollPlant Biotechnologies Ltd.	—	-0.4	-162.0	-369.3	-2524.1	-86.8	2	NEUTRAL	-86.5
CLGN CollPlant Biotechnologies Ltd.	—	-0.4	-162.0	-369.3	-2524.1	-86.8	2	NEUTRAL	-86.5
OMER Omeros Corporation	$1.4B	9.7	-89.2	71.8	46.4	—	5	NEUTRAL	349.5
OMER Omeros Corporation	$1.4B	9.7	-89.2	71.8	46.4	—	5	NEUTRAL	349.5
SOLTF Nxera Pharma Co., Ltd.	$720M	-14.1	-12.0	-1.7	-2.6	7.5	4	NEUTRAL	22.2
SOLTF Nxera Pharma Co., Ltd.	$720M	-14.1	-12.0	-1.7	-2.6	7.5	4	NEUTRAL	22.2
MLLCF Molecular Partners AG	$150M	-2.4	-62.1	650.3	—	-100.0	2	NEUTRAL	14.6
MLLCF Molecular Partners AG	$150M	-2.4	-62.1	650.3	—	-100.0	2	NEUTRAL	14.6
PRNAF Alterity Therapeutics Limited	$90M	-3.4	-117.0	-556.9	—	-41.1	4	NEUTRAL	13233.3
PRNAF Alterity Therapeutics Limited	$90M	-3.4	-117.0	-556.9	—	-41.1	4	NEUTRAL	13233.3
OKYO OKYO Pharma Limited	$60M	-6.1	-213.7	128.1	—	—	3	NEUTRAL	-26.9
OKYO OKYO Pharma Limited	$60M	-6.1	-213.7	128.1	—	—	3	NEUTRAL	-26.9
CLNN Clene Inc.	$50M	-1.1	237.2	132.5	-14915.6	-31.1	2	NEUTRAL	-40.5
CLNN Clene Inc.	$50M	-1.1	237.2	132.5	-14915.6	-31.1	2	NEUTRAL	-40.5
KNTPF Kintor Pharmaceutical Limited	$110M	-3.7	-111.3	-105.7	-145.6	3136.1	3	NEUTRAL	-6.7
KNTPF Kintor Pharmaceutical Limited	$110M	-3.7	-111.3	-105.7	-145.6	3136.1	3	NEUTRAL	-6.7
BXPHF Botanix Pharmaceuticals Limited	$40M	-0.6	-181.3	-285.1	-203.1	1249.3	2	NEUTRAL	-88.1
BXPHF Botanix Pharmaceuticals Limited	$40M	-0.6	-181.3	-285.1	-203.1	1249.3	2	NEUTRAL	-88.1
MMIRF MedMira Inc.	$30M	-13.6	11.8	21.7	-200.5	45.7	4	NEUTRAL	-55.8
MMIRF MedMira Inc.	$30M	-13.6	11.8	21.7	-200.5	45.7	4	NEUTRAL	-55.8
ENVB Enveric Biosciences, Inc.	$10M	-0.1	-170.0	3225.6	—	—	4	NEUTRAL	-81.4
ENVB Enveric Biosciences, Inc.	$10M	-0.1	-170.0	3225.6	—	—	4	NEUTRAL	-81.4
BCLI Brainstorm Cell Therapeutics Inc.	$10M	-1.0	119.2	76.7	—	-100.0	1	NEUTRAL	31.0
BCLI Brainstorm Cell Therapeutics Inc.	$10M	-1.0	119.2	76.7	—	-100.0	1	NEUTRAL	31.0
HLSQ Tessera Defense and Homeland Security Inc	—	—	—	—	—	—	—	N/A	—
HLSQ Tessera Defense and Homeland Security Inc	—	—	—	—	—	—	—	N/A	—
GRI GRI Bio, Inc.	—	-0.0	-142.0	1227.5	—	—	5	NEUTRAL	-96.5
GRI GRI Bio, Inc.	—	-0.0	-142.0	1227.5	—	—	5	NEUTRAL	-96.5
QNTM Quantum BioPharma Ltd.	$20M	-0.6	-425.3	175.1	—	—	4	NEUTRAL	-79.1
QNTM Quantum BioPharma Ltd.	$20M	-0.6	-425.3	175.1	—	—	4	NEUTRAL	-79.1
SIGY Sigyn Therapeutics, Inc.	—	-0.0	61.7	32.8	—	-100.0	1	NEUTRAL	-99.1
SIGY Sigyn Therapeutics, Inc.	—	-0.0	61.7	32.8	—	-100.0	1	NEUTRAL	-99.1
PHMMF Pharma Mar, S.A.	$1.6B	21.9	24.9	35.9	-2.0	15.5	7	NEUTRAL	-7.5
PHMMF Pharma Mar, S.A.	$1.6B	21.9	24.9	35.9	-2.0	15.5	7	NEUTRAL	-7.5
INRLF Valneva SE	$640M	-2.8	-118.0	-54.8	-89.3	-27.2	1	NEUTRAL	-31.5
INRLF Valneva SE	$640M	-2.8	-118.0	-54.8	-89.3	-27.2	1	NEUTRAL	-31.5
XLO Xilio Therapeutics, Inc.	$60M	-6.0	-55.0	43.1	-34.1	327.3	6	NEUTRAL	982.1
XLO Xilio Therapeutics, Inc.	$60M	-6.0	-55.0	43.1	-34.1	327.3	6	NEUTRAL	982.1
CNTN Canton Strategic Holdings Inc	$170M	-1.4	-14.6	-7.2	-1287.2	—	2	NEUTRAL	—
CNTN Canton Strategic Holdings Inc	$170M	-1.4	-14.6	-7.2	-1287.2	—	2	NEUTRAL	—
RBSH Rebus Holdings, Inc.	—	-0.0	-9.7	8.9	—	—	2	NEUTRAL	0.0
RBSH Rebus Holdings, Inc.	—	-0.0	-9.7	8.9	—	—	2	NEUTRAL	0.0
VRCI Verde Science, Inc.	—	-0.0	72.3	23.0	—	—	5	NEUTRAL	1900.0
VRCI Verde Science, Inc.	—	-0.0	72.3	23.0	—	—	5	NEUTRAL	1900.0
LIMNW Liminatus Pharma, Inc. Warrants	—	-0.2	-4165.9	252.1	—	—	2	NEUTRAL	-85.8
LIMNW Liminatus Pharma, Inc. Warrants	—	-0.2	-4165.9	252.1	—	—	2	NEUTRAL	-85.8
HAVLF HAVN Life Sciences Inc.	—	-0.0	-275.3	-163.4	5734.1	876.8	3	NEUTRAL	0.0
HAVLF HAVN Life Sciences Inc.	—	-0.0	-275.3	-163.4	5734.1	876.8	3	NEUTRAL	0.0
CBDG THC Farmaceuticals, Inc.	—	-41.9	2.0	-0.9	—	28.1	5	NEUTRAL	83.2
CBDG THC Farmaceuticals, Inc.	—	-41.9	2.0	-0.9	—	28.1	5	NEUTRAL	83.2
VSTM Verastem, Inc.	$680M	-3.1	-471.2	6197.3	-86.5	3995.7	4	NEUTRAL	-12.5
VSTM Verastem, Inc.	$680M	-3.1	-471.2	6197.3	-86.5	3995.7	4	NEUTRAL	-12.5
INTI Inhibitor Therapeutics, Inc.	$20M	-5.1	358.8	88.0	—	—	1	NEUTRAL	96.0
INTI Inhibitor Therapeutics, Inc.	$20M	-5.1	358.8	88.0	—	—	1	NEUTRAL	96.0
LIMN Liminatus Pharma, Inc. Class A Common Stock	$10M	-0.2	294.4	252.1	—	—	4	NEUTRAL	-95.5
LIMN Liminatus Pharma, Inc. Class A Common Stock	$10M	-0.2	294.4	252.1	—	—	4	NEUTRAL	-95.5
VBIO Valion Bio, Inc.	$10M	-0.0	-122.7	-45.5	—	—	2	NEUTRAL	—
VBIO Valion Bio, Inc.	$10M	-0.0	-122.7	-45.5	—	—	2	NEUTRAL	—
MTNB Matinas BioPharma Holdings, Inc.	—	-0.1	-154.3	-504.1	—	—	4	NEUTRAL	-90.6
MTNB Matinas BioPharma Holdings, Inc.	—	-0.1	-154.3	-504.1	—	—	4	NEUTRAL	-90.6
RARE Ultragenyx Pharmaceutical Inc.	$1.5B	-2.6	839.4	-67.5	-43.0	17.5	2	NEUTRAL	-49.2
RARE Ultragenyx Pharmaceutical Inc.	$1.5B	-2.6	839.4	-67.5	-43.0	17.5	2	NEUTRAL	-49.2
TENX Tenax Therapeutics, Inc.	$50M	-1.3	-59.8	1235.8	—	—	1	NEUTRAL	-74.0
TENX Tenax Therapeutics, Inc.	$50M	-1.3	-59.8	1235.8	—	—	1	NEUTRAL	-74.0
VRPX Virpax Pharmaceuticals, Inc.	—	-0.0	2.6	0.4	—	—	1	NEUTRAL	-55.6
VRPX Virpax Pharmaceuticals, Inc.	—	-0.0	2.6	0.4	—	—	1	NEUTRAL	-55.6
RGIN Regenicin, Inc.	—	-0.0	16.9	4.1	—	—	4	NEUTRAL	0.0
RGIN Regenicin, Inc.	—	-0.0	16.9	4.1	—	—	4	NEUTRAL	0.0
ONCO Onconetix, Inc.	—	-0.1	-105.2	-83.7	-16748.3	-51.3	3	NEUTRAL	-75.7
ONCO Onconetix, Inc.	—	-0.1	-105.2	-83.7	-16748.3	-51.3	3	NEUTRAL	-75.7
SRNE Sorrento Therapeutics, Inc.	—	-0.0	1502.8	468.4	-633.7	16.9	2	NEUTRAL	-77.1
SRNE Sorrento Therapeutics, Inc.	—	-0.0	1502.8	468.4	-633.7	16.9	2	NEUTRAL	-77.1
GLSI Greenwich LifeSciences, Inc.	$250M	-11.0	-951.6	299.9	—	—	2	LEAN BEAR	68.0
GLSI Greenwich LifeSciences, Inc.	$250M	-11.0	-951.6	299.9	—	—	2	LEAN BEAR	68.0
MDWD MediWound Ltd.	$170M	-8.4	-72.4	-255.1	-239.1	-40.3	2	LEAN BEAR	-22.7
MDWD MediWound Ltd.	$170M	-8.4	-72.4	-255.1	-239.1	-40.3	2	LEAN BEAR	-22.7
ACRV Acrivon Therapeutics, Inc. Common Stock	$90M	-1.1	-64.6	5251.5	—	—	1	LEAN BEAR	9.9
ACRV Acrivon Therapeutics, Inc. Common Stock	$90M	-1.1	-64.6	5251.5	—	—	1	LEAN BEAR	9.9
AURX Nuo Therapeutics, Inc.	$60M	-29.9	170.6	280.3	-15.7	166.6	3	LEAN BEAR	-35.9
AURX Nuo Therapeutics, Inc.	$60M	-29.9	170.6	280.3	-15.7	166.6	3	LEAN BEAR	-35.9
SGMOQ Sangamo Therapeutics, Inc.	$60M	—	—	—	—	—	—	LEAN BEAR	—
SGMOQ Sangamo Therapeutics, Inc.	$60M	—	—	—	—	—	—	LEAN BEAR	—
GWIN Glorywin Entertainment Group, Inc.	$230M	-26081.4	11.7	5.1	—	—	1	LEAN BEAR	254.3
GWIN Glorywin Entertainment Group, Inc.	$230M	-26081.4	11.7	5.1	—	—	1	LEAN BEAR	254.3
CLYYF Celyad Oncology S.A.	$10M	2.7	-114.9	-1433.2	64360.6	102.9	4	LEAN BEAR	-31.7
CLYYF Celyad Oncology S.A.	$10M	2.7	-114.9	-1433.2	64360.6	102.9	4	LEAN BEAR	-31.7
PBLA Panbela Therapeutics, Inc.	—	-0.0	270.3	240.0	—	100.0	3	LEAN BEAR	-77.8
PBLA Panbela Therapeutics, Inc.	—	-0.0	270.3	240.0	—	100.0	3	LEAN BEAR	-77.8
MNOV MediciNova, Inc.	$90M	-8.2	-25.6	-78.2	-504.8	583.9	3	LEAN BEAR	42.4
MNOV MediciNova, Inc.	$90M	-8.2	-25.6	-78.2	-504.8	583.9	3	LEAN BEAR	42.4
PTIX Protagenic Therapeutics, Inc.	—	0.3	-485.4	-367.8	—	100.0	6	LEAN BEAR	-77.1
PTIX Protagenic Therapeutics, Inc.	—	0.3	-485.4	-367.8	—	100.0	6	LEAN BEAR	-77.1
KLDO Kaleido Biosciences, Inc.	—	-0.0	-591.2	1121.9	-4292.5	13.2	2	LEAN BEAR	0.0
KLDO Kaleido Biosciences, Inc.	—	-0.0	-591.2	1121.9	-4292.5	13.2	2	LEAN BEAR	0.0
MENS Jyong Biotech Ltd. Ordinary Shares	$170M	—	—	—	—	—	—	LEAN BEAR	-95.5
MENS Jyong Biotech Ltd. Ordinary Shares	$170M	—	—	—	—	—	—	LEAN BEAR	-95.5
NVCT Nuvectis Pharma, Inc.	$580M	-16.7	-214.6	174.4	—	—	1	LEAN BEAR	261.7
NVCT Nuvectis Pharma, Inc.	$580M	-16.7	-214.6	174.4	—	—	1	LEAN BEAR	261.7
INDP Indaptus Therapeutics, Inc.	$270M	-0.3	-318.0	6437.4	—	—	4	LEAN BEAR	-32.0
INDP Indaptus Therapeutics, Inc.	$270M	-0.3	-318.0	6437.4	—	—	4	LEAN BEAR	-32.0
GLSHQ Gelesis Holdings, Inc.	—	-0.0	391.0	-233.6	-693.9	-45.8	3	LEAN BEAR	0.0
GLSHQ Gelesis Holdings, Inc.	—	-0.0	391.0	-233.6	-693.9	-45.8	3	LEAN BEAR	0.0
WINT Windtree Therapeutics, Inc.	—	-0.0	1111.0	-2375.5	—	—	3	LEAN BEAR	-99.6
WINT Windtree Therapeutics, Inc.	—	-0.0	1111.0	-2375.5	—	—	3	LEAN BEAR	-99.6
VINC Vincerx Pharma, Inc.	—	-0.0	-3136.4	910.2	—	-18.7	5	LEAN BEAR	-72.2
VINC Vincerx Pharma, Inc.	—	-0.0	-3136.4	910.2	—	-18.7	5	LEAN BEAR	-72.2
XNCR Xencor, Inc.	$1.8B	-11.4	-29.1	-152.4	-42.4	-36.1	2	LEAN BEAR	110.0
XNCR Xencor, Inc.	$1.8B	-11.4	-29.1	-152.4	-42.4	-36.1	2	LEAN BEAR	110.0
PROK ProKidney Corp.	$580M	-3.0	9.2	13.2	-18948.0	55.2	1	LEAN BEAR	-33.9
PROK ProKidney Corp.	$580M	-3.0	9.2	13.2	-18948.0	55.2	1	LEAN BEAR	-33.9
KTTA Pasithea Therapeutics Corp.	$20M	-0.2	-65.5	0.0	—	—	4	LEAN BEAR	-35.8
KTTA Pasithea Therapeutics Corp.	$20M	-0.2	-65.5	0.0	—	—	4	LEAN BEAR	-35.8
CELZ Creative Medical Technology Holdings, Inc.	—	-0.5	-78.0	8335.2	—	-50.0	2	LEAN BEAR	-71.7
CELZ Creative Medical Technology Holdings, Inc.	—	-0.5	-78.0	8335.2	—	-50.0	2	LEAN BEAR	-71.7
MDXG MiMedx Group, Inc.	$670M	114.8	2.9	5.8	-23.1	-2.4	6	LEAN BEAR	-32.8
MDXG MiMedx Group, Inc.	$670M	114.8	2.9	5.8	-23.1	-2.4	6	LEAN BEAR	-32.8
XRTX XORTX Therapeutics Inc.	—	-0.3	-99.1	-68.5	—	—	3	LEAN BEAR	108.3
XRTX XORTX Therapeutics Inc.	—	-0.3	-99.1	-68.5	—	—	3	LEAN BEAR	108.3
FPMI FluoroPharma Medical, Inc.	—	-0.0	22.7	39.7	—	—	2	LEAN BEAR	100.0
FPMI FluoroPharma Medical, Inc.	—	-0.0	22.7	39.7	—	—	2	LEAN BEAR	100.0
TLOG TetraLogic Pharmaceuticals Corporation	—	-0.0	382.3	479.8	—	—	1	LEAN BEAR	-50.0
TLOG TetraLogic Pharmaceuticals Corporation	—	-0.0	382.3	479.8	—	—	1	LEAN BEAR	-50.0
DCOY Decoy Therapeutics Inc.	—	—	—	—	—	—	—	LEAN BEAR	—
DCOY Decoy Therapeutics Inc.	—	—	—	—	—	—	—	LEAN BEAR	—
CSPHF CStone Pharmaceuticals	$1.2B	-17.9	-74.4	-553.0	-123.0	-36.4	4	LEAN BEAR	-24.5
CSPHF CStone Pharmaceuticals	$1.2B	-17.9	-74.4	-553.0	-123.0	-36.4	4	LEAN BEAR	-24.5
BDRX Biodexa Pharmaceuticals Plc	—	-0.0	-116.7	-229.9	—	-100.0	4	LEAN BEAR	-98.1
BDRX Biodexa Pharmaceuticals Plc	—	-0.0	-116.7	-229.9	—	-100.0	4	LEAN BEAR	-98.1
LYRA Lyra Therapeutics, Inc.	—	-0.0	-6595.0	-671.6	-99300.0	-74.1	4	LEAN BEAR	-98.4
LYRA Lyra Therapeutics, Inc.	—	-0.0	-6595.0	-671.6	-99300.0	-74.1	4	LEAN BEAR	-98.4
GNFTF Genfit S.a.	$790M	-4.5	-575.3	-453.0	-124.0	1.4	4	LEAN BEAR	323.4
GNFTF Genfit S.a.	$790M	-4.5	-575.3	-453.0	-124.0	1.4	4	LEAN BEAR	323.4
ATOS Atossa Therapeutics, Inc.	$20M	-0.5	-89.2	-4213.1	—	—	2	LEAN BEAR	-83.0
ATOS Atossa Therapeutics, Inc.	$20M	-0.5	-89.2	-4213.1	—	—	2	LEAN BEAR	-83.0
GBIM GlobeImmune, Inc.	—	-0.0	-66.2	25.0	-91.5	55.1	4	LEAN BEAR	0.0
GBIM GlobeImmune, Inc.	—	-0.0	-66.2	25.0	-91.5	55.1	4	LEAN BEAR	0.0
JAGX Jaguar Health, Inc.	—	-0.0	-501.9	-118.9	-1035.3	135.5	4	LEAN BEAR	-99.7
JAGX Jaguar Health, Inc.	—	-0.0	-501.9	-118.9	-1035.3	135.5	4	LEAN BEAR	-99.7
AMBS Amarantus BioScience Holdings, Inc.	—	-0.0	7.3	3.8	-4080.5	—	3	LEAN BEAR	-66.7
AMBS Amarantus BioScience Holdings, Inc.	—	-0.0	7.3	3.8	-4080.5	—	3	LEAN BEAR	-66.7
PBMWW Psyence Biomedical Ltd. Warrant	—	—	—	—	—	—	—	LEAN BEAR	-29.7
PBMWW Psyence Biomedical Ltd. Warrant	—	—	—	—	—	—	—	LEAN BEAR	-29.7
GSTC GlobeStar Therapeutics Corporation	—	-0.0	60.9	49.1	—	—	4	LEAN BEAR	0.0
GSTC GlobeStar Therapeutics Corporation	—	-0.0	60.9	49.1	—	—	4	LEAN BEAR	0.0
DNAG DNAPrint Genomics, Inc.	—	-0.0	63.1	-156.0	-826.7	-15.2	3	LEAN BEAR	100.0
DNAG DNAPrint Genomics, Inc.	—	-0.0	63.1	-156.0	-826.7	-15.2	3	LEAN BEAR	100.0
RVLPQ RVL Pharmaceuticals plc	—	-0.0	-182.4	-101.1	-289.3	5.6	3	LEAN BEAR	0.0
RVLPQ RVL Pharmaceuticals plc	—	-0.0	-182.4	-101.1	-289.3	5.6	3	LEAN BEAR	0.0
ATRA Atara Biotherapeutics, Inc.	$90M	-8.0	46.3	30.3	-767.3	-96.7	2	LEAN BEAR	-34.4
ATRA Atara Biotherapeutics, Inc.	$90M	-8.0	46.3	30.3	-767.3	-96.7	2	LEAN BEAR	-34.4
XBIT XBiotech Inc.	$70M	-1.5	-29.9	-201.2	—	—	2	LEAN BEAR	-17.1
XBIT XBiotech Inc.	$70M	-1.5	-29.9	-201.2	—	—	2	LEAN BEAR	-17.1
VTIAF FamiCord AG	$50M	-7.1	-84.3	-13.6	-5.1	0.1	5	LEAN BEAR	16.0
VTIAF FamiCord AG	$50M	-7.1	-84.3	-13.6	-5.1	0.1	5	LEAN BEAR	16.0
ALGS Aligos Therapeutics, Inc.	$30M	-0.8	-113.6	-1246.4	-5.4	893.0	2	LEAN BEAR	-46.2
ALGS Aligos Therapeutics, Inc.	$30M	-0.8	-113.6	-1246.4	-5.4	893.0	2	LEAN BEAR	-46.2
CMRA Comera Life Sciences Holdings, Inc.	—	-0.0	235.6	124.2	-1580.0	81.8	4	LEAN BEAR	0.0
CMRA Comera Life Sciences Holdings, Inc.	—	-0.0	235.6	124.2	-1580.0	81.8	4	LEAN BEAR	0.0
BPTH Bio-Path Holdings, Inc.	—	-0.0	49.0	15.2	—	-100.0	1	LEAN BEAR	-99.6
BPTH Bio-Path Holdings, Inc.	—	-0.0	49.0	15.2	—	-100.0	1	LEAN BEAR	-99.6
SRBCF Sirona Biochem Corp.	—	-0.7	111.4	1025.7	-34808.5	-119.4	2	LEAN BEAR	-57.9
SRBCF Sirona Biochem Corp.	—	-0.7	111.4	1025.7	-34808.5	-119.4	2	LEAN BEAR	-57.9
TBPH Theravance Biopharma Inc	$880M	16.0	20.9	-7.2	-28.5	35.1	7	LEAN BEAR	21.2
TBPH Theravance Biopharma Inc	$880M	16.0	20.9	-7.2	-28.5	35.1	7	LEAN BEAR	21.2
EQ Equillium, Inc.	$90M	-5.5	-59.0	2703.6	—	-100.0	3	LEAN BEAR	-4.7
EQ Equillium, Inc.	$90M	-5.5	-59.0	2703.6	—	-100.0	3	LEAN BEAR	-4.7
PTN Palatin Technologies, Inc.	$20M	-1.8	-877.5	1176.9	-1449.1	—	5	LEAN BEAR	18.9
PTN Palatin Technologies, Inc.	$20M	-1.8	-877.5	1176.9	-1449.1	—	5	LEAN BEAR	18.9
BOLT Bolt Biotherapeutics, Inc.	$10M	-0.2	-111.6	-138.8	-154400.0	12.8	3	LEAN BEAR	-39.0
BOLT Bolt Biotherapeutics, Inc.	$10M	-0.2	-111.6	-138.8	-154400.0	12.8	3	LEAN BEAR	-39.0
SKYE Skye Bioscience, Inc.	$10M	-0.2	-233.9	389.5	—	—	3	LEAN BEAR	-60.6
SKYE Skye Bioscience, Inc.	$10M	-0.2	-233.9	389.5	—	—	3	LEAN BEAR	-60.6
LSTA Lisata Therapeutics, Inc.	$10M	-0.9	-99.9	590.1	—	-90.7	2	LEAN BEAR	-40.0
LSTA Lisata Therapeutics, Inc.	$10M	-0.9	-99.9	590.1	—	-90.7	2	LEAN BEAR	-40.0
PYPD PolyPid Ltd.	$100M	-3.5	-1913.8	231.6	—	—	3	LEAN BEAR	54.0
PYPD PolyPid Ltd.	$100M	-3.5	-1913.8	231.6	—	—	3	LEAN BEAR	54.0
PARD Poniard Pharmaceuticals, Inc.	—	-0.0	-210.4	-442.5	—	—	3	LEAN BEAR	0.0
PARD Poniard Pharmaceuticals, Inc.	—	-0.0	-210.4	-442.5	—	—	3	LEAN BEAR	0.0
TVGN Tevogen Bio Holdings Inc.	$30M	-1.2	235.3	244.1	—	—	5	LEAN BEAR	710.5
TVGN Tevogen Bio Holdings Inc.	$30M	-1.2	235.3	244.1	—	—	5	LEAN BEAR	710.5
ALZN Alzamend Neuro Inc	$10M	-0.6	-373.2	-30751.3	—	—	1	LEAN BEAR	-44.1
ALZN Alzamend Neuro Inc	$10M	-0.6	-373.2	-30751.3	—	—	1	LEAN BEAR	-44.1
BPMUF Basilea Pharmaceutica AG	$940M	15.7	140.1	185.7	23.5	49.5	9	LEAN BEAR	12.6
BPMUF Basilea Pharmaceutica AG	$940M	15.7	140.1	185.7	23.5	49.5	9	LEAN BEAR	12.6
ANNX Annexon, Inc.	$690M	-3.6	-105.3	-11323.3	—	—	2	BEARISH	38.3
ANNX Annexon, Inc.	$690M	-3.6	-105.3	-11323.3	—	—	2	BEARISH	38.3
SNTI Senti Biosciences, Inc.	$10M	-0.2	-466.5	-430.9	-75000.0	—	2	BEARISH	-77.6
SNTI Senti Biosciences, Inc.	$10M	-0.2	-466.5	-430.9	-75000.0	—	2	BEARISH	-77.6
CODX Co-Diagnostics, Inc.	$10M	-0.0	-174.8	-218.8	-3782.4	-28.1	3	BEARISH	-89.8
CODX Co-Diagnostics, Inc.	$10M	-0.0	-174.8	-218.8	-3782.4	-28.1	3	BEARISH	-89.8
ARTL Artelo Biosciences, Inc.	—	-0.0	-705.7	-1031.2	—	—	5	BEARISH	-91.4
ARTL Artelo Biosciences, Inc.	—	-0.0	-705.7	-1031.2	—	—	5	BEARISH	-91.4
OGEN Oragenics, Inc.	—	-0.1	-1307.1	4273.7	—	—	3	BEARISH	-64.8
OGEN Oragenics, Inc.	—	-0.1	-1307.1	4273.7	—	—	3	BEARISH	-64.8
SLXN Silexion Therapeutics Ltd.	—	-0.0	-17022.0	-931.4	—	—	3	BEARISH	-93.1
SLXN Silexion Therapeutics Ltd.	—	-0.0	-17022.0	-931.4	—	—	3	BEARISH	-93.1
IPIX Innovation Pharmaceuticals Inc.	—	-0.0	-115.7	-377.9	—	-133.3	3	BEARISH	-93.3
IPIX Innovation Pharmaceuticals Inc.	—	-0.0	-115.7	-377.9	—	-133.3	3	BEARISH	-93.3
BIOAF Bioasis Technologies Inc.	—	-0.1	135.1	538.8	-661.8	614.1	2	BEARISH	-50.0
BIOAF Bioasis Technologies Inc.	—	-0.1	135.1	538.8	-661.8	614.1	2	BEARISH	-50.0
CSBR Champions Oncology, Inc.	$70M	-62.5	-30.5	-25.2	-5.3	4.4	4	BEARISH	-22.8
CSBR Champions Oncology, Inc.	$70M	-62.5	-30.5	-25.2	-5.3	4.4	4	BEARISH	-22.8
ELUT Elutia Inc	$30M	0.6	-397.0	-290.2	-315.0	-48.8	6	BEARISH	-12.0
ELUT Elutia Inc	$30M	0.6	-397.0	-290.2	-315.0	-48.8	6	BEARISH	-12.0
LONA LeonaBio, Inc.	$20M	—	—	—	—	—	—	BEARISH	—
LONA LeonaBio, Inc.	$20M	—	—	—	—	—	—	BEARISH	—
APVO Aptevo Therapeutics Inc.	—	-0.0	-420.3	-4688.7	—	—	1	BEARISH	-92.9
APVO Aptevo Therapeutics Inc.	—	-0.0	-420.3	-4688.7	—	—	1	BEARISH	-92.9
MCET MultiCell Technologies, Inc.	—	-0.1	101.2	99.1	-81.8	1532.7	5	BEARISH	0.0
MCET MultiCell Technologies, Inc.	—	-0.1	101.2	99.1	-81.8	1532.7	5	BEARISH	0.0
NNLX NanoLogix, Inc.	—	—	—	—	—	—	—	BEARISH	-20.0
NNLX NanoLogix, Inc.	—	—	—	—	—	—	—	BEARISH	-20.0
SNBIF SanBio Company Limited	$1.3B	-19.7	-50.0	1250.3	—	—	4	BEARISH	0.0
SNBIF SanBio Company Limited	$1.3B	-19.7	-50.0	1250.3	—	—	4	BEARISH	0.0
REPL Replimune Group, Inc.	$1.1B	-4.1	-107.9	-2853.5	—	—	1	BEARISH	210.4
REPL Replimune Group, Inc.	$1.1B	-4.1	-107.9	-2853.5	—	—	1	BEARISH	210.4
GALT Galectin Therapeutics Inc.	$260M	-9.1	21.9	99.4	—	—	2	BEARISH	-6.7
GALT Galectin Therapeutics Inc.	$260M	-9.1	21.9	99.4	—	—	2	BEARISH	-6.7
SCNLF Scancell Holdings plc	$150M	-17.9	254.8	3518.0	—	-10.6	1	BEARISH	5.9
SCNLF Scancell Holdings plc	$150M	-17.9	254.8	3518.0	—	-10.6	1	BEARISH	5.9
RANI Rani Therapeutics Holdings, Inc.	$50M	-3.0	-179.1	245.5	-432.7	306.4	5	BEARISH	59.3
RANI Rani Therapeutics Holdings, Inc.	$50M	-3.0	-179.1	245.5	-432.7	306.4	5	BEARISH	59.3
PROT Proteonomix, Inc.	—	-0.0	77.5	-1239.4	—	-63.1	4	BEARISH	0.0
PROT Proteonomix, Inc.	—	-0.0	77.5	-1239.4	—	-63.1	4	BEARISH	0.0
JUNS Jupiter Neurosciences, Inc.	—	-0.1	-1888.7	5586.0	-9380.9	—	3	BEARISH	-98.0
JUNS Jupiter Neurosciences, Inc.	—	-0.1	-1888.7	5586.0	-9380.9	—	3	BEARISH	-98.0
REPCF RepliCel Life Sciences Inc.	—	-9.4	-248.8	-13.9	-80.9	200.0	6	BEARISH	0.0
REPCF RepliCel Life Sciences Inc.	—	-9.4	-248.8	-13.9	-80.9	200.0	6	BEARISH	0.0
FATE Fate Therapeutics, Inc.	$270M	-2.2	-60.7	-140.1	-1448.6	-23.4	2	BEARISH	109.0
FATE Fate Therapeutics, Inc.	$270M	-2.2	-60.7	-140.1	-1448.6	-23.4	2	BEARISH	109.0
ALEC Alector, Inc.	$200M	-1.6	-385.1	66.8	-692.5	-82.9	1	BEARISH	-39.7
ALEC Alector, Inc.	$200M	-1.6	-385.1	66.8	-692.5	-82.9	1	BEARISH	-39.7
TELO Telomir Pharmaceuticals, Inc. Common Stock	$80M	-0.8	-213.1	3515.1	—	—	4	BEARISH	-15.1
TELO Telomir Pharmaceuticals, Inc. Common Stock	$80M	-0.8	-213.1	3515.1	—	—	4	BEARISH	-15.1
ELOX Eloxx Pharmaceuticals, Inc.	$50M	-10.2	-107.5	81.5	—	—	4	BEARISH	15509900.5
ELOX Eloxx Pharmaceuticals, Inc.	$50M	-10.2	-107.5	81.5	—	—	4	BEARISH	15509900.5
ABVC ABVC BioPharma, Inc.	$30M	-3.4	-82.2	-43.0	—	-100.0	2	BEARISH	-66.2
ABVC ABVC BioPharma, Inc.	$30M	-3.4	-82.2	-43.0	—	-100.0	2	BEARISH	-66.2
NRXBF NurExone Biologic Inc.	$30M	—	—	—	—	—	—	BEARISH	—
NRXBF NurExone Biologic Inc.	$30M	—	—	—	—	—	—	BEARISH	—
EMMA Emmaus Life Sciences, Inc.	—	-0.4	9.9	-9.3	21.2	11.0	4	BEARISH	423.8
EMMA Emmaus Life Sciences, Inc.	—	-0.4	9.9	-9.3	21.2	11.0	4	BEARISH	423.8
CTNM Contineum Therapeutics, Inc.	$490M	-7.6	-28.0	-541.6	—	—	4	BEARISH	19.2
CTNM Contineum Therapeutics, Inc.	$490M	-7.6	-28.0	-541.6	—	—	4	BEARISH	19.2
ANVS Annovis Bio, Inc.	$50M	-0.7	-703.7	170.2	—	—	1	BEARISH	-44.6
ANVS Annovis Bio, Inc.	$50M	-0.7	-703.7	170.2	—	—	1	BEARISH	-44.6
MDCLF MedinCell S.A.	$1.2B	-24.4	264.0	116.8	-152.1	129.2	6	BEARISH	392.7
MDCLF MedinCell S.A.	$1.2B	-24.4	264.0	116.8	-152.1	129.2	6	BEARISH	392.7
PLYX Polaryx Therapeutics, Inc. Common Stock	$100M	-17.1	-35.9	437.3	—	—	2	BEARISH	—
PLYX Polaryx Therapeutics, Inc. Common Stock	$100M	-17.1	-35.9	437.3	—	—	2	BEARISH	—
POLBF Poolbeg Pharma PLC	$70M	-9.2	-117.0	-516.5	—	—	1	BEARISH	125.4
POLBF Poolbeg Pharma PLC	$70M	-9.2	-117.0	-516.5	—	—	1	BEARISH	125.4
BTAIQ BioXcel Therapeutics, Inc.	—	—	—	—	—	—	—	BEARISH	—
BTAIQ BioXcel Therapeutics, Inc.	—	—	—	—	—	—	—	BEARISH	—
RVPH Reviva Pharmaceuticals Holdings, Inc.	$10M	-0.1	-32.2	45.6	—	—	4	BEARISH	38.5
RVPH Reviva Pharmaceuticals Holdings, Inc.	$10M	-0.1	-32.2	45.6	—	—	4	BEARISH	38.5
ARDS Aridis Pharmaceuticals, Inc.	—	-0.0	4.8	10.0	-19.9	2227.6	4	BEARISH	-92.3
ARDS Aridis Pharmaceuticals, Inc.	—	-0.0	4.8	10.0	-19.9	2227.6	4	BEARISH	-92.3
EHOS Ehouse Global, Inc.	—	-0.0	161.0	52.5	—	—	1	BEARISH	900.0
EHOS Ehouse Global, Inc.	—	-0.0	161.0	52.5	—	—	1	BEARISH	900.0
RCAR RenovaCare, Inc.	—	-0.0	-436.6	812.3	—	—	2	BEARISH	0.0
RCAR RenovaCare, Inc.	—	-0.0	-436.6	812.3	—	—	2	BEARISH	0.0
NNBP Nanobac Pharmaceuticals, Incorporated	—	0.0	358.0	221.2	-26718.6	-92.2	3	BEARISH	0.0
NNBP Nanobac Pharmaceuticals, Incorporated	—	0.0	358.0	221.2	-26718.6	-92.2	3	BEARISH	0.0
IMVIF IMV Inc.	—	-0.2	-503.3	-2870.5	—	—	1	BEARISH	1900.0
IMVIF IMV Inc.	—	-0.2	-503.3	-2870.5	—	—	1	BEARISH	1900.0
SNANF Sona Nanotech Inc.	$30M	-15.4	526.4	236.5	—	—	1	BEARISH	-47.3
SNANF Sona Nanotech Inc.	$30M	-15.4	526.4	236.5	—	—	1	BEARISH	-47.3
AIMD Ainos, Inc.	$10M	-0.5	-196.3	-69.4	-3022849.3	-87.7	1	BEARISH	-61.2
AIMD Ainos, Inc.	$10M	-0.5	-196.3	-69.4	-3022849.3	-87.7	1	BEARISH	-61.2
CNBX CNBX Pharmaceuticals Inc.	—	-0.5	17.8	13.3	—	100.0	3	BEARISH	-71.4
CNBX CNBX Pharmaceuticals Inc.	—	-0.5	17.8	13.3	—	100.0	3	BEARISH	-71.4
AFFY Affymax, Inc.	—	-0.0	98.1	-302.0	17164.3	-99.9	5	BEARISH	77.8
AFFY Affymax, Inc.	—	-0.0	98.1	-302.0	17164.3	-99.9	5	BEARISH	77.8
CARM Carisma Therapeutics, Inc.	—	0.0	-134.1	-376.4	98.8	159.7	3	BEARISH	-99.8
CARM Carisma Therapeutics, Inc.	—	0.0	-134.1	-376.4	98.8	159.7	3	BEARISH	-99.8
NURPF Neuren Pharmaceuticals Limited	$1.8B	128.1	61.3	282.5	14.6	7.2	5	BEARISH	19.0
NURPF Neuren Pharmaceuticals Limited	$1.8B	128.1	61.3	282.5	14.6	7.2	5	BEARISH	19.0
AVBP ArriVent BioPharma, Inc.	$1.3B	-7.7	-53.1	2345.1	—	—	3	BEARISH	53.1
AVBP ArriVent BioPharma, Inc.	$1.3B	-7.7	-53.1	2345.1	—	—	3	BEARISH	53.1
SLNCF Silence Therapeutics plc	$570M	-2.8	-90.4	137.0	—	-97.6	1	BEARISH	175.9
SLNCF Silence Therapeutics plc	$570M	-2.8	-90.4	137.0	—	-97.6	1	BEARISH	175.9
AVIR Atea Pharmaceuticals, Inc.	$410M	-2.5	-58.1	974.6	—	—	3	BEARISH	78.1
AVIR Atea Pharmaceuticals, Inc.	$410M	-2.5	-58.1	974.6	—	—	3	BEARISH	78.1
WHWK Whitehawk Therapeutics Inc	$210M	-3.3	-45.0	963.4	—	-100.0	1	BEARISH	93.7
WHWK Whitehawk Therapeutics Inc	$210M	-3.3	-45.0	963.4	—	-100.0	1	BEARISH	93.7
VTVT vTv Therapeutics Inc.	$80M	-277.9	-11.7	91.2	—	216600.0	4	BEARISH	27.4
VTVT vTv Therapeutics Inc.	$80M	-277.9	-11.7	91.2	—	216600.0	4	BEARISH	27.4
CNTB Connect Biopharma Holdings Limited	$60M	-1.1	-128.0	1785.6	-1249.0	-79.7	2	BEARISH	-38.2
CNTB Connect Biopharma Holdings Limited	$60M	-1.1	-128.0	1785.6	-1249.0	-79.7	2	BEARISH	-38.2
FNCHQ Finch Therapeutics Group, Inc.	$20M	—	—	—	—	—	—	BEARISH	—
FNCHQ Finch Therapeutics Group, Inc.	$20M	—	—	—	—	—	—	BEARISH	—
IMUC EOM Pharmaceuticals Holdings, Inc.	$20M	-10.5	64.4	131.0	—	—	4	BEARISH	269.5
IMUC EOM Pharmaceuticals Holdings, Inc.	$20M	-10.5	64.4	131.0	—	—	4	BEARISH	269.5
MLECW Moolec Science S.A.	—	-0.0	-174.7	-31.5	-91.8	170.4	3	BEARISH	10.8
MLECW Moolec Science S.A.	—	-0.0	-174.7	-31.5	-91.8	170.4	3	BEARISH	10.8
SCNI Scinai Immunotherapeutics Ltd.	—	-0.0	-19.2	-53.3	-435.4	162.7	2	BEARISH	-4.3
SCNI Scinai Immunotherapeutics Ltd.	—	-0.0	-19.2	-53.3	-435.4	162.7	2	BEARISH	-4.3
ATXI Avenue Therapeutics, Inc.	—	-0.5	-120.0	178.4	—	-100.0	2	BEARISH	-43.4
ATXI Avenue Therapeutics, Inc.	—	-0.5	-120.0	178.4	—	-100.0	2	BEARISH	-43.4
ORIC ORIC Pharmaceuticals, Inc.	$1.3B	-9.0	-39.8	-102.9	—	—	3	BEARISH	4.3
ORIC ORIC Pharmaceuticals, Inc.	$1.3B	-9.0	-39.8	-102.9	—	—	3	BEARISH	4.3
IVVD Invivyd, Inc.	$240M	-2.1	-95.9	-302.5	-310.8	26.3	2	BEARISH	-31.8
IVVD Invivyd, Inc.	$240M	-2.1	-95.9	-302.5	-310.8	26.3	2	BEARISH	-31.8
SNNAQ Sienna Biopharmaceuticals, Inc.	—	-0.0	-140.9	-331.4	—	—	2	BEARISH	9900.0
SNNAQ Sienna Biopharmaceuticals, Inc.	—	-0.0	-140.9	-331.4	—	—	2	BEARISH	9900.0
BTAX Biostax Corp.	—	-0.0	7.3	5.8	—	—	2	BEARISH	100.0
BTAX Biostax Corp.	—	-0.0	7.3	5.8	—	—	2	BEARISH	100.0
ALPS Alps Group Inc	$70M	—	—	—	—	—	—	BEARISH	—
ALPS Alps Group Inc	$70M	—	—	—	—	—	—	BEARISH	—
ANEB Anebulo Pharmaceuticals, Inc.	$10M	-2.1	-69.7	650.7	—	—	1	BEARISH	-86.7
ANEB Anebulo Pharmaceuticals, Inc.	$10M	-2.1	-69.7	650.7	—	—	1	BEARISH	-86.7
IRD Opus Genetics, Inc.	$380M	-3.6	-4796.5	59.8	-1072.6	-36.1	3	BEARISH	154.4
IRD Opus Genetics, Inc.	$380M	-3.6	-4796.5	59.8	-1072.6	-36.1	3	BEARISH	154.4
AOBI American Oriental Bioengineering, Inc.	—	-0.0	-28.2	-16.5	-118.1	-10.2	3	BEARISH	1081.8
AOBI American Oriental Bioengineering, Inc.	—	-0.0	-28.2	-16.5	-118.1	-10.2	3	BEARISH	1081.8
DYAI Dyadic International, Inc.	$20M	-2.1	522.6	1288.0	-221.0	1.5	3	BEARISH	-64.1
DYAI Dyadic International, Inc.	$20M	-2.1	522.6	1288.0	-221.0	1.5	3	BEARISH	-64.1
TOVX Theriva Biologics, Inc.	$10M	-0.3	-101.9	-213.5	—	—	2	BEARISH	-40.8
TOVX Theriva Biologics, Inc.	$10M	-0.3	-101.9	-213.5	—	—	2	BEARISH	-40.8
OXBOF Oxford BioDynamics Plc	—	-0.3	-920.3	-356.4	-649.8	131.0	4	BEARISH	-85.1
OXBOF Oxford BioDynamics Plc	—	-0.3	-920.3	-356.4	-649.8	131.0	4	BEARISH	-85.1
PHGUF Pharming Group N.V.	$780M	66.6	3.7	5.8	1.7	7.8	7	BEARISH	-26.0
PHGUF Pharming Group N.V.	$780M	66.6	3.7	5.8	1.7	7.8	7	BEARISH	-26.0
CDXS Codexis, Inc.	$150M	-4.0	-69.4	-37.8	-80.5	35.9	3	BEARISH	-45.6
CDXS Codexis, Inc.	$150M	-4.0	-69.4	-37.8	-80.5	35.9	3	BEARISH	-45.6
PSYBF PsyBio Therapeutics Corp	—	-0.0	344.6	135.0	—	—	2	BEARISH	-90.0
PSYBF PsyBio Therapeutics Corp	—	-0.0	344.6	135.0	—	—	2	BEARISH	-90.0
LIFS Life Stem Genetics Inc.	—	-2.5	-126.7	-111.5	—	—	2	BEARISH	0.0
LIFS Life Stem Genetics Inc.	—	-2.5	-126.7	-111.5	—	—	2	BEARISH	0.0
HLUN HEALTHeUNIVERSE, Inc.	—	—	—	—	—	—	—	BEARISH	900.0
HLUN HEALTHeUNIVERSE, Inc.	—	—	—	—	—	—	—	BEARISH	900.0
PZRXQ PhaseRx, Inc.	—	-0.0	-228.2	8803.4	—	—	2	BEARISH	0.0
PZRXQ PhaseRx, Inc.	—	-0.0	-228.2	8803.4	—	—	2	BEARISH	0.0
NTII Neurobiological Technologies, Inc.	—	0.0	48.7	441.6	89.7	99.7	4	BEARISH	0.0
NTII Neurobiological Technologies, Inc.	—	0.0	48.7	441.6	89.7	99.7	4	BEARISH	0.0
AMPE Ampio Pharmaceuticals, Inc.	—	-0.0	-114.0	1652.6	-838.4	—	4	BEARISH	6681.5
AMPE Ampio Pharmaceuticals, Inc.	—	-0.0	-114.0	1652.6	-838.4	—	4	BEARISH	6681.5
MRZM Marizyme, Inc.	—	-0.0	117.5	-190.1	—	-69.0	3	BEARISH	29900.0
MRZM Marizyme, Inc.	—	-0.0	117.5	-190.1	—	-69.0	3	BEARISH	29900.0
MRPI Mera Pharmaceuticals, Inc.	—	-10000.0	24.3	18.3	-159.9	4.8	5	BEARISH	0.0
MRPI Mera Pharmaceuticals, Inc.	—	-10000.0	24.3	18.3	-159.9	4.8	5	BEARISH	0.0
THER Theralink Technologies, Inc.	—	-0.0	6.0	-69.7	5363.6	32.8	2	BEARISH	0.0
THER Theralink Technologies, Inc.	—	-0.0	6.0	-69.7	5363.6	32.8	2	BEARISH	0.0
ZBIO Zenas BioPharma, Inc.	$1.8B	-2.9	-199.0	5842.1	-11145.6	-93.3	2	BEARISH	27.9
ZBIO Zenas BioPharma, Inc.	$1.8B	-2.9	-199.0	5842.1	-11145.6	-93.3	2	BEARISH	27.9
SGP SpyGlass Pharma, Inc. Common Stock	$830M	—	—	—	—	—	—	BEARISH	—
SGP SpyGlass Pharma, Inc. Common Stock	$830M	—	—	—	—	—	—	BEARISH	—
ACHV Achieve Life Sciences, Inc.	$740M	-4.7	-845.0	24.6	—	—	2	BEARISH	133.6
ACHV Achieve Life Sciences, Inc.	$740M	-4.7	-845.0	24.6	—	—	2	BEARISH	133.6
ORMP Oramed Pharmaceuticals Inc.	$180M	1.1	74.1	-4.3	—	-100.0	4	BEARISH	76.1
ORMP Oramed Pharmaceuticals Inc.	$180M	1.1	74.1	-4.3	—	-100.0	4	BEARISH	76.1
ENTX Entera Bio Ltd.	$140M	-8.2	-138.9	314.4	—	-100.0	1	BEARISH	54.6
ENTX Entera Bio Ltd.	$140M	-8.2	-138.9	314.4	—	-100.0	1	BEARISH	54.6
ADCT ADC Therapeutics S.A.	$140M	-1.7	45.3	260.9	-86.1	2.0	2	BEARISH	-72.0
ADCT ADC Therapeutics S.A.	$140M	-1.7	45.3	260.9	-86.1	2.0	2	BEARISH	-72.0
OTLK Outlook Therapeutics, Inc.	$110M	-0.3	256.9	1372.0	-225766.7	-169.4	4	BEARISH	-43.0
OTLK Outlook Therapeutics, Inc.	$110M	-0.3	256.9	1372.0	-225766.7	-169.4	4	BEARISH	-43.0
ICCC ImmuCell Corporation	$90M	115.2	2.6	10.2	25.5	8.5	6	BEARISH	47.7
ICCC ImmuCell Corporation	$90M	115.2	2.6	10.2	25.5	8.5	6	BEARISH	47.7
LOBEF Lobe Sciences Ltd.	$10M	-2.7	359.0	181.6	—	—	2	BEARISH	9.5
LOBEF Lobe Sciences Ltd.	$10M	-2.7	359.0	181.6	—	—	2	BEARISH	9.5
TPST Tempest Therapeutics, Inc.	$10M	-0.2	-931.1	-564.2	—	—	1	BEARISH	-92.0
MTVA MetaVia Inc.	$10M	-0.4	-175.7	209.3	—	—	0	BEARISH	-86.4
MTVA MetaVia Inc.	$10M	-0.4	-175.7	209.3	—	—	0	BEARISH	-86.4
TPST Tempest Therapeutics, Inc.	$10M	-0.2	-931.1	-564.2	—	—	1	BEARISH	-92.0
HCWB HCW Biologics Inc.	—	-0.0	-133.5	-36.8	-3849.9	707.0	3	BEARISH	-92.6
HCWB HCW Biologics Inc.	—	-0.0	-133.5	-36.8	-3849.9	707.0	3	BEARISH	-92.6
NBIO Nascent Biotech, Inc.	—	-0.0	230.6	328.8	—	—	5	BEARISH	-97.1
NBIO Nascent Biotech, Inc.	—	-0.0	230.6	328.8	—	—	5	BEARISH	-97.1
INFIQ Infinity Pharmaceuticals, Inc.	—	-0.0	109.5	60.9	-1707.7	—	2	BEARISH	-98.0
INFIQ Infinity Pharmaceuticals, Inc.	—	-0.0	109.5	60.9	-1707.7	—	2	BEARISH	-98.0
SPRC SciSparc Ltd.	—	-0.0	-311.5	-90652.5	-721.8	-48.8	3	BEARISH	-25.2
SPRC SciSparc Ltd.	—	-0.0	-311.5	-90652.5	-721.8	-48.8	3	BEARISH	-25.2
BSSP Baseline Productions, Inc.	—	-0.0	167.7	64.9	—	—	2	BEARISH	-99.0
BSSP Baseline Productions, Inc.	—	-0.0	167.7	64.9	—	—	2	BEARISH	-99.0
EXOZ eXoZymes, Inc.	$50M	-4.8	-187.2	913.0	—	—	2	BEARISH	-58.8
EXOZ eXoZymes, Inc.	$50M	-4.8	-187.2	913.0	—	—	2	BEARISH	-58.8
NIKI Niki BioSolutions, Inc.	—	—	—	—	—	—	—	BEARISH	—
NIKI Niki BioSolutions, Inc.	—	—	—	—	—	—	—	BEARISH	—
VBIZF Viva Biotech Holdings	$400M	15.4	9.0	8.9	8.0	-15.5	5	BEARISH	-31.6
VBIZF Viva Biotech Holdings	$400M	15.4	9.0	8.9	8.0	-15.5	5	BEARISH	-31.6
BBIXF Bonus Biogroup Ltd.	$50M	-17.8	3245.0	2543.1	—	—	2	BEARISH	-42.9
BBIXF Bonus Biogroup Ltd.	$50M	-17.8	3245.0	2543.1	—	—	2	BEARISH	-42.9
NICXF Nicox S.A.	$30M	-7.0	-243.6	-114.4	-302.5	—	2	BEARISH	0.0
NICXF Nicox S.A.	$30M	-7.0	-243.6	-114.4	-302.5	—	2	BEARISH	0.0
HOPHF Hemogenyx Pharmaceuticals Plc	$20M	-3.6	-647.5	-822.2	—	—	2	BEARISH	0.0
HOPHF Hemogenyx Pharmaceuticals Plc	$20M	-3.6	-647.5	-822.2	—	—	2	BEARISH	0.0
LVCLF Algorae Pharmaceuticals Limited	$20M	-4.7	-83.9	-39069.8	—	451.3	3	BEARISH	51.6
LVCLF Algorae Pharmaceuticals Limited	$20M	-4.7	-83.9	-39069.8	—	451.3	3	BEARISH	51.6
BIVI BioVie Inc.	$10M	-0.5	-0.0	-0.0	—	—	3	BEARISH	-26.6
BIVI BioVie Inc.	$10M	-0.5	-0.0	-0.0	—	—	3	BEARISH	-26.6
XSNX NovAccess Global Inc.	—	-0.0	27.7	18.0	—	—	3	BEARISH	-33.3
XSNX NovAccess Global Inc.	—	-0.0	27.7	18.0	—	—	3	BEARISH	-33.3
CHNXF ChitogenX Inc.	—	-0.2	23.2	36.2	—	—	2	BEARISH	48.0
CHNXF ChitogenX Inc.	—	-0.2	23.2	36.2	—	—	2	BEARISH	48.0
FORU ForU Holdings, Inc.	—	-0.0	759.2	-476.4	—	-100.0	2	BEARISH	100.0
FORU ForU Holdings, Inc.	—	-0.0	759.2	-476.4	—	-100.0	2	BEARISH	100.0
NSHSF NanoSphere Health Sciences Inc.	—	-1.8	4.6	11.1	—	—	1	BEARISH	-50.0
NSHSF NanoSphere Health Sciences Inc.	—	-1.8	4.6	11.1	—	—	1	BEARISH	-50.0
AVCTF Avacta Group Plc	$440M	-7.9	-553.3	-1587.8	-33970.3	-65.3	2	BEARISH	25.6
AVCTF Avacta Group Plc	$440M	-7.9	-553.3	-1587.8	-33970.3	-65.3	2	BEARISH	25.6
HNSBF Hansa Biopharma AB	$330M	-4.2	159.8	1182.7	-541.7	-3.7	2	BEARISH	9.7
HNSBF Hansa Biopharma AB	$330M	-4.2	159.8	1182.7	-541.7	-3.7	2	BEARISH	9.7
FBIOP Fortress Biotech, Inc.	$130M	0.6	107.5	-87.8	-2.5	15.5	6	BEARISH	124.5
FBIOP Fortress Biotech, Inc.	$130M	0.6	107.5	-87.8	-2.5	15.5	6	BEARISH	124.5
FHTX Foghorn Therapeutics Inc.	$120M	-2.0	81.9	26.3	-44.7	52.0	4	BEARISH	-59.0
FHTX Foghorn Therapeutics Inc.	$120M	-2.0	81.9	26.3	-44.7	52.0	4	BEARISH	-59.0
VICP Vicapsys Life Sciences, Inc.	$20M	-80.2	31.3	17.6	—	—	5	BEARISH	-63.3
VICP Vicapsys Life Sciences, Inc.	$20M	-80.2	31.3	17.6	—	—	5	BEARISH	-63.3
RLFTY MindMaze Therapeutics Holding S.A.	—	-2.1	-66.6	-70.4	-1182.3	-71.4	3	BEARISH	-94.0
RLFTY MindMaze Therapeutics Holding S.A.	—	-2.1	-66.6	-70.4	-1182.3	-71.4	3	BEARISH	-94.0
ELTX Elicio Therapeutics, Inc.	$40M	-0.9	-774.6	2147.3	—	—	4	BEARISH	-82.5
ELTX Elicio Therapeutics, Inc.	$40M	-0.9	-774.6	2147.3	—	—	4	BEARISH	-82.5
SEOVF Sernova Corp.	$30M	-3.6	57.0	76.3	—	—	3	BEARISH	-34.1
SEOVF Sernova Corp.	$30M	-3.6	57.0	76.3	—	—	3	BEARISH	-34.1
USRM U.S. Stem Cell, Inc.	—	-0.0	20.8	23.4	-2836.8	-59.1	5	BEARISH	0.0
USRM U.S. Stem Cell, Inc.	—	-0.0	20.8	23.4	-2836.8	-59.1	5	BEARISH	0.0
JANX Janux Therapeutics, Inc.	$1.0B	-10.3	-10.7	516.9	-214.0	7162.0	4	BEARISH	-28.6
JANX Janux Therapeutics, Inc.	$1.0B	-10.3	-10.7	516.9	-214.0	7162.0	4	BEARISH	-28.6
STRO Sutro Biopharma, Inc.	$150M	-0.9	266.8	43.6	-391.6	-56.3	4	BEARISH	70.0
STRO Sutro Biopharma, Inc.	$150M	-0.9	266.8	43.6	-391.6	-56.3	4	BEARISH	70.0
IBIO iBio, Inc.	$70M	-3.5	-65.7	21688.6	—	-75.0	4	BEARISH	37.2
IBIO iBio, Inc.	$70M	-3.5	-65.7	21688.6	—	-75.0	4	BEARISH	37.2
TIL Instil Bio, Inc.	$50M	-1.6	-25.3	-69.1	—	—	4	BEARISH	-62.2
TIL Instil Bio, Inc.	$50M	-1.6	-25.3	-69.1	—	—	4	BEARISH	-62.2
IGC IGC Pharma, Inc.	$30M	-3.3	-105.2	-118.3	-757.7	-6.7	2	BEARISH	-33.2
IGC IGC Pharma, Inc.	$30M	-3.3	-105.2	-118.3	-757.7	-6.7	2	BEARISH	-33.2
ACTU Actuate Therapeutics Inc	$20M	-0.9	2457.6	541.3	—	—	3	BEARISH	-88.2
ACTU Actuate Therapeutics Inc	$20M	-0.9	2457.6	541.3	—	—	3	BEARISH	-88.2
TCRX TScan Therapeutics, Inc.	$20M	-0.4	-95.8	-159.4	-2888.6	2.2	2	BEARISH	-84.7
TCRX TScan Therapeutics, Inc.	$20M	-0.4	-95.8	-159.4	-2888.6	2.2	2	BEARISH	-84.7
PVCT Provectus Biopharmaceuticals, Inc.	$20M	-4.8	78.1	83.4	—	-100.0	5	BEARISH	-38.4
PVCT Provectus Biopharmaceuticals, Inc.	$20M	-4.8	78.1	83.4	—	-100.0	5	BEARISH	-38.4
NCNA NuCana plc	$10M	-0.3	-70.7	-739.9	—	—	4	BEARISH	-77.6
NCNA NuCana plc	$10M	-0.3	-70.7	-739.9	—	—	4	BEARISH	-77.6
GDTC CytoMed Therapeutics Limited	$10M	-2.6	-90.6	-106.7	-1125.6	62.6	1	BEARISH	-56.2
GDTC CytoMed Therapeutics Limited	$10M	-2.6	-90.6	-106.7	-1125.6	62.6	1	BEARISH	-56.2
RNUGF ReNeuron Group plc	—	-0.0	-153.3	532.8	-1809.6	194.9	3	BEARISH	0.0
RNUGF ReNeuron Group plc	—	-0.0	-153.3	532.8	-1809.6	194.9	3	BEARISH	0.0
BVAXF BioVaxys Technology Corp.	—	-0.9	310.6	48.4	—	—	1	BEARISH	-61.2
BVAXF BioVaxys Technology Corp.	—	-0.9	310.6	48.4	—	—	1	BEARISH	-61.2
KNBIF Kane Biotech Inc.	—	-2.1	439.7	-2166.6	-10238.1	-97.9	2	BEARISH	-43.7
KNBIF Kane Biotech Inc.	—	-2.1	439.7	-2166.6	-10238.1	-97.9	2	BEARISH	-43.7
PMCB PharmaCyte Biotech, Inc.	—	-0.2	-45.6	142.9	—	—	2	BEARISH	-59.2
PMCB PharmaCyte Biotech, Inc.	—	-0.2	-45.6	142.9	—	—	2	BEARISH	-59.2
CDXI Cardax, Inc.	—	-0.0	81.1	38.5	-1740.8	-27.3	2	BEARISH	0.0
CDXI Cardax, Inc.	—	-0.0	81.1	38.5	-1740.8	-27.3	2	BEARISH	0.0
EVGN Evogene Ltd.	—	-0.4	265.3	101.3	-509.5	-80.4	3	BEARISH	-63.0
EVGN Evogene Ltd.	—	-0.4	265.3	101.3	-509.5	-80.4	3	BEARISH	-63.0
SYVC Synovics Pharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
SYVC Synovics Pharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
ADYX Adynxx, Inc.	—	-0.0	1148.3	259.7	—	-95.1	2	BEARISH	0.0
ADYX Adynxx, Inc.	—	-0.0	1148.3	259.7	—	-95.1	2	BEARISH	0.0
CASIF CASI Pharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	—
CASIF CASI Pharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	—
CFRXQ ContraFect Corp.	—	-0.0	544.7	276.9	—	—	1	BEARISH	-98.0
CFRXQ ContraFect Corp.	—	-0.0	544.7	276.9	—	—	1	BEARISH	-98.0
ARNI Arno Therapeutics, Inc.	—	-0.0	250.7	111.6	—	—	3	BEARISH	0.0
ARNI Arno Therapeutics, Inc.	—	-0.0	250.7	111.6	—	—	3	BEARISH	0.0
LIPO Lipella Pharmaceuticals Inc.	—	-0.0	-361.8	4105.8	—	-64.1	1	BEARISH	-99.9
LIPO Lipella Pharmaceuticals Inc.	—	-0.0	-361.8	4105.8	—	-64.1	1	BEARISH	-99.9
PFND Pathfinder Cell Therapy, Inc.	—	-0.0	22.4	46.3	—	—	2	BEARISH	0.0
PFND Pathfinder Cell Therapy, Inc.	—	-0.0	22.4	46.3	—	—	2	BEARISH	0.0
PANC Panacos Pharmaceuticals, Inc.	—	-0.0	-168.8	-792.8	-33966.7	-45.9	1	BEARISH	0.0
PANC Panacos Pharmaceuticals, Inc.	—	-0.0	-168.8	-792.8	-33966.7	-45.9	1	BEARISH	0.0
CBIO Crescent Biopharma, Inc.	$530M	-1.9	-107.7	1928.6	—	—	5	BEARISH	20.3
CBIO Crescent Biopharma, Inc.	$530M	-1.9	-107.7	1928.6	—	—	5	BEARISH	20.3
EDIT Editas Medicine, Inc.	$400M	-3.5	-118.8	71.4	-153.3	20.8	4	BEARISH	-26.2
EDIT Editas Medicine, Inc.	$400M	-3.5	-118.8	71.4	-153.3	20.8	4	BEARISH	-26.2
MGNX MacroGenics, Inc.	$230M	-16.3	-32.6	33.8	59.4	2.3	2	BEARISH	110.6
MGNX MacroGenics, Inc.	$230M	-16.3	-32.6	33.8	59.4	2.3	2	BEARISH	110.6
VANI Vivani Medical, Inc.	$110M	-3.5	-220.4	-127.1	—	—	4	BEARISH	-14.6
VANI Vivani Medical, Inc.	$110M	-3.5	-220.4	-127.1	—	—	4	BEARISH	-14.6
ACHFF Arch Biopartners Inc.	$40M	-19.5	73.5	165.4	—	100.0	2	BEARISH	-33.2
ACHFF Arch Biopartners Inc.	$40M	-19.5	73.5	165.4	—	100.0	2	BEARISH	-33.2
COCP Cocrystal Pharma, Inc.	$20M	-1.5	-311.7	-3697.6	-3013.3	—	2	BEARISH	-8.7
COCP Cocrystal Pharma, Inc.	$20M	-1.5	-311.7	-3697.6	-3013.3	—	2	BEARISH	-8.7
IMRN Immuron Limited	$10M	-3.1	-74.6	-356.5	-54.4	28.7	5	BEARISH	-42.9
IMRN Immuron Limited	$10M	-3.1	-74.6	-356.5	-54.4	28.7	5	BEARISH	-42.9
SYBX Synlogic, Inc.	$10M	-20.7	-5.3	306.3	—	—	2	BEARISH	-33.5
SYBX Synlogic, Inc.	$10M	-20.7	-5.3	306.3	—	—	2	BEARISH	-33.5
QNCX Quince Therapeutics, Inc.	$10M	-0.4	-153.8	1282.0	—	—	4	BEARISH	1702.5
QNCX Quince Therapeutics, Inc.	$10M	-0.4	-153.8	1282.0	—	—	4	BEARISH	1702.5
AAGH America Great Health	—	2.0	-12.2	22.4	-635.8	-5.1	4	BEARISH	-66.7
AAGH America Great Health	—	2.0	-12.2	22.4	-635.8	-5.1	4	BEARISH	-66.7
RGBPP Regen BioPharma, Inc.	—	-0.0	20.3	12.8	-1079.8	0.0	4	BEARISH	-98.3
RGBPP Regen BioPharma, Inc.	—	-0.0	20.3	12.8	-1079.8	0.0	4	BEARISH	-98.3
NCEL NewcelX Ltd.	—	8.6	-48.0	-39.1	—	—	2	BEARISH	—
NCEL NewcelX Ltd.	—	8.6	-48.0	-39.1	—	—	2	BEARISH	—
PPCB Propanc Biopharma, Inc.	—	-0.0	-161.9	-166.7	—	—	4	BEARISH	-70.2
PPCB Propanc Biopharma, Inc.	—	-0.0	-161.9	-166.7	—	—	4	BEARISH	-70.2
ISCO International Stem Cell Corporation	—	-4.6	30.4	-10.8	-2.7	3.4	6	BEARISH	123.1
ISCO International Stem Cell Corporation	—	-4.6	30.4	-10.8	-2.7	3.4	6	BEARISH	123.1
FGHQF Frontage Holdings Corporation	$350M	28.9	4.2	4.5	4.6	2.1	6	BEARISH	16.8
FGHQF Frontage Holdings Corporation	$350M	28.9	4.2	4.5	4.6	2.1	6	BEARISH	16.8
SGMT Sagimet Biosciences Inc.	$300M	-7.1	-24.4	-231.4	—	—	3	BEARISH	30.9
SGMT Sagimet Biosciences Inc.	$300M	-7.1	-24.4	-231.4	—	—	3	BEARISH	30.9
BRIBF Brii Biosciences Limited	$90M	-3.1	-16.9	-94.3	—	-81.5	4	BEARISH	-46.0
BRIBF Brii Biosciences Limited	$90M	-3.1	-16.9	-94.3	—	-81.5	4	BEARISH	-46.0
SYGGF Synairgen plc	—	-0.2	-114.6	-853.1	—	—	2	BEARISH	-50.0
SYGGF Synairgen plc	—	-0.2	-114.6	-853.1	—	—	2	BEARISH	-50.0
GHRS GH Research PLC	$1.6B	-22.9	-18.8	2015.5	—	—	2	BEARISH	69.0
GHRS GH Research PLC	$1.6B	-22.9	-18.8	2015.5	—	—	2	BEARISH	69.0
LXRX Lexicon Pharmaceuticals, Inc.	$810M	-12.1	-40.2	-99.7	-4591.8	-29.0	3	BEARISH	59.6
LXRX Lexicon Pharmaceuticals, Inc.	$810M	-12.1	-40.2	-99.7	-4591.8	-29.0	3	BEARISH	59.6
ACRS Aclaris Therapeutics, Inc.	$610M	-7.6	-59.1	-206.5	-1320.1	-51.0	3	BEARISH	134.8
ACRS Aclaris Therapeutics, Inc.	$610M	-7.6	-59.1	-206.5	-1320.1	-51.0	3	BEARISH	134.8
XBIO Xenetic Biosciences, Inc.	$10M	-1.9	-47.0	523.4	-140.7	33.3	4	BEARISH	-29.0
XBIO Xenetic Biosciences, Inc.	$10M	-1.9	-47.0	523.4	-140.7	33.3	4	BEARISH	-29.0
OBX Obsidian Therapeutics Inc.	$10M	—	—	—	—	—	—	BEARISH	—
OBX Obsidian Therapeutics Inc.	$10M	—	—	—	—	—	—	BEARISH	—
SQZB SQZ Biotechnologies Company	—	-0.0	-203.4	-410.2	—	-44.6	0	BEARISH	-14.3
SQZB SQZ Biotechnologies Company	—	-0.0	-203.4	-410.2	—	-44.6	0	BEARISH	-14.3
SYBE SYBLEU Inc	—	-3.1	71.5	-202.2	-685.7	—	2	BEARISH	0.0
SYBE SYBLEU Inc	—	-3.1	71.5	-202.2	-685.7	—	2	BEARISH	0.0
STOK Stoke Therapeutics, Inc.	$1.6B	-7.6	-61.1	-318.5	-660.8	-86.2	2	BEARISH	8.6
STOK Stoke Therapeutics, Inc.	$1.6B	-7.6	-61.1	-318.5	-660.8	-86.2	2	BEARISH	8.6
IMTX Immatics N.V.	$1.0B	-4.2	-47.8	-858.3	-683.4	-68.0	2	BEARISH	-15.7
IMTX Immatics N.V.	$1.0B	-4.2	-47.8	-858.3	-683.4	-68.0	2	BEARISH	-15.7
ODTX Odyssey Therapeutics, Inc.	$1.0B	—	—	—	—	—	—	BEARISH	—
ODTX Odyssey Therapeutics, Inc.	$1.0B	—	—	—	—	—	—	BEARISH	—
SVRA Savara Inc.	$990M	-8.3	-105.5	-15438.9	—	—	2	BEARISH	35.9
SVRA Savara Inc.	$990M	-8.3	-105.5	-15438.9	—	—	2	BEARISH	35.9
DSGN Design Therapeutics, Inc.	$770M	-10.5	-34.1	1787.8	—	—	1	BEARISH	81.7
DSGN Design Therapeutics, Inc.	$770M	-10.5	-34.1	1787.8	—	—	1	BEARISH	81.7
RZLT Rezolute, Inc.	$390M	-5.3	-59.0	1060.6	—	—	2	BEARISH	-57.5
RZLT Rezolute, Inc.	$390M	-5.3	-59.0	1060.6	—	—	2	BEARISH	-57.5
OCGN Ocugen, Inc.	$350M	-4.0	1211.7	190.2	-1671.8	-3.7	2	BEARISH	-39.3
OCGN Ocugen, Inc.	$350M	-4.0	1211.7	190.2	-1671.8	-3.7	2	BEARISH	-39.3
CAMP CAMP4 Therapeutics Corporation	$250M	-1.8	-545.9	48.4	-1884.8	40.2	2	BEARISH	35.6
CAMP CAMP4 Therapeutics Corporation	$250M	-1.8	-545.9	48.4	-1884.8	40.2	2	BEARISH	35.6
RNAC Cartesian Therapeutics, Inc.	$220M	-1.2	241.0	37.3	—	44.0	2	BEARISH	-28.1
RNAC Cartesian Therapeutics, Inc.	$220M	-1.2	241.0	37.3	—	44.0	2	BEARISH	-28.1
APLMW Apollomics, Inc.	$160M	-3.0	-4655.8	1929.8	1188.0	—	2	BEARISH	-59.6
APLMW Apollomics, Inc.	$160M	-3.0	-4655.8	1929.8	1188.0	—	2	BEARISH	-59.6
ARMP Armata Pharmaceuticals, Inc.	$130M	-0.7	127.8	-54.7	2953.8	-35.1	2	BEARISH	18.9
ARMP Armata Pharmaceuticals, Inc.	$130M	-0.7	127.8	-54.7	2953.8	-35.1	2	BEARISH	18.9
BDTX Black Diamond Therapeutics, Inc.	$110M	-2.6	-37.2	-1604.9	—	-100.0	1	BEARISH	-49.2
BDTX Black Diamond Therapeutics, Inc.	$110M	-2.6	-37.2	-1604.9	—	-100.0	1	BEARISH	-49.2
OSTX OS Therapies Incorporated	$70M	-1.5	1924.5	268.9	—	—	1	BEARISH	-18.5
OSTX OS Therapies Incorporated	$70M	-1.5	1924.5	268.9	—	—	1	BEARISH	-18.5
GOSS Gossamer Bio, Inc.	$70M	-0.2	178.7	117.2	182.9	32.4	3	BEARISH	-94.6
GOSS Gossamer Bio, Inc.	$70M	-0.2	178.7	117.2	182.9	32.4	3	BEARISH	-94.6
INNMF Amplia Therapeutics Limited	$40M	-6.6	-55.4	-129.9	—	-32.9	3	BEARISH	-20.0
INNMF Amplia Therapeutics Limited	$40M	-6.6	-55.4	-129.9	—	-32.9	3	BEARISH	-20.0
RVXCF Resverlogix Corp.	$20M	-1.8	11.5	25.3	—	—	4	BEARISH	-11.2
RVXCF Resverlogix Corp.	$20M	-1.8	11.5	25.3	—	—	4	BEARISH	-11.2
AIM AIM ImmunoTech Inc.	$10M	-0.0	-2382.3	-513.5	-14569.2	-21.5	5	BEARISH	-92.8
AIM AIM ImmunoTech Inc.	$10M	-0.0	-2382.3	-513.5	-14569.2	-21.5	5	BEARISH	-92.8
MVMDF The More Life Company Corp.	$10M	-6.2	-190.3	2590.3	-2792.5	-82.4	1	BEARISH	177.6
MVMDF The More Life Company Corp.	$10M	-6.2	-190.3	2590.3	-2792.5	-82.4	1	BEARISH	177.6
KALA KALA BIO, Inc.	$10M	-0.0	-345.3	-913.5	—	-100.0	4	BEARISH	-99.4
KALA KALA BIO, Inc.	$10M	-0.0	-345.3	-913.5	—	-100.0	4	BEARISH	-99.4
HIND Vyome Holdings, Inc.	$10M	-0.1	-193.1	516.3	-2543.3	-98.0	4	BEARISH	-65.3
HIND Vyome Holdings, Inc.	$10M	-0.1	-193.1	516.3	-2543.3	-98.0	4	BEARISH	-65.3
GNPX Genprex, Inc.	—	-0.0	-203.9	3484.8	—	—	4	BEARISH	-98.7
GNPX Genprex, Inc.	—	-0.0	-203.9	3484.8	—	—	4	BEARISH	-98.7
APLIF Appili Therapeutics Inc	—	-0.1	27.5	94.3	-2486.7	159.8	2	BEARISH	-50.0
APLIF Appili Therapeutics Inc	—	-0.1	27.5	94.3	-2486.7	159.8	2	BEARISH	-50.0
CMND Clearmind Medicine Inc.	—	-0.1	-104.0	593.4	—	—	2	BEARISH	-99.8
CMND Clearmind Medicine Inc.	—	-0.1	-104.0	593.4	—	—	2	BEARISH	-99.8
CEROW CERo Therapeutics Holdings, Inc.	—	-0.0	101.5	60.5	—	-100.0	1	BEARISH	-88.0
CEROW CERo Therapeutics Holdings, Inc.	—	-0.0	101.5	60.5	—	-100.0	1	BEARISH	-88.0
HESG Health Sciences Group, Inc.	—	-0.0	69.4	44.6	-19219.1	101.6	3	BEARISH	-90.0
HESG Health Sciences Group, Inc.	—	-0.0	69.4	44.6	-19219.1	101.6	3	BEARISH	-90.0
TSOI Therapeutic Solutions International, Inc.	—	-0.1	-187.6	-130.3	-5123.0	-99.7	4	BEARISH	0.0
TSOI Therapeutic Solutions International, Inc.	—	-0.1	-187.6	-130.3	-5123.0	-99.7	4	BEARISH	0.0
MRES Institute of Biomedical Research Corp.	—	-4.8	301783.0	-6062.7	—	—	1	BEARISH	-71.8
MRES Institute of Biomedical Research Corp.	—	-4.8	301783.0	-6062.7	—	—	1	BEARISH	-71.8
CANF Can-Fite BioPharma Ltd.	—	-0.3	-184.2	353.7	-2277.7	-40.1	2	BEARISH	-82.1
CANF Can-Fite BioPharma Ltd.	—	-0.3	-184.2	353.7	-2277.7	-40.1	2	BEARISH	-82.1
STAB Statera Biopharma, Inc.	—	-0.0	-298.8	2085.4	-769.5	1459.1	3	BEARISH	-99.0
STAB Statera Biopharma, Inc.	—	-0.0	-298.8	2085.4	-769.5	1459.1	3	BEARISH	-99.0
SCPX Scorpius Holdings, Inc.	—	-0.0	0.0	0.0	-428.3	-75.5	0	BEARISH	-90.9
SCPX Scorpius Holdings, Inc.	—	-0.0	0.0	0.0	-428.3	-75.5	0	BEARISH	-90.9
SEPN Septerna Inc	$1.7B	-69.8	-6.3	-93.1	-48.7	17878.5	5	BEARISH	98.5
SEPN Septerna Inc	$1.7B	-69.8	-6.3	-93.1	-48.7	17878.5	5	BEARISH	98.5
FDMT 4D Molecular Therapeutics, Inc.	$710M	-5.0	-43.3	-182.0	-1929.0	278712.1	4	BEARISH	56.6
FDMT 4D Molecular Therapeutics, Inc.	$710M	-5.0	-43.3	-182.0	-1929.0	278712.1	4	BEARISH	56.6
EPRX Eupraxia Pharmaceuticals Inc.	$240M	-7.1	-68.6	8742.2	—	—	3	BEARISH	19.3
EPRX Eupraxia Pharmaceuticals Inc.	$240M	-7.1	-68.6	8742.2	—	—	3	BEARISH	19.3
NKTX Nkarta, Inc.	$180M	-1.6	-38.8	-75.4	—	—	1	BEARISH	16.7
NKTX Nkarta, Inc.	$180M	-1.6	-38.8	-75.4	—	—	1	BEARISH	16.7
IBO Impact BioMedical Inc.	$50M	-4.5	10.8	-30.4	-23300.0	—	5	BEARISH	-34.5
IBO Impact BioMedical Inc.	$50M	-4.5	10.8	-30.4	-23300.0	—	5	BEARISH	-34.5
IXHL Incannex Healthcare Limited	$40M	-2.9	-163.9	14055.6	—	378.7	5	BEARISH	-75.2
IXHL Incannex Healthcare Limited	$40M	-2.9	-163.9	14055.6	—	378.7	5	BEARISH	-75.2
ERNAW Ernexa Therapeutics Inc. Warrants	—	—	—	—	—	—	—	BEARISH	—
ERNAW Ernexa Therapeutics Inc. Warrants	—	—	—	—	—	—	—	BEARISH	—
AMGXF AnGes, Inc.	$140M	-3.7	-160.6	-111.8	-531.3	-16.1	4	BEARISH	0.0
AMGXF AnGes, Inc.	$140M	-3.7	-160.6	-111.8	-531.3	-16.1	4	BEARISH	0.0
MYMX Mymetics Corporation	—	-0.0	16.6	357.9	-3012.0	-62.8	2	BEARISH	0.0
MYMX Mymetics Corporation	—	-0.0	16.6	357.9	-3012.0	-62.8	2	BEARISH	0.0
IMMB Immunotech Laboratories, Inc.	—	—	—	—	—	—	—	BEARISH	100.0
IMMB Immunotech Laboratories, Inc.	—	—	—	—	—	—	—	BEARISH	100.0
ATRX Adhera Therapeutics Inc	—	-0.0	18.6	6.5	—	—	1	BEARISH	-99.0
ATRX Adhera Therapeutics Inc	—	-0.0	18.6	6.5	—	—	1	BEARISH	-99.0
NWPHF Newron Pharmaceuticals S.p.A.	$420M	-6.0	83.9	-32.1	-513.4	—	1	BEARISH	—
NWPHF Newron Pharmaceuticals S.p.A.	$420M	-6.0	83.9	-32.1	-513.4	—	1	BEARISH	—
ARCT Arcturus Therapeutics Holdings Inc.	$370M	-3.9	-46.3	-2501.0	-803.8	-79.1	1	BEARISH	-36.4
ARCT Arcturus Therapeutics Holdings Inc.	$370M	-3.9	-46.3	-2501.0	-803.8	-79.1	1	BEARISH	-36.4
ENSC Ensysce Biosciences, Inc.	$10M	-0.1	-968.3	792.9	-220.8	-77.6	3	BEARISH	-83.7
ENSC Ensysce Biosciences, Inc.	$10M	-0.1	-968.3	792.9	-220.8	-77.6	3	BEARISH	-83.7
APRE Aprea Therapeutics, Inc.	$10M	-0.6	-47.4	378.1	—	-99.8	2	BEARISH	-52.4
APRE Aprea Therapeutics, Inc.	$10M	-0.6	-47.4	378.1	—	-99.8	2	BEARISH	-52.4
VAXX Vaxxinity, Inc.	—	-0.2	-150.6	2534.7	—	—	0	BEARISH	-99.5
VAXX Vaxxinity, Inc.	—	-0.2	-150.6	2534.7	—	—	0	BEARISH	-99.5
SYRS Syros Pharmaceuticals, Inc.	—	-0.0	-777.0	960.6	—	-90.5	0	BEARISH	300.0
SYRS Syros Pharmaceuticals, Inc.	—	-0.0	-777.0	960.6	—	-90.5	0	BEARISH	300.0
DVHGF Devonian Health Group Inc.	$20M	-3.8	-76.1	-75.1	-1098.1	-91.5	1	BEARISH	37.7
DVHGF Devonian Health Group Inc.	$20M	-3.8	-76.1	-75.1	-1098.1	-91.5	1	BEARISH	37.7
MDCX Medicus Pharma Ltd. Common Stock	$10M	-0.1	-3904.0	-693.1	—	—	2	BEARISH	-92.8
MDCX Medicus Pharma Ltd. Common Stock	$10M	-0.1	-3904.0	-693.1	—	—	2	BEARISH	-92.8
FAMDF Futura Medical plc	—	-0.3	-203.4	-1029.2	-72.8	1.5	3	BEARISH	-94.4
FAMDF Futura Medical plc	—	-0.3	-203.4	-1029.2	-72.8	1.5	3	BEARISH	-94.4
OCEA Ocean Biomedical, Inc.	—	-0.0	36.5	0.3	—	—	1	BEARISH	-83.0
OCEA Ocean Biomedical, Inc.	—	-0.0	36.5	0.3	—	—	1	BEARISH	-83.0
BHVN Biohaven Ltd.	$1.9B	-2.8	-799.5	-1083.0	—	—	3	BEARISH	-13.1
BHVN Biohaven Ltd.	$1.9B	-2.8	-799.5	-1083.0	—	—	3	BEARISH	-13.1
PVLA Palvella Therapeutics, Inc.	$1.9B	-27.4	-46.6	137.5	—	—	3	BEARISH	109.5
PVLA Palvella Therapeutics, Inc.	$1.9B	-27.4	-46.6	137.5	—	—	3	BEARISH	109.5
TYRA Tyra Biosciences, Inc.	$1.2B	-8.5	-45.3	-2390.9	—	—	2	BEARISH	52.2
TYRA Tyra Biosciences, Inc.	$1.2B	-8.5	-45.3	-2390.9	—	—	2	BEARISH	52.2
VOR Vor Biopharma Inc.	$1.0B	-0.1	-73.6	22.2	—	—	3	BEARISH	-52.4
VOR Vor Biopharma Inc.	$1.0B	-0.1	-73.6	22.2	—	—	3	BEARISH	-52.4
ABUS Arbutus Biopharma Corp	$880M	5.6	89.6	86.7	-507.2	1078.8	4	BEARISH	-3.0
ABUS Arbutus Biopharma Corp	$880M	5.6	89.6	86.7	-507.2	1078.8	4	BEARISH	-3.0
SLBT SL Science Holding Ltd	$880M	—	—	—	—	—	—	BEARISH	—
SLBT SL Science Holding Ltd	$880M	—	—	—	—	—	—	BEARISH	—
EIKN Eikon Therapeutics, Inc. Common Stock	$400M	—	—	—	—	—	—	BEARISH	—
EIKN Eikon Therapeutics, Inc. Common Stock	$400M	—	—	—	—	—	—	BEARISH	—
CLVLF Clinuvel Pharmaceuticals Limited	$290M	11.9	29.5	262.1	41.1	13.1	6	BEARISH	-28.1
CLVLF Clinuvel Pharmaceuticals Limited	$290M	11.9	29.5	262.1	41.1	13.1	6	BEARISH	-28.1
UPB Upstream Bio, Inc.	$270M	-1.7	-46.0	-1266.4	-5136.1	49.2	3	BEARISH	-70.9
UPB Upstream Bio, Inc.	$270M	-1.7	-46.0	-1266.4	-5136.1	49.2	3	BEARISH	-70.9
TRDA Entrada Therapeutics, Inc.	$210M	-1.4	-54.1	-236.6	-4762.0	-94.1	1	BEARISH	-8.5
TRDA Entrada Therapeutics, Inc.	$210M	-1.4	-54.1	-236.6	-4762.0	-94.1	1	BEARISH	-8.5
ELDN Eledon Pharmaceuticals, Inc.	$190M	-2.5	-110.7	411.1	—	—	2	BEARISH	-6.4
ELDN Eledon Pharmaceuticals, Inc.	$190M	-2.5	-110.7	411.1	—	—	2	BEARISH	-6.4
DTIL Precision BioSciences, Inc.	$170M	-2.3	-135.1	203.1	—	3473.0	5	BEARISH	16.0
DTIL Precision BioSciences, Inc.	$170M	-2.3	-135.1	203.1	—	3473.0	5	BEARISH	16.0
NRXP NRx Pharmaceuticals, Inc.	$130M	-3.9	131.2	61.3	-1500.5	—	5	BEARISH	-12.9
NRXP NRx Pharmaceuticals, Inc.	$130M	-3.9	131.2	61.3	-1500.5	—	5	BEARISH	-12.9
HURA TuHURA Biosciences, Inc.	$120M	-3.5	-161.4	-137.6	—	—	2	BEARISH	-24.8
HURA TuHURA Biosciences, Inc.	$120M	-3.5	-161.4	-137.6	—	—	2	BEARISH	-24.8
AARD Aardvark Therapeutics, Inc. Common Stock	$110M	-1.6	-66.0	-3642.4	—	—	1	BEARISH	-66.1
AARD Aardvark Therapeutics, Inc. Common Stock	$110M	-1.6	-66.0	-3642.4	—	—	1	BEARISH	-66.1
ADAG Adagene Inc.	$110M	-6.0	-72.6	324.2	-1011.1	1054.7	4	BEARISH	42.5
ADAG Adagene Inc.	$110M	-6.0	-72.6	324.2	-1011.1	1054.7	4	BEARISH	42.5
KRRO Korro Bio, Inc.	$100M	-1.0	-97.7	-196.6	—	-62.1	2	BEARISH	-78.0
KRRO Korro Bio, Inc.	$100M	-1.0	-97.7	-196.6	—	-62.1	2	BEARISH	-78.0
RNXT RenovoRx, Inc.	$70M	-5.0	-125.2	4391.9	-320.2	198.5	3	BEARISH	17.9
RNXT RenovoRx, Inc.	$70M	-5.0	-125.2	4391.9	-320.2	198.5	3	BEARISH	17.9
BOLD Boundless Bio, Inc.	$60M	-0.9	-67.9	807.9	—	—	2	BEARISH	113.0
BOLD Boundless Bio, Inc.	$60M	-0.9	-67.9	807.9	—	—	2	BEARISH	113.0
INMB INmune Bio, Inc.	$50M	-2.8	-74.8	-475.4	—	-100.0	2	BEARISH	-9.4
INMB INmune Bio, Inc.	$50M	-2.8	-74.8	-475.4	—	-100.0	2	BEARISH	-9.4
NDTP NDT Pharmaceuticals Inc.	$40M	-50.0	-3.8	-1.5	-458.3	—	4	BEARISH	-78.2
NDTP NDT Pharmaceuticals Inc.	$40M	-50.0	-3.8	-1.5	-458.3	—	4	BEARISH	-78.2
TELIF Telescope Innovations Corp.	$20M	-7.2	-229.2	-80.7	-116.8	66.3	2	BEARISH	13.6
NEUP Neuphoria Therapeutics Inc.	$20M	-0.5	-0.2	-0.2	-417.7	-91.9	4	BEARISH	-75.0
NEUP Neuphoria Therapeutics Inc.	$20M	-0.5	-0.2	-0.2	-417.7	-91.9	4	BEARISH	-75.0
TELIF Telescope Innovations Corp.	$20M	-7.2	-229.2	-80.7	-116.8	66.3	2	BEARISH	13.6
MDNAF Medicenna Therapeutics Corp.	$20M	—	—	—	—	—	—	BEARISH	—
MDNAF Medicenna Therapeutics Corp.	$20M	—	—	—	—	—	—	BEARISH	—
KPTI Karyopharm Therapeutics Inc.	$20M	-0.0	79.0	36.3	-200.5	6.8	2	BEARISH	-87.1
KPTI Karyopharm Therapeutics Inc.	$20M	-0.0	79.0	36.3	-200.5	6.8	2	BEARISH	-87.1
ALLR Allarity Therapeutics, Inc.	$20M	-1.3	-157.1	-96.5	—	—	2	BEARISH	-35.8
ALLR Allarity Therapeutics, Inc.	$20M	-1.3	-157.1	-96.5	—	—	2	BEARISH	-35.8
PHYOF IXICO plc	$10M	-3.8	-32.4	-40.1	-28.5	-1.5	2	BEARISH	0.0
PHYOF IXICO plc	$10M	-3.8	-32.4	-40.1	-28.5	-1.5	2	BEARISH	0.0
CTXR Citius Pharmaceuticals, Inc.	$10M	-0.3	-70.3	-85.4	-593.3	4456.8	3	BEARISH	-61.2
CTXR Citius Pharmaceuticals, Inc.	$10M	-0.3	-70.3	-85.4	-593.3	4456.8	3	BEARISH	-61.2
GTBP GT Biopharma, Inc.	$10M	-0.1	-798.9	927.8	—	—	2	BEARISH	-62.8
GTBP GT Biopharma, Inc.	$10M	-0.1	-798.9	927.8	—	—	2	BEARISH	-62.8
ADIL Adial Pharmaceuticals, Inc.	$10M	-0.2	-2011.6	159.6	—	—	3	BEARISH	-56.2
ADIL Adial Pharmaceuticals, Inc.	$10M	-0.2	-2011.6	159.6	—	—	3	BEARISH	-56.2
SNGX Soligenix, Inc.	$10M	-0.3	-241.7	304.6	—	—	4	BEARISH	-88.4
SNGX Soligenix, Inc.	$10M	-0.3	-241.7	304.6	—	—	4	BEARISH	-88.4
NRSN NeuroSense Therapeutics Ltd.	$10M	-0.4	779.3	571.3	—	—	3	BEARISH	-83.9
NRSN NeuroSense Therapeutics Ltd.	$10M	-0.4	779.3	571.3	—	—	3	BEARISH	-83.9
PLRZ Polyrizon Ltd.	$10M	-2.3	-30.9	-68.2	—	—	1	BEARISH	46.9
PLRZ Polyrizon Ltd.	$10M	-2.3	-30.9	-68.2	—	—	1	BEARISH	46.9
ENGNW enGene Holdings Inc. Warrants	$10M	-6.9	-2.3	134.1	—	-100.0	2	BEARISH	-69.2
ENGNW enGene Holdings Inc. Warrants	$10M	-6.9	-2.3	134.1	—	-100.0	2	BEARISH	-69.2
VRAX Virax Biolabs Group Limited	—	-0.1	-207.4	-812.1	-40439.1	-87.7	4	BEARISH	255.2
VRAX Virax Biolabs Group Limited	—	-0.1	-207.4	-812.1	-40439.1	-87.7	4	BEARISH	255.2
HTDS Hard to Treat Diseases Inc.	—	—	—	—	—	—	—	BEARISH	-95.0
HTDS Hard to Treat Diseases Inc.	—	—	—	—	—	—	—	BEARISH	-95.0
XENO Xeno Transplants Corporation	—	-0.0	-286.5	78.1	—	—	1	BEARISH	0.0
XENO Xeno Transplants Corporation	—	-0.0	-286.5	78.1	—	—	1	BEARISH	0.0
EFTR eFFECTOR Therapeutics, Inc.	—	-0.0	1737.6	607.9	—	-91.9	4	BEARISH	0.0
EFTR eFFECTOR Therapeutics, Inc.	—	-0.0	1737.6	607.9	—	-91.9	4	BEARISH	0.0
CHMMF Chimeric Therapeutics Limited	—	-0.0	1115.1	183.2	—	98.4	3	BEARISH	0.0
CHMMF Chimeric Therapeutics Limited	—	-0.0	1115.1	183.2	—	98.4	3	BEARISH	0.0
RMTG Regenerative Medical Technology Group Inc.	—	-0.1	9.6	-3.3	-72.2	—	3	BEARISH	—
RMTG Regenerative Medical Technology Group Inc.	—	-0.1	9.6	-3.3	-72.2	—	3	BEARISH	—
EVLO Evelo Biosciences, Inc.	—	-0.0	948.0	605.0	—	—	2	BEARISH	-80.0
EVLO Evelo Biosciences, Inc.	—	-0.0	948.0	605.0	—	—	2	BEARISH	-80.0
NTRR Neutra Corp.	—	1.0	1.2	-42.9	632.2	1449.2	6	BEARISH	-33.3
NTRR Neutra Corp.	—	1.0	1.2	-42.9	632.2	1449.2	6	BEARISH	-33.3
CALA Calithera Biosciences, Inc.	—	-0.0	-141.5	979.6	—	-100.0	1	BEARISH	0.0
CALA Calithera Biosciences, Inc.	—	-0.0	-141.5	979.6	—	-100.0	1	BEARISH	0.0
IDRSF Idorsia Ltd	$1.4B	-3.4	27.1	-344.5	-203.1	-8.1	1	BEARISH	17.0
IDRSF Idorsia Ltd	$1.4B	-3.4	27.1	-344.5	-203.1	-8.1	1	BEARISH	17.0
CGEM Cullinan Therapeutics, Inc.	$950M	-4.6	-50.3	1635.6	—	—	1	BEARISH	158.5
CGEM Cullinan Therapeutics, Inc.	$950M	-4.6	-50.3	1635.6	—	—	1	BEARISH	158.5
JBIO Jade Biosciences, Inc.	$860M	-5.1	-47.8	629.9	—	—	3	BEARISH	55.0
JBIO Jade Biosciences, Inc.	$860M	-5.1	-47.8	629.9	—	—	3	BEARISH	55.0
MNPR Monopar Therapeutics Inc.	$520M	-33.3	-19.5	523.8	—	—	2	BEARISH	-8.0
MNPR Monopar Therapeutics Inc.	$520M	-33.3	-19.5	523.8	—	—	2	BEARISH	-8.0
ASMB Assembly Biosciences, Inc.	$450M	41.0	-0.0	56.2	-28.8	125.1	4	BEARISH	-8.4
ASMB Assembly Biosciences, Inc.	$450M	41.0	-0.0	56.2	-28.8	125.1	4	BEARISH	-8.4
ABEO Abeona Therapeutics Inc.	$290M	-4.4	-43.1	-5983.3	-177.4	6280.0	2	BEARISH	-4.7
ABEO Abeona Therapeutics Inc.	$290M	-4.4	-43.1	-5983.3	-177.4	6280.0	2	BEARISH	-4.7
PRQR ProQR Therapeutics N.V.	$170M	-3.7	-57.9	139.7	-99.6	12.7	2	BEARISH	-24.1
PRQR ProQR Therapeutics N.V.	$170M	-3.7	-57.9	139.7	-99.6	12.7	2	BEARISH	-24.1
IMUX Immunic, Inc.	$110M	-1.7	-138.2	345.6	—	—	5	BEARISH	-17.1
IMUX Immunic, Inc.	$110M	-1.7	-138.2	345.6	—	—	5	BEARISH	-17.1
BMEA Biomea Fusion, Inc.	$90M	-2.6	-164.1	210.3	—	—	2	BEARISH	-39.2
BMEA Biomea Fusion, Inc.	$90M	-2.6	-164.1	210.3	—	—	2	BEARISH	-39.2
PMN ProMIS Neurosciences, Inc.	$80M	-0.6	-172.3	844.3	—	—	2	BEARISH	-17.5
PMN ProMIS Neurosciences, Inc.	$80M	-0.6	-172.3	844.3	—	—	2	BEARISH	-17.5
AVEFF Avecho Biotechnology Limited	$20M	-13.3	-238.0	200.0	-3227.5	83.1	5	BEARISH	0.0
AVEFF Avecho Biotechnology Limited	$20M	-13.3	-238.0	200.0	-3227.5	83.1	5	BEARISH	0.0
CMMB Chemomab Therapeutics Ltd.	$10M	-1.4	-82.7	-314.7	—	—	1	BEARISH	-45.8
CMMB Chemomab Therapeutics Ltd.	$10M	-1.4	-82.7	-314.7	—	—	1	BEARISH	-45.8
ANTH Anthera Pharmaceuticals, Inc.	—	-0.0	-251.4	1107.5	—	—	1	BEARISH	0.0
ANTH Anthera Pharmaceuticals, Inc.	—	-0.0	-251.4	1107.5	—	—	1	BEARISH	0.0
GNLKQ GeneLink, Inc.	—	-0.0	73.0	82.1	-183.0	-33.6	3	BEARISH	0.0
GNLKQ GeneLink, Inc.	—	-0.0	73.0	82.1	-183.0	-33.6	3	BEARISH	0.0
GLABF Gemina Laboratories Ltd.	—	-3.0	42.7	32.4	-7838.5	—	5	BEARISH	-85.1
GLABF Gemina Laboratories Ltd.	—	-3.0	42.7	32.4	-7838.5	—	5	BEARISH	-85.1
OZYMF Strategic Partners A/S	—	21.7	0.9	-117.6	1019.0	—	5	BEARISH	0.0
OZYMF Strategic Partners A/S	—	21.7	0.9	-117.6	1019.0	—	5	BEARISH	0.0
SILO Silo Pharma, Inc.	—	-0.3	-91.2	645.1	—	-25.0	3	BEARISH	113.0
SILO Silo Pharma, Inc.	—	-0.3	-91.2	645.1	—	-25.0	3	BEARISH	113.0
MAJI Nextel Medical Corp.	—	-0.8	-0.6	7.4	—	—	1	BEARISH	—
MAJI Nextel Medical Corp.	—	-0.8	-0.6	7.4	—	—	1	BEARISH	—
SNDX Syndax Pharmaceuticals, Inc.	$1.6B	-7.0	-255.9	-270.9	-67.8	222.3	4	BEARISH	12.2
SNDX Syndax Pharmaceuticals, Inc.	$1.6B	-7.0	-255.9	-270.9	-67.8	222.3	4	BEARISH	12.2
HBMHF HBM Holdings Limited	$1.3B	17.0	58.2	96.1	53.0	133.3	6	BEARISH	-8.8
HBMHF HBM Holdings Limited	$1.3B	17.0	58.2	96.1	53.0	133.3	6	BEARISH	-8.8
ARDX Ardelyx, Inc.	$830M	-14.8	-38.6	-22.7	-13.8	16.8	4	BEARISH	-37.7
ARDX Ardelyx, Inc.	$830M	-14.8	-38.6	-22.7	-13.8	16.8	4	BEARISH	-37.7
LXEO Lexeo Therapeutics, Inc. Common Stock	$280M	-3.1	-46.8	-249.1	—	—	3	BEARISH	-46.8
LXEO Lexeo Therapeutics, Inc. Common Stock	$280M	-3.1	-46.8	-249.1	—	—	3	BEARISH	-46.8
BOVNF BioInvent International AB (publ)	$220M	-3.0	-88.2	20101.5	-964.0	-87.2	1	BEARISH	0.0
BOVNF BioInvent International AB (publ)	$220M	-3.0	-88.2	20101.5	-964.0	-87.2	1	BEARISH	0.0
EDSA Edesa Biotech, Inc.	$40M	-2.3	-122.9	759.6	—	—	1	BEARISH	50.2
EDSA Edesa Biotech, Inc.	$40M	-2.3	-122.9	759.6	—	—	1	BEARISH	50.2
CLCS Cell Source, Inc.	$30M	-4.0	27.7	34.5	—	—	4	BEARISH	11.9
CLCS Cell Source, Inc.	$30M	-4.0	27.7	34.5	—	—	4	BEARISH	11.9
CNTX Context Therapeutics Inc.	$30M	-0.6	-76.1	841.7	—	—	2	BEARISH	-68.1
CNTX Context Therapeutics Inc.	$30M	-0.6	-76.1	841.7	—	—	2	BEARISH	-68.1
PPBT Purple Biotech Ltd.	—	-0.0	-111.3	-99.1	—	—	2	BEARISH	157.7
PPBT Purple Biotech Ltd.	—	-0.0	-111.3	-99.1	—	—	2	BEARISH	157.7
NAVBQ Navidea Biopharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	—
NAVBQ Navidea Biopharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	—
CLDI Calidi Biotherapeutics, Inc.	—	-0.0	-713.6	-1404.6	—	—	4	BEARISH	-95.9
CLDI Calidi Biotherapeutics, Inc.	—	-0.0	-713.6	-1404.6	—	—	4	BEARISH	-95.9
RNAZ TransCode Therapeutics, Inc.	—	-0.0	-59.2	-21.0	—	—	1	BEARISH	-85.2
RNAZ TransCode Therapeutics, Inc.	—	-0.0	-59.2	-21.0	—	—	1	BEARISH	-85.2
ARUXF Acrux Limited	—	-7.1	-276.2	-405.6	-26.5	-56.9	3	BEARISH	-93.4
ARUXF Acrux Limited	—	-7.1	-276.2	-405.6	-26.5	-56.9	3	BEARISH	-93.4
PREDQ Predictive Discovery Limited	—	—	—	—	—	—	—	BEARISH	—
PREDQ Predictive Discovery Limited	—	—	—	—	—	—	—	BEARISH	—
RADX Radiopharm Theranostics Limited	—	—	—	—	—	—	—	BEARISH	-74.7
RADX Radiopharm Theranostics Limited	—	—	—	—	—	—	—	BEARISH	-74.7
MYNDF MYND Life Sciences Inc.	—	-2.2	9.5	34.0	—	—	5	BEARISH	-41.3
MYNDF MYND Life Sciences Inc.	—	-2.2	9.5	34.0	—	—	5	BEARISH	-41.3
SEPSF Asep Medical Holdings Inc	—	-0.4	-36.4	-75.5	-844.8	208.8	5	BEARISH	-97.2
SEPSF Asep Medical Holdings Inc	—	-0.4	-36.4	-75.5	-844.8	208.8	5	BEARISH	-97.2
ENDV Endonovo Therapeutics, Inc.	—	-0.1	9.2	4.5	—	-100.0	3	BEARISH	-50.0
ENDV Endonovo Therapeutics, Inc.	—	-0.1	9.2	4.5	—	-100.0	3	BEARISH	-50.0
ACUT Accustem Sciences Inc.	—	-1.3	49.7	34.0	-256.7	2610.7	4	BEARISH	-91.0
ACUT Accustem Sciences Inc.	—	-1.3	49.7	34.0	-256.7	2610.7	4	BEARISH	-91.0
ELAB PMGC Holdings Inc.	—	-0.0	-73.0	-66.6	-225.1	408.6	3	BEARISH	-99.9
ELAB PMGC Holdings Inc.	—	-0.0	-73.0	-66.6	-225.1	408.6	3	BEARISH	-99.9
ADXN Addex Therapeutics Ltd	—	-0.5	-150.5	-168.4	-17543.0	-48.1	2	BEARISH	-67.3
ADXN Addex Therapeutics Ltd	—	-0.5	-150.5	-168.4	-17543.0	-48.1	2	BEARISH	-67.3
ZLDAF Zelira Therapeutics Limited	—	-1.6	-294.0	349.6	-185107971.7	-94.8	1	BEARISH	-1.4
ZLDAF Zelira Therapeutics Limited	—	-1.6	-294.0	349.6	-185107971.7	-94.8	1	BEARISH	-1.4
AGTX Agentix Corp.	—	-1.9	14.5	10.8	—	—	3	BEARISH	-55.6
AGTX Agentix Corp.	—	-1.9	14.5	10.8	—	—	3	BEARISH	-55.6
AGIO Agios Pharmaceuticals, Inc.	$1.9B	-4.5	-34.3	-82.5	-225.1	140.6	4	BEARISH	-20.6
AGIO Agios Pharmaceuticals, Inc.	$1.9B	-4.5	-34.3	-82.5	-225.1	140.6	4	BEARISH	-20.6
ZYME Zymeworks Inc.	$1.9B	-12.5	-72.3	-156.9	-980.8	-69.8	2	BEARISH	48.5
ZYME Zymeworks Inc.	$1.9B	-12.5	-72.3	-156.9	-980.8	-69.8	2	BEARISH	48.5
NUVB Nuvation Bio Inc.	$1.8B	-11.8	-47.8	70.2	-198.3	1083.6	4	BEARISH	38.6
NUVB Nuvation Bio Inc.	$1.8B	-11.8	-47.8	70.2	-198.3	1083.6	4	BEARISH	38.6
CMPS COMPASS Pathways plc	$1.6B	-2.1	-319.1	48.8	—	—	2	BEARISH	106.2
CMPS COMPASS Pathways plc	$1.6B	-2.1	-319.1	48.8	—	—	2	BEARISH	106.2
IMCR Immunocore Holdings plc	$1.5B	-164.8	-2.3	-472.0	-0.7	13.4	4	BEARISH	-17.3
IMCR Immunocore Holdings plc	$1.5B	-164.8	-2.3	-472.0	-0.7	13.4	4	BEARISH	-17.3
TSHA Taysha Gene Therapies, Inc.	$1.5B	-11.0	-47.1	961.0	—	-32.3	3	BEARISH	45.6
TSHA Taysha Gene Therapies, Inc.	$1.5B	-11.0	-47.1	961.0	—	-32.3	3	BEARISH	45.6
INBX Inhibrx Biosciences Inc.	$1.4B	-10.9	-1773.6	55.8	—	-100.0	4	BEARISH	185.4
INBX Inhibrx Biosciences Inc.	$1.4B	-10.9	-1773.6	55.8	—	-100.0	4	BEARISH	185.4
NBTX Nanobiotix S.A.	$1.3B	-20.8	380.7	158.8	-941.2	-73.7	3	BEARISH	37.4
NBTX Nanobiotix S.A.	$1.3B	-20.8	380.7	158.8	-941.2	-73.7	3	BEARISH	37.4
KURA Kura Oncology, Inc.	$950M	-3.2	-167.7	56.3	-327.3	-7.3	1	BEARISH	15.8
KURA Kura Oncology, Inc.	$950M	-3.2	-167.7	56.3	-327.3	-7.3	1	BEARISH	15.8
CADL Candel Therapeutics, Inc.	$750M	-7.2	-81.8	219.4	—	—	2	BEARISH	83.8
CADL Candel Therapeutics, Inc.	$750M	-7.2	-81.8	219.4	—	—	2	BEARISH	83.8
ZVRA Zevra Therapeutics, Inc.	$590M	10.4	34.8	-1356.4	22.1	119.4	6	BEARISH	5.9
ZVRA Zevra Therapeutics, Inc.	$590M	10.4	34.8	-1356.4	22.1	119.4	6	BEARISH	5.9
PRME Prime Medicine, Inc.	$540M	-2.7	-373.3	-271.3	-3649.0	-17.9	3	BEARISH	-46.7
PRME Prime Medicine, Inc.	$540M	-2.7	-373.3	-271.3	-3649.0	-17.9	3	BEARISH	-46.7
AUTL Autolus Therapeutics plc	$470M	-1.7	-132.9	451.5	-85.6	292.0	3	BEARISH	6.6
AUTL Autolus Therapeutics plc	$470M	-1.7	-132.9	451.5	-85.6	292.0	3	BEARISH	6.6
OVID Ovid Therapeutics Inc.	$440M	-5.0	-26.0	-43.7	-2047.6	-76.2	3	BEARISH	73.7
OVID Ovid Therapeutics Inc.	$440M	-5.0	-26.0	-43.7	-2047.6	-76.2	3	BEARISH	73.7
NGNE Neurogene Inc.	$410M	-4.7	-45.3	-111469.0	—	—	2	BEARISH	42.7
NGNE Neurogene Inc.	$410M	-4.7	-45.3	-111469.0	—	—	2	BEARISH	42.7
CCCC C4 Therapeutics, Inc.	$330M	-3.0	-48.1	-175.0	-355.9	2.3	4	BEARISH	37.2
CCCC C4 Therapeutics, Inc.	$330M	-3.0	-48.1	-175.0	-355.9	2.3	4	BEARISH	37.2
CYDY CytoDyn Inc.	$270M	-5.8	41.5	21.3	—	100.0	3	BEARISH	-23.0
CYDY CytoDyn Inc.	$270M	-5.8	41.5	21.3	—	100.0	3	BEARISH	-23.0
IFRX InflaRx N.V.	$250M	-3.1	-38.5	251.5	—	-106.2	4	BEARISH	26.5
IFRX InflaRx N.V.	$250M	-3.1	-38.5	251.5	—	-106.2	4	BEARISH	26.5
CGEN Compugen Ltd.	$220M	6.2	49.6	-90.2	-269.3	886.7	5	BEARISH	44.4
CGEN Compugen Ltd.	$220M	6.2	49.6	-90.2	-269.3	886.7	5	BEARISH	44.4
CUE Cue Biopharma, Inc.	$190M	-0.9	-1603.5	1241.9	-1943.2	354.4	3	BEARISH	17.8
CUE Cue Biopharma, Inc.	$190M	-0.9	-1603.5	1241.9	-1943.2	354.4	3	BEARISH	17.8
ABOS Acumen Pharmaceuticals, Inc.	$150M	-1.2	-120.5	389.8	—	—	2	BEARISH	16.6
ABOS Acumen Pharmaceuticals, Inc.	$150M	-1.2	-120.5	389.8	—	—	2	BEARISH	16.6
IPHA Innate Pharma S.A.	$150M	-2.6	1600.0	254.7	-630.0	-91.4	2	BEARISH	-21.2
IPHA Innate Pharma S.A.	$150M	-2.6	1600.0	254.7	-630.0	-91.4	2	BEARISH	-21.2
PYXS Pyxis Oncology, Inc.	$140M	-1.5	-179.1	1953.9	—	291.4	2	BEARISH	-2.3
PYXS Pyxis Oncology, Inc.	$140M	-1.5	-179.1	1953.9	—	291.4	2	BEARISH	-2.3
MXCT MaxCyte, Inc.	$110M	-3.2	-20.4	-38.9	-122.0	-13.2	2	BEARISH	-33.1
MXCT MaxCyte, Inc.	$110M	-3.2	-20.4	-38.9	-122.0	-13.2	2	BEARISH	-33.1
VRCA Verrica Pharmaceuticals Inc.	$80M	-2.5	473.3	437.4	-224.4	106.2	5	BEARISH	-1.4
VRCA Verrica Pharmaceuticals Inc.	$80M	-2.5	473.3	437.4	-224.4	106.2	5	BEARISH	-1.4
BETRF BetterLife Pharma Inc.	$30M	-12.0	14.6	14.7	—	—	4	BEARISH	252.4
BETRF BetterLife Pharma Inc.	$30M	-12.0	14.6	14.7	—	—	4	BEARISH	252.4
KZIA Kazia Therapeutics Ltd ADR	$20M	-1.3	-196.1	162.7	—	250944.3	5	BEARISH	35.3
KZIA Kazia Therapeutics Ltd ADR	$20M	-1.3	-196.1	162.7	—	250944.3	5	BEARISH	35.3
LPCN Lipocine Inc.	$20M	-1.1	-60.9	662.3	-1379.6	-62.7	2	BEARISH	-31.0
LPCN Lipocine Inc.	$20M	-1.1	-60.9	662.3	-1379.6	-62.7	2	BEARISH	-31.0
IMNN Imunon, Inc.	$10M	-0.3	-429.7	-226.7	—	—	2	BEARISH	-75.6
IMNN Imunon, Inc.	$10M	-0.3	-429.7	-226.7	—	—	2	BEARISH	-75.6
AKTX Akari Therapeutics, Plc	$10M	-0.0	-139.9	-175.8	—	—	3	BEARISH	-77.8
AKTX Akari Therapeutics, Plc	$10M	-0.0	-139.9	-175.8	—	—	3	BEARISH	-77.8
EVFM Evofem Biosciences, Inc.	—	-0.1	20.1	26.0	-419.1	4.5	2	BEARISH	-44.8
EVFM Evofem Biosciences, Inc.	—	-0.1	20.1	26.0	-419.1	4.5	2	BEARISH	-44.8
IMNM Immunome, Inc.	$2.0B	-8.2	-64.0	-2208.4	—	-100.0	4	BEARISH	84.3
IMNM Immunome, Inc.	$2.0B	-8.2	-64.0	-2208.4	—	-100.0	4	BEARISH	84.3
TRVI Trevi Therapeutics, Inc.	$2.0B	-41.2	-19.7	-1451.7	—	—	3	BEARISH	48.0
TRVI Trevi Therapeutics, Inc.	$2.0B	-41.2	-19.7	-1451.7	—	—	3	BEARISH	48.0
QURE uniQure N.V.	$1.6B	-5.8	-157.6	37.9	-1387.8	30.2	4	BEARISH	-57.3
QURE uniQure N.V.	$1.6B	-5.8	-157.6	37.9	-1387.8	30.2	4	BEARISH	-57.3
RAPP Rapport Therapeutics, Inc. Common Stock	$1.5B	-10.6	-40.0	3981.5	—	—	4	BEARISH	12.2
RAPP Rapport Therapeutics, Inc. Common Stock	$1.5B	-10.6	-40.0	3981.5	—	—	4	BEARISH	12.2
OCUL Ocular Therapeutix, Inc.	$1.5B	-4.9	-73.0	-31671.3	-584.5	-8.1	3	BEARISH	-37.0
OCUL Ocular Therapeutix, Inc.	$1.5B	-4.9	-73.0	-31671.3	-584.5	-8.1	3	BEARISH	-37.0
ANAB AnaptysBio, Inc.	$1.4B	7.2	-1146.3	466.0	668.9	92.9	5	BEARISH	127.7
ANAB AnaptysBio, Inc.	$1.4B	7.2	-1146.3	466.0	668.9	92.9	5	BEARISH	127.7
NKTR Nektar Therapeutics	$1.2B	-6.5	-35.8	-29.2	-401.0	-27.2	3	BEARISH	-25.9
NKTR Nektar Therapeutics	$1.2B	-6.5	-35.8	-29.2	-401.0	-27.2	3	BEARISH	-25.9
BCAX Bicara Therapeutics Inc. Common Stock	$1.2B	-5.7	-41.0	583.9	—	—	2	BEARISH	6.1
BCAX Bicara Therapeutics Inc. Common Stock	$1.2B	-5.7	-41.0	583.9	—	—	2	BEARISH	6.1
LBRX LB Pharmaceuticals Inc Common Stock	$1.1B	-12.5	-25.8	-768.9	—	—	2	BEARISH	134.7
LBRX LB Pharmaceuticals Inc Common Stock	$1.1B	-12.5	-25.8	-768.9	—	—	2	BEARISH	134.7
MGTX MeiraGTx Holdings plc	$1.0B	14.2	72.3	96.7	50.0	948.3	7	BEARISH	30.5
MGTX MeiraGTx Holdings plc	$1.0B	14.2	72.3	96.7	50.0	948.3	7	BEARISH	30.5
AKTS Aktis Oncology, Inc.	$990M	-17.6	-29.9	276.4	-713.5	-36.1	5	BEARISH	18875.4
AKTS Aktis Oncology, Inc.	$990M	-17.6	-29.9	276.4	-713.5	-36.1	5	BEARISH	18875.4
ANRO Alto Neuroscience, Inc.	$870M	-10.0	-49.2	-201.4	—	—	3	BEARISH	509.6
ANRO Alto Neuroscience, Inc.	$870M	-10.0	-49.2	-201.4	—	—	3	BEARISH	509.6
AVTX Avalo Therapeutics, Inc.	$790M	-3.2	-36.3	-148.4	—	-86.6	4	BEARISH	15.7
AVTX Avalo Therapeutics, Inc.	$790M	-3.2	-36.3	-148.4	—	-86.6	4	BEARISH	15.7
SLDB Solid Biosciences Inc.	$670M	-3.6	-65.5	-1012.6	—	—	3	BEARISH	16.7
SLDB Solid Biosciences Inc.	$670M	-3.6	-65.5	-1012.6	—	—	3	BEARISH	16.7
CLYM Climb Bio, Inc.	$630M	-13.2	-27.1	-88.6	—	—	2	BEARISH	455.3
CLYM Climb Bio, Inc.	$630M	-13.2	-27.1	-88.6	—	—	2	BEARISH	455.3
AURA Aura Biosciences, Inc.	$630M	-3.4	-53.5	-1360.0	—	—	4	BEARISH	-1.0
AURA Aura Biosciences, Inc.	$630M	-3.4	-53.5	-1360.0	—	—	4	BEARISH	-1.0
IMMX Immix Biopharma, Inc.	$530M	-11.0	-34.2	1509.2	—	—	4	BEARISH	365.4
IMMX Immix Biopharma, Inc.	$530M	-11.0	-34.2	1509.2	—	—	4	BEARISH	365.4
TECX Tectonic Therapeutic, Inc.	$430M	-4.9	-33.8	-6371.3	—	—	1	BEARISH	43.9
TECX Tectonic Therapeutic, Inc.	$430M	-4.9	-33.8	-6371.3	—	—	1	BEARISH	43.9
FENC Fennec Pharmaceuticals Inc.	$350M	-78.5	-18.6	-76.2	11.0	77.8	6	BEARISH	6.4
FENC Fennec Pharmaceuticals Inc.	$350M	-78.5	-18.6	-76.2	11.0	77.8	6	BEARISH	6.4
ARTV Artiva Biotherapeutics, Inc.	$330M	-2.1	-36.6	-954.6	—	—	3	BEARISH	133.9
ARTV Artiva Biotherapeutics, Inc.	$330M	-2.1	-36.6	-954.6	—	—	3	BEARISH	133.9
SPHDF Santhera Pharmaceuticals Holding AG	$270M	-6.6	-464.2	715.5	-44.5	26.5	3	BEARISH	37.4
SPHDF Santhera Pharmaceuticals Holding AG	$270M	-6.6	-464.2	715.5	-44.5	26.5	3	BEARISH	37.4
IKT Inhibikase Therapeutics, Inc.	$260M	-4.2	-52.0	920.5	—	—	3	BEARISH	24.2
IKT Inhibikase Therapeutics, Inc.	$260M	-4.2	-52.0	920.5	—	—	3	BEARISH	24.2
QTTB Q32 Bio Inc.	$240M	2.9	72.1	435.2	—	—	5	BEARISH	295.7
QTTB Q32 Bio Inc.	$240M	2.9	72.1	435.2	—	—	5	BEARISH	295.7
PRLD Prelude Therapeutics Incorporated	$210M	-4.6	-57.7	14236.3	-244.1	220.3	5	BEARISH	143.1
PRLD Prelude Therapeutics Incorporated	$210M	-4.6	-57.7	14236.3	-244.1	220.3	5	BEARISH	143.1
ZNTL Zentalis Pharmaceuticals, Inc.	$180M	-1.0	-83.7	-2245.4	—	-100.0	2	BEARISH	63.6
ZNTL Zentalis Pharmaceuticals, Inc.	$180M	-1.0	-83.7	-2245.4	—	-100.0	2	BEARISH	63.6
ALXO ALX Oncology Holdings Inc.	$160M	-1.1	-80.6	-851.1	—	—	4	BEARISH	-32.6
ALXO ALX Oncology Holdings Inc.	$160M	-1.1	-80.6	-851.1	—	—	4	BEARISH	-32.6
CRBP Corbus Pharmaceuticals Holdings, Inc.	$110M	-0.9	-95.6	738.2	—	—	1	BEARISH	-53.0
CRBP Corbus Pharmaceuticals Holdings, Inc.	$110M	-0.9	-95.6	738.2	—	—	1	BEARISH	-53.0
CRDF Cardiff Oncology, Inc.	$90M	-1.9	-94.1	443.4	-8876.9	-7.0	3	BEARISH	-46.1
CRDF Cardiff Oncology, Inc.	$90M	-1.9	-94.1	443.4	-8876.9	-7.0	3	BEARISH	-46.1
ACET Adicet Bio, Inc.	$60M	-0.6	-78.1	-553.5	—	—	4	BEARISH	-50.6
ACET Adicet Bio, Inc.	$60M	-0.6	-78.1	-553.5	—	—	4	BEARISH	-50.6
SER Serina Therapeutics, Inc.	$30M	-1.0	-206.3	1868.6	—	-100.0	3	BEARISH	-62.7
SER Serina Therapeutics, Inc.	$30M	-1.0	-206.3	1868.6	—	-100.0	3	BEARISH	-62.7
XTLB XTL Biopharmaceuticals Ltd.	—	-1.0	-26.8	-38.7	-88.2	—	3	BEARISH	87.8
XTLB XTL Biopharmaceuticals Ltd.	—	-1.0	-26.8	-38.7	-88.2	—	3	BEARISH	87.8
CDT CDT Equity Inc.	—	-0.0	13.1	5.4	9.1	—	7	BEARISH	-82.2
CDT CDT Equity Inc.	—	-0.0	13.1	5.4	9.1	—	7	BEARISH	-82.2
HXBM Helix BioMedix, Inc.	—	—	—	—	—	—	—	BEARISH	-6.0
HXBM Helix BioMedix, Inc.	—	—	—	—	—	—	—	BEARISH	-6.0
BRVE Braveheart Bio, Inc.	$1.5B	—	—	—	—	—	—	BEARISH	—
BRVE Braveheart Bio, Inc.	$1.5B	—	—	—	—	—	—	BEARISH	—
APMD Apnimed, Inc.	$860M	—	—	—	—	—	—	BEARISH	—
APMD Apnimed, Inc.	$860M	—	—	—	—	—	—	BEARISH	—
GENSF Genus plc	$1.9B	5.0	45.8	14.4	80.4	28.9	7	BEARISH	-17.7
GENSF Genus plc	$1.9B	5.0	45.8	14.4	80.4	28.9	7	BEARISH	-17.7
COAG Hemab Therapeutics Holdings, Inc. Common Stock	$1.4B	—	—	—	—	—	—	BEARISH	—
COAG Hemab Therapeutics Holdings, Inc. Common Stock	$1.4B	—	—	—	—	—	—	BEARISH	—
KLRA Kailera Therapeutics, Inc.	$1.4B	—	—	—	—	—	—	BEARISH	—
KLRA Kailera Therapeutics, Inc.	$1.4B	—	—	—	—	—	—	BEARISH	—
KARD Kardigan, Inc.	$1.3B	—	—	—	—	—	—	BEARISH	—
KARD Kardigan, Inc.	$1.3B	—	—	—	—	—	—	BEARISH	—
AVLN Avalyn Pharma Inc. Common Stock	$1.2B	—	—	—	—	—	—	BEARISH	—
AVLN Avalyn Pharma Inc. Common Stock	$1.2B	—	—	—	—	—	—	BEARISH	—
SPTX Seaport Therapeutics, Inc. Common Stock	$990M	—	—	—	—	—	—	BEARISH	—
SPTX Seaport Therapeutics, Inc. Common Stock	$990M	—	—	—	—	—	—	BEARISH	—
MLTX MoonLake Immunotherapeutics	$960M	-3.0	-67.4	2902.7	—	—	1	BEARISH	61.6
MLTX MoonLake Immunotherapeutics	$960M	-3.0	-67.4	2902.7	—	—	1	BEARISH	61.6
WVE Wave Life Sciences Ltd.	$740M	-3.5	-68.3	-2645.3	-3052.6	-30.4	5	BEARISH	-46.2
WVE Wave Life Sciences Ltd.	$740M	-3.5	-68.3	-2645.3	-3052.6	-30.4	5	BEARISH	-46.2
FTH Faeth Therapeutics, Inc.	$730M	—	—	—	—	—	—	BEARISH	—
FTH Faeth Therapeutics, Inc.	$730M	—	—	—	—	—	—	BEARISH	—
DRUG Bright Minds Biosciences Inc.	$500M	-24.3	-13.7	-105758.3	—	—	3	BEARISH	-12.5
DRUG Bright Minds Biosciences Inc.	$500M	-24.3	-13.7	-105758.3	—	—	3	BEARISH	-12.5
OCS Oculis Holding AG	$500M	-5.2	-44.0	-31.0	—	-6.9	3	BEARISH	-49.8
OCS Oculis Holding AG	$500M	-5.2	-44.0	-31.0	—	-6.9	3	BEARISH	-49.8
PRTA Prothena Corporation plc	$440M	-10.1	-14.4	-871.5	-1839.9	427.3	5	BEARISH	-15.7
PRTA Prothena Corporation plc	$440M	-10.1	-14.4	-871.5	-1839.9	427.3	5	BEARISH	-15.7
MPLT MapLight Therapeutics, Inc.	$420M	-1.9	-57.5	-366.6	—	—	2	BEARISH	—
MPLT MapLight Therapeutics, Inc.	$420M	-1.9	-57.5	-366.6	—	—	2	BEARISH	—
ZURA Zura Bio Limited	$390M	-3.6	-54.3	910.3	—	—	2	BEARISH	1.7
ZURA Zura Bio Limited	$390M	-3.6	-54.3	910.3	—	—	2	BEARISH	1.7
CABA Cabaletta Bio, Inc.	$330M	-1.3	-93.2	-1308.0	—	—	3	BEARISH	-13.4
CABA Cabaletta Bio, Inc.	$330M	-1.3	-93.2	-1308.0	—	—	3	BEARISH	-13.4
BBOT BridgeBio Oncology Therapeutics Inc.	$310M	-0.0	-56.4	-157.3	—	—	1	BEARISH	-67.7
BBOT BridgeBio Oncology Therapeutics Inc.	$310M	-0.0	-56.4	-157.3	—	—	1	BEARISH	-67.7
FULC Fulcrum Therapeutics, Inc.	$280M	-3.0	-32.4	2389.1	—	—	4	BEARISH	-60.5
FULC Fulcrum Therapeutics, Inc.	$280M	-3.0	-32.4	2389.1	—	—	4	BEARISH	-60.5
SABS SAB Biotherapeutics, Inc.	$270M	0.8	-11.3	-48.4	—	-100.0	3	BEARISH	50.5
SABS SAB Biotherapeutics, Inc.	$270M	0.8	-11.3	-48.4	—	-100.0	3	BEARISH	50.5
PALI Palisade Bio, Inc.	$250M	-2.7	-51.4	815.6	-2114.8	—	5	BEARISH	9.9
PALI Palisade Bio, Inc.	$250M	-2.7	-51.4	815.6	-2114.8	—	5	BEARISH	9.9
NWBO Northwest Biotherapeutics, Inc.	$250M	-6.0	55.8	-188.7	-1142.6	98.6	3	BEARISH	-39.7
NWBO Northwest Biotherapeutics, Inc.	$250M	-6.0	55.8	-188.7	-1142.6	98.6	3	BEARISH	-39.7
HLOSF Healios K.K.	$240M	57.9	3.7	-129.2	17028.6	-47.1	4	BEARISH	-56.6
HLOSF Healios K.K.	$240M	57.9	3.7	-129.2	17028.6	-47.1	4	BEARISH	-56.6
AKBA Akebia Therapeutics, Inc.	$230M	-8.0	-109.4	15.6	-18.1	7.5	6	BEARISH	-67.7
AKBA Akebia Therapeutics, Inc.	$230M	-8.0	-109.4	15.6	-18.1	7.5	6	BEARISH	-67.7
NAGE Niagen Bioscience Inc	$220M	14.4	21.8	44.7	3.2	11.0	6	BEARISH	-64.6
NAGE Niagen Bioscience Inc	$220M	14.4	21.8	44.7	3.2	11.0	6	BEARISH	-64.6
YARW Yarrow Bioscience Inc	$210M	—	—	—	—	—	—	BEARISH	—
YARW Yarrow Bioscience Inc	$210M	—	—	—	—	—	—	BEARISH	—
NBP NovaBridge Biosciences	$160M	-2.4	-45.7	-617.8	—	—	1	BEARISH	-64.8
NBP NovaBridge Biosciences	$160M	-2.4	-45.7	-617.8	—	—	1	BEARISH	-64.8
VRXA Veraxa Biotech Holding AG	$160M	—	—	—	—	—	—	BEARISH	—
VRXA Veraxa Biotech Holding AG	$160M	—	—	—	—	—	—	BEARISH	—
IMRX Immuneering Corporation	$150M	-3.9	-52.1	-112.8	—	—	4	BEARISH	-36.0
IMRX Immuneering Corporation	$150M	-3.9	-52.1	-112.8	—	—	4	BEARISH	-36.0
CMPX Compass Therapeutics, Inc.	$150M	-2.1	-56.7	1526.3	—	—	4	BEARISH	-74.5
CMPX Compass Therapeutics, Inc.	$150M	-2.1	-56.7	1526.3	—	—	4	BEARISH	-74.5
TNXP Tonix Pharmaceuticals Holding Corp.	$140M	-0.7	-81.8	-276.2	-299.4	196.0	3	BEARISH	-62.8
TNXP Tonix Pharmaceuticals Holding Corp.	$140M	-0.7	-81.8	-276.2	-299.4	196.0	3	BEARISH	-62.8
CLLS Cellectis S.A.	$140M	-2.2	-94.6	118.6	-417.3	0.5	2	BEARISH	-56.5
CLLS Cellectis S.A.	$140M	-2.2	-94.6	118.6	-417.3	0.5	2	BEARISH	-56.5
ORPOF OSE Immunotherapeutics S.A.	$100M	—	—	—	—	—	—	BEARISH	—
ORPOF OSE Immunotherapeutics S.A.	$100M	—	—	—	—	—	—	BEARISH	—
MIST Milestone Pharmaceuticals Inc.	$100M	-1.2	-35522.6	587.8	-5118.8	—	5	BEARISH	-52.1
MIST Milestone Pharmaceuticals Inc.	$100M	-1.2	-35522.6	587.8	-5118.8	—	5	BEARISH	-52.1
HUMA Humacyte, Inc.	$90M	-1.0	-547.9	-500.7	-9064.5	-73.6	3	BEARISH	-70.4
HUMA Humacyte, Inc.	$90M	-1.0	-547.9	-500.7	-9064.5	-73.6	3	BEARISH	-70.4
JWCTF JW (Cayman) Therapeutics Co. Ltd	$80M	-2.9	-98.4	-35.5	-45.3	36.2	4	BEARISH	-58.9
JWCTF JW (Cayman) Therapeutics Co. Ltd	$80M	-2.9	-98.4	-35.5	-45.3	36.2	4	BEARISH	-58.9
INO Inovio Pharmaceuticals, Inc.	$80M	-1.0	-409.9	257.7	—	-100.0	1	BEARISH	-51.0
INO Inovio Pharmaceuticals, Inc.	$80M	-1.0	-409.9	257.7	—	-100.0	1	BEARISH	-51.0
GANX Gain Therapeutics, Inc.	$70M	-3.4	-268.3	1288.8	—	—	4	BEARISH	-6.0
GANX Gain Therapeutics, Inc.	$70M	-3.4	-268.3	1288.8	—	—	4	BEARISH	-6.0
RECEF Recce Pharmaceuticals Ltd	$70M	-6.3	277.4	402.1	—	11.3	2	BEARISH	-63.3
RECEF Recce Pharmaceuticals Ltd	$70M	-6.3	277.4	402.1	—	11.3	2	BEARISH	-63.3
MAIA MAIA Biotechnology, Inc.	$70M	-1.9	-218.7	330.4	—	—	3	BEARISH	-28.3
MAIA MAIA Biotechnology, Inc.	$70M	-1.9	-218.7	330.4	—	—	3	BEARISH	-28.3
KLRS Kalaris Therapeutics Inc	$60M	-1.3	-79.9	109.5	—	—	0	BEARISH	-55.5
KLRS Kalaris Therapeutics Inc	$60M	-1.3	-79.9	109.5	—	—	0	BEARISH	-55.5
IMA ImageneBio Inc	$50M	-0.9	-40.7	-594.7	—	—	3	BEARISH	-46.0
IMA ImageneBio Inc	$50M	-0.9	-40.7	-594.7	—	—	3	BEARISH	-46.0
BSEM BioStem Technologies, Inc.	$50M	-1.6	-74.7	-84.3	-113.6	-119.6	2	BEARISH	-45.3
BSEM BioStem Technologies, Inc.	$50M	-1.6	-74.7	-84.3	-113.6	-119.6	2	BEARISH	-45.3
DWTX Dogwood Therapeutics, Inc.	$50M	-0.2	-47.8	-39.7	—	—	2	BEARISH	-79.3
DWTX Dogwood Therapeutics, Inc.	$50M	-0.2	-47.8	-39.7	—	—	2	BEARISH	-79.3
GRCE Grace Therapeutics, Inc.	$30M	-1.6	-13.8	-21.9	—	—	1	BEARISH	-32.6
GRCE Grace Therapeutics, Inc.	$30M	-1.6	-13.8	-21.9	—	—	1	BEARISH	-32.6
ESLA Estrella Immunopharma, Inc.	$20M	-1.9	148.1	102.1	—	—	3	BEARISH	-65.1
ESLA Estrella Immunopharma, Inc.	$20M	-1.9	148.1	102.1	—	—	3	BEARISH	-65.1
DTCFF Defence Therapeutics Inc.	$20M	-3.5	-237.8	-86.8	—	—	4	BEARISH	-45.0
DTCFF Defence Therapeutics Inc.	$20M	-3.5	-237.8	-86.8	—	—	4	BEARISH	-45.0
MRKR Marker Therapeutics, Inc.	$20M	-2.2	-76.9	-1014.3	—	-77.1	2	BEARISH	15.6
MRKR Marker Therapeutics, Inc.	$20M	-2.2	-76.9	-1014.3	—	-77.1	2	BEARISH	15.6
NXTC NextCure, Inc.	$20M	-0.5	-195.2	949.7	—	—	2	BEARISH	-10.5
NXTC NextCure, Inc.	$20M	-0.5	-195.2	949.7	—	—	2	BEARISH	-10.5
CKDXF Ceryvyn Therapeutics Limited	$10M	0.2	-234.2	64023.3	—	-92.0	4	BEARISH	-97.7
CKDXF Ceryvyn Therapeutics Limited	$10M	0.2	-234.2	64023.3	—	-92.0	4	BEARISH	-97.7
LGVN Longeveron Inc.	$10M	-0.3	-203.6	-2062.6	-2116.0	-42.7	4	BEARISH	-65.2
LGVN Longeveron Inc.	$10M	-0.3	-203.6	-2062.6	-2116.0	-42.7	4	BEARISH	-65.2
IUGNF Imugene Limited	$10M	-0.1	-273.9	-901.2	—	-73.7	1	BEARISH	-87.2
XCUR Exicure, Inc.	$10M	-0.9	-168.4	779.8	—	—	2	BEARISH	-72.0
XCUR Exicure, Inc.	$10M	-0.9	-168.4	779.8	—	—	2	BEARISH	-72.0
IUGNF Imugene Limited	$10M	-0.1	-273.9	-901.2	—	-73.7	1	BEARISH	-87.2
LNAI Lunai Bioworks Inc.	$10M	-0.0	-21.6	30.2	—	—	2	BEARISH	-87.0
LNAI Lunai Bioworks Inc.	$10M	-0.0	-21.6	30.2	—	—	2	BEARISH	-87.0
QNRX Quoin Pharmaceuticals, Ltd.	$10M	-0.3	-578.6	221.3	—	—	1	BEARISH	-38.2
QNRX Quoin Pharmaceuticals, Ltd.	$10M	-0.3	-578.6	221.3	—	—	1	BEARISH	-38.2
BLRX BioLineRx Ltd.	$10M	-1.4	-63.5	-113.0	-1029.3	-94.3	3	BEARISH	-38.8
BLRX BioLineRx Ltd.	$10M	-1.4	-63.5	-113.0	-1029.3	-94.3	3	BEARISH	-38.8
ENLV Enlivex Therapeutics Ltd.	$10M	0.0	209.7	-0.4	—	—	5	BEARISH	-97.4
ENLV Enlivex Therapeutics Ltd.	$10M	0.0	209.7	-0.4	—	—	5	BEARISH	-97.4
PLUR Pluri Inc.	$10M	-0.4	163.6	-483.9	-1755.2	-24.0	2	BEARISH	-76.8
PLUR Pluri Inc.	$10M	-0.4	163.6	-483.9	-1755.2	-24.0	2	BEARISH	-76.8
PXXLF Poxel S.A.	$10M	-0.4	222.8	275.8	-624.6	-73.2	2	BEARISH	-12.0
PXXLF Poxel S.A.	$10M	-0.4	222.8	275.8	-624.6	-73.2	2	BEARISH	-12.0
ZEOX Zeo ScientifiX, Inc.	$10M	-2.2	-140.0	105.8	-5.6	—	2	BEARISH	—
ZEOX Zeo ScientifiX, Inc.	$10M	-2.2	-140.0	105.8	-5.6	—	2	BEARISH	—
INTS Intensity Therapeutics, Inc.	$10M	-0.7	-195.9	4123.4	—	—	5	BEARISH	-46.6
INTS Intensity Therapeutics, Inc.	$10M	-0.7	-195.9	4123.4	—	—	5	BEARISH	-46.6
CALC CalciMedica, Inc.	$10M	-0.2	-365.7	118.3	—	—	4	BEARISH	-89.5
CALC CalciMedica, Inc.	$10M	-0.2	-365.7	118.3	—	—	4	BEARISH	-89.5
OPTBF OptiBiotix Health PLC	$10M	-1.4	-102.1	-102.1	-231.5	-12.9	4	BEARISH	109900.0
OPTBF OptiBiotix Health PLC	$10M	-1.4	-102.1	-102.1	-231.5	-12.9	4	BEARISH	109900.0
GSGTF GenSight Biologics S.A.	$10M	-1.1	104.0	107.2	848.8	-139.6	2	BEARISH	-57.9
GSGTF GenSight Biologics S.A.	$10M	-1.1	104.0	107.2	848.8	-139.6	2	BEARISH	-57.9
SUVZ Suvanza Pharma, LLC	—	—	—	—	—	—	—	BEARISH	0.0
SUVZ Suvanza Pharma, LLC	—	—	—	—	—	—	—	BEARISH	0.0
VSBC VitaSpring Biomedical Co. Ltd.	—	-4.8	35.7	8.9	—	-100.0	3	BEARISH	-98.9
VSBC VitaSpring Biomedical Co. Ltd.	—	-4.8	35.7	8.9	—	-100.0	3	BEARISH	-98.9
PXMD PaxMedica, Inc. Common Stock	—	-0.0	-7716.2	572.1	—	—	2	BEARISH	400.0
PXMD PaxMedica, Inc. Common Stock	—	-0.0	-7716.2	572.1	—	—	2	BEARISH	400.0
FNAM Evolutionary Genomics, Inc.	—	-0.0	62.2	-99.6	—	—	2	BEARISH	0.0
FNAM Evolutionary Genomics, Inc.	—	-0.0	62.2	-99.6	—	—	2	BEARISH	0.0
KAPA Kairos Pharma, Ltd.	—	-0.8	-114.0	-301.0	—	—	3	BEARISH	-80.3
KAPA Kairos Pharma, Ltd.	—	-0.8	-114.0	-301.0	—	—	3	BEARISH	-80.3
BPTSY Biophytis S.A.	—	-0.0	376.0	1163.5	—	—	2	BEARISH	-87.5
BPTSY Biophytis S.A.	—	-0.0	376.0	1163.5	—	—	2	BEARISH	-87.5
ITMC Itoco Inc.	—	-0.0	303.4	96.7	—	—	2	BEARISH	0.0
ITMC Itoco Inc.	—	-0.0	303.4	96.7	—	—	2	BEARISH	0.0
BICTF Biocure Technology Inc.	—	-0.1	-889.9	60.0	—	—	1	BEARISH	0.0
BICTF Biocure Technology Inc.	—	-0.1	-889.9	60.0	—	—	1	BEARISH	0.0
FBLG FibroBiologics, Inc. Common Stock	—	-0.2	-660.1	-511.6	—	—	4	BEARISH	-88.2
FBLG FibroBiologics, Inc. Common Stock	—	-0.2	-660.1	-511.6	—	—	4	BEARISH	-88.2
IBOGF Universal Ibogaine Inc.	—	-0.5	-94.8	5.5	-9.4	208.2	4	BEARISH	-98.8
IBOGF Universal Ibogaine Inc.	—	-0.5	-94.8	5.5	-9.4	208.2	4	BEARISH	-98.8
HMGN Hemagen Diagnostics, Inc.	—	-0.0	29.1	-24.6	-18.6	-21.4	2	BEARISH	100.0
HMGN Hemagen Diagnostics, Inc.	—	-0.0	29.1	-24.6	-18.6	-21.4	2	BEARISH	100.0
RASP Actavia Life Sciences, Inc.	—	-0.1	20.1	14.5	—	—	2	BEARISH	-87.5
RASP Actavia Life Sciences, Inc.	—	-0.1	20.1	14.5	—	—	2	BEARISH	-87.5
ADTX Aditxt, Inc.	—	-0.0	622.6	49.4	-131159.8	-74.1	1	BEARISH	-100.0
ADTX Aditxt, Inc.	—	-0.0	622.6	49.4	-131159.8	-74.1	1	BEARISH	-100.0
TCRT Alaunos Therapeutics, Inc.	—	-0.4	-185.9	-607.2	—	-50.0	1	BEARISH	-66.9
TCRT Alaunos Therapeutics, Inc.	—	-0.4	-185.9	-607.2	—	-50.0	1	BEARISH	-66.9
BBLG Bone Biologics Corporation	—	-0.3	-55.0	2257.6	—	—	2	BEARISH	-83.0
BBLG Bone Biologics Corporation	—	-0.3	-55.0	2257.6	—	—	2	BEARISH	-83.0
RGRX RegeneRx Biopharmaceuticals, Inc.	—	-0.0	53.5	45.8	-2006.3	-0.0	3	BEARISH	450.0
RGRX RegeneRx Biopharmaceuticals, Inc.	—	-0.0	53.5	45.8	-2006.3	-0.0	3	BEARISH	450.0
VIVS VivoSim Labs, Inc.	—	-0.0	1259.6	159.9	-14410.0	—	2	BEARISH	-93.9
VIVS VivoSim Labs, Inc.	—	-0.0	1259.6	159.9	-14410.0	—	2	BEARISH	-93.9
TNGNQ Tengion, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
TNGNQ Tengion, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
VPRO Viropro Inc.	—	-0.0	-19.7	-4.8	-269.7	155.0	2	BEARISH	0.0
VPRO Viropro Inc.	—	-0.0	-19.7	-4.8	-269.7	155.0	2	BEARISH	0.0
DRMA Dermata Therapeutics, Inc.	—	-0.3	-183.9	734.5	—	—	2	BEARISH	-78.4
DRMA Dermata Therapeutics, Inc.	—	-0.3	-183.9	734.5	—	—	2	BEARISH	-78.4
ONCSQ OncoSec Medical Incorporated	—	-0.0	-410.2	452.1	—	—	2	BEARISH	-90.0
ONCSQ OncoSec Medical Incorporated	—	-0.0	-410.2	452.1	—	—	2	BEARISH	-90.0
ENZC Enzolytics Inc.	—	-9.3	105.9	1.4	—	—	7	BEARISH	100.0
ENZC Enzolytics Inc.	—	-9.3	105.9	1.4	—	—	7	BEARISH	100.0
WSNAF Wesana Health Holdings Inc.	—	-0.1	1113.6	90.8	—	—	3	BEARISH	-87.1
WSNAF Wesana Health Holdings Inc.	—	-0.1	1113.6	90.8	—	—	3	BEARISH	-87.1
LEXX Lexaria Bioscience Corp.	—	-0.5	-150.3	-504.2	—	-68.5	4	BEARISH	-80.9
LEXX Lexaria Bioscience Corp.	—	-0.5	-150.3	-504.2	—	-68.5	4	BEARISH	-80.9
VRXAW Veraxa Biotech AG	—	—	—	—	—	—	—	BEARISH	—
VRXAW Veraxa Biotech AG	—	—	—	—	—	—	—	BEARISH	—
PCSA Processa Pharmaceuticals, Inc.	—	-0.3	-464.2	1977.5	—	—	2	BEARISH	-67.5
PCSA Processa Pharmaceuticals, Inc.	—	-0.3	-464.2	1977.5	—	—	2	BEARISH	-67.5
MBAI MBody AI Ltd.	—	—	—	—	—	—	—	BEARISH	—
MBAI MBody AI Ltd.	—	—	—	—	—	—	—	BEARISH	—
NBRVF Nabriva Therapeutics plc	—	—	—	—	—	—	—	BEARISH	-0.0
NBRVF Nabriva Therapeutics plc	—	—	—	—	—	—	—	BEARISH	-0.0
CVKD Cadrenal Therapeutics, Inc. Common Stock	—	-0.2	-275.2	-540.4	—	—	3	BEARISH	-93.1
CVKD Cadrenal Therapeutics, Inc. Common Stock	—	-0.2	-275.2	-540.4	—	—	3	BEARISH	-93.1
BNIGF Beroni Group Limited	—	-0.1	-1153.4	-274.8	-15945.7	-40.4	4	BEARISH	0.0
BNIGF Beroni Group Limited	—	-0.1	-1153.4	-274.8	-15945.7	-40.4	4	BEARISH	0.0
SRPT Sarepta Therapeutics, Inc.	$1.9B	-12.2	-9.5	-6.3	-1.2	-20.4	4	BEARISH	-9.4
SRPT Sarepta Therapeutics, Inc.	$1.9B	-12.2	-9.5	-6.3	-1.2	-20.4	4	BEARISH	-9.4
MESO Mesoblast Limited	$1.8B	-32.0	-9.9	-6.3	-25.2	599.2	5	BEARISH	-13.5
MESO Mesoblast Limited	$1.8B	-32.0	-9.9	-6.3	-25.2	599.2	5	BEARISH	-13.5
GENB Generate Biomedicines, Inc.	$1.8B	-12.9	-28.2	-175.0	-1065.2	—	1	BEARISH	—
GENB Generate Biomedicines, Inc.	$1.8B	-12.9	-28.2	-175.0	-1065.2	—	1	BEARISH	—
GPCR Structure Therapeutics Inc.	$1.6B	-9.1	-20.2	-1134.3	—	—	3	BEARISH	6.3
GPCR Structure Therapeutics Inc.	$1.6B	-9.1	-20.2	-1134.3	—	—	3	BEARISH	6.3
INVA Innoviva, Inc.	$1.5B	4.2	36.7	15.0	-69.8	19.8	7	BEARISH	12.8
INVA Innoviva, Inc.	$1.5B	4.2	36.7	15.0	-69.8	19.8	7	BEARISH	12.8
ASPHF Ascentage Pharma Group International	$1.4B	-6.4	-316.9	-211.0	-270.2	-29.1	1	BEARISH	-58.3
ASPHF Ascentage Pharma Group International	$1.4B	-6.4	-316.9	-211.0	-270.2	-29.1	1	BEARISH	-58.3
DMRA Damora Therapeutics, Inc.	$1.3B	—	—	—	—	—	—	BEARISH	—
DMRA Damora Therapeutics, Inc.	$1.3B	—	—	—	—	—	—	BEARISH	—
TRAX First Tracks Biotherapeutics Inc	$1.2B	—	—	—	—	—	—	BEARISH	—
TRAX First Tracks Biotherapeutics Inc	$1.2B	—	—	—	—	—	—	BEARISH	—
ASCLF Ascletis Pharma Inc.	$1.1B	-11.7	-38.0	-12387.1	—	-95.5	2	BEARISH	-14.8
ASCLF Ascletis Pharma Inc.	$1.1B	-11.7	-38.0	-12387.1	—	-95.5	2	BEARISH	-14.8
CRVS Corvus Pharmaceuticals, Inc.	$920M	-17.0	-35.4	-415.6	—	—	4	BEARISH	50.1
CRVS Corvus Pharmaceuticals, Inc.	$920M	-17.0	-35.4	-415.6	—	—	4	BEARISH	50.1
GLUE Monte Rosa Therapeutics, Inc.	$890M	-4.8	-42.7	149.9	-483.9	-83.9	3	BEARISH	40.0
GLUE Monte Rosa Therapeutics, Inc.	$890M	-4.8	-42.7	149.9	-483.9	-83.9	3	BEARISH	40.0
ALMS Alumis Inc.	$850M	-1.8	-93.6	2645.2	-8557.2	-63.1	2	BEARISH	68.7
ALMS Alumis Inc.	$850M	-1.8	-93.6	2645.2	-8557.2	-63.1	2	BEARISH	68.7
SANA Sana Biotechnology, Inc.	$800M	-3.8	-152.9	-242.3	—	—	3	BEARISH	-21.9
SANA Sana Biotechnology, Inc.	$800M	-3.8	-152.9	-242.3	—	—	3	BEARISH	-21.9
GERN Geron Corporation	$770M	-12.0	-29.2	-74.1	-29.0	24.4	2	BEARISH	-14.9
GERN Geron Corporation	$770M	-12.0	-29.2	-74.1	-29.0	24.4	2	BEARISH	-14.9
IVEVF Inventiva S.A.	$760M	-5.9	5541.6	502.1	-347346.6	-57.3	4	BEARISH	41.2
IVEVF Inventiva S.A.	$760M	-5.9	5541.6	502.1	-347346.6	-57.3	4	BEARISH	41.2
ATTO Attovia Therapeutics, Inc.	$740M	-18.5	-294.4	-1137.2	-4597.1	-50.5	4	BEARISH	308.8
ATTO Attovia Therapeutics, Inc.	$740M	-18.5	-294.4	-1137.2	-4597.1	-50.5	4	BEARISH	308.8
OLMA Olema Pharmaceuticals, Inc.	$720M	-3.9	-52.7	585.3	—	—	2	BEARISH	-25.4
OLMA Olema Pharmaceuticals, Inc.	$720M	-3.9	-52.7	585.3	—	—	2	BEARISH	-25.4
BLSM BlossomHill Therapeutics, Inc.	$570M	—	—	—	—	—	—	BEARISH	—
BLSM BlossomHill Therapeutics, Inc.	$570M	—	—	—	—	—	—	BEARISH	—
CTMX CytomX Therapeutics, Inc.	$560M	-5.7	-37.8	305.9	-1457.4	-87.0	2	BEARISH	-23.6
CTMX CytomX Therapeutics, Inc.	$560M	-5.7	-37.8	305.9	-1457.4	-87.0	2	BEARISH	-23.6
CRMD CorMedix Inc.	$560M	3.0	54.9	57.2	25.5	280.5	5	BEARISH	-34.9
CRMD CorMedix Inc.	$560M	3.0	54.9	57.2	25.5	280.5	5	BEARISH	-34.9
PHAT Phathom Pharmaceuticals, Inc.	$560M	-5.4	26.4	8.9	-23.7	110.2	4	BEARISH	-43.7
PHAT Phathom Pharmaceuticals, Inc.	$560M	-5.4	26.4	8.9	-23.7	110.2	4	BEARISH	-43.7
ALT Altimmune, Inc.	$530M	-3.5	-28.9	-43.1	—	55.0	4	BEARISH	-20.4
ALT Altimmune, Inc.	$530M	-3.5	-28.9	-43.1	—	55.0	4	BEARISH	-20.4
ALLO Allogene Therapeutics, Inc.	$520M	-2.2	-42.4	-81.9	-919.8	—	5	BEARISH	21.0
ALLO Allogene Therapeutics, Inc.	$520M	-2.2	-42.4	-81.9	-919.8	—	5	BEARISH	21.0
ARVN Arvinas, Inc.	$480M	39.0	1.6	-519.3	67.8	-15.0	4	BEARISH	-18.8
ARVN Arvinas, Inc.	$480M	39.0	1.6	-519.3	67.8	-15.0	4	BEARISH	-18.8
AGMB AgomAb Therapeutics N.V. American Depositary Shares	$420M	—	—	—	—	—	—	BEARISH	—
AGMB AgomAb Therapeutics N.V. American Depositary Shares	$420M	—	—	—	—	—	—	BEARISH	—
SPRY ARS Pharmaceuticals, Inc.	$400M	-1.9	-210.3	-424.3	-185.2	4.1	2	BEARISH	-59.7
SPRY ARS Pharmaceuticals, Inc.	$400M	-1.9	-210.3	-424.3	-185.2	4.1	2	BEARISH	-59.7
PTCHF PureTech Health plc	$380M	8.2	14.7	-97.5	1890.6	-3.3	5	BEARISH	-0.7
PTCHF PureTech Health plc	$380M	8.2	14.7	-97.5	1890.6	-3.3	5	BEARISH	-0.7
RGNX REGENXBIO Inc.	$380M	-2.0	-137.6	-368.4	21.0	12.0	2	BEARISH	-23.9
KYTX Kyverna Therapeutics, Inc.	$380M	-2.1	-87.2	14267.8	—	—	2	BEARISH	4.2
KYTX Kyverna Therapeutics, Inc.	$380M	-2.1	-87.2	14267.8	—	—	2	BEARISH	4.2
RGNX REGENXBIO Inc.	$380M	-2.0	-137.6	-368.4	21.0	12.0	2	BEARISH	-23.9
RLMD Relmada Therapeutics, Inc.	$380M	-3.9	-55.7	460.5	—	—	3	BEARISH	66.7
RLMD Relmada Therapeutics, Inc.	$380M	-3.9	-55.7	460.5	—	—	3	BEARISH	66.7
BNTC Benitec Biopharma Inc.	$310M	-9.2	-33.2	1840.8	—	—	3	BEARISH	-29.6
BNTC Benitec Biopharma Inc.	$310M	-9.2	-33.2	1840.8	—	—	3	BEARISH	-29.6
LRMR Larimar Therapeutics, Inc.	$310M	-1.5	-139.6	590.9	—	—	2	BEARISH	-28.7
LRMR Larimar Therapeutics, Inc.	$310M	-1.5	-139.6	590.9	—	—	2	BEARISH	-28.7
VNDA Vanda Pharmaceuticals Inc.	$280M	-1.0	-77.8	-201.0	-123.7	6.0	3	BEARISH	-9.2
VNDA Vanda Pharmaceuticals Inc.	$280M	-1.0	-77.8	-201.0	-123.7	6.0	3	BEARISH	-9.2
RCKT Rocket Pharmaceuticals, Inc.	$280M	-16.0	-4.8	-137.8	—	—	3	BEARISH	-19.0
RCKT Rocket Pharmaceuticals, Inc.	$280M	-16.0	-4.8	-137.8	—	—	3	BEARISH	-19.0
IPSC Century Therapeutics, Inc.	$280M	-1.5	-49.7	-60.0	—	-100.0	2	BEARISH	206.1
IPSC Century Therapeutics, Inc.	$280M	-1.5	-49.7	-60.0	—	-100.0	2	BEARISH	206.1
SCTX Scribe Therapeutics Inc.	$270M	—	—	—	—	—	—	BEARISH	—
SCTX Scribe Therapeutics Inc.	$270M	—	—	—	—	—	—	BEARISH	—
XFOR X4 Pharmaceuticals, Inc.	$270M	-2.4	-113.1	-281.1	-183.5	-51.6	4	BEARISH	-21.8
XFOR X4 Pharmaceuticals, Inc.	$270M	-2.4	-113.1	-281.1	-183.5	-51.6	4	BEARISH	-21.8
EYPT EyePoint Pharmaceuticals, Inc.	$270M	-0.9	-148.7	-3014.8	-18633.1	-94.6	2	BEARISH	-74.8
EYPT EyePoint Pharmaceuticals, Inc.	$270M	-0.9	-148.7	-3014.8	-18633.1	-94.6	2	BEARISH	-74.8
VOGX Vogenx Inc.	$250M	—	—	—	—	—	—	BEARISH	—
ORYZF Oryzon Genomics S.A.	$250M	-87.6	-3.0	-7.2	-1.6	12.6	4	BEARISH	-8.3
ORYZF Oryzon Genomics S.A.	$250M	-87.6	-3.0	-7.2	-1.6	12.6	4	BEARISH	-8.3
DBVT DBV Technologies S.A.	$250M	-2.7	-142.6	-2201.5	—	-100.0	2	BEARISH	4.8
DBVT DBV Technologies S.A.	$250M	-2.7	-142.6	-2201.5	—	-100.0	2	BEARISH	4.8
VOGX Vogenx Inc.	$250M	—	—	—	—	—	—	BEARISH	—
BIOA BioAge Labs Inc.	$250M	-2.8	-28.2	-142.3	-1064.7	168.1	4	BEARISH	11.7
BIOA BioAge Labs Inc.	$250M	-2.8	-28.2	-142.3	-1064.7	168.1	4	BEARISH	11.7
EVMN Evommune, Inc.	$250M	-2.4	-29.6	-82.4	—	—	2	BEARISH	—
EVMN Evommune, Inc.	$250M	-2.4	-29.6	-82.4	—	—	2	BEARISH	—
LYEL Lyell Immunopharma, Inc.	$230M	-0.6	-93.3	-227.7	-1118875.0	-55.0	3	BEARISH	-44.0
LYEL Lyell Immunopharma, Inc.	$230M	-0.6	-93.3	-227.7	-1118875.0	-55.0	3	BEARISH	-44.0
BCYC Bicycle Therapeutics plc	$230M	-1.2	-32.3	-1197.0	-8002.1	217.4	4	BEARISH	-59.4
BCYC Bicycle Therapeutics plc	$230M	-1.2	-32.3	-1197.0	-8002.1	217.4	4	BEARISH	-59.4
LCTX Lineage Cell Therapeutics, Inc.	$230M	-6.6	-59.0	-171.3	138.6	19.9	5	BEARISH	-45.0
LCTX Lineage Cell Therapeutics, Inc.	$230M	-6.6	-59.0	-171.3	138.6	19.9	5	BEARISH	-45.0
SION Sionna Therapeutics, Inc.	$220M	-2.3	-32.3	-137.7	—	—	0	BEARISH	-82.8
SION Sionna Therapeutics, Inc.	$220M	-2.3	-32.3	-137.7	—	—	0	BEARISH	-82.8
CHRS Coherus Oncology, Inc.	$180M	-1.1	-145.4	1854.0	-144.2	-64.3	2	BEARISH	-28.4
CHRS Coherus Oncology, Inc.	$180M	-1.1	-145.4	1854.0	-144.2	-64.3	2	BEARISH	-28.4
AVXL Anavex Life Sciences Corp.	$170M	-7.0	-23.6	411.7	—	—	2	BEARISH	-79.8
AVXL Anavex Life Sciences Corp.	$170M	-7.0	-23.6	411.7	—	—	2	BEARISH	-79.8
PEPG PepGen Inc.	$160M	-1.5	-75.5	-327.5	—	—	4	BEARISH	-51.6
PEPG PepGen Inc.	$160M	-1.5	-75.5	-327.5	—	—	4	BEARISH	-51.6
VYGR Voyager Therapeutics, Inc.	$150M	-1.4	-54.1	-131.1	-773.2	-19.1	2	BEARISH	-47.6
VYGR Voyager Therapeutics, Inc.	$150M	-1.4	-54.1	-131.1	-773.2	-19.1	2	BEARISH	-47.6
NGEN NervGen Pharma Corp. Common stock	$150M	—	—	—	—	—	—	BEARISH	—
NGEN NervGen Pharma Corp. Common stock	$150M	—	—	—	—	—	—	BEARISH	—
TARA Protara Therapeutics, Inc.	$150M	-2.0	-45.8	-41.3	—	—	2	BEARISH	-38.8
TARA Protara Therapeutics, Inc.	$150M	-2.0	-45.8	-41.3	—	—	2	BEARISH	-38.8
NERV Minerva Neurosciences, Inc.	$150M	-0.1	337.5	10.0	—	—	1	BEARISH	56.2
NERV Minerva Neurosciences, Inc.	$150M	-0.1	337.5	10.0	—	—	1	BEARISH	56.2
SPRB Spruce Biosciences, Inc.	$130M	-1.1	-106.0	772.2	—	-100.0	4	BEARISH	413.6
SPRB Spruce Biosciences, Inc.	$130M	-1.1	-106.0	772.2	—	-100.0	4	BEARISH	413.6
RNA Atrium Therapeutics, Inc.	$130M	-2.0	-36.9	455.9	-672.0	235.3	5	BEARISH	-82.0
RNA Atrium Therapeutics, Inc.	$130M	-2.0	-36.9	455.9	-672.0	235.3	5	BEARISH	-82.0
TNYA Tenaya Therapeutics, Inc.	$120M	-1.1	-121.9	1769.3	-3909.3	—	3	BEARISH	-66.4
TNYA Tenaya Therapeutics, Inc.	$120M	-1.1	-121.9	1769.3	-3909.3	—	3	BEARISH	-66.4
CRBU Caribou Biosciences, Inc.	$120M	-1.1	-78.3	-695.0	-1619.9	10.0	3	BEARISH	-46.0
CRBU Caribou Biosciences, Inc.	$120M	-1.1	-78.3	-695.0	-1619.9	10.0	3	BEARISH	-46.0
UNCY Unicycive Therapeutics, Inc.	$110M	-2.5	-101.1	349.9	—	—	4	BEARISH	-5.4
UNCY Unicycive Therapeutics, Inc.	$110M	-2.5	-101.1	349.9	—	—	4	BEARISH	-5.4
VXRT Vaxart, Inc.	$110M	2.9	67.0	149.6	-49.6	201.1	6	BEARISH	15.0
VXRT Vaxart, Inc.	$110M	2.9	67.0	149.6	-49.6	201.1	6	BEARISH	15.0
LENZ LENZ Therapeutics, Inc.	$110M	-0.9	-59.2	17313.3	-581.8	329.5	3	BEARISH	-92.7
LENZ LENZ Therapeutics, Inc.	$110M	-0.9	-59.2	17313.3	-581.8	329.5	3	BEARISH	-92.7
OKUR OnKure Therapeutics, Inc.	$100M	-0.7	-46.9	1464.5	—	—	4	BEARISH	-4.1
OKUR OnKure Therapeutics, Inc.	$100M	-0.7	-46.9	1464.5	—	—	4	BEARISH	-4.1
NMRA Neumora Therapeutics, Inc. Common Stock	$90M	-0.4	-187.1	231.9	—	—	2	BEARISH	-71.3
NMRA Neumora Therapeutics, Inc. Common Stock	$90M	-0.4	-187.1	231.9	—	—	2	BEARISH	-71.3
CNXU Conexeu Sciences Inc.	$80M	—	—	—	—	—	—	BEARISH	—
CNXU Conexeu Sciences Inc.	$80M	—	—	—	—	—	—	BEARISH	—
CGTX Cognition Therapeutics, Inc.	$80M	-4.8	-83.8	6061.8	—	—	3	BEARISH	-38.7
CGTX Cognition Therapeutics, Inc.	$80M	-4.8	-83.8	6061.8	—	—	3	BEARISH	-38.7
NTHI Neonc Technologies Holdings, Inc.	$80M	—	—	—	—	—	—	BEARISH	-69.7
NTHI Neonc Technologies Holdings, Inc.	$80M	—	—	—	—	—	—	BEARISH	-69.7
PTHS Pelthos Therapeutics Inc.	$70M	-0.5	4767.3	-97.0	-150.1	—	2	BEARISH	-23.7
PTHS Pelthos Therapeutics Inc.	$70M	-0.5	4767.3	-97.0	-150.1	—	2	BEARISH	-23.7
ALDX Aldeyra The	$70M	-3.0	-49.5	269.3	—	—	4	BEARISH	-77.7
ALDX Aldeyra The	$70M	-3.0	-49.5	269.3	—	—	4	BEARISH	-77.7
PLRX Pliant Therapeutics, Inc.	$60M	-0.7	-50.3	-438.3	—	—	3	BEARISH	-29.0
PLRX Pliant Therapeutics, Inc.	$60M	-0.7	-50.3	-438.3	—	—	3	BEARISH	-29.0
GUTS Fractyl Health, Inc.	$60M	-0.4	1063.0	-568.7	—	-100.0	4	BEARISH	-72.3
GUTS Fractyl Health, Inc.	$60M	-0.4	1063.0	-568.7	—	-100.0	4	BEARISH	-72.3
ONCY Oncolytics Biotech Inc.	$60M	-2.6	90135.4	285.1	—	—	1	BEARISH	-56.1
ONCY Oncolytics Biotech Inc.	$60M	-2.6	90135.4	285.1	—	—	1	BEARISH	-56.1
HBPCF Helix BioPharma Corp.	$60M	-22.3	-50.8	-21.5	—	—	3	BEARISH	28.3
HBPCF Helix BioPharma Corp.	$60M	-22.3	-50.8	-21.5	—	—	3	BEARISH	28.3
CING Cingulate Inc.	$60M	-1.0	-198.7	-1452.8	—	—	4	BEARISH	13.6
CING Cingulate Inc.	$60M	-1.0	-198.7	-1452.8	—	—	4	BEARISH	13.6
MGX Metagenomi, Inc. Common Stock	$40M	-0.4	-60.6	-268.2	10693.4	-59.8	1	BEARISH	-57.3
MGX Metagenomi, Inc. Common Stock	$40M	-0.4	-60.6	-268.2	10693.4	-59.8	1	BEARISH	-57.3
PRRUF Immutep Ltd	$40M	-0.6	-96.5	2212.5	-328.8	153.6	3	BEARISH	-84.2
PRRUF Immutep Ltd	$40M	-0.6	-96.5	2212.5	-328.8	153.6	3	BEARISH	-84.2
KYNB Kyntra Bio, Inc.	$30M	0.1	-115.2	29.6	-812.3	—	2	BEARISH	—
KYNB Kyntra Bio, Inc.	$30M	0.1	-115.2	29.6	-812.3	—	2	BEARISH	—
MCRB Seres Therapeutics, Inc.	$30M	-1.2	-66.6	-87.8	622.4	—	3	BEARISH	-85.7
MCRB Seres Therapeutics, Inc.	$30M	-1.2	-66.6	-87.8	622.4	—	3	BEARISH	-85.7
IMMP Immutep Limited	$30M	-0.6	-112.5	2661.4	-328.8	195.3	4	BEARISH	-88.0
IMMP Immutep Limited	$30M	-0.6	-112.5	2661.4	-328.8	195.3	4	BEARISH	-88.0
ATYR aTyr Pharma, Inc.	$30M	-0.5	-98.4	-1890.1	—	—	2	BEARISH	-58.4
ATYR aTyr Pharma, Inc.	$30M	-0.5	-98.4	-1890.1	—	—	2	BEARISH	-58.4
BCDA BioCardia, Inc.	$20M	-1.4	-1803.2	519.4	—	—	3	BEARISH	-21.8
BCDA BioCardia, Inc.	$20M	-1.4	-1803.2	519.4	—	—	3	BEARISH	-21.8
RDTCF Rapid Dose Therapeutics Corp.	$10M	-4.2	54.7	78.9	-106.0	33.0	3	BEARISH	-49.1
ACXP Acurx Pharmaceuticals, Inc.	$10M	-0.4	-128.1	241.9	—	—	3	BEARISH	-72.4
ACXP Acurx Pharmaceuticals, Inc.	$10M	-0.4	-128.1	241.9	—	—	3	BEARISH	-72.4
RDTCF Rapid Dose Therapeutics Corp.	$10M	-4.2	54.7	78.9	-106.0	33.0	3	BEARISH	-49.1
OTLC Oncotelic Therapeutics, Inc.	$10M	0.0	0.0	-0.0	155.3	—	5	BEARISH	-69.5
OTLC Oncotelic Therapeutics, Inc.	$10M	0.0	0.0	-0.0	155.3	—	5	BEARISH	-69.5
CLRB Cellectar Biosciences, Inc.	$10M	-0.4	-119.6	717.6	—	—	3	BEARISH	-69.2
CLRB Cellectar Biosciences, Inc.	$10M	-0.4	-119.6	717.6	—	—	3	BEARISH	-69.2
MSLE Satellos Bioscience Inc.	$10M	—	—	—	—	—	—	BEARISH	—
MSLE Satellos Bioscience Inc.	$10M	—	—	—	—	—	—	BEARISH	—
LTRN Lantern Pharma Inc.	$10M	-0.5	-400.9	115.9	—	—	2	BEARISH	-78.5
LTRN Lantern Pharma Inc.	$10M	-0.5	-400.9	115.9	—	—	2	BEARISH	-78.5
TVRD Tvardi Therapeutics, Inc.	$10M	-0.4	-126.2	296.9	—	—	1	BEARISH	-97.0
TVRD Tvardi Therapeutics, Inc.	$10M	-0.4	-126.2	296.9	—	—	1	BEARISH	-97.0
PHIO Phio Pharmaceuticals Corp.	$10M	-0.7	-113.7	2701.6	—	—	2	BEARISH	-59.3
PHIO Phio Pharmaceuticals Corp.	$10M	-0.7	-113.7	2701.6	—	—	2	BEARISH	-59.3
JSPR Jasper Therapeutics, Inc.	$10M	-0.4	-255.0	773.9	—	—	2	BEARISH	-76.5
JSPR Jasper Therapeutics, Inc.	$10M	-0.4	-255.0	773.9	—	—	2	BEARISH	-76.5
PRVCF PreveCeutical Medical Inc.	$10M	-16.7	9.9	96.4	—	—	3	BEARISH	-56.2
PRVCF PreveCeutical Medical Inc.	$10M	-16.7	9.9	96.4	—	—	3	BEARISH	-56.2
HMTXF Hemostemix Inc	$10M	-2.4	69.9	190.1	—	—	1	BEARISH	-38.1
HMTXF Hemostemix Inc	$10M	-2.4	69.9	190.1	—	—	1	BEARISH	-38.1
PASG Passage Bio, Inc.	$10M	-0.4	-169.1	159.0	—	—	3	BEARISH	-49.3
PASG Passage Bio, Inc.	$10M	-0.4	-169.1	159.0	—	—	3	BEARISH	-49.3
LABT Lakewood-Amedex Biotherapeutics, Inc.	—	—	—	—	—	—	—	BEARISH	—
LABT Lakewood-Amedex Biotherapeutics, Inc.	—	—	—	—	—	—	—	BEARISH	—
ERNA Ernexa Therapeutics Inc.	—	-0.2	-320.7	626.9	—	-100.0	5	BEARISH	-89.6
ERNA Ernexa Therapeutics Inc.	—	-0.2	-320.7	626.9	—	-100.0	5	BEARISH	-89.6
PBIGF Paradigm Biopharmaceuticals Limited	—	-1.6	-550.4	1492.1	-60158.9	17.4	3	BEARISH	-99.2
PBIGF Paradigm Biopharmaceuticals Limited	—	-1.6	-550.4	1492.1	-60158.9	17.4	3	BEARISH	-99.2
MBIO Mustang Bio, Inc.	—	-1.0	-58.1	36.6	—	—	2	BEARISH	-70.0
MBIO Mustang Bio, Inc.	—	-1.0	-58.1	36.6	—	—	2	BEARISH	-70.0
ZVSA ZyVersa Therapeutics, Inc.	—	-0.0	817.1	242.0	—	-100.0	1	BEARISH	-44.1
ZVSA ZyVersa Therapeutics, Inc.	—	-0.0	817.1	242.0	—	-100.0	1	BEARISH	-44.1
REVB Revelation Biosciences, Inc.	—	-0.1	-154.8	1317.2	—	—	3	BEARISH	-47.9
MBRX Moleculin Biotech, Inc.	—	-0.0	-1371.6	-494.1	—	—	2	BEARISH	-96.4
MBRX Moleculin Biotech, Inc.	—	-0.0	-1371.6	-494.1	—	—	2	BEARISH	-96.4
REVB Revelation Biosciences, Inc.	—	-0.1	-154.8	1317.2	—	—	3	BEARISH	-47.9
CRIS Curis, Inc.	—	-0.1	455.3	-23281.0	—	-62.2	3	BEARISH	-97.6
CRIS Curis, Inc.	—	-0.1	455.3	-23281.0	—	-62.2	3	BEARISH	-97.6
SCPS Scopus BioPharma Inc.	—	-0.0	132.3	53.6	—	—	2	BEARISH	33.3
SCPS Scopus BioPharma Inc.	—	-0.0	132.3	53.6	—	—	2	BEARISH	33.3
BRTX BioRestorative Therapies, Inc.	—	-0.1	-241.1	2112.9	-9298.3	-8.5	3	BEARISH	-92.3
BRTX BioRestorative Therapies, Inc.	—	-0.1	-241.1	2112.9	-9298.3	-8.5	3	BEARISH	-92.3
CYYNF Cynata Therapeutics Limited	—	-0.3	-542.5	1354.9	—	-40.0	2	BEARISH	-98.8
CYYNF Cynata Therapeutics Limited	—	-0.3	-542.5	1354.9	—	-40.0	2	BEARISH	-98.8
XAGE Longevity Health Holdings Inc.	—	-0.0	109.8	56.6	-475.6	60.3	3	BEARISH	-79.8
XAGE Longevity Health Holdings Inc.	—	-0.0	109.8	56.6	-475.6	60.3	3	BEARISH	-79.8
CLAZF Claritas Pharmaceuticals, Inc.	—	0.0	-170.1	15.9	—	—	3	BEARISH	-99.0
CLAZF Claritas Pharmaceuticals, Inc.	—	0.0	-170.1	15.9	—	—	3	BEARISH	-99.0
AXIM AXIM Biotechnologies, Inc.	—	-1.6	3.0	24.9	-90.9	2142.6	5	BEARISH	-38.2
AXIM AXIM Biotechnologies, Inc.	—	-1.6	3.0	24.9	-90.9	2142.6	5	BEARISH	-38.2
PKTX ProtoKinetix, Incorporated	—	-0.7	-117.2	-115.0	—	—	2	BEARISH	-96.4
PKTX ProtoKinetix, Incorporated	—	-0.7	-117.2	-115.0	—	—	2	BEARISH	-96.4
BXRXQ Baudax Bio, Inc.	—	—	—	—	—	—	—	BEARISH	-90.0
BXRXQ Baudax Bio, Inc.	—	—	—	—	—	—	—	BEARISH	-90.0
AZTR Azitra, Inc.	—	-0.1	-256.7	-959.6	—	—	4	BEARISH	-81.7
AZTR Azitra, Inc.	—	-0.1	-256.7	-959.6	—	—	4	BEARISH	-81.7
GBLX GB Sciences, Inc.	—	-0.0	19.5	17.2	-103.2	—	3	BEARISH	-50.0
GBLX GB Sciences, Inc.	—	-0.0	19.5	17.2	-103.2	—	3	BEARISH	-50.0
GOVX GeoVax Labs, Inc.	—	-0.0	-891.6	1530.7	—	-100.0	3	BEARISH	-97.6
GOVX GeoVax Labs, Inc.	—	-0.0	-891.6	1530.7	—	-100.0	3	BEARISH	-97.6
BLEG Branded Legacy, Inc.	—	-0.0	2011.7	147.0	—	-29.4	2	BEARISH	-98.6
BLEG Branded Legacy, Inc.	—	-0.0	2011.7	147.0	—	-29.4	2	BEARISH	-98.6
AGNPF Grey Matters Health Inc.	—	—	-140.9	-64.7	—	—	3	BEARISH	-50.0
AGNPF Grey Matters Health Inc.	—	—	-140.9	-64.7	—	—	3	BEARISH	-50.0
YECO EV Biologics, Inc.	—	-0.0	4.7	15.0	18.6	347.3	6	BEARISH	-99.9
SETO SETO Holdings, Inc.	—	-7.5	-22.5	-8.5	-32.2	9760.2	6	NEUTRAL	17.6
SETO SETO Holdings, Inc.	—	-7.5	-22.5	-8.5	-32.2	9760.2	6	NEUTRAL	17.6
MSPR MSP Recovery, Inc.	—	-0.0	127.6	-506.2	-84750.5	—	2	LEAN BEAR	-100.0
MSPR MSP Recovery, Inc.	—	-0.0	127.6	-506.2	-84750.5	—	2	LEAN BEAR	-100.0
BJDX Bluejay Diagnostics, Inc.	—	-0.1	-98.9	5625.8	—	—	4	LEAN BEAR	-86.3
BJDX Bluejay Diagnostics, Inc.	—	-0.1	-98.9	5625.8	—	—	4	LEAN BEAR	-86.3
THMO ThermoGenesis Holdings, Inc.	—	-0.0	-417.9	-71.5	-67.8	-7.5	3	LEAN BEAR	0.0
THMO ThermoGenesis Holdings, Inc.	—	-0.0	-417.9	-71.5	-67.8	-7.5	3	LEAN BEAR	0.0
ALGWF Alliance Growers Corp.	—	—	—	—	—	—	—	BEARISH	0.0
ALGWF Alliance Growers Corp.	—	—	—	—	—	—	—	BEARISH	0.0
CANN Trees Corporation	—	-3.1	284.2	-3.9	-15.1	-24.7	4	BEARISH	-67.0
CANN Trees Corporation	—	-3.1	284.2	-3.9	-15.1	-24.7	4	BEARISH	-67.0
LTHO Legacy Technology Holdings, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
LTHO Legacy Technology Holdings, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
PRMD PrimeMD Inc	—	0.0	42.8	34.3	159.9	—	3	BEARISH	200.0
PRMD PrimeMD Inc	—	0.0	42.8	34.3	159.9	—	3	BEARISH	200.0
IHGP Jun An Kang Group Inc.	—	2.0	0.5	0.5	1.0	64.0	6	BEARISH	-98.2
IHGP Jun An Kang Group Inc.	—	2.0	0.5	0.5	1.0	64.0	6	BEARISH	-98.2
CVSI CV Sciences, Inc.	—	-1.0	-118.9	-46.0	-26.0	-14.9	1	BEARISH	-74.5
CVSI CV Sciences, Inc.	—	-1.0	-118.9	-46.0	-26.0	-14.9	1	BEARISH	-74.5
YECO EV Biologics, Inc.	—	-0.0	4.7	15.0	18.6	347.3	6	BEARISH	-99.9
ABSI Absci Corporation	$1.9B	-13.8	-57.7	-213.1	-10443.4	-62.3	5	BULLISH	253.7
ABSI Absci Corporation	$1.9B	-13.8	-57.7	-213.1	-10443.4	-62.3	5	BULLISH	253.7
AMN AMN Healthcare Services, Inc.	$1.4B	13.6	15.6	8.9	3.1	24.0	8	BULLISH	83.6
AMN AMN Healthcare Services, Inc.	$1.4B	13.6	15.6	8.9	3.1	24.0	8	BULLISH	83.6
HSTM HealthStream, Inc.	$900M	43.1	6.0	6.5	8.0	8.8	8	BULLISH	12.3
HSTM HealthStream, Inc.	$900M	43.1	6.0	6.5	8.0	8.8	8	BULLISH	12.3
SDEV Stablecoin Development Corp.	$380M	—	—	—	—	—	—	BULLISH	—
SDEV Stablecoin Development Corp.	$380M	—	—	—	—	—	—	BULLISH	—
INFU InfuSystem Holdings, Inc.	$270M	31.3	15.0	11.4	8.7	2.5	9	BULLISH	28.1
INFU InfuSystem Holdings, Inc.	$270M	31.3	15.0	11.4	8.7	2.5	9	BULLISH	28.1
OSUR OraSure Technologies, Inc.	$270M	-5.7	-14.1	-23.5	20.4	-18.9	4	BULLISH	26.0
OSUR OraSure Technologies, Inc.	$270M	-5.7	-14.1	-23.5	20.4	-18.9	4	BULLISH	26.0
PMVP PMV Pharmaceuticals, Inc.	$100M	-1.3	-70.9	815.8	—	—	2	BULLISH	31.6
PMVP PMV Pharmaceuticals, Inc.	$100M	-1.3	-70.9	815.8	—	—	2	BULLISH	31.6
MYO Myomo, Inc.	$60M	-4.8	-123.8	-74.2	-34.4	6.1	3	BULLISH	75.9
MYO Myomo, Inc.	$60M	-4.8	-123.8	-74.2	-34.4	6.1	3	BULLISH	75.9
ICU SeaStar Medical Holding Corporation	$10M	-1.2	-356.9	415.0	-606.5	123.6	4	BULLISH	-24.8
ICU SeaStar Medical Holding Corporation	$10M	-1.2	-356.9	415.0	-606.5	123.6	4	BULLISH	-24.8
SHPH Shuttle Pharmaceuticals Holdings, Inc.	—	-0.1	-90.1	-46.0	—	—	4	BULLISH	-6.9
SHPH Shuttle Pharmaceuticals Holdings, Inc.	—	-0.1	-90.1	-46.0	—	—	4	BULLISH	-6.9
FTRE Fortrea Holdings Inc.	$1.9B	-21.5	-15.3	0.6	-1.9	-2.1	6	BULLISH	110.1
FTRE Fortrea Holdings Inc.	$1.9B	-21.5	-15.3	0.6	-1.9	-2.1	6	BULLISH	110.1
AZTA Azenta, Inc.	$1.8B	-14.1	-7.7	-1.4	1.5	1.5	4	BULLISH	22.7
AZTA Azenta, Inc.	$1.8B	-14.1	-7.7	-1.4	1.5	1.5	4	BULLISH	22.7
NVAX Novavax, Inc.	$1.7B	-6.9	323.7	29.2	-94.2	-61.6	2	BULLISH	10.1
NVAX Novavax, Inc.	$1.7B	-6.9	323.7	29.2	-94.2	-61.6	2	BULLISH	10.1
NUTX Nutex Health, Inc.	$1.5B	8.3	49.2	53.9	31.2	6.9	7	BULLISH	107.4
NUTX Nutex Health, Inc.	$1.5B	8.3	49.2	53.9	31.2	6.9	7	BULLISH	107.4
CERT Certara, Inc.	$1.5B	-21.1	-6.7	0.6	-59.3	0.7	6	BULLISH	-30.0
CERT Certara, Inc.	$1.5B	-21.1	-6.7	0.6	-59.3	0.7	6	BULLISH	-30.0
USPH U.S. Physical Therapy, Inc.	$1.3B	492.5	-1.3	7.7	0.7	17.1	5	BULLISH	-2.1
USPH U.S. Physical Therapy, Inc.	$1.3B	492.5	-1.3	7.7	0.7	17.1	5	BULLISH	-2.1
CTKB Cytek Biosciences, Inc.	$760M	-9.4	-23.0	-40.8	-25.3	5.4	3	BULLISH	62.6
CTKB Cytek Biosciences, Inc.	$760M	-9.4	-23.0	-40.8	-25.3	5.4	3	BULLISH	62.6
KHTRF Knight Therapeutics Inc.	$730M	70.2	1.9	2.6	-2.3	42.4	8	BULLISH	69.0
KHTRF Knight Therapeutics Inc.	$730M	70.2	1.9	2.6	-2.3	42.4	8	BULLISH	69.0
MASS 908 Devices Inc.	$520M	-13.6	-25.1	-103.8	-74.0	4.6	5	BULLISH	41.2
MASS 908 Devices Inc.	$520M	-13.6	-25.1	-103.8	-74.0	4.6	5	BULLISH	41.2
TKNO Alpha Teknova, Inc.	$480M	-28.5	-24.2	-17.2	-26.0	12.3	4	BULLISH	41.1
TKNO Alpha Teknova, Inc.	$480M	-28.5	-24.2	-17.2	-26.0	12.3	4	BULLISH	41.1
RCEL Avita Medical Inc.	$320M	-8.8	211.5	-292.6	-35.3	1.0	4	BULLISH	142.3
RCEL Avita Medical Inc.	$320M	-8.8	211.5	-292.6	-35.3	1.0	4	BULLISH	142.3
SEER Seer, Inc.	$120M	-1.8	-26.4	-58.8	-544.8	-13.3	3	BULLISH	2.3
SEER Seer, Inc.	$120M	-1.8	-26.4	-58.8	-544.8	-13.3	3	BULLISH	2.3
HBIO Harvard Bioscience, Inc.	$40M	-3.6	-89.9	1.8	-12.8	-1.1	7	BULLISH	86.2
HBIO Harvard Bioscience, Inc.	$40M	-3.6	-89.9	1.8	-12.8	-1.1	7	BULLISH	86.2
AHG Akso Health Group	$980M	-4.4	-50.1	-44.9	-546.5	22.7	4	BULLISH	-31.6
AHG Akso Health Group	$980M	-4.4	-50.1	-44.9	-546.5	22.7	4	BULLISH	-31.6
PACB Pacific Biosciences of California, Inc.	$790M	-5.9	-929.3	-29.4	-114.7	2.0	2	BULLISH	84.1
PACB Pacific Biosciences of California, Inc.	$790M	-5.9	-929.3	-29.4	-114.7	2.0	2	BULLISH	84.1
QSI Quantum-Si incorporated	$310M	-3.3	-49.1	-121.8	-6841.3	-53.0	3	BULLISH	6.2
QSI Quantum-Si incorporated	$310M	-3.3	-49.1	-121.8	-6841.3	-53.0	3	BULLISH	6.2
NAUT Nautilus Biotechnolgy, Inc.	$250M	-4.4	-36.2	-66.2	-7615.3	—	3	BULLISH	134.7
NAUT Nautilus Biotechnolgy, Inc.	$250M	-4.4	-36.2	-66.2	-7615.3	—	3	BULLISH	134.7
ZCMD Zhongchao Inc.	—	-0.0	-38.0	-109.0	-92.6	-18.9	5	BULLISH	62.3
ZCMD Zhongchao Inc.	—	-0.0	-38.0	-109.0	-92.6	-18.9	5	BULLISH	62.3
OPRX OptimizeRx Corp.	$160M	35.2	3.7	6.1	-3.4	-5.8	8	BULLISH	-54.9
OPRX OptimizeRx Corp.	$160M	35.2	3.7	6.1	-3.4	-5.8	8	BULLISH	-54.9
TLSA Tiziana Life Sciences Ltd	$70M	-4.1	-1250.8	978.2	—	—	1	BULLISH	-42.6
TLSA Tiziana Life Sciences Ltd	$70M	-4.1	-1250.8	978.2	—	—	1	BULLISH	-42.6
CSTL Castle Biosciences, Inc.	$1.1B	-53.9	-4.2	-10.6	-2.0	3.2	4	BULLISH	54.5
CSTL Castle Biosciences, Inc.	$1.1B	-53.9	-4.2	-10.6	-2.0	3.2	4	BULLISH	54.5
AGEN Agenus Inc.	$350M	3.1	-33.2	-20.4	-1.6	30.5	6	BULLISH	114.4
AGEN Agenus Inc.	$350M	3.1	-33.2	-20.4	-1.6	30.5	6	BULLISH	114.4
UTMD Utah Medical Products, Inc.	$240M	22.6	8.8	24.1	31.5	-7.0	7	BULLISH	17.0
UTMD Utah Medical Products, Inc.	$240M	22.6	8.8	24.1	31.5	-7.0	7	BULLISH	17.0
RMTI Rockwell Medical, Inc.	$30M	-6.2	-15.5	-14.8	-6.6	-21.1	6	BULLISH	626.9
RMTI Rockwell Medical, Inc.	$30M	-6.2	-15.5	-14.8	-6.6	-21.1	6	BULLISH	626.9
EXHI Exlites Holdings International, Inc.	$20M	-750.0	-66.7	-65.8	-35.4	283.9	4	BULLISH	246.2
EXHI Exlites Holdings International, Inc.	$20M	-750.0	-66.7	-65.8	-35.4	283.9	4	BULLISH	246.2
CSCIF COSCIENS Biopharma Inc.	—	-0.5	-19.9	-18.7	-6.4	—	1	BULLISH	—
CSCIF COSCIENS Biopharma Inc.	—	-0.5	-19.9	-18.7	-6.4	—	1	BULLISH	—
DNA Ginkgo Bioworks Holdings, Inc.	$810M	-2.5	-56.3	-44.0	-231.7	-51.5	2	BULLISH	-15.9
DNA Ginkgo Bioworks Holdings, Inc.	$810M	-2.5	-56.3	-44.0	-231.7	-51.5	2	BULLISH	-15.9
YDES YD Bio Limited Ordinary Shares	$570M	—	—	—	—	—	—	BULLISH	-54.7
YDES YD Bio Limited Ordinary Shares	$570M	—	—	—	—	—	—	BULLISH	-54.7
DMAC DiaMedica Therapeutics Inc.	$440M	-11.4	-114.6	616.3	—	—	2	BULLISH	20.0
DMAC DiaMedica Therapeutics Inc.	$440M	-11.4	-114.6	616.3	—	—	2	BULLISH	20.0
MYGN Myriad Genetics, Inc.	$430M	-3.8	-32.5	-19.5	-22.7	-3.2	4	BULLISH	-41.3
MYGN Myriad Genetics, Inc.	$430M	-3.8	-32.5	-19.5	-22.7	-3.2	4	BULLISH	-41.3
SRZN Surrozen, Inc.	$220M	-0.7	387.2	11.1	1003.5	-8.8	2	BULLISH	114.6
SRZN Surrozen, Inc.	$220M	-0.7	387.2	11.1	1003.5	-8.8	2	BULLISH	114.6
MREO Mereo BioPharma Group plc	$60M	-2.1	-67.8	6194.3	—	-100.0	2	BULLISH	-81.5
MREO Mereo BioPharma Group plc	$60M	-2.1	-67.8	6194.3	—	-100.0	2	BULLISH	-81.5
CVM CEL-SCI Corporation	$20M	-0.9	-252.5	-142.9	—	-100.0	4	BULLISH	-76.8
CVM CEL-SCI Corporation	$20M	-0.9	-252.5	-142.9	—	-100.0	4	BULLISH	-76.8
SXTP 60 Degrees Pharmaceuticals, Inc.	—	-0.2	-321.8	-390.2	-1089.2	68.0	3	BULLISH	-5.4
SXTP 60 Degrees Pharmaceuticals, Inc.	—	-0.2	-321.8	-390.2	-1089.2	68.0	3	BULLISH	-5.4
DGWPF DrÃ¤gerwerk AG & Co. KGaA	$1.9B	12.8	10.9	9.8	3.4	6.5	9	BULLISH	79.5
DGWPF DrÃ¤gerwerk AG & Co. KGaA	$1.9B	12.8	10.9	9.8	3.4	6.5	9	BULLISH	79.5
COGZF Cogstate Limited	$400M	32.9	49.6	94.6	22.4	3.7	6	BULLISH	85.7
COGZF Cogstate Limited	$400M	32.9	49.6	94.6	22.4	3.7	6	BULLISH	85.7
SPHRF Starpharma Holdings Limited	$240M	-46.8	-83.3	-941.6	-725.1	50.8	5	BULLISH	480.0
SPHRF Starpharma Holdings Limited	$240M	-46.8	-83.3	-941.6	-725.1	50.8	5	BULLISH	480.0
SIGA SIGA Technologies, Inc.	$240M	-77.5	-1.5	-18.3	30.4	-70.1	1	BULLISH	-63.4
SIGA SIGA Technologies, Inc.	$240M	-77.5	-1.5	-18.3	30.4	-70.1	1	BULLISH	-63.4
SPOK Spok Holdings, Inc.	$230M	18.3	8.4	10.0	11.8	-3.4	5	BULLISH	-32.7
SPOK Spok Holdings, Inc.	$230M	18.3	8.4	10.0	11.8	-3.4	5	BULLISH	-32.7
DIUXF Diaceutics PLC	$200M	-609.4	-4.7	-7.3	-15.9	58.0	4	BULLISH	68.6
DIUXF Diaceutics PLC	$200M	-609.4	-4.7	-7.3	-15.9	58.0	4	BULLISH	68.6
QTRX Quanterix Corporation	$170M	-1.4	-46.5	-59.0	-148.7	23.4	2	BULLISH	-34.3
QTRX Quanterix Corporation	$170M	-1.4	-46.5	-59.0	-148.7	23.4	2	BULLISH	-34.3
INKT MiNK Therapeutics, Inc.	$60M	-5.2	57.9	42.8	—	—	3	BULLISH	-14.1
INKT MiNK Therapeutics, Inc.	$60M	-5.2	57.9	42.8	—	—	3	BULLISH	-14.1
VRHI Veri Medtech Holdings Inc.	$40M	—	—	—	—	—	—	BULLISH	—
VRHI Veri Medtech Holdings Inc.	$40M	—	—	—	—	—	—	BULLISH	—
CRVO CervoMed Inc.	$30M	-0.9	-107.6	1244.8	—	—	2	BULLISH	-62.4
CRVO CervoMed Inc.	$30M	-0.9	-107.6	1244.8	—	—	2	BULLISH	-62.4
YDESW YD Bio Limited Warrants	—	—	—	—	—	—	—	BULLISH	-60.5
YDESW YD Bio Limited Warrants	—	—	—	—	—	—	—	BULLISH	-60.5
BLFS BioLife Solutions, Inc.	$1.8B	36.1	13.2	13.2	158.4	34.4	6	BULLISH	42.8
BLFS BioLife Solutions, Inc.	$1.8B	36.1	13.2	13.2	158.4	34.4	6	BULLISH	42.8
OM Outset Medical, Inc.	$70M	-1.0	-59.2	-97.3	-56.8	-1.3	4	BULLISH	-71.8
OM Outset Medical, Inc.	$70M	-1.0	-59.2	-97.3	-56.8	-1.3	4	BULLISH	-71.8
BCTXZ BriaCell Therapeutics Corp. Warrant	—	-0.3	-168.1	-2016.9	—	—	1	BULLISH	39.8
BCTXZ BriaCell Therapeutics Corp. Warrant	—	-0.3	-168.1	-2016.9	—	—	1	BULLISH	39.8
SENS Senseonics Holdings, Inc.	$410M	-4.4	-118.2	-901.4	-253.4	79.0	3	BULLISH	19.6
SENS Senseonics Holdings, Inc.	$410M	-4.4	-118.2	-901.4	-253.4	79.0	3	BULLISH	19.6
BFRG Bullfrog AI Holdings, Inc. Common Stock	$10M	-1.3	-130.7	-3026.9	-636.8	798.5	6	BULLISH	-58.1
BFRG Bullfrog AI Holdings, Inc. Common Stock	$10M	-1.3	-130.7	-3026.9	-636.8	798.5	6	BULLISH	-58.1
MBXBF Microbix Biosystems Inc.	$30M	-8.5	-16.4	-14.6	-19.9	-27.1	3	BULLISH	18.5
MBXBF Microbix Biosystems Inc.	$30M	-8.5	-16.4	-14.6	-19.9	-27.1	3	BULLISH	18.5
ZIVO ZIVO Bioscience, Inc.	$20M	-2.9	185.9	147.5	—	-62.5	2	BULLISH	-67.5
ZIVO ZIVO Bioscience, Inc.	$20M	-2.9	185.9	147.5	—	-62.5	2	BULLISH	-67.5
SAEYY Redcare Pharmacy N.V.	$1.6B	-33.6	-8.7	-1.2	0.6	20.5	2	BULLISH	-4.7
SAEYY Redcare Pharmacy N.V.	$1.6B	-33.6	-8.7	-1.2	0.6	20.5	2	BULLISH	-4.7
KMTS Kestra Medical Technologies, Ltd.	$1.6B	-10.3	-56.6	-96.8	-135.6	452.0	4	BULLISH	13.6
KMTS Kestra Medical Technologies, Ltd.	$1.6B	-10.3	-56.6	-96.8	-135.6	452.0	4	BULLISH	13.6
SLGL Sol-Gel Technologies Ltd.	$240M	-12.8	-35.9	-228.0	36.4	282.9	3	BULLISH	144.1
SLGL Sol-Gel Technologies Ltd.	$240M	-12.8	-35.9	-228.0	36.4	282.9	3	BULLISH	144.1
FRNM Freenome, Inc.	$130M	—	—	—	—	—	—	BULLISH	—
FRNM Freenome, Inc.	$130M	—	—	—	—	—	—	BULLISH	—
INCR InterCure Ltd.	$60M	-4.8	-15.9	-10.2	-1.3	-10.8	2	BULLISH	-34.3
INCR InterCure Ltd.	$60M	-4.8	-15.9	-10.2	-1.3	-10.8	2	BULLISH	-34.3
BYSI BeyondSpring Inc.	$30M	-4.8	20.3	15.7	—	100.0	2	BULLISH	-56.0
BYSI BeyondSpring Inc.	$30M	-4.8	20.3	15.7	—	100.0	2	BULLISH	-56.0
PULM Pulmatrix, Inc.	$10M	-1.4	-98.3	-835.1	—	-100.0	3	BULLISH	-68.0
PULM Pulmatrix, Inc.	$10M	-1.4	-98.3	-835.1	—	-100.0	3	BULLISH	-68.0
NDRA ENDRA Life Sciences Inc.	$10M	-1.0	-152.0	-105.1	—	—	4	BULLISH	5.4
NDRA ENDRA Life Sciences Inc.	$10M	-1.0	-152.0	-105.1	—	—	4	BULLISH	5.4
NXL Nexalin Technology, Inc.	—	-0.4	-240.3	-1401.4	-18412.7	24.2	4	BULLISH	551.3
NXL Nexalin Technology, Inc.	—	-0.4	-240.3	-1401.4	-18412.7	24.2	4	BULLISH	551.3
DRTSW Alpha Tau Medical Ltd.	$1.6B	-14.2	-141.7	-17.1	—	—	3	BULLISH	1253.3
DRTSW Alpha Tau Medical Ltd.	$1.6B	-14.2	-141.7	-17.1	—	—	3	BULLISH	1253.3
MDRX Veradigm Inc.	$830M	-7.3	4.3	7.0	6.2	-39.7	5	BULLISH	4.3
MDRX Veradigm Inc.	$830M	-7.3	4.3	7.0	6.2	-39.7	5	BULLISH	4.3
TTRX Turn Therapeutics Inc.	$400M	-45.7	-952.4	115.0	—	—	2	BULLISH	—
TTRX Turn Therapeutics Inc.	$400M	-45.7	-952.4	115.0	—	—	2	BULLISH	—
OBIO Orchestra BioMed Holdings, Inc.	$360M	-6.0	-397.3	468.3	-26994.3	986.1	4	BULLISH	133.3
OBIO Orchestra BioMed Holdings, Inc.	$360M	-6.0	-397.3	468.3	-26994.3	986.1	4	BULLISH	133.3
EMBC Embecta Corp.	$340M	3.8	-13.6	26.3	7.8	-7.6	5	BULLISH	-61.1
EMBC Embecta Corp.	$340M	3.8	-13.6	26.3	7.8	-7.6	5	BULLISH	-61.1
CPIX Cumberland Pharmaceuticals Inc.	$110M	-10.3	-46.7	-41.6	-2472.5	-25.7	3	BULLISH	136.9
CPIX Cumberland Pharmaceuticals Inc.	$110M	-10.3	-46.7	-41.6	-2472.5	-25.7	3	BULLISH	136.9
NTRB Nutriband Inc.	$90M	-12.7	-100.7	-264.9	-201.3	-37.3	3	BULLISH	0.1
NTRB Nutriband Inc.	$90M	-12.7	-100.7	-264.9	-201.3	-37.3	3	BULLISH	0.1
TELA TELA Bio, Inc.	$50M	-1.5	1232.5	-260.3	-58.4	6.1	3	BULLISH	-24.0
TELA TELA Bio, Inc.	$50M	-1.5	1232.5	-260.3	-58.4	6.1	3	BULLISH	-24.0
NEGXF NexgenRx Inc.	$30M	18.8	30.1	-9.7	19.7	12.0	4	BULLISH	120.0
NEGXF NexgenRx Inc.	$30M	18.8	30.1	-9.7	19.7	12.0	4	BULLISH	120.0
JCRRF JCR Pharmaceuticals Co., Ltd.	$440M	72.0	4.7	0.9	4.4	-3.1	4	BULLISH	inf
JCRRF JCR Pharmaceuticals Co., Ltd.	$440M	72.0	4.7	0.9	4.4	-3.1	4	BULLISH	inf
ATGGF Actinogen Medical Limited	$220M	-11.2	-146.7	-361.2	—	-63.0	1	BULLISH	140.0
ATGGF Actinogen Medical Limited	$220M	-11.2	-146.7	-361.2	—	-63.0	1	BULLISH	140.0
INGN Inogen, Inc.	$160M	-6.6	-13.1	-27.8	-4.0	3.2	5	BULLISH	-29.1
INGN Inogen, Inc.	$160M	-6.6	-13.1	-27.8	-4.0	3.2	5	BULLISH	-29.1
AEMD Aethlon Medical, Inc.	—	-0.6	-142.9	-2931.8	—	—	4	BULLISH	-82.3
AEMD Aethlon Medical, Inc.	—	-0.6	-142.9	-2931.8	—	—	4	BULLISH	-82.3
CVALF Covalon Technologies Ltd.	$70M	25.3	14.3	28.5	28.0	4.2	8	BULLISH	95.7
CVALF Covalon Technologies Ltd.	$70M	25.3	14.3	28.5	28.0	4.2	8	BULLISH	95.7
XCRT Xcelerate Inc.	$10M	-11.4	71.8	24.0	—	-142.3	2	BULLISH	61.8
XCRT Xcelerate Inc.	$10M	-11.4	71.8	24.0	—	-142.3	2	BULLISH	61.8
CVGRF City View Green Holdings Inc.	—	-2.3	75.6	105.0	—	—	4	BULLISH	-42.7
CVGRF City View Green Holdings Inc.	—	-2.3	75.6	105.0	—	—	4	BULLISH	-42.7
VMD Viemed Healthcare, Inc.	$350M	24.2	10.2	11.8	3.5	25.2	4	BULLISH	31.8
VMD Viemed Healthcare, Inc.	$350M	24.2	10.2	11.8	3.5	25.2	4	BULLISH	31.8
DMTRF 3-D Matrix, Ltd.	$350M	13.8	92.3	29.3	50.9	56.9	5	BULLISH	80.0
DMTRF 3-D Matrix, Ltd.	$350M	13.8	92.3	29.3	50.9	56.9	5	BULLISH	80.0
BGM BGM Group Ltd.	$120M	-1.9	-0.5	-0.2	-8.7	—	3	BULLISH	-97.0
BGM BGM Group Ltd.	$120M	-1.9	-0.5	-0.2	-8.7	—	3	BULLISH	-97.0
LITS Lite Strategy, Inc.	$50M	-0.2	-170.9	-28.2	—	—	2	BULLISH	-46.1
LITS Lite Strategy, Inc.	$50M	-0.2	-170.9	-28.2	—	—	2	BULLISH	-46.1
SCYX SCYNEXIS, Inc.	$30M	-2.8	-18.4	-120.7	3147.7	489.8	5	BULLISH	533.4
GRDX GridAI Technologies Corp.	$30M	-0.9	-55.6	-51.7	-14927.4	67.4	2	BULLISH	-11.2
GRDX GridAI Technologies Corp.	$30M	-0.9	-55.6	-51.7	-14927.4	67.4	2	BULLISH	-11.2
SCYX SCYNEXIS, Inc.	$30M	-2.8	-18.4	-120.7	3147.7	489.8	5	BULLISH	533.4
NSRX Nasus Pharma Ltd.	$30M	—	—	—	—	—	—	BULLISH	-34.7
NSRX Nasus Pharma Ltd.	$30M	—	—	—	—	—	—	BULLISH	-34.7
PMI Picard Medical, Inc.	$10M	-0.3	-1631.2	-469.0	-191.6	—	2	BULLISH	-36.3
PMI Picard Medical, Inc.	$10M	-0.3	-1631.2	-469.0	-191.6	—	2	BULLISH	-36.3
LKFT Lakefront Biotherapeutics N.V.	$1.9B	—	—	—	—	—	—	BULLISH	—
LKFT Lakefront Biotherapeutics N.V.	$1.9B	—	—	—	—	—	—	BULLISH	—
XERS Xeris Biopharma Holdings, Inc.	$1.6B	-93.5	118.2	18.3	-33.8	36.3	6	BULLISH	13.4
XERS Xeris Biopharma Holdings, Inc.	$1.6B	-93.5	118.2	18.3	-33.8	36.3	6	BULLISH	13.4
RIGL Rigel Pharmaceuticals, Inc.	$870M	2.7	126.9	88.5	22.0	3.3	4	BULLISH	67.4
RIGL Rigel Pharmaceuticals, Inc.	$870M	2.7	126.9	88.5	22.0	3.3	4	BULLISH	67.4
GYRE Gyre Therapeutics, Inc.	$790M	-35.7	-15.6	-22.3	-36.4	16.8	3	BULLISH	-6.2
GYRE Gyre Therapeutics, Inc.	$790M	-35.7	-15.6	-22.3	-36.4	16.8	3	BULLISH	-6.2
ENGN enGene Holdings Inc.	$130M	-6.9	-2.3	134.1	—	-100.0	2	BULLISH	-74.5
ENGN enGene Holdings Inc.	$130M	-6.9	-2.3	134.1	—	-100.0	2	BULLISH	-74.5
RLYB Rallybio Corporation	$90M	2.2	64.9	-1399.7	—	-15.1	6	BULLISH	3191.6
RLYB Rallybio Corporation	$90M	2.2	64.9	-1399.7	—	-15.1	6	BULLISH	3191.6
MRAI Marpai, Inc.	$90M	-4.5	47.4	28.0	-110.0	-29.7	3	BULLISH	150.4
MRAI Marpai, Inc.	$90M	-4.5	47.4	28.0	-110.0	-29.7	3	BULLISH	150.4
NRXS NeurAxis, Inc.	$90M	-9.2	-143.2	464.1	-118.1	65.2	6	BULLISH	128.6
NRXS NeurAxis, Inc.	$90M	-9.2	-143.2	464.1	-118.1	65.2	6	BULLISH	128.6
MCUJF Medicure Inc.	$20M	-4.1	-49.9	-54.9	-19.2	38.3	4	BULLISH	186.2
MCUJF Medicure Inc.	$20M	-4.1	-49.9	-54.9	-19.2	38.3	4	BULLISH	186.2
POM POMDOCTOR Ltd	$10M	—	—	—	—	—	—	BULLISH	—
POM POMDOCTOR Ltd	$10M	—	—	—	—	—	—	BULLISH	—
ABPO Abpro Holdings, Inc.	—	—	—	—	—	—	—	BULLISH	—
ABPO Abpro Holdings, Inc.	—	—	—	—	—	—	—	BULLISH	—
SY So-Young International Inc.	$360M	-10.0	-15.7	-22.3	-11.4	14.1	4	BULLISH	-27.8
SY So-Young International Inc.	$360M	-10.0	-15.7	-22.3	-11.4	14.1	4	BULLISH	-27.8
NMAD NOMAD Power Solutions, Inc.	$50M	—	—	—	—	—	—	BULLISH	—
NMAD NOMAD Power Solutions, Inc.	$50M	—	—	—	—	—	—	BULLISH	—
PPTDF PeptiDream Inc.	$940M	-38.3	-7.1	-9.6	-25.7	47.8	4	BULLISH	-34.3
PPTDF PeptiDream Inc.	$940M	-38.3	-7.1	-9.6	-25.7	47.8	4	BULLISH	-34.3
LFCR Lifecore Biomedical, Inc.	$250M	-5.9	227.6	-2.0	-18.0	-4.8	4	BULLISH	-8.8
LFCR Lifecore Biomedical, Inc.	$250M	-5.9	227.6	-2.0	-18.0	-4.8	4	BULLISH	-8.8
CELU Celularity Inc.	$50M	-0.6	349.7	-195.2	17.6	-62.8	2	BULLISH	-21.6
CELU Celularity Inc.	$50M	-0.6	349.7	-195.2	17.6	-62.8	2	BULLISH	-21.6
BNR Burning Rock Biotech Limited	$20M	-1.7	-12.8	-41.7	-13.7	-6.6	2	BULLISH	89.0
BNR Burning Rock Biotech Limited	$20M	-1.7	-12.8	-41.7	-13.7	-6.6	2	BULLISH	89.0
COSM Cosmos Health Inc.	$20M	-0.6	-104.0	-41.2	-32.1	33.8	4	BULLISH	-65.5
COSM Cosmos Health Inc.	$20M	-0.6	-104.0	-41.2	-32.1	33.8	4	BULLISH	-65.5
VSEE VSee Health, Inc.	—	-0.1	-1488.9	-87.7	-197.2	-9.3	5	BULLISH	-95.7
VSEE VSee Health, Inc.	—	-0.1	-1488.9	-87.7	-197.2	-9.3	5	BULLISH	-95.7
SOPH SOPHiA GENETICS S.A.	$680M	-7.0	-101.2	-155.2	-95.9	23.6	3	BULLISH	81.3
SOPH SOPHiA GENETICS S.A.	$680M	-7.0	-101.2	-155.2	-95.9	23.6	3	BULLISH	81.3
FLGT Fulgent Genetics, Inc.	$610M	-7.6	-8.0	-12.6	-34.6	6.8	4	BULLISH	-8.6
FLGT Fulgent Genetics, Inc.	$610M	-7.6	-8.0	-12.6	-34.6	6.8	4	BULLISH	-8.6
ANTX AN2 Therapeutics, Inc.	$210M	-5.3	-50.1	1243.3	—	—	2	BULLISH	342.6
ANTX AN2 Therapeutics, Inc.	$210M	-5.3	-50.1	1243.3	—	—	2	BULLISH	342.6
ESMC Escalon Medical Corp.	—	1.7	57.5	0.0	91.0	-11.6	5	BULLISH	8.4
ESMC Escalon Medical Corp.	—	1.7	57.5	0.0	91.0	-11.6	5	BULLISH	8.4
SHWGF Shandong Weigao Group Medical Polymer Company Limited	$1.9B	9.2	14.0	15.7	11.3	-0.2	4	BULLISH	-44.7
SHWGF Shandong Weigao Group Medical Polymer Company Limited	$1.9B	9.2	14.0	15.7	11.3	-0.2	4	BULLISH	-44.7
CASBF CanSino Biologics Inc.	$1.6B	523.4	0.8	-1.2	11.0	32.5	7	BULLISH	-29.6
CASBF CanSino Biologics Inc.	$1.6B	523.4	0.8	-1.2	11.0	32.5	7	BULLISH	-29.6
UMCN UMC, Inc.	$30M	-66.9	-840.4	-95.6	-590.7	2325.0	4	BULLISH	79.2
UMCN UMC, Inc.	$30M	-66.9	-840.4	-95.6	-590.7	2325.0	4	BULLISH	79.2
FZMD Fuse Medical, Inc.	—	15.0	-177.1	-13.7	6.2	-5.8	5	BULLISH	-45.0
FZMD Fuse Medical, Inc.	—	15.0	-177.1	-13.7	6.2	-5.8	5	BULLISH	-45.0
HRGN Harvard Apparatus Regenerative Technology Inc.	$40M	-5.5	239.0	256.6	-409.4	—	2	BULLISH	—
HRGN Harvard Apparatus Regenerative Technology Inc.	$40M	-5.5	239.0	256.6	-409.4	—	2	BULLISH	—
FLNA Filana Therapeutics, Inc.	$40M	-1.1	-13.5	38.9	—	—	2	BULLISH	—
FLNA Filana Therapeutics, Inc.	$40M	-1.1	-13.5	38.9	—	—	2	BULLISH	—
INAB IN8bio, Inc.	$10M	-0.7	-111.1	-576.1	—	—	4	BULLISH	-39.4
INAB IN8bio, Inc.	$10M	-0.7	-111.1	-576.1	—	—	4	BULLISH	-39.4
HEPA Hepion Pharmaceuticals, Inc.	—	-0.3	-125.6	710.2	—	—	3	BULLISH	76.1
HEPA Hepion Pharmaceuticals, Inc.	—	-0.3	-125.6	710.2	—	—	3	BULLISH	76.1
VCNX Vaccinex, Inc.	—	-0.5	776.6	414.6	-1584.0	226.6	3	BULLISH	62.9
VCNX Vaccinex, Inc.	—	-0.5	776.6	414.6	-1584.0	226.6	3	BULLISH	62.9
SGHT Sight Sciences, Inc.	$460M	-15.3	-48.4	-145.7	-19.0	9.3	4	BULLISH	154.6
SGHT Sight Sciences, Inc.	$460M	-15.3	-48.4	-145.7	-19.0	9.3	4	BULLISH	154.6
XGN Exagen Inc.	$200M	-10.0	-113.8	-79.2	-16.0	20.8	3	BULLISH	-25.6
XGN Exagen Inc.	$200M	-10.0	-113.8	-79.2	-16.0	20.8	3	BULLISH	-25.6
PDSB PDS Biotechnology Corporation	$40M	-1.2	-544.0	456.9	—	—	1	BULLISH	-26.6
PDSB PDS Biotechnology Corporation	$40M	-1.2	-544.0	456.9	—	—	1	BULLISH	-26.6
BCTX BriaCell Therapeutics Corp.	$40M	-0.3	-179.9	-2435.2	—	—	2	BULLISH	-67.9
BCTX BriaCell Therapeutics Corp.	$40M	-0.3	-179.9	-2435.2	—	—	2	BULLISH	-67.9
FDMDF 4DMedical Limited	$1.8B	-11.0	-194.6	65.5	-1194.8	188.6	5	BULLISH	129.0
FDMDF 4DMedical Limited	$1.8B	-11.0	-194.6	65.5	-1194.8	188.6	5	BULLISH	129.0
CTOR Citius Oncology, Inc.	$90M	-2.0	-126.6	-109.8	-597.4	—	3	BULLISH	-51.8
CTOR Citius Oncology, Inc.	$90M	-2.0	-126.6	-109.8	-597.4	—	3	BULLISH	-51.8
SNWV SANUWAVE Health Inc.	$40M	2.9	-238.8	4.8	-7.0	12.0	7	BULLISH	-87.1
SNWV SANUWAVE Health Inc.	$40M	2.9	-238.8	4.8	-7.0	12.0	7	BULLISH	-87.1
GCAN Trafalgar International, Inc.	—	0.4	-162.2	1112.4	—	-100.0	4	BULLISH	-28.0
GCAN Trafalgar International, Inc.	—	0.4	-162.2	1112.4	—	-100.0	4	BULLISH	-28.0
KROS Keros Therapeutics, Inc.	$230M	-3.1	-17.2	-392.2	—	-93.6	3	BULLISH	-25.6
KROS Keros Therapeutics, Inc.	$230M	-3.1	-17.2	-392.2	—	-93.6	3	BULLISH	-25.6
EVAX Evaxion Biotech A/S	$20M	-0.5	-109.8	-260.4	—	135.9	6	BULLISH	-27.9
EVAX Evaxion Biotech A/S	$20M	-0.5	-109.8	-260.4	—	135.9	6	BULLISH	-27.9
MEDS DataMEDS AI, Inc.	$10M	-0.1	-142327.8	-322403.1	-1031.7	339160.3	4	BULLISH	18.7
MEDS DataMEDS AI, Inc.	$10M	-0.1	-142327.8	-322403.1	-1031.7	339160.3	4	BULLISH	18.7
BMNDF Biomind Labs Inc.	$40M	-24.5	85.8	101.7	—	—	2	BULLISH	2811.4
BMNDF Biomind Labs Inc.	$40M	-24.5	85.8	101.7	—	—	2	BULLISH	2811.4
DRTS Alpha Tau Medical Ltd	$1.3B	-14.2	-141.7	-17.1	—	—	3	BULLISH	238.0
DRTS Alpha Tau Medical Ltd	$1.3B	-14.2	-141.7	-17.1	—	—	3	BULLISH	238.0
CSSPF NIOX Group Plc	$380M	40.0	16.6	23.1	24.6	27.2	6	BULLISH	-2.3
CSSPF NIOX Group Plc	$380M	40.0	16.6	23.1	24.6	27.2	6	BULLISH	-2.3
HITI High Tide Inc.	$230M	-9.9	-26.9	1.6	5.7	27.2	3	BULLISH	-27.1
HITI High Tide Inc.	$230M	-9.9	-26.9	1.6	5.7	27.2	3	BULLISH	-27.1
BITRF Biotron Limited	$20M	-3.6	-137.4	-107.4	-113.4	-24.0	3	BULLISH	219.2
BITRF Biotron Limited	$20M	-3.6	-137.4	-107.4	-113.4	-24.0	3	BULLISH	219.2
CURX Curanex Pharmaceuticals Inc Common Stock	$10M	-0.6	-218.7	-392.2	—	—	1	BULLISH	-69.5
CURX Curanex Pharmaceuticals Inc Common Stock	$10M	-0.6	-218.7	-392.2	—	—	1	BULLISH	-69.5
QPTFF Quest PharmaTech Inc.	$10M	1.6	3.9	-1.7	—	—	4	BULLISH	125.6
QPTFF Quest PharmaTech Inc.	$10M	1.6	3.9	-1.7	—	—	4	BULLISH	125.6
LGNDZ Ligand Pharmaceuticals, Inc.	—	0.0	20.4	11.3	76.2	—	3	BULLISH	—
LGNDZ Ligand Pharmaceuticals, Inc.	—	0.0	20.4	11.3	76.2	—	3	BULLISH	—
EKTAF Elekta AB (publ)	$2.0B	-54.7	-6.5	6.2	-18.2	-7.5	2	BULLISH	3.5
EKTAF Elekta AB (publ)	$2.0B	-54.7	-6.5	6.2	-18.2	-7.5	2	BULLISH	3.5
ADAPY Adaptimmune Therapeutics plc	$10M	-0.1	-1341.1	268.4	-221.8	-54.0	0	BULLISH	-69.5
ADAPY Adaptimmune Therapeutics plc	$10M	-0.1	-1341.1	268.4	-221.8	-54.0	0	BULLISH	-69.5
NKGN NKGen Biotech, Inc.	—	-0.0	150.9	—	-4511.3	—	3	BULLISH	-90.0
NKGN NKGen Biotech, Inc.	—	-0.0	150.9	—	-4511.3	—	3	BULLISH	-90.0
TRVN Trevena, Inc.	—	-0.0	344.3	-3198.4	-1745.2	-82.9	3	BULLISH	0.0
TRVN Trevena, Inc.	—	-0.0	344.3	-3198.4	-1745.2	-82.9	3	BULLISH	0.0
ALRTF ALR Technologies Inc.	$10M	-1.4	54.2	8.3	-151734.7	—	2	BULLISH	30.9
ALRTF ALR Technologies Inc.	$10M	-1.4	54.2	8.3	-151734.7	—	2	BULLISH	30.9
AIMLF AI/ML Innovations Inc.	$10M	-1.9	-702.6	6389.8	—	-50.4	1	BULLISH	-2.7
AIMLF AI/ML Innovations Inc.	$10M	-1.9	-702.6	6389.8	—	-50.4	1	BULLISH	-2.7
HALB Halberd Corporation	—	-31.8	11.6	12.4	—	-52.1	1	BULLISH	-13.0
HALB Halberd Corporation	—	-31.8	11.6	12.4	—	-52.1	1	BULLISH	-13.0
CBIH Cannabis Bioscience International Holdings, Inc.	—	-0.0	48.2	34.0	-341.5	-58.2	1	BULLISH	-60.0
CBIH Cannabis Bioscience International Holdings, Inc.	—	-0.0	48.2	34.0	-341.5	-58.2	1	BULLISH	-60.0
AAWH Ascend Wellness Holdings, Inc.	$110M	-1.0	388.6	3.1	-7.8	-8.4	3	BULLISH	-21.9
AAWH Ascend Wellness Holdings, Inc.	$110M	-1.0	388.6	3.1	-7.8	-8.4	3	BULLISH	-21.9
LPCUF Lee's Pharmaceutical Holdings Limited	$110M	4.1	9.9	0.2	11.9	81.2	8	BULLISH	-1.3
LPCUF Lee's Pharmaceutical Holdings Limited	$110M	4.1	9.9	0.2	11.9	81.2	8	BULLISH	-1.3
HYPR Hyperfine, Inc.	$80M	-2.3	-97.0	-395.6	-238.2	53.2	5	BULLISH	-37.1
HYPR Hyperfine, Inc.	$80M	-2.3	-97.0	-395.6	-238.2	53.2	5	BULLISH	-37.1
EUDA EUDA Health Holdings Limited	$30M	-7.7	-5.5	104.7	-39.4	30.1	6	BULLISH	-57.3
EUDA EUDA Health Holdings Limited	$30M	-7.7	-5.5	104.7	-39.4	30.1	6	BULLISH	-57.3
REZNF Street Capital Inc.	—	-3.3	20.7	15.0	—	-44.3	5	BULLISH	74.5
REZNF Street Capital Inc.	—	-3.3	20.7	15.0	—	-44.3	5	BULLISH	74.5
STTK Shattuck Labs, Inc.	$610M	-13.2	-39.2	-29.3	—	-66.6	4	BULLISH	182.8
STTK Shattuck Labs, Inc.	$610M	-13.2	-39.2	-29.3	—	-66.6	4	BULLISH	182.8
ACIU AC Immune S.A.	$280M	-5.2	-78.5	96.7	12.4	-39.5	2	BULLISH	-10.2
ACIU AC Immune S.A.	$280M	-5.2	-78.5	96.7	12.4	-39.5	2	BULLISH	-10.2
LIANY LianMedical	$10M	1.3	74.7	-612.1	—	—	6	BULLISH	7.9
LIANY LianMedical	$10M	1.3	74.7	-612.1	—	—	6	BULLISH	7.9
MGRX Mangoceuticals, Inc.	$10M	-0.4	-95.1	-82.6	-1909.1	-38.9	4	BULLISH	-79.3
MGRX Mangoceuticals, Inc.	$10M	-0.4	-95.1	-82.6	-1909.1	-38.9	4	BULLISH	-79.3
CYBQY CYBERDYNE Inc.	$270M	170.0	0.4	-0.8	-3.9	-11.1	2	BULLISH	11.8
CYBQY CYBERDYNE Inc.	$270M	170.0	0.4	-0.8	-3.9	-11.1	2	BULLISH	11.8
ANIX Anixa Biosciences, Inc.	$100M	-9.7	-67.1	-1110.2	—	—	3	BULLISH	-13.0
ANIX Anixa Biosciences, Inc.	$100M	-9.7	-67.1	-1110.2	—	—	3	BULLISH	-13.0
INIS Radnostix, Inc.	$30M	-0.0	-29489557.0	-23.1	-33.0	-23.7	1	BULLISH	5.0
INIS Radnostix, Inc.	$30M	-0.0	-29489557.0	-23.1	-33.0	-23.7	1	BULLISH	5.0
TXTM ProText Mobility, Inc.	$10M	58.0	-0.4	-0.3	—	-100.0	1	BULLISH	87.1
TXTM ProText Mobility, Inc.	$10M	58.0	-0.4	-0.3	—	-100.0	1	BULLISH	87.1
MLAB Mesa Laboratories, Inc.	$740M	154.1	3.9	3.2	-6.5	3.4	8	BULLISH	88.5
MLAB Mesa Laboratories, Inc.	$740M	154.1	3.9	3.2	-6.5	3.4	8	BULLISH	88.5
BDSX Biodesix, Inc.	$230M	-8.7	-540.0	-31.9	-27.1	34.5	6	BULLISH	261.4
BDSX Biodesix, Inc.	$230M	-8.7	-540.0	-31.9	-27.1	34.5	6	BULLISH	261.4
LOVFF Cannara Biotech Inc.	$150M	18.8	11.4	12.2	15.2	15.4	7	BULLISH	15.6
LOVFF Cannara Biotech Inc.	$150M	18.8	11.4	12.2	15.2	15.4	7	BULLISH	15.6
BNGO Bionano Genomics, Inc.	$20M	-0.4	-83.6	-89.6	-90.8	10.0	6	BULLISH	-21.9
BNGO Bionano Genomics, Inc.	$20M	-0.4	-83.6	-89.6	-90.8	10.0	6	BULLISH	-21.9
AJYG AJ1G, Inc.	—	—	—	—	—	—	—	BULLISH	380.1
AJYG AJ1G, Inc.	—	—	—	—	—	—	—	BULLISH	380.1
PBM Psyence Biomedical Ltd.	—	—	—	—	—	—	—	BULLISH	75.1
PBM Psyence Biomedical Ltd.	—	—	—	—	—	—	—	BULLISH	75.1
STSN Stemsation International, Inc.	—	-11.0	-2.8	-1.6	—	—	3	LEAN BULL	185.2
STSN Stemsation International, Inc.	—	-11.0	-2.8	-1.6	—	—	3	LEAN BULL	185.2
PRGO Perrigo Company plc	$2.0B	-1.1	-49.6	3.1	7.3	-4.2	4	LEAN BULL	-35.2
PRGO Perrigo Company plc	$2.0B	-1.1	-49.6	3.1	7.3	-4.2	4	LEAN BULL	-35.2
NTLA Intellia Therapeutics, Inc.	$1.7B	-3.6	-55.4	-92.1	-1392.3	12.6	4	LEAN BULL	-34.6
NTLA Intellia Therapeutics, Inc.	$1.7B	-3.6	-55.4	-92.1	-1392.3	12.6	4	LEAN BULL	-34.6
PAHC Phibro Animal Health Corporation	$1.5B	15.1	29.7	13.2	5.5	17.1	7	LEAN BULL	-8.5
PAHC Phibro Animal Health Corporation	$1.5B	15.1	29.7	13.2	5.5	17.1	7	LEAN BULL	-8.5
SI Shoulder Innovations, Inc.	$390M	-11.1	-28.2	-69.1	-59.1	—	1	LEAN BULL	58.1
SI Shoulder Innovations, Inc.	$390M	-11.1	-28.2	-69.1	-59.1	—	1	LEAN BULL	58.1
ENTA Enanta Pharmaceuticals, Inc.	$380M	-5.4	-70.1	141.5	-135.8	0.7	4	LEAN BULL	22.1
ENTA Enanta Pharmaceuticals, Inc.	$380M	-5.4	-70.1	141.5	-135.8	0.7	4	LEAN BULL	22.1
LAB Standard BioTools Inc.	$290M	-3.2	-18.1	-69.4	-133.1	-45.2	5	LEAN BULL	-41.8
LAB Standard BioTools Inc.	$290M	-3.2	-18.1	-69.4	-133.1	-45.2	5	LEAN BULL	-41.8
PLX Protalix BioTherapeutics, Inc.	$220M	11.2	31.2	47.1	19.0	30.1	5	LEAN BULL	14.8
PLX Protalix BioTherapeutics, Inc.	$220M	11.2	31.2	47.1	19.0	30.1	5	LEAN BULL	14.8
CBUS Cibus, Inc.	$130M	-1.0	-225.9	-157.2	-2227.9	-10.3	2	LEAN BULL	27.6
CBUS Cibus, Inc.	$130M	-1.0	-225.9	-157.2	-2227.9	-10.3	2	LEAN BULL	27.6
CORBF Global Cord Blood Corporation	$130M	1.5	104.3	-167.2	35.9	—	4	LEAN BULL	-4.9
CORBF Global Cord Blood Corporation	$130M	1.5	104.3	-167.2	35.9	—	4	LEAN BULL	-4.9
BIOYF BioSyent Inc.	$130M	19.0	23.7	23.8	14.3	41.0	5	LEAN BULL	35.0
BIOYF BioSyent Inc.	$130M	19.0	23.7	23.8	14.3	41.0	5	LEAN BULL	35.0
HOWL Werewolf Therapeutics, Inc.	$50M	-1.3	-119.9	354.7	17.5	—	4	LEAN BULL	-52.4
HOWL Werewolf Therapeutics, Inc.	$50M	-1.3	-119.9	354.7	17.5	—	4	LEAN BULL	-52.4
MDAI Spectral AI, Inc.	$50M	-4.8	99.0	97.9	-118.5	-45.0	2	LEAN BULL	-27.5
MDAI Spectral AI, Inc.	$50M	-4.8	99.0	97.9	-118.5	-45.0	2	LEAN BULL	-27.5
RMSL REMSleep Holdings, Inc.	—	-0.0	4286484750.6	1769.6	-702.2	-27.1	2	LEAN BULL	-51.5
RMSL REMSleep Holdings, Inc.	—	-0.0	4286484750.6	1769.6	-702.2	-27.1	2	LEAN BULL	-51.5
AIBT Aibotics Inc.	—	—	—	—	—	—	—	LEAN BULL	—
AIBT Aibotics Inc.	—	—	—	—	—	—	—	LEAN BULL	—
ACOG Alpha Cognition Inc	$140M	-8.3	-55.3	-198.4	-144.3	232.7	2	LEAN BULL	14.8
ACOG Alpha Cognition Inc	$140M	-8.3	-55.3	-198.4	-144.3	232.7	2	LEAN BULL	14.8
ACIXF Acarix AB (publ)	$30M	-6.2	-86.1	-207.4	-410.8	65.2	4	LEAN BULL	-30.7
ACIXF Acarix AB (publ)	$30M	-6.2	-86.1	-207.4	-410.8	65.2	4	LEAN BULL	-30.7
CPIVF Captiva Verde Wellness Corp.	$20M	-32.8	-48.9	-123.3	—	—	2	LEAN BULL	384.6
CPIVF Captiva Verde Wellness Corp.	$20M	-32.8	-48.9	-123.3	—	—	2	LEAN BULL	384.6
ZHCLF Zenith Capital Corp.	$20M	-0.0	35107.2	37766.2	-360.0	—	3	LEAN BULL	42.9
ZHCLF Zenith Capital Corp.	$20M	-0.0	35107.2	37766.2	-360.0	—	3	LEAN BULL	42.9
GLWLF Glow Lifetech Corp.	$10M	-50.0	-11.1	-21.1	-26.6	59.2	5	LEAN BULL	-5.3
GLWLF Glow Lifetech Corp.	$10M	-50.0	-11.1	-21.1	-26.6	59.2	5	LEAN BULL	-5.3
PCYN Procyon Corporation	—	117.4	-13.9	-10.8	2.7	6.4	3	LEAN BULL	145.4
PCYN Procyon Corporation	—	117.4	-13.9	-10.8	2.7	6.4	3	LEAN BULL	145.4
VIR Vir Biotechnology, Inc.	$1.9B	-6.0	-26.1	-38.9	33.5	1495.9	4	LEAN BULL	96.0
VIR Vir Biotechnology, Inc.	$1.9B	-6.0	-26.1	-38.9	33.5	1495.9	4	LEAN BULL	96.0
NYMXF Nymox Pharmaceutical Corporation	—	-0.7	193.9	89.4	—	—	2	LEAN BULL	-44.4
NYMXF Nymox Pharmaceutical Corporation	—	-0.7	193.9	89.4	—	—	2	LEAN BULL	-44.4
LUCY Lucyd, Inc	$10M	-0.7	-84.6	-209.4	-165.3	72.5	4	LEAN BULL	-54.5
LUCY Lucyd, Inc	$10M	-0.7	-84.6	-209.4	-165.3	72.5	4	LEAN BULL	-54.5
CV CapsoVision, Inc.	$310M	-9.8	-226.6	-73.0	-205.4	—	2	LEAN BULL	31.3
CV CapsoVision, Inc.	$310M	-9.8	-226.6	-73.0	-205.4	—	2	LEAN BULL	31.3
SMTI Sanara MedTech Inc.	$320M	-9.4	-147.7	19.8	-1.6	12.9	5	LEAN BULL	13.2
SMTI Sanara MedTech Inc.	$320M	-9.4	-147.7	19.8	-1.6	12.9	5	LEAN BULL	13.2
NNVC NanoViricides, Inc.	$30M	-3.1	-189.3	-0.0	—	—	2	LEAN BULL	-11.1
NNVC NanoViricides, Inc.	$30M	-3.1	-189.3	-0.0	—	—	2	LEAN BULL	-11.1
TGIFF 1933 Industries Inc.	—	6.2	-14.6	-33.1	8.9	-11.8	5	LEAN BULL	1.4
TGIFF 1933 Industries Inc.	—	6.2	-14.6	-33.1	8.9	-11.8	5	LEAN BULL	1.4
ELMD Electromed, Inc.	$230M	20.5	23.3	32.5	17.5	15.3	8	LEAN BULL	14.8
ELMD Electromed, Inc.	$230M	20.5	23.3	32.5	17.5	15.3	8	LEAN BULL	14.8
DBCCF Decibel Cannabis Company Inc.	$50M	-105.6	-1.0	-3.0	11.7	26.5	3	LEAN BULL	-23.4
DBCCF Decibel Cannabis Company Inc.	$50M	-105.6	-1.0	-3.0	11.7	26.5	3	LEAN BULL	-23.4
RVVTF Revive Therapeutics Ltd.	$10M	-1.0	-1114.6	25.7	—	—	2	LEAN BULL	97.2
RVVTF Revive Therapeutics Ltd.	$10M	-1.0	-1114.6	25.7	—	—	2	LEAN BULL	97.2
PHRRF PharmaTher Holdings Ltd.	—	-8.3	-125.3	309.7	—	—	2	LEAN BULL	-71.8
PHRRF PharmaTher Holdings Ltd.	—	-8.3	-125.3	309.7	—	—	2	LEAN BULL	-71.8
KRSA Korsana Biosciences, Inc.	$140M	—	—	—	—	—	—	LEAN BULL	—
KRSA Korsana Biosciences, Inc.	$140M	—	—	—	—	—	—	LEAN BULL	—
SINT Sintx Technologies, Inc.	$10M	-0.4	-408.3	-216.8	-598.7	0.2	3	LEAN BULL	-45.7
SINT Sintx Technologies, Inc.	$10M	-0.4	-408.3	-216.8	-598.7	0.2	3	LEAN BULL	-45.7
PSNL Personalis, Inc.	$1.7B	-14.9	-50.3	-149.3	-141.7	-13.3	2	LEAN BULL	135.6
PSNL Personalis, Inc.	$1.7B	-14.9	-50.3	-149.3	-141.7	-13.3	2	LEAN BULL	135.6
NWKHY Netcare Limited	$1.2B	11.8	31.4	23.7	6.7	12.6	7	LEAN BULL	45.8
NWKHY Netcare Limited	$1.2B	11.8	31.4	23.7	6.7	12.6	7	LEAN BULL	45.8
MNKD MannKind Corporation	$1.2B	-27.2	71.4	4.0	-17.4	30.5	2	LEAN BULL	-29.4
MNKD MannKind Corporation	$1.2B	-27.2	71.4	4.0	-17.4	30.5	2	LEAN BULL	-29.4
DGNOF DIAGNOS Inc.	$40M	-11.6	-988.8	-2061.6	-7539.8	-36.9	3	LEAN BULL	58.5
DGNOF DIAGNOS Inc.	$40M	-11.6	-988.8	-2061.6	-7539.8	-36.9	3	LEAN BULL	58.5
ATNM Actinium Pharmaceuticals, Inc.	$40M	3.2	45.9	-197.8	79.7	—	3	LEAN BULL	-26.9
ATNM Actinium Pharmaceuticals, Inc.	$40M	3.2	45.9	-197.8	79.7	—	3	LEAN BULL	-26.9
TRAW Traws Pharma, Inc.	$10M	-1.1	35.4	225.5	—	606.3	3	LEAN BULL	-69.9
TRAW Traws Pharma, Inc.	$10M	-1.1	35.4	225.5	—	606.3	3	LEAN BULL	-69.9
VTGN VistaGen Therapeutics, Inc.	$10M	-0.2	-131.6	644.6	-3499.8	161.3	2	LEAN BULL	-92.1
VTGN VistaGen Therapeutics, Inc.	$10M	-0.2	-131.6	644.6	-3499.8	161.3	2	LEAN BULL	-92.1
HLYK HealthLynked Corp.	$10M	-1.7	63.5	-580.7	-328.1	-46.7	3	LEAN BULL	24.0
HLYK HealthLynked Corp.	$10M	-1.7	63.5	-580.7	-328.1	-46.7	3	LEAN BULL	24.0
NMTRQ 9 Meters Biopharma, Inc.	—	—	—	—	—	—	—	LEAN BULL	0.0
NMTRQ 9 Meters Biopharma, Inc.	—	—	—	—	—	—	—	LEAN BULL	0.0
BFRGW Bullfrog AI Holdings, Inc. Warrants	—	-1.3	-130.7	-3026.9	-636.8	798.5	6	LEAN BULL	-89.6
BFRGW Bullfrog AI Holdings, Inc. Warrants	—	-1.3	-130.7	-3026.9	-636.8	798.5	6	LEAN BULL	-89.6
ASBP Aspire Biopharma Holdings, Inc.	—	-1.1	-1032.1	1368.4	-2009.6	—	6	LEAN BULL	-96.6
ASBP Aspire Biopharma Holdings, Inc.	—	-1.1	-1032.1	1368.4	-2009.6	—	6	LEAN BULL	-96.6
CLCFF Christina Lake Cannabis Corp.	—	-1.9	-37.8	-14.8	-10.0	-18.1	2	LEAN BULL	-39.8
CLCFF Christina Lake Cannabis Corp.	—	-1.9	-37.8	-14.8	-10.0	-18.1	2	LEAN BULL	-39.8
CBDD CBD of Denver, Inc.	—	-12.3	-0.1	-28.9	-2.7	19.0	3	LEAN BULL	-33.3
CBDD CBD of Denver, Inc.	—	-12.3	-0.1	-28.9	-2.7	19.0	3	LEAN BULL	-33.3
OWLT Owlet, Inc.	$90M	-11.8	180.6	-50.5	-1.8	28.0	6	LEAN BULL	-39.5
OWLT Owlet, Inc.	$90M	-11.8	180.6	-50.5	-1.8	28.0	6	LEAN BULL	-39.5
SERA Sera Prognostics, Inc.	$80M	-3.1	-45.0	-184.9	-30463.3	-35.2	3	LEAN BULL	-29.8
SERA Sera Prognostics, Inc.	$80M	-3.1	-45.0	-184.9	-30463.3	-35.2	3	LEAN BULL	-29.8
HYFT MindWalk Holdings Corp.	$60M	-5.2	-78.4	-298.7	-93.9	-16.9	5	LEAN BULL	-24.7
HYFT MindWalk Holdings Corp.	$60M	-5.2	-78.4	-298.7	-93.9	-16.9	5	LEAN BULL	-24.7
VERU Veru Inc.	$40M	-4.2	-62.3	-211.2	—	-100.0	3	LEAN BULL	-35.5
VERU Veru Inc.	$40M	-4.2	-62.3	-211.2	—	-100.0	3	LEAN BULL	-35.5
CNSP CNS Pharmaceuticals, Inc.	$10M	-0.2	-106.6	748.6	—	—	3	LEAN BULL	-38.9
CNSP CNS Pharmaceuticals, Inc.	$10M	-0.2	-106.6	748.6	—	—	3	LEAN BULL	-38.9
EBS Emergent BioSolutions Inc.	$330M	-1.8	-40.3	-5.5	-76.9	-9.6	5	LEAN BULL	-31.0
EBS Emergent BioSolutions Inc.	$330M	-1.8	-40.3	-5.5	-76.9	-9.6	5	LEAN BULL	-31.0
BMKDF BioMark Diagnostics Inc.	$40M	-41.5	-142.6	-2900.2	-2846.3	-61.2	2	LEAN BULL	60.8
BMKDF BioMark Diagnostics Inc.	$40M	-41.5	-142.6	-2900.2	-2846.3	-61.2	2	LEAN BULL	60.8
CUBT Curative Biotechnology, Inc.	$10M	-2.3	31.0	15.3	—	—	4	LEAN BULL	-27.4
CUBT Curative Biotechnology, Inc.	$10M	-2.3	31.0	15.3	—	—	4	LEAN BULL	-27.4
RMRK Rimrock Gold Corp.	—	5.7	8.6	6.4	—	-100.0	2	LEAN BULL	0.0
RMRK Rimrock Gold Corp.	—	5.7	8.6	6.4	—	-100.0	2	LEAN BULL	0.0
CTTH CTT Pharmaceutical Holdings, Inc.	—	-42.3	-272.8	-210.7	—	—	2	LEAN BULL	-5.0
CTTH CTT Pharmaceutical Holdings, Inc.	—	-42.3	-272.8	-210.7	—	—	2	LEAN BULL	-5.0
ADMT ADM Tronics Unlimited, Inc.	—	-8.6	-16.2	-11.9	-29.1	4.7	4	LEAN BULL	-49.0
ADMT ADM Tronics Unlimited, Inc.	—	-8.6	-16.2	-11.9	-29.1	4.7	4	LEAN BULL	-49.0
AMPH Amphastar Pharmaceuticals, Inc.	$1.1B	14.6	10.3	7.5	16.5	1.4	6	LEAN BULL	-5.8
AMPH Amphastar Pharmaceuticals, Inc.	$1.1B	14.6	10.3	7.5	16.5	1.4	6	LEAN BULL	-5.8
WHTCF WELL Health Technologies Corp.	$790M	170.4	0.5	5.4	-2.7	38.6	6	LEAN BULL	-20.0
WHTCF WELL Health Technologies Corp.	$790M	170.4	0.5	5.4	-2.7	38.6	6	LEAN BULL	-20.0
HSCS HeartSciences Inc.	$10M	-1.3	-639.9	0.2	—	-0.7	4	LEAN BULL	20.4
HSCS HeartSciences Inc.	$10M	-1.3	-639.9	0.2	—	-0.7	4	LEAN BULL	20.4
CBWTF Auxly Cannabis Group Inc.	$250M	10.3	16.6	2.2	16.8	10.8	7	LEAN BULL	64.4
CBWTF Auxly Cannabis Group Inc.	$250M	10.3	16.6	2.2	16.8	10.8	7	LEAN BULL	64.4
ECOR electroCore, Inc.	$90M	-6.0	1761.5	336.0	-32.4	33.5	3	LEAN BULL	105.3
ECOR electroCore, Inc.	$90M	-6.0	1761.5	336.0	-32.4	33.5	3	LEAN BULL	105.3
NNCSF Nanosonics Limited	$610M	48.9	19.3	35.7	8.1	19.0	7	LEAN BULL	-28.4
NNCSF Nanosonics Limited	$610M	48.9	19.3	35.7	8.1	19.0	7	LEAN BULL	-28.4
APUS Apimeds Pharmaceuticals US, Inc	—	-0.1	-100.1	-12.6	—	—	2	LEAN BULL	-81.2
APUS Apimeds Pharmaceuticals US, Inc	—	-0.1	-100.1	-12.6	—	—	2	LEAN BULL	-81.2
CNNA Cann American Corp.	—	0.4	-312.1	-287.6	-7986.6	-64.9	3	LEAN BULL	96.0
CNNA Cann American Corp.	—	0.4	-312.1	-287.6	-7986.6	-64.9	3	LEAN BULL	96.0
GNLX Genelux Corporation	$110M	-2.9	-168.9	20537.7	—	—	2	LEAN BULL	-41.8
GNLX Genelux Corporation	$110M	-2.9	-168.9	20537.7	—	—	2	LEAN BULL	-41.8
HSTC HST Global, Inc.	$100M	-27.8	-5.0	-2.1	2.7	—	3	LEAN BULL	349900.0
HSTC HST Global, Inc.	$100M	-27.8	-5.0	-2.1	2.7	—	3	LEAN BULL	349900.0
RNTX Rein Therapeutics Inc.	$20M	-0.4	-753.6	53.9	—	—	3	LEAN BULL	-32.1
RNTX Rein Therapeutics Inc.	$20M	-0.4	-753.6	53.9	—	—	3	LEAN BULL	-32.1
BEAT HeartBeam, Inc.	$20M	-0.8	-328.4	2958.2	—	—	3	LEAN BULL	-73.7
BEAT HeartBeam, Inc.	$20M	-0.8	-328.4	2958.2	—	—	3	LEAN BULL	-73.7
EWLL eWellness Healthcare Corp.	—	-0.2	69.3	46.3	—	-99.2	1	LEAN BULL	900.0
EWLL eWellness Healthcare Corp.	—	-0.2	69.3	46.3	—	-99.2	1	LEAN BULL	900.0
BRAXF Braxia Scientific Corp.	—	-0.1	-254.6	-2393.3	-184.2	27.6	3	LEAN BULL	-92.2
BRAXF Braxia Scientific Corp.	—	-0.1	-254.6	-2393.3	-184.2	27.6	3	LEAN BULL	-92.2
SLDX Stella Diagnostics Inc.	—	-0.7	18.1	21.7	-195.2	—	4	LEAN BULL	-50.0
SLDX Stella Diagnostics Inc.	—	-0.7	18.1	21.7	-195.2	—	4	LEAN BULL	-50.0
STEK Stemtech Corporation	—	-0.0	58.2	37.1	-46.5	-38.6	2	LEAN BULL	-99.2
STEK Stemtech Corporation	—	-0.0	58.2	37.1	-46.5	-38.6	2	LEAN BULL	-99.2
NMLSF Restart Life Sciences Corp.	—	-1.8	-214.3	-153.9	-307.0	—	2	LEAN BULL	83.8
NMLSF Restart Life Sciences Corp.	—	-1.8	-214.3	-153.9	-307.0	—	2	LEAN BULL	83.8
BIXT Bioxytran, Inc.	—	-0.7	92.2	68.7	—	—	4	LEAN BULL	-66.3
BIXT Bioxytran, Inc.	—	-0.7	92.2	68.7	—	—	4	LEAN BULL	-66.3
HRTX Heron Therapeutics, Inc.	$70M	-1.9	334.6	-7.6	-14.6	1.0	3	LEAN BULL	-72.2
HRTX Heron Therapeutics, Inc.	$70M	-1.9	334.6	-7.6	-14.6	1.0	3	LEAN BULL	-72.2
NVYTF Novacyt S.A.	$40M	-0.8	-97.2	-129.7	-161.6	181.0	5	LEAN BULL	14.0
NVYTF Novacyt S.A.	$40M	-0.8	-97.2	-129.7	-161.6	181.0	5	LEAN BULL	14.0
ARAY Accuray Incorporated	$30M	-0.7	-80.1	-11.3	-1.9	-12.3	2	LEAN BULL	-83.0
ARAY Accuray Incorporated	$30M	-0.7	-80.1	-11.3	-1.9	-12.3	2	LEAN BULL	-83.0
MAZE Maze Therapeutics, Inc.	$1.5B	-9.6	-37.3	-112.3	—	—	3	NEUTRAL	2.4
MAZE Maze Therapeutics, Inc.	$1.5B	-9.6	-37.3	-112.3	—	—	3	NEUTRAL	2.4
SPRO Spero Therapeutics, Inc.	$70M	8.5	19.2	-128.5	—	-7.0	7	NEUTRAL	-39.3
SPRO Spero Therapeutics, Inc.	$70M	8.5	19.2	-128.5	—	-7.0	7	NEUTRAL	-39.3
AEON AEON Biopharma, Inc.	$10M	-0.1	350.0	98.0	—	—	2	NEUTRAL	-67.1
AEON AEON Biopharma, Inc.	$10M	-0.1	350.0	98.0	—	—	2	NEUTRAL	-67.1
ORGS Orgenesis Inc.	$10M	-0.3	764.3	1083.0	2628.2	-192.0	1	NEUTRAL	-26.6
ORGS Orgenesis Inc.	$10M	-0.3	764.3	1083.0	2628.2	-192.0	1	NEUTRAL	-26.6
CPMV Mosaic ImmunoEngineering Inc.	—	-1.2	9.2	7.5	—	—	2	NEUTRAL	-84.9
CPMV Mosaic ImmunoEngineering Inc.	—	-1.2	9.2	7.5	—	—	2	NEUTRAL	-84.9
FOXO FOXO Technologies Inc.	—	0.0	-62.5	-3.2	172.6	44.0	3	NEUTRAL	2182.2
FOXO FOXO Technologies Inc.	—	0.0	-62.5	-3.2	172.6	44.0	3	NEUTRAL	2182.2
IOBCF Ion Beam Applications S.A.	$530M	18.3	39.6	26.8	2.9	41.2	5	NEUTRAL	43.7
IOBCF Ion Beam Applications S.A.	$530M	18.3	39.6	26.8	2.9	41.2	5	NEUTRAL	43.7
CAPR Capricor Therapeutics, Inc.	$510M	-3.7	-73.7	-107.5	—	-100.0	3	NEUTRAL	14.4
CAPR Capricor Therapeutics, Inc.	$510M	-3.7	-73.7	-107.5	—	-100.0	3	NEUTRAL	14.4
PBYI Puma Biotechnology, Inc.	$480M	17.7	22.0	52.8	14.5	-2.9	6	NEUTRAL	80.5
PBYI Puma Biotechnology, Inc.	$480M	17.7	22.0	52.8	14.5	-2.9	6	NEUTRAL	80.5
GRUSF Grown Rogue International Inc.	$110M	-25.4	-20.2	12.8	-8.8	58.1	5	NEUTRAL	6.5
GRUSF Grown Rogue International Inc.	$110M	-25.4	-20.2	12.8	-8.8	58.1	5	NEUTRAL	6.5
DARE Dare Bioscience, Inc.	$10M	-1.1	165.3	136.8	-1590.4	7816.7	3	NEUTRAL	-60.8
DARE Dare Bioscience, Inc.	$10M	-1.1	165.3	136.8	-1590.4	7816.7	3	NEUTRAL	-60.8
PBFFF Planet Based Foods Global Inc.	—	-0.9	69.6	63.1	—	100.0	2	NEUTRAL	-78.1
PBFFF Planet Based Foods Global Inc.	—	-0.9	69.6	63.1	—	100.0	2	NEUTRAL	-78.1
ERGO Entia Biosciences, Inc.	—	-0.0	106.8	92.5	-1021.5	-23.5	5	NEUTRAL	900.0
ERGO Entia Biosciences, Inc.	—	-0.0	106.8	92.5	-1021.5	-23.5	5	NEUTRAL	900.0
HIGR Hi-Great Group Holding Company	—	-19.3	30.7	30.8	-177.4	-40.3	1	NEUTRAL	-91.3
HIGR Hi-Great Group Holding Company	—	-19.3	30.7	30.8	-177.4	-40.3	1	NEUTRAL	-91.3
KAYS Kaya Holdings, Inc.	—	-0.0	141.1	-11929.1	-158865.8	-102.0	3	NEUTRAL	-97.2
KAYS Kaya Holdings, Inc.	—	-0.0	141.1	-11929.1	-158865.8	-102.0	3	NEUTRAL	-97.2
SYRA Syra Health Corp. Class A Common Stock	$10M	91.7	5.2	11.3	10.5	0.3	4	NEUTRAL	927.8
SYRA Syra Health Corp. Class A Common Stock	$10M	91.7	5.2	11.3	10.5	0.3	4	NEUTRAL	927.8
KPRX Kiora Pharmaceuticals, Inc.	$10M	-1.0	-56.4	-2884.1	—	—	2	NEUTRAL	-9.5
KPRX Kiora Pharmaceuticals, Inc.	$10M	-1.0	-56.4	-2884.1	—	—	2	NEUTRAL	-9.5
HBRM Herborium Group, Inc.	—	-4.7	0.6	0.6	0.7	-2.7	5	NEUTRAL	0.0
HBRM Herborium Group, Inc.	—	-4.7	0.6	0.6	0.7	-2.7	5	NEUTRAL	0.0
VYCO Vycor Medical, Inc.	—	-37.2	1.5	-1.1	-5.3	1.6	6	NEUTRAL	-61.7
VYCO Vycor Medical, Inc.	—	-37.2	1.5	-1.1	-5.3	1.6	6	NEUTRAL	-61.7
SAGD South American Gold Corp.	—	-0.5	106.5	49.7	—	—	1	NEUTRAL	900.0
SAGD South American Gold Corp.	—	-0.5	106.5	49.7	—	—	1	NEUTRAL	900.0
ATEC Alphatec Holdings, Inc.	$1.5B	-13.9	-623.1	-7.6	-12.1	19.5	5	NEUTRAL	-28.2
ATEC Alphatec Holdings, Inc.	$1.5B	-13.9	-623.1	-7.6	-12.1	19.5	5	NEUTRAL	-28.2
NEO NeoGenomics, Inc.	$470M	-9.3	-6.3	-4.8	1.1	11.2	5	NEUTRAL	111.8
NEO NeoGenomics, Inc.	$470M	-9.3	-6.3	-4.8	1.1	11.2	5	NEUTRAL	111.8
COYA Coya Therapeutics, Inc.	$110M	-4.5	-0.1	-18.8	-2723.4	1793.8	3	NEUTRAL	-17.8
COYA Coya Therapeutics, Inc.	$110M	-4.5	-0.1	-18.8	-2723.4	1793.8	3	NEUTRAL	-17.8
BIAFW bioAffinity Technologies, Inc.	$10M	-0.1	-1860.2	-352.6	-222.8	-23.2	4	NEUTRAL	175.2
BIAFW bioAffinity Technologies, Inc.	$10M	-0.1	-1860.2	-352.6	-222.8	-23.2	4	NEUTRAL	175.2
AFMDQ Affimed N.V.	—	—	—	—	—	—	—	NEUTRAL	—
AFMDQ Affimed N.V.	—	—	—	—	—	—	—	NEUTRAL	—
PNTG The Pennant Group, Inc.	$1.4B	41.7	9.6	5.5	3.0	37.9	6	NEUTRAL	61.7
PNTG The Pennant Group, Inc.	$1.4B	41.7	9.6	5.5	3.0	37.9	6	NEUTRAL	61.7
ANL Adlai Nortye Ltd.	$800M	-7.7	-22.4	-317.5	-36.3	223.4	4	NEUTRAL	738.3
ANL Adlai Nortye Ltd.	$800M	-7.7	-22.4	-317.5	-36.3	223.4	4	NEUTRAL	738.3
CDIO Cardio Diagnostics Holdings, Inc.	$10M	-0.7	-75.4	-230.9	-28012.5	-25.9	3	NEUTRAL	-54.0
CDIO Cardio Diagnostics Holdings, Inc.	$10M	-0.7	-75.4	-230.9	-28012.5	-25.9	3	NEUTRAL	-54.0
VASO Vaso Corporation	$50M	18.5	10.0	-3055.8	7.5	-8.0	8	NEUTRAL	153.9
VASO Vaso Corporation	$50M	18.5	10.0	-3055.8	7.5	-8.0	8	NEUTRAL	153.9
PETV PetVivo Holdings, Inc.	$30M	-2.4	-326.3	-286.3	-1163.4	0.8	4	NEUTRAL	-37.0
PETV PetVivo Holdings, Inc.	$30M	-2.4	-326.3	-286.3	-1163.4	0.8	4	NEUTRAL	-37.0
CLGN CollPlant Biotechnologies Ltd.	—	-0.4	-162.0	-369.3	-2524.1	-86.8	2	NEUTRAL	-86.5
CLGN CollPlant Biotechnologies Ltd.	—	-0.4	-162.0	-369.3	-2524.1	-86.8	2	NEUTRAL	-86.5
SAFLY Safilo Group S.p.A.	$1.4B	14.3	22.4	19.9	8.7	-4.8	7	NEUTRAL	40.1
SAFLY Safilo Group S.p.A.	$1.4B	14.3	22.4	19.9	8.7	-4.8	7	NEUTRAL	40.1
OMER Omeros Corporation	$1.4B	9.7	-89.2	71.8	46.4	—	5	NEUTRAL	349.5
OMER Omeros Corporation	$1.4B	9.7	-89.2	71.8	46.4	—	5	NEUTRAL	349.5
CAIHF CPBIO Holding Company Limited	$830M	10.5	10.0	8.1	3.4	73.4	8	NEUTRAL	282.1
CAIHF CPBIO Holding Company Limited	$830M	10.5	10.0	8.1	3.4	73.4	8	NEUTRAL	282.1
VREX Varex Imaging Corporation	$780M	35.2	4.6	7.6	7.5	5.3	6	NEUTRAL	50.9
VREX Varex Imaging Corporation	$780M	35.2	4.6	7.6	7.5	5.3	6	NEUTRAL	50.9
SOLTF Nxera Pharma Co., Ltd.	$720M	-14.1	-12.0	-1.7	-2.6	7.5	4	NEUTRAL	22.2
SOLTF Nxera Pharma Co., Ltd.	$720M	-14.1	-12.0	-1.7	-2.6	7.5	4	NEUTRAL	22.2
SUSRF Surgical Science Sweden AB	$270M	27.3	2.1	2.7	8.2	8.1	6	NEUTRAL	-46.5
SUSRF Surgical Science Sweden AB	$270M	27.3	2.1	2.7	8.2	8.1	6	NEUTRAL	-46.5
HWAIF Healwell AI Inc.	$170M	-6.1	-21.9	-10.8	19.4	54.1	5	NEUTRAL	-47.0
HWAIF Healwell AI Inc.	$170M	-6.1	-21.9	-10.8	19.4	54.1	5	NEUTRAL	-47.0
MLLCF Molecular Partners AG	$150M	-2.4	-62.1	650.3	—	-100.0	2	NEUTRAL	14.6
MLLCF Molecular Partners AG	$150M	-2.4	-62.1	650.3	—	-100.0	2	NEUTRAL	14.6
PRNAF Alterity Therapeutics Limited	$90M	-3.4	-117.0	-556.9	—	-41.1	4	NEUTRAL	13233.3
PRNAF Alterity Therapeutics Limited	$90M	-3.4	-117.0	-556.9	—	-41.1	4	NEUTRAL	13233.3
OKYO OKYO Pharma Limited	$60M	-6.1	-213.7	128.1	—	—	3	NEUTRAL	-26.9
OKYO OKYO Pharma Limited	$60M	-6.1	-213.7	128.1	—	—	3	NEUTRAL	-26.9
SETO SETO Holdings, Inc.	—	-7.5	-22.5	-8.5	-32.2	9760.2	6	NEUTRAL	17.6
SETO SETO Holdings, Inc.	—	-7.5	-22.5	-8.5	-32.2	9760.2	6	NEUTRAL	17.6
YBGJ Yubo International Biotech Limited	—	-0.8	28.2	30.1	—	9417.8	5	NEUTRAL	-19.4
YBGJ Yubo International Biotech Limited	—	-0.8	28.2	30.1	—	9417.8	5	NEUTRAL	-19.4
PRCNF Pure Global Cannabis Inc.	—	—	—	—	—	—	—	NEUTRAL	0.0
PRCNF Pure Global Cannabis Inc.	—	—	—	—	—	—	—	NEUTRAL	0.0
EDXC Endexx Corporation	—	-0.0	51.8	0.5	—	-125.6	2	NEUTRAL	-95.8
EDXC Endexx Corporation	—	-0.0	51.8	0.5	—	-125.6	2	NEUTRAL	-95.8
LVRLF CordovaCann Corp.	—	-1.0	47.4	-18.4	-6.5	-2.8	4	NEUTRAL	-35.2
LVRLF CordovaCann Corp.	—	-1.0	47.4	-18.4	-6.5	-2.8	4	NEUTRAL	-35.2
XBRAF Xebra Brands Ltd.	—	-0.1	-542.1	-2373.1	—	-100.0	1	NEUTRAL	-98.5
XBRAF Xebra Brands Ltd.	—	-0.1	-542.1	-2373.1	—	-100.0	1	NEUTRAL	-98.5
CBIA Canopus Biopharma, Inc.	—	-0.0	1457.1	15327.7	—	—	1	NEUTRAL	0.0
CBIA Canopus Biopharma, Inc.	—	-0.0	1457.1	15327.7	—	—	1	NEUTRAL	0.0
HRAL Hear AtLast Holdings, Inc.	—	-0.3	16.3	89.4	—	—	3	NEUTRAL	-20.0
HRAL Hear AtLast Holdings, Inc.	—	-0.3	16.3	89.4	—	—	3	NEUTRAL	-20.0
NSRS North Springs Resources Corp.	—	-0.0	-92.1	-21.1	—	—	2	NEUTRAL	0.0
NSRS North Springs Resources Corp.	—	-0.0	-92.1	-21.1	—	—	2	NEUTRAL	0.0
MNZO Manzo Pharmaceuticals, Inc.	—	-1.0	4.6	4.1	—	—	2	NEUTRAL	0.0
MNZO Manzo Pharmaceuticals, Inc.	—	-1.0	4.6	4.1	—	—	2	NEUTRAL	0.0
CLNN Clene Inc.	$50M	-1.1	237.2	132.5	-14915.6	-31.1	2	NEUTRAL	-40.5
CLNN Clene Inc.	$50M	-1.1	237.2	132.5	-14915.6	-31.1	2	NEUTRAL	-40.5
SXTC China SXT Pharmaceuticals, Inc.	—	-0.3	-32.7	-254.3	13.7	42.5	6	NEUTRAL	47.0
SXTC China SXT Pharmaceuticals, Inc.	—	-0.3	-32.7	-254.3	13.7	42.5	6	NEUTRAL	47.0
MOTS Motus GI Holdings, Inc.	—	-0.0	-1069.0	-1348.2	-3301.6	-47.9	4	NEUTRAL	1900.0
MOTS Motus GI Holdings, Inc.	—	-0.0	-1069.0	-1348.2	-3301.6	-47.9	4	NEUTRAL	1900.0
ANIP ANI Pharmaceuticals, Inc.	$1.6B	14.9	20.0	20.7	9.3	30.9	7	NEUTRAL	-20.0
ANIP ANI Pharmaceuticals, Inc.	$1.6B	14.9	20.0	20.7	9.3	30.9	7	NEUTRAL	-20.0
ARRJF Arjo AB (publ)	$790M	19.0	5.0	4.3	4.5	-3.5	6	NEUTRAL	-16.9
ARRJF Arjo AB (publ)	$790M	19.0	5.0	4.3	4.5	-3.5	6	NEUTRAL	-16.9
ACB Aurora Cannabis Inc.	$240M	-2.9	-13.9	-0.4	-149.7	-9.4	5	NEUTRAL	-31.6
ACB Aurora Cannabis Inc.	$240M	-2.9	-13.9	-0.4	-149.7	-9.4	5	NEUTRAL	-31.6
ETRA Electra Therapeutics Inc.	$220M	—	—	—	—	—	—	N/A	—
ETRA Electra Therapeutics Inc.	$220M	—	—	—	—	—	—	N/A	—
KNTPF Kintor Pharmaceutical Limited	$110M	-3.7	-111.3	-105.7	-145.6	3136.1	3	NEUTRAL	-6.7
KNTPF Kintor Pharmaceutical Limited	$110M	-3.7	-111.3	-105.7	-145.6	3136.1	3	NEUTRAL	-6.7
POSC Positron Corporation	$60M	-5.7	1961.0	-1406.8	-734.6	-22.9	2	NEUTRAL	26.4
POSC Positron Corporation	$60M	-5.7	1961.0	-1406.8	-734.6	-22.9	2	NEUTRAL	26.4
BXPHF Botanix Pharmaceuticals Limited	$40M	-0.6	-181.3	-285.1	-203.1	1249.3	2	NEUTRAL	-88.1
BXPHF Botanix Pharmaceuticals Limited	$40M	-0.6	-181.3	-285.1	-203.1	1249.3	2	NEUTRAL	-88.1
MMIRF MedMira Inc.	$30M	-13.6	11.8	21.7	-200.5	45.7	4	NEUTRAL	-55.8
MMIRF MedMira Inc.	$30M	-13.6	11.8	21.7	-200.5	45.7	4	NEUTRAL	-55.8
ENVB Enveric Biosciences, Inc.	$10M	-0.1	-170.0	3225.6	—	—	4	NEUTRAL	-81.4
ENVB Enveric Biosciences, Inc.	$10M	-0.1	-170.0	3225.6	—	—	4	NEUTRAL	-81.4
BCLI Brainstorm Cell Therapeutics Inc.	$10M	-1.0	119.2	76.7	—	-100.0	1	NEUTRAL	31.0
BCLI Brainstorm Cell Therapeutics Inc.	$10M	-1.0	119.2	76.7	—	-100.0	1	NEUTRAL	31.0
HYHY Hydrogen Hybrid Technologies, Inc.	—	-0.0	-138.6	-342.9	—	16.1	4	NEUTRAL	0.0
HYHY Hydrogen Hybrid Technologies, Inc.	—	-0.0	-138.6	-342.9	—	16.1	4	NEUTRAL	0.0
HLSQ Tessera Defense and Homeland Security Inc	—	—	—	—	—	—	—	N/A	—
HLSQ Tessera Defense and Homeland Security Inc	—	—	—	—	—	—	—	N/A	—
CNGGF Cann Group Limited	—	0.3	-9.6	-35.6	-150.3	-32.1	4	NEUTRAL	-43.5
CNGGF Cann Group Limited	—	0.3	-9.6	-35.6	-150.3	-32.1	4	NEUTRAL	-43.5
CLRD Clearday, Inc.	—	-0.0	41.6	33.3	-296.5	-39.1	3	NEUTRAL	108.3
CLRD Clearday, Inc.	—	-0.0	41.6	33.3	-296.5	-39.1	3	NEUTRAL	108.3
SVSO SheerVision, Inc.	—	-0.0	31.8	-24.5	42.2	-32.8	3	NEUTRAL	0.0
SVSO SheerVision, Inc.	—	-0.0	31.8	-24.5	42.2	-32.8	3	NEUTRAL	0.0
ERUC ER Urgent Care Holdings, Inc.	—	—	—	—	—	—	—	N/A	-99.0
ERUC ER Urgent Care Holdings, Inc.	—	—	—	—	—	—	—	N/A	-99.0
CENBF CEN Biotech, Inc.	—	-0.0	32.0	-64.0	569.4	-54.9	5	NEUTRAL	200.0
CENBF CEN Biotech, Inc.	—	-0.0	32.0	-64.0	569.4	-54.9	5	NEUTRAL	200.0
GRI GRI Bio, Inc.	—	-0.0	-142.0	1227.5	—	—	5	NEUTRAL	-96.5
GRI GRI Bio, Inc.	—	-0.0	-142.0	1227.5	—	—	5	NEUTRAL	-96.5
GBCS Selectis Health, Inc.	$20M	1.2	1850.1	-22.2	171.7	-21.3	4	NEUTRAL	154.7
GBCS Selectis Health, Inc.	$20M	1.2	1850.1	-22.2	171.7	-21.3	4	NEUTRAL	154.7
QNTM Quantum BioPharma Ltd.	$20M	-0.6	-425.3	175.1	—	—	4	NEUTRAL	-79.1
QNTM Quantum BioPharma Ltd.	$20M	-0.6	-425.3	175.1	—	—	4	NEUTRAL	-79.1
SIGY Sigyn Therapeutics, Inc.	—	-0.0	61.7	32.8	—	-100.0	1	NEUTRAL	-99.1
SIGY Sigyn Therapeutics, Inc.	—	-0.0	61.7	32.8	—	-100.0	1	NEUTRAL	-99.1
ACAI Safeplus International Holdings Limited	—	-0.4	-205.0	-617.4	-224.7	-94.2	1	NEUTRAL	200.0
ACAI Safeplus International Holdings Limited	—	-0.4	-205.0	-617.4	-224.7	-94.2	1	NEUTRAL	200.0
ITNS Itonis, Inc.	—	-53.9	2.9	16.1	-299.0	-55.8	3	NEUTRAL	33.3
ITNS Itonis, Inc.	—	-53.9	2.9	16.1	-299.0	-55.8	3	NEUTRAL	33.3
PHMMF Pharma Mar, S.A.	$1.6B	21.9	24.9	35.9	-2.0	15.5	7	NEUTRAL	-7.5
PHMMF Pharma Mar, S.A.	$1.6B	21.9	24.9	35.9	-2.0	15.5	7	NEUTRAL	-7.5
INRLF Valneva SE	$640M	-2.8	-118.0	-54.8	-89.3	-27.2	1	NEUTRAL	-31.5
INRLF Valneva SE	$640M	-2.8	-118.0	-54.8	-89.3	-27.2	1	NEUTRAL	-31.5
XLO Xilio Therapeutics, Inc.	$60M	-6.0	-55.0	43.1	-34.1	327.3	6	NEUTRAL	982.1
XLO Xilio Therapeutics, Inc.	$60M	-6.0	-55.0	43.1	-34.1	327.3	6	NEUTRAL	982.1
CNVIF Conavi Medical Corp.	$10M	13.2	57.4	363.8	-4867.7	—	2	NEUTRAL	—
CNVIF Conavi Medical Corp.	$10M	13.2	57.4	363.8	-4867.7	—	2	NEUTRAL	—
DVLP Golden Developing Solutions, Inc.	—	-0.0	450.9	46.1	-166.7	—	6	NEUTRAL	-90.0
DVLP Golden Developing Solutions, Inc.	—	-0.0	450.9	46.1	-166.7	—	6	NEUTRAL	-90.0
OMCL Omnicell, Inc.	$1.5B	39.3	3.1	3.2	7.8	8.5	9	NEUTRAL	12.2
OMCL Omnicell, Inc.	$1.5B	39.3	3.1	3.2	7.8	8.5	9	NEUTRAL	12.2
PCRX Pacira BioSciences, Inc.	$990M	71.6	2.0	1.8	2.4	5.7	8	NEUTRAL	-0.2
PCRX Pacira BioSciences, Inc.	$990M	71.6	2.0	1.8	2.4	5.7	8	NEUTRAL	-0.2
CNTN Canton Strategic Holdings Inc	$170M	-1.4	-14.6	-7.2	-1287.2	—	2	NEUTRAL	—
CNTN Canton Strategic Holdings Inc	$170M	-1.4	-14.6	-7.2	-1287.2	—	2	NEUTRAL	—
FCHS First Choice Healthcare Solutions, Inc.	—	-0.0	61.1	51.6	—	140.3	4	NEUTRAL	-38.5
FCHS First Choice Healthcare Solutions, Inc.	—	-0.0	61.1	51.6	—	140.3	4	NEUTRAL	-38.5
FORZ Forza Innovations Inc.	—	-0.0	91.9	0.0	11330.0	8.7	3	NEUTRAL	0.0
FORZ Forza Innovations Inc.	—	-0.0	91.9	0.0	11330.0	8.7	3	NEUTRAL	0.0
FRLI FrÃ©lii, Inc.	—	-0.0	-671.6	-265.5	-10546.4	378.8	4	NEUTRAL	0.0
FRLI FrÃ©lii, Inc.	—	-0.0	-671.6	-265.5	-10546.4	378.8	4	NEUTRAL	0.0
RBSH Rebus Holdings, Inc.	—	-0.0	-9.7	8.9	—	—	2	NEUTRAL	0.0
RBSH Rebus Holdings, Inc.	—	-0.0	-9.7	8.9	—	—	2	NEUTRAL	0.0
VPHIF Valeo Pharma Inc.	—	-0.0	65.5	19863.3	-65.0	-0.2	2	NEUTRAL	-99.8
VPHIF Valeo Pharma Inc.	—	-0.0	65.5	19863.3	-65.0	-0.2	2	NEUTRAL	-99.8
BGXXQ Bright Green Corporation	—	—	—	—	—	—	—	NEUTRAL	—
BGXXQ Bright Green Corporation	—	—	—	—	—	—	—	NEUTRAL	—
OCLG Oncologix Tech Inc.	—	-0.0	255.0	—	—	-20.4	2	NEUTRAL	0.0
OCLG Oncologix Tech Inc.	—	-0.0	255.0	—	—	-20.4	2	NEUTRAL	0.0
VRCI Verde Science, Inc.	—	-0.0	72.3	23.0	—	—	5	NEUTRAL	1900.0
VRCI Verde Science, Inc.	—	-0.0	72.3	23.0	—	—	5	NEUTRAL	1900.0
PASO Patient Access Solutions, Inc.	—	-0.0	540.4	691.6	0.6	—	2	NEUTRAL	9900.0
PASO Patient Access Solutions, Inc.	—	-0.0	540.4	691.6	0.6	—	2	NEUTRAL	9900.0
ISCNF Isracann Biosciences Inc.	—	-0.5	-252.3	2640.8	—	—	2	NEUTRAL	0.0
ISCNF Isracann Biosciences Inc.	—	-0.5	-252.3	2640.8	—	—	2	NEUTRAL	0.0
LIMNW Liminatus Pharma, Inc. Warrants	—	-0.2	-4165.9	252.1	—	—	2	NEUTRAL	-85.8
LIMNW Liminatus Pharma, Inc. Warrants	—	-0.2	-4165.9	252.1	—	—	2	NEUTRAL	-85.8
HAVLF HAVN Life Sciences Inc.	—	-0.0	-275.3	-163.4	5734.1	876.8	3	NEUTRAL	0.0
HAVLF HAVN Life Sciences Inc.	—	-0.0	-275.3	-163.4	5734.1	876.8	3	NEUTRAL	0.0
DRWN Quantum Medical Transport, Inc.	—	0.3	25.7	20.8	2.2	-96.3	4	NEUTRAL	0.0
DRWN Quantum Medical Transport, Inc.	—	0.3	25.7	20.8	2.2	-96.3	4	NEUTRAL	0.0
BBBT Black Bird Biotech, Inc.	—	-0.0	129.1	137.7	-3333.2	-61.0	2	NEUTRAL	0.0
BBBT Black Bird Biotech, Inc.	—	-0.0	129.1	137.7	-3333.2	-61.0	2	NEUTRAL	0.0
GMVDF G Medical Innovations Holdings Ltd	—	-0.0	662.5	718.7	-585.5	—	1	NEUTRAL	0.0
GMVDF G Medical Innovations Holdings Ltd	—	-0.0	662.5	718.7	-585.5	—	1	NEUTRAL	0.0
RLBD Real Brands, Inc.	—	-0.0	62.2	111.8	—	204.2	5	NEUTRAL	-90.0
RLBD Real Brands, Inc.	—	-0.0	62.2	111.8	—	204.2	5	NEUTRAL	-90.0
CBDG THC Farmaceuticals, Inc.	—	-41.9	2.0	-0.9	—	28.1	5	NEUTRAL	83.2
CBDG THC Farmaceuticals, Inc.	—	-41.9	2.0	-0.9	—	28.1	5	NEUTRAL	83.2
VSTM Verastem, Inc.	$680M	-3.1	-471.2	6197.3	-86.5	3995.7	4	NEUTRAL	-12.5
VSTM Verastem, Inc.	$680M	-3.1	-471.2	6197.3	-86.5	3995.7	4	NEUTRAL	-12.5
ASTH Astrana Health, Inc.	$1.8B	43.4	5.1	4.7	2.0	58.9	5	NEUTRAL	27.4
ASTH Astrana Health, Inc.	$1.8B	43.4	5.1	4.7	2.0	58.9	5	NEUTRAL	27.4
EVOTF Evotec SE	$1.2B	-2.6	-26.1	-14.9	-32.5	-7.7	2	NEUTRAL	-8.1
EVOTF Evotec SE	$1.2B	-2.6	-26.1	-14.9	-32.5	-7.7	2	NEUTRAL	-8.1
OPK OPKO Health, Inc.	$1.2B	-16.4	-5.9	-3.0	-5.1	-11.5	2	NEUTRAL	0.7
OPK OPKO Health, Inc.	$1.2B	-16.4	-5.9	-3.0	-5.1	-11.5	2	NEUTRAL	0.7
CSWYF China Shineway Pharmaceutical Group Limited	$760M	5.9	21.7	50.7	21.6	277.6	4	NEUTRAL	-12.7
CSWYF China Shineway Pharmaceutical Group Limited	$760M	5.9	21.7	50.7	21.6	277.6	4	NEUTRAL	-12.7
INTI Inhibitor Therapeutics, Inc.	$20M	-5.1	358.8	88.0	—	—	1	NEUTRAL	96.0
INTI Inhibitor Therapeutics, Inc.	$20M	-5.1	358.8	88.0	—	—	1	NEUTRAL	96.0
LIMN Liminatus Pharma, Inc. Class A Common Stock	$10M	-0.2	294.4	252.1	—	—	4	NEUTRAL	-95.5
LIMN Liminatus Pharma, Inc. Class A Common Stock	$10M	-0.2	294.4	252.1	—	—	4	NEUTRAL	-95.5
VBIO Valion Bio, Inc.	$10M	-0.0	-122.7	-45.5	—	—	2	NEUTRAL	—
VBIO Valion Bio, Inc.	$10M	-0.0	-122.7	-45.5	—	—	2	NEUTRAL	—
IDTA IDenta Corp.	—	8.7	13.8	25.0	-9.1	57.3	8	NEUTRAL	72.2
IDTA IDenta Corp.	—	8.7	13.8	25.0	-9.1	57.3	8	NEUTRAL	72.2
VVOS Vivos Therapeutics, Inc.	—	-0.1	-6663.0	-267.4	-106.4	45.2	3	NEUTRAL	-95.2
VVOS Vivos Therapeutics, Inc.	—	-0.1	-6663.0	-267.4	-106.4	45.2	3	NEUTRAL	-95.2
UPC Universe Pharmaceuticals Inc.	—	-1.3	-2.1	-23.4	-17.2	-39.4	3	NEUTRAL	2.3
UPC Universe Pharmaceuticals Inc.	—	-1.3	-2.1	-23.4	-17.2	-39.4	3	NEUTRAL	2.3
MTNB Matinas BioPharma Holdings, Inc.	—	-0.1	-154.3	-504.1	—	—	4	NEUTRAL	-90.6
MTNB Matinas BioPharma Holdings, Inc.	—	-0.1	-154.3	-504.1	—	—	4	NEUTRAL	-90.6
TNPH Tian'an Pharmaceutical Co., Ltd.	—	-1699.6	0.3	33.0	—	-100.0	3	NEUTRAL	983.3
TNPH Tian'an Pharmaceutical Co., Ltd.	—	-1699.6	0.3	33.0	—	-100.0	3	NEUTRAL	983.3
RARE Ultragenyx Pharmaceutical Inc.	$1.5B	-2.6	839.4	-67.5	-43.0	17.5	2	NEUTRAL	-49.2
RARE Ultragenyx Pharmaceutical Inc.	$1.5B	-2.6	839.4	-67.5	-43.0	17.5	2	NEUTRAL	-49.2
EBRCZ EBR Systems, Inc.	$140M	-1.9	-102.2	22812.5	-661.9	305113.7	3	NEUTRAL	-75.0
EBRCZ EBR Systems, Inc.	$140M	-1.9	-102.2	22812.5	-661.9	305113.7	3	NEUTRAL	-75.0
HCAT Health Catalyst, Inc.	$130M	-0.5	-118.1	-27.1	-57.5	-7.5	5	NEUTRAL	-37.7
HCAT Health Catalyst, Inc.	$130M	-0.5	-118.1	-27.1	-57.5	-7.5	5	NEUTRAL	-37.7
TENX Tenax Therapeutics, Inc.	$50M	-1.3	-59.8	1235.8	—	—	1	NEUTRAL	-74.0
TENX Tenax Therapeutics, Inc.	$50M	-1.3	-59.8	1235.8	—	—	1	NEUTRAL	-74.0
ACON Aclarion, Inc.	$10M	-0.3	-59.0	-1069.5	-10899.5	33.1	3	NEUTRAL	-68.6
ACON Aclarion, Inc.	$10M	-0.3	-59.0	-1069.5	-10899.5	33.1	3	NEUTRAL	-68.6
HENC Hero Technologies Inc.	—	-0.1	-10112.1	3310.9	—	100.0	4	NEUTRAL	0.0
HENC Hero Technologies Inc.	—	-0.1	-10112.1	3310.9	—	100.0	4	NEUTRAL	0.0
BTTX Better Therapeutics, Inc.	—	-0.0	2351.8	1050.0	—	-100.0	1	NEUTRAL	-0.0
BTTX Better Therapeutics, Inc.	—	-0.0	2351.8	1050.0	—	-100.0	1	NEUTRAL	-0.0
VRPX Virpax Pharmaceuticals, Inc.	—	-0.0	2.6	0.4	—	—	1	NEUTRAL	-55.6
VRPX Virpax Pharmaceuticals, Inc.	—	-0.0	2.6	0.4	—	—	1	NEUTRAL	-55.6
KHRNF Khiron Life Sciences Corp.	—	-0.2	-74.7	-41.4	-105.6	76.2	2	NEUTRAL	0.0
KHRNF Khiron Life Sciences Corp.	—	-0.2	-74.7	-41.4	-105.6	76.2	2	NEUTRAL	0.0
RGIN Regenicin, Inc.	—	-0.0	16.9	4.1	—	—	4	NEUTRAL	0.0
RGIN Regenicin, Inc.	—	-0.0	16.9	4.1	—	—	4	NEUTRAL	0.0
ONCO Onconetix, Inc.	—	-0.1	-105.2	-83.7	-16748.3	-51.3	3	NEUTRAL	-75.7
ONCO Onconetix, Inc.	—	-0.1	-105.2	-83.7	-16748.3	-51.3	3	NEUTRAL	-75.7
SRNE Sorrento Therapeutics, Inc.	—	-0.0	1502.8	468.4	-633.7	16.9	2	NEUTRAL	-77.1
SRNE Sorrento Therapeutics, Inc.	—	-0.0	1502.8	468.4	-633.7	16.9	2	NEUTRAL	-77.1
LTGHY Life Healthcare Group Holdings Limited	$1.0B	2.4	52.6	6.9	6.2	19.4	7	LEAN BEAR	3.7
LTGHY Life Healthcare Group Holdings Limited	$1.0B	2.4	52.6	6.9	6.2	19.4	7	LEAN BEAR	3.7
GLSI Greenwich LifeSciences, Inc.	$250M	-11.0	-951.6	299.9	—	—	2	LEAN BEAR	68.0
GLSI Greenwich LifeSciences, Inc.	$250M	-11.0	-951.6	299.9	—	—	2	LEAN BEAR	68.0
MDWD MediWound Ltd.	$170M	-8.4	-72.4	-255.1	-239.1	-40.3	2	LEAN BEAR	-22.7
MDWD MediWound Ltd.	$170M	-8.4	-72.4	-255.1	-239.1	-40.3	2	LEAN BEAR	-22.7
ACRV Acrivon Therapeutics, Inc. Common Stock	$90M	-1.1	-64.6	5251.5	—	—	1	LEAN BEAR	9.9
ACRV Acrivon Therapeutics, Inc. Common Stock	$90M	-1.1	-64.6	5251.5	—	—	1	LEAN BEAR	9.9
AURX Nuo Therapeutics, Inc.	$60M	-29.9	170.6	280.3	-15.7	166.6	3	LEAN BEAR	-35.9
AURX Nuo Therapeutics, Inc.	$60M	-29.9	170.6	280.3	-15.7	166.6	3	LEAN BEAR	-35.9
STLN Starling Oncology, Inc.	$630M	—	—	—	—	—	—	LEAN BEAR	—
STLN Starling Oncology, Inc.	$630M	—	—	—	—	—	—	LEAN BEAR	—
SGMOQ Sangamo Therapeutics, Inc.	$60M	—	—	—	—	—	—	LEAN BEAR	—
SGMOQ Sangamo Therapeutics, Inc.	$60M	—	—	—	—	—	—	LEAN BEAR	—
OSSFF Embla Medical hf.	$1.9B	18.9	10.7	7.7	11.3	11.7	7	LEAN BEAR	-5.6
OSSFF Embla Medical hf.	$1.9B	18.9	10.7	7.7	11.3	11.7	7	LEAN BEAR	-5.6
SGIPF Sugi Holdings Co.,Ltd.	$1.8B	14.6	8.8	9.6	3.6	-12.7	5	LEAN BEAR	-41.7
SGIPF Sugi Holdings Co.,Ltd.	$1.8B	14.6	8.8	9.6	3.6	-12.7	5	LEAN BEAR	-41.7
GWIN Glorywin Entertainment Group, Inc.	$230M	-26081.4	11.7	5.1	—	—	1	LEAN BEAR	254.3
GWIN Glorywin Entertainment Group, Inc.	$230M	-26081.4	11.7	5.1	—	—	1	LEAN BEAR	254.3
MILFF 1CM Inc.	$30M	7.4	15.1	7.4	2.5	7.3	7	LEAN BEAR	-28.8
MILFF 1CM Inc.	$30M	7.4	15.1	7.4	2.5	7.3	7	LEAN BEAR	-28.8
BIOQ Bioqual, Inc.	$30M	-7.1	-2.8	-4.3	-0.8	-16.6	3	LEAN BEAR	-17.5
BIOQ Bioqual, Inc.	$30M	-7.1	-2.8	-4.3	-0.8	-16.6	3	LEAN BEAR	-17.5
CLYYF Celyad Oncology S.A.	$10M	2.7	-114.9	-1433.2	64360.6	102.9	4	LEAN BEAR	-31.7
CLYYF Celyad Oncology S.A.	$10M	2.7	-114.9	-1433.2	64360.6	102.9	4	LEAN BEAR	-31.7
PBLA Panbela Therapeutics, Inc.	—	-0.0	270.3	240.0	—	100.0	3	LEAN BEAR	-77.8
PBLA Panbela Therapeutics, Inc.	—	-0.0	270.3	240.0	—	100.0	3	LEAN BEAR	-77.8
RBOT Vicarious Surgical Inc.	—	-0.0	-223.8	-476.5	—	—	1	LEAN BEAR	-99.0
RBOT Vicarious Surgical Inc.	—	-0.0	-223.8	-476.5	—	—	1	LEAN BEAR	-99.0
MNOV MediciNova, Inc.	$90M	-8.2	-25.6	-78.2	-504.8	583.9	3	LEAN BEAR	42.4
MNOV MediciNova, Inc.	$90M	-8.2	-25.6	-78.2	-504.8	583.9	3	LEAN BEAR	42.4
PTIX Protagenic Therapeutics, Inc.	—	0.3	-485.4	-367.8	—	100.0	6	LEAN BEAR	-77.1
PTIX Protagenic Therapeutics, Inc.	—	0.3	-485.4	-367.8	—	100.0	6	LEAN BEAR	-77.1
KLDO Kaleido Biosciences, Inc.	—	-0.0	-591.2	1121.9	-4292.5	13.2	2	LEAN BEAR	0.0
KLDO Kaleido Biosciences, Inc.	—	-0.0	-591.2	1121.9	-4292.5	13.2	2	LEAN BEAR	0.0
CELG-RI Bristol-Myers Squibb Company Ce	$260M	0.0	38.8	20.8	23.3	1.8	8	LEAN BEAR	289.2
CELG-RI Bristol-Myers Squibb Company Ce	$260M	0.0	38.8	20.8	23.3	1.8	8	LEAN BEAR	289.2
MENS Jyong Biotech Ltd. Ordinary Shares	$170M	—	—	—	—	—	—	LEAN BEAR	-95.5
MENS Jyong Biotech Ltd. Ordinary Shares	$170M	—	—	—	—	—	—	LEAN BEAR	-95.5
OWCP OWC Pharmaceutical Research Corp.	—	-0.0	-34.4	1662.7	—	—	2	LEAN BEAR	0.0
OWCP OWC Pharmaceutical Research Corp.	—	-0.0	-34.4	1662.7	—	—	2	LEAN BEAR	0.0
AYRWF Ayr Wellness Inc.	—	-0.0	-65.7	-16.1	-53.2	-2.4	3	LEAN BEAR	-84.9
AYRWF Ayr Wellness Inc.	—	-0.0	-65.7	-16.1	-53.2	-2.4	3	LEAN BEAR	-84.9
TRCNF Transnational Cannabis Ltd.	—	-0.0	-178.2	-75.5	—	—	1	LEAN BEAR	-96.0
TRCNF Transnational Cannabis Ltd.	—	-0.0	-178.2	-75.5	—	—	1	LEAN BEAR	-96.0
RNVA Rennova Health, Inc.	—	-0.5	23.5	-4.3	-241.1	43.3	5	LEAN BEAR	9900.0
RNVA Rennova Health, Inc.	—	-0.5	23.5	-4.3	-241.1	43.3	5	LEAN BEAR	9900.0
NNRX Nutranomics, Inc.	—	-0.1	58.6	-70.9	-150.9	46.4	4	LEAN BEAR	0.0
NNRX Nutranomics, Inc.	—	-0.1	58.6	-70.9	-150.9	46.4	4	LEAN BEAR	0.0
CLABF Core One Labs Inc.	—	-0.3	-233.7	-70.3	-897.6	-69.3	3	LEAN BEAR	-100.0
CLABF Core One Labs Inc.	—	-0.3	-233.7	-70.3	-897.6	-69.3	3	LEAN BEAR	-100.0
FFNTF 4Front Ventures Corp.	—	-0.0	73.3	-15.3	-37.4	-34.7	3	LEAN BEAR	-90.0
FFNTF 4Front Ventures Corp.	—	-0.0	73.3	-15.3	-37.4	-34.7	3	LEAN BEAR	-90.0
NVCT Nuvectis Pharma, Inc.	$580M	-16.7	-214.6	174.4	—	—	1	LEAN BEAR	261.7
NVCT Nuvectis Pharma, Inc.	$580M	-16.7	-214.6	174.4	—	—	1	LEAN BEAR	261.7
INDP Indaptus Therapeutics, Inc.	$270M	-0.3	-318.0	6437.4	—	—	4	LEAN BEAR	-32.0
INDP Indaptus Therapeutics, Inc.	$270M	-0.3	-318.0	6437.4	—	—	4	LEAN BEAR	-32.0
MSPR MSP Recovery, Inc.	—	-0.0	127.6	-506.2	-84750.5	—	2	LEAN BEAR	-100.0
MSPR MSP Recovery, Inc.	—	-0.0	127.6	-506.2	-84750.5	—	2	LEAN BEAR	-100.0
HADV Health Advance Inc.	—	-2.9	60.0	-29.9	—	—	1	LEAN BEAR	-55.6
HADV Health Advance Inc.	—	-2.9	60.0	-29.9	—	—	1	LEAN BEAR	-55.6
GLSHQ Gelesis Holdings, Inc.	—	-0.0	391.0	-233.6	-693.9	-45.8	3	LEAN BEAR	0.0
GLSHQ Gelesis Holdings, Inc.	—	-0.0	391.0	-233.6	-693.9	-45.8	3	LEAN BEAR	0.0
WMGR Wellness Matrix Group, Inc.	—	-0.0	24.4	19.3	—	—	2	LEAN BEAR	0.0
WMGR Wellness Matrix Group, Inc.	—	-0.0	24.4	19.3	—	—	2	LEAN BEAR	0.0
BDPT BioAdaptives Inc.	—	-0.0	80.2	56.3	3009.0	169.7	3	LEAN BEAR	-96.9
BDPT BioAdaptives Inc.	—	-0.0	80.2	56.3	3009.0	169.7	3	LEAN BEAR	-96.9
WINT Windtree Therapeutics, Inc.	—	-0.0	1111.0	-2375.5	—	—	3	LEAN BEAR	-99.6
WINT Windtree Therapeutics, Inc.	—	-0.0	1111.0	-2375.5	—	—	3	LEAN BEAR	-99.6
UTRS Minerva Surgical, Inc.	—	-0.0	-170.1	-43.9	-60.0	3.1	1	LEAN BEAR	0.0
UTRS Minerva Surgical, Inc.	—	-0.0	-170.1	-43.9	-60.0	3.1	1	LEAN BEAR	0.0
HDVY Health Discovery Corporation	—	-0.1	-3852.6	357.6	—	-100.0	1	LEAN BEAR	0.0
HDVY Health Discovery Corporation	—	-0.1	-3852.6	357.6	—	-100.0	1	LEAN BEAR	0.0
TRLFF Maven Brands Inc.	—	-0.3	54.0	-28.1	—	-200.0	3	LEAN BEAR	9900.0
TRLFF Maven Brands Inc.	—	-0.3	54.0	-28.1	—	-200.0	3	LEAN BEAR	9900.0
BIEI Premier Biomedical, Inc.	—	-18.9	9.8	7.4	—	-100.0	5	LEAN BEAR	-31.2
BIEI Premier Biomedical, Inc.	—	-18.9	9.8	7.4	—	-100.0	5	LEAN BEAR	-31.2
CYPS Cyclo3pss Corporation	—	—	—	—	—	—	—	LEAN BEAR	400.0
CYPS Cyclo3pss Corporation	—	—	—	—	—	—	—	LEAN BEAR	400.0
CXBS Corix Bioscience, Inc.	—	—	—	—	—	—	—	LEAN BEAR	0.0
CXBS Corix Bioscience, Inc.	—	—	—	—	—	—	—	LEAN BEAR	0.0
SKVI Skinvisible, Inc.	—	-1.0	10.0	7.2	-5110.7	0.0	2	LEAN BEAR	-6.8
SKVI Skinvisible, Inc.	—	-1.0	10.0	7.2	-5110.7	0.0	2	LEAN BEAR	-6.8
IMRSQ IMRIS Inc.	—	—	—	—	—	—	—	LEAN BEAR	0.0
IMRSQ IMRIS Inc.	—	—	—	—	—	—	—	LEAN BEAR	0.0
VINC Vincerx Pharma, Inc.	—	-0.0	-3136.4	910.2	—	-18.7	5	LEAN BEAR	-72.2
VINC Vincerx Pharma, Inc.	—	-0.0	-3136.4	910.2	—	-18.7	5	LEAN BEAR	-72.2
FLWPF The Flowr Corporation	—	—	-335.3	207.1	-1827.8	38.5	3	LEAN BEAR	-100.0
FLWPF The Flowr Corporation	—	—	-335.3	207.1	-1827.8	38.5	3	LEAN BEAR	-100.0
CWWBF Plant-Based Investment Corp.	—	-0.0	-95.9	-3827.0	167.3	-218.9	3	LEAN BEAR	0.0
CWWBF Plant-Based Investment Corp.	—	-0.0	-95.9	-3827.0	167.3	-218.9	3	LEAN BEAR	0.0
SPLM Sentry Petroleum Ltd	—	-0.1	-184.2	-129.4	—	—	1	LEAN BEAR	0.0
SPLM Sentry Petroleum Ltd	—	-0.1	-184.2	-129.4	—	—	1	LEAN BEAR	0.0
ETBI Eastgate Biotech Corp.	—	-2.6	93.4	134.9	-7057.2	-53.0	3	LEAN BEAR	-10.0
ETBI Eastgate Biotech Corp.	—	-2.6	93.4	134.9	-7057.2	-53.0	3	LEAN BEAR	-10.0
SESI SES Solar Inc.	—	-0.5	16.7	1.7	28.0	324.6	7	LEAN BEAR	0.0
SESI SES Solar Inc.	—	-0.5	16.7	1.7	28.0	324.6	7	LEAN BEAR	0.0
OMRX Orthometrix, Inc.	—	0.0	30.7	-48.6	-238.0	-29.6	2	LEAN BEAR	0.0
OMRX Orthometrix, Inc.	—	0.0	30.7	-48.6	-238.0	-29.6	2	LEAN BEAR	0.0
RDDTF Radient Technologies Inc.	—	—	98.9	263.2	-131.7	-20.4	3	LEAN BEAR	0.0
RDDTF Radient Technologies Inc.	—	—	98.9	263.2	-131.7	-20.4	3	LEAN BEAR	0.0
FLOOF Flower One Holdings Inc.	—	-0.0	111.5	-21.8	-15.4	-19.8	2	LEAN BEAR	0.0
FLOOF Flower One Holdings Inc.	—	-0.0	111.5	-21.8	-15.4	-19.8	2	LEAN BEAR	0.0
XNCR Xencor, Inc.	$1.8B	-11.4	-29.1	-152.4	-42.4	-36.1	2	LEAN BEAR	110.0
XNCR Xencor, Inc.	$1.8B	-11.4	-29.1	-152.4	-42.4	-36.1	2	LEAN BEAR	110.0
PROK ProKidney Corp.	$580M	-3.0	9.2	13.2	-18948.0	55.2	1	LEAN BEAR	-33.9
PROK ProKidney Corp.	$580M	-3.0	9.2	13.2	-18948.0	55.2	1	LEAN BEAR	-33.9
KTTA Pasithea Therapeutics Corp.	$20M	-0.2	-65.5	0.0	—	—	4	LEAN BEAR	-35.8
KTTA Pasithea Therapeutics Corp.	$20M	-0.2	-65.5	0.0	—	—	4	LEAN BEAR	-35.8
MEDIF MediPharm Labs Corp.	$20M	-6.0	-13.2	-15.4	0.0	-6.7	4	LEAN BEAR	-8.4
MEDIF MediPharm Labs Corp.	$20M	-6.0	-13.2	-15.4	0.0	-6.7	4	LEAN BEAR	-8.4
BIEL Bioelectronics Corporation	$10M	-13.9	6.3	24.0	-132.4	-63.1	1	LEAN BEAR	100.0
BIEL Bioelectronics Corporation	$10M	-13.9	6.3	24.0	-132.4	-63.1	1	LEAN BEAR	100.0
BJDX Bluejay Diagnostics, Inc.	—	-0.1	-98.9	5625.8	—	—	4	LEAN BEAR	-86.3
BJDX Bluejay Diagnostics, Inc.	—	-0.1	-98.9	5625.8	—	—	4	LEAN BEAR	-86.3
XAIR Beyond Air, Inc.	—	-0.1	-337.4	-128.4	-539.2	107.3	5	LEAN BEAR	16.1
XAIR Beyond Air, Inc.	—	-0.1	-337.4	-128.4	-539.2	107.3	5	LEAN BEAR	16.1
CELZ Creative Medical Technology Holdings, Inc.	—	-0.5	-78.0	8335.2	—	-50.0	2	LEAN BEAR	-71.7
CELZ Creative Medical Technology Holdings, Inc.	—	-0.5	-78.0	8335.2	—	-50.0	2	LEAN BEAR	-71.7
LFMDP LifeMD, Inc.	$160M	-5.4	-687.6	135.4	-15.0	-16.7	4	LEAN BEAR	-2.8
LFMDP LifeMD, Inc.	$160M	-5.4	-687.6	135.4	-15.0	-16.7	4	LEAN BEAR	-2.8
MDXG MiMedx Group, Inc.	$670M	114.8	2.9	5.8	-23.1	-2.4	6	LEAN BEAR	-32.8
MDXG MiMedx Group, Inc.	$670M	114.8	2.9	5.8	-23.1	-2.4	6	LEAN BEAR	-32.8
EKDHF EKF Diagnostics Holdings plc	$150M	42.4	12.4	17.0	9.3	-4.9	7	LEAN BEAR	-19.6
EKDHF EKF Diagnostics Holdings plc	$150M	42.4	12.4	17.0	9.3	-4.9	7	LEAN BEAR	-19.6
DXR Daxor Corporation	$60M	8.6	19.0	17.7	-14382.9	161.9	4	LEAN BEAR	-21.9
DXR Daxor Corporation	$60M	8.6	19.0	17.7	-14382.9	161.9	4	LEAN BEAR	-21.9
LEEEF Leef Brands Inc.	$40M	-2.0	222.4	-39.5	-17.9	8.4	5	LEAN BEAR	-22.7
LEEEF Leef Brands Inc.	$40M	-2.0	222.4	-39.5	-17.9	8.4	5	LEAN BEAR	-22.7
REMI Remedent, Inc.	—	-0.1	-11.3	-4.3	-86.4	14.2	6	LEAN BEAR	300.0
REMI Remedent, Inc.	—	-0.1	-11.3	-4.3	-86.4	14.2	6	LEAN BEAR	300.0
XRTX XORTX Therapeutics Inc.	—	-0.3	-99.1	-68.5	—	—	3	LEAN BEAR	108.3
XRTX XORTX Therapeutics Inc.	—	-0.3	-99.1	-68.5	—	—	3	LEAN BEAR	108.3
VIVE Viveve Medical, Inc.	—	-0.0	-222.0	-1442.3	-314.1	2.4	3	LEAN BEAR	0.0
VIVE Viveve Medical, Inc.	—	-0.0	-222.0	-1442.3	-314.1	2.4	3	LEAN BEAR	0.0
FPMI FluoroPharma Medical, Inc.	—	-0.0	22.7	39.7	—	—	2	LEAN BEAR	100.0
FPMI FluoroPharma Medical, Inc.	—	-0.0	22.7	39.7	—	—	2	LEAN BEAR	100.0
XSVT Xsovt Brands, Inc.	—	-0.0	241.0	189.8	-134.3	300584.1	4	LEAN BEAR	-99.5
XSVT Xsovt Brands, Inc.	—	-0.0	241.0	189.8	-134.3	300584.1	4	LEAN BEAR	-99.5
VDRM ViaDerma, Inc.	—	28.7	133.1	-25.3	-214.1	5.3	3	LEAN BEAR	0.0
VDRM ViaDerma, Inc.	—	28.7	133.1	-25.3	-214.1	5.3	3	LEAN BEAR	0.0
SLNX Solanbridge Group, Inc.	—	-7.0	149.0	74.1	—	—	2	LEAN BEAR	400.0
SLNX Solanbridge Group, Inc.	—	-7.0	149.0	74.1	—	—	2	LEAN BEAR	400.0
TLOG TetraLogic Pharmaceuticals Corporation	—	-0.0	382.3	479.8	—	—	1	LEAN BEAR	-50.0
TLOG TetraLogic Pharmaceuticals Corporation	—	-0.0	382.3	479.8	—	—	1	LEAN BEAR	-50.0
DCOY Decoy Therapeutics Inc.	—	—	—	—	—	—	—	LEAN BEAR	—
DCOY Decoy Therapeutics Inc.	—	—	—	—	—	—	—	LEAN BEAR	—
TNON Tenon Medical, Inc.	—	-0.1	-549.9	-452.2	-316.7	80.9	4	LEAN BEAR	203.3
TNON Tenon Medical, Inc.	—	-0.1	-549.9	-452.2	-316.7	80.9	4	LEAN BEAR	203.3
CSPHF CStone Pharmaceuticals	$1.2B	-17.9	-74.4	-553.0	-123.0	-36.4	4	LEAN BEAR	-24.5
CSPHF CStone Pharmaceuticals	$1.2B	-17.9	-74.4	-553.0	-123.0	-36.4	4	LEAN BEAR	-24.5
BDRX Biodexa Pharmaceuticals Plc	—	-0.0	-116.7	-229.9	—	-100.0	4	LEAN BEAR	-98.1
BDRX Biodexa Pharmaceuticals Plc	—	-0.0	-116.7	-229.9	—	-100.0	4	LEAN BEAR	-98.1
LYRA Lyra Therapeutics, Inc.	—	-0.0	-6595.0	-671.6	-99300.0	-74.1	4	LEAN BEAR	-98.4
LYRA Lyra Therapeutics, Inc.	—	-0.0	-6595.0	-671.6	-99300.0	-74.1	4	LEAN BEAR	-98.4
GNFTF Genfit S.a.	$790M	-4.5	-575.3	-453.0	-124.0	1.4	4	LEAN BEAR	323.4
GNFTF Genfit S.a.	$790M	-4.5	-575.3	-453.0	-124.0	1.4	4	LEAN BEAR	323.4
DH Definitive Healthcare Corp.	$100M	-0.6	-75.0	96.7	-9.8	-5.0	6	LEAN BEAR	-73.8
DH Definitive Healthcare Corp.	$100M	-0.6	-75.0	96.7	-9.8	-5.0	6	LEAN BEAR	-73.8
BOEUF Bonesupport Holding AB (publ)	$1.5B	68.7	24.6	42.3	23.0	20.8	6	LEAN BEAR	-26.5
BOEUF Bonesupport Holding AB (publ)	$1.5B	68.7	24.6	42.3	23.0	20.8	6	LEAN BEAR	-26.5
ITHUF iAnthus Capital Holdings, Inc.	$30M	-0.6	53.1	-9.2	-40.8	-9.9	1	LEAN BEAR	-46.7
ITHUF iAnthus Capital Holdings, Inc.	$30M	-0.6	53.1	-9.2	-40.8	-9.9	1	LEAN BEAR	-46.7
ATOS Atossa Therapeutics, Inc.	$20M	-0.5	-89.2	-4213.1	—	—	2	LEAN BEAR	-83.0
ATOS Atossa Therapeutics, Inc.	$20M	-0.5	-89.2	-4213.1	—	—	2	LEAN BEAR	-83.0
HCTI Healthcare Triangle, Inc.	$10M	-0.0	-57.4	-19.3	-48.0	116.4	3	LEAN BEAR	-99.6
HCTI Healthcare Triangle, Inc.	$10M	-0.0	-57.4	-19.3	-48.0	116.4	3	LEAN BEAR	-99.6
GBIM GlobeImmune, Inc.	—	-0.0	-66.2	25.0	-91.5	55.1	4	LEAN BEAR	0.0
GBIM GlobeImmune, Inc.	—	-0.0	-66.2	25.0	-91.5	55.1	4	LEAN BEAR	0.0
JAGX Jaguar Health, Inc.	—	-0.0	-501.9	-118.9	-1035.3	135.5	4	LEAN BEAR	-99.7
JAGX Jaguar Health, Inc.	—	-0.0	-501.9	-118.9	-1035.3	135.5	4	LEAN BEAR	-99.7
AMBS Amarantus BioScience Holdings, Inc.	—	-0.0	7.3	3.8	-4080.5	—	3	LEAN BEAR	-66.7
AMBS Amarantus BioScience Holdings, Inc.	—	-0.0	7.3	3.8	-4080.5	—	3	LEAN BEAR	-66.7
DKSC Dakshidin Corporation	—	-45.8	-113.2	-9.1	—	—	2	LEAN BEAR	300.0
DKSC Dakshidin Corporation	—	-45.8	-113.2	-9.1	—	—	2	LEAN BEAR	300.0
PBMWW Psyence Biomedical Ltd. Warrant	—	—	—	—	—	—	—	LEAN BEAR	-29.7
PBMWW Psyence Biomedical Ltd. Warrant	—	—	—	—	—	—	—	LEAN BEAR	-29.7
NMRD Nemaura Medical Inc.	—	-0.0	45.5	-457.0	—	-491.0	1	LEAN BEAR	0.0
NMRD Nemaura Medical Inc.	—	-0.0	45.5	-457.0	—	-491.0	1	LEAN BEAR	0.0
IONKF Ionic Brands Corp.	—	-0.0	-395.1	-29.9	-53.6	179.4	4	LEAN BEAR	0.0
IONKF Ionic Brands Corp.	—	-0.0	-395.1	-29.9	-53.6	179.4	4	LEAN BEAR	0.0
STAA STAAR Surgical Company	$1.1B	280.9	1.1	3.5	8.6	51.3	5	LEAN BEAR	-17.3
STAA STAAR Surgical Company	$1.1B	280.9	1.1	3.5	8.6	51.3	5	LEAN BEAR	-17.3
GSTC GlobeStar Therapeutics Corporation	—	-0.0	60.9	49.1	—	—	4	LEAN BEAR	0.0
GSTC GlobeStar Therapeutics Corporation	—	-0.0	60.9	49.1	—	—	4	LEAN BEAR	0.0
LTUS Lotus Pharmaceuticals, Inc.	—	-385.1	14.7	-340.1	—	—	3	LEAN BEAR	29.1
LTUS Lotus Pharmaceuticals, Inc.	—	-385.1	14.7	-340.1	—	—	3	LEAN BEAR	29.1
CHOOF Choom Holdings Inc.	—	-0.0	3772.9	-35.1	-140.0	4.6	4	LEAN BEAR	0.0
CHOOF Choom Holdings Inc.	—	-0.0	3772.9	-35.1	-140.0	4.6	4	LEAN BEAR	0.0
DNAG DNAPrint Genomics, Inc.	—	-0.0	63.1	-156.0	-826.7	-15.2	3	LEAN BEAR	100.0
DNAG DNAPrint Genomics, Inc.	—	-0.0	63.1	-156.0	-826.7	-15.2	3	LEAN BEAR	100.0
RVLPQ RVL Pharmaceuticals plc	—	-0.0	-182.4	-101.1	-289.3	5.6	3	LEAN BEAR	0.0
CSTF CuraScientific Corp	—	-0.0	-72.1	17.4	-2482.5	954.6	5	LEAN BEAR	0.0
CSTF CuraScientific Corp	—	-0.0	-72.1	17.4	-2482.5	954.6	5	LEAN BEAR	0.0
RVLPQ RVL Pharmaceuticals plc	—	-0.0	-182.4	-101.1	-289.3	5.6	3	LEAN BEAR	0.0
NPRRF Nipro Corporation	$1.5B	—	—	—	—	—	—	LEAN BEAR	9.7
NPRRF Nipro Corporation	$1.5B	—	—	—	—	—	—	LEAN BEAR	9.7
LJUIF SSY Group Limited	$1.2B	16.1	15.5	11.9	13.6	-30.2	4	LEAN BEAR	0.0
LJUIF SSY Group Limited	$1.2B	16.1	15.5	11.9	13.6	-30.2	4	LEAN BEAR	0.0
AONC American Oncology Network, Inc.	$320M	-15.9	5.6	-14.7	0.3	37.5	6	LEAN BEAR	29.4
AONC American Oncology Network, Inc.	$320M	-15.9	5.6	-14.7	0.3	37.5	6	LEAN BEAR	29.4
EDTXF Spectral Medical Inc	$240M	-9.1	64.9	19.4	53.3	1.5	2	LEAN BEAR	-23.1
EDTXF Spectral Medical Inc	$240M	-9.1	64.9	19.4	53.3	1.5	2	LEAN BEAR	-23.1
ATRA Atara Biotherapeutics, Inc.	$90M	-8.0	46.3	30.3	-767.3	-96.7	2	LEAN BEAR	-34.4
ATRA Atara Biotherapeutics, Inc.	$90M	-8.0	46.3	30.3	-767.3	-96.7	2	LEAN BEAR	-34.4
XBIT XBiotech Inc.	$70M	-1.5	-29.9	-201.2	—	—	2	LEAN BEAR	-17.1
XBIT XBiotech Inc.	$70M	-1.5	-29.9	-201.2	—	—	2	LEAN BEAR	-17.1
VTIAF FamiCord AG	$50M	-7.1	-84.3	-13.6	-5.1	0.1	5	LEAN BEAR	16.0
VTIAF FamiCord AG	$50M	-7.1	-84.3	-13.6	-5.1	0.1	5	LEAN BEAR	16.0
ALGS Aligos Therapeutics, Inc.	$30M	-0.8	-113.6	-1246.4	-5.4	893.0	2	LEAN BEAR	-46.2
ALGS Aligos Therapeutics, Inc.	$30M	-0.8	-113.6	-1246.4	-5.4	893.0	2	LEAN BEAR	-46.2
CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares	$10M	—	—	—	—	—	—	LEAN BEAR	-71.2
CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares	$10M	—	—	—	—	—	—	LEAN BEAR	-71.2
THMO ThermoGenesis Holdings, Inc.	—	-0.0	-417.9	-71.5	-67.8	-7.5	3	LEAN BEAR	0.0
THMO ThermoGenesis Holdings, Inc.	—	-0.0	-417.9	-71.5	-67.8	-7.5	3	LEAN BEAR	0.0
CMRA Comera Life Sciences Holdings, Inc.	—	-0.0	235.6	124.2	-1580.0	81.8	4	LEAN BEAR	0.0
CMRA Comera Life Sciences Holdings, Inc.	—	-0.0	235.6	124.2	-1580.0	81.8	4	LEAN BEAR	0.0
BPTH Bio-Path Holdings, Inc.	—	-0.0	49.0	15.2	—	-100.0	1	LEAN BEAR	-99.6
BPTH Bio-Path Holdings, Inc.	—	-0.0	49.0	15.2	—	-100.0	1	LEAN BEAR	-99.6
PBIO Pressure BioSciences, Inc.	—	-0.0	100.6	84.5	-1687.2	-25.3	3	LEAN BEAR	-60.0
PBIO Pressure BioSciences, Inc.	—	-0.0	100.6	84.5	-1687.2	-25.3	3	LEAN BEAR	-60.0
AQSZF Aequus Pharmaceuticals Inc.	—	3.1	10.0	17.6	147.2	122.3	5	LEAN BEAR	-66.7
AQSZF Aequus Pharmaceuticals Inc.	—	3.1	10.0	17.6	147.2	122.3	5	LEAN BEAR	-66.7
SRBCF Sirona Biochem Corp.	—	-0.7	111.4	1025.7	-34808.5	-119.4	2	LEAN BEAR	-57.9
SRBCF Sirona Biochem Corp.	—	-0.7	111.4	1025.7	-34808.5	-119.4	2	LEAN BEAR	-57.9
ARYC Arrayit Corporation	—	-0.0	116.8	89.8	-513.1	-30.5	2	LEAN BEAR	-90.0
ARYC Arrayit Corporation	—	-0.0	116.8	89.8	-513.1	-30.5	2	LEAN BEAR	-90.0
UPDC UPD Holding Corp.	—	-0.0	198.3	1243.8	-858.8	—	2	LEAN BEAR	200.0
UPDC UPD Holding Corp.	—	-0.0	198.3	1243.8	-858.8	—	2	LEAN BEAR	200.0
ENMI DH Enchantment Inc.	—	-0.5	52.9	-49.5	-32.2	26.9	5	LEAN BEAR	-75.0
ENMI DH Enchantment Inc.	—	-0.5	52.9	-49.5	-32.2	26.9	5	LEAN BEAR	-75.0
BIOGY BioGaia AB (publ)	$1.3B	33.2	30.7	52.8	23.4	9.5	6	LEAN BEAR	10.7
BIOGY BioGaia AB (publ)	$1.3B	33.2	30.7	52.8	23.4	9.5	6	LEAN BEAR	10.7
TBPH Theravance Biopharma Inc	$880M	16.0	20.9	-7.2	-28.5	35.1	7	LEAN BEAR	21.2
TBPH Theravance Biopharma Inc	$880M	16.0	20.9	-7.2	-28.5	35.1	7	LEAN BEAR	21.2
KIDS OrthoPediatrics Corp.	$570M	-13.2	-11.4	-4.6	-10.2	14.5	6	LEAN BEAR	20.3
KIDS OrthoPediatrics Corp.	$570M	-13.2	-11.4	-4.6	-10.2	14.5	6	LEAN BEAR	20.3
CLVSF CellaVision AB (publ)	$330M	31.2	15.1	17.1	16.3	-1.9	6	LEAN BEAR	-27.4
CLVSF CellaVision AB (publ)	$330M	31.2	15.1	17.1	16.3	-1.9	6	LEAN BEAR	-27.4
EQ Equillium, Inc.	$90M	-5.5	-59.0	2703.6	—	-100.0	3	LEAN BEAR	-4.7
EQ Equillium, Inc.	$90M	-5.5	-59.0	2703.6	—	-100.0	3	LEAN BEAR	-4.7
MRMD MariMed Inc.	$30M	-1.8	-28.4	-0.9	-8.6	4.2	4	LEAN BEAR	-57.1
MRMD MariMed Inc.	$30M	-1.8	-28.4	-0.9	-8.6	4.2	4	LEAN BEAR	-57.1
PTN Palatin Technologies, Inc.	$20M	-1.8	-877.5	1176.9	-1449.1	—	5	LEAN BEAR	18.9
PTN Palatin Technologies, Inc.	$20M	-1.8	-877.5	1176.9	-1449.1	—	5	LEAN BEAR	18.9
BOLT Bolt Biotherapeutics, Inc.	$10M	-0.2	-111.6	-138.8	-154400.0	12.8	3	LEAN BEAR	-39.0
BOLT Bolt Biotherapeutics, Inc.	$10M	-0.2	-111.6	-138.8	-154400.0	12.8	3	LEAN BEAR	-39.0
EBYH Strainsforpains, Inc.	—	-18.9	-3.4	16.3	-603.3	1679.9	5	LEAN BEAR	24.6
EBYH Strainsforpains, Inc.	—	-18.9	-3.4	16.3	-603.3	1679.9	5	LEAN BEAR	24.6
SDCCQ SmileDirectClub Inc Class A	—	-0.0	-72.6	-19.0	-17.5	-23.4	3	LEAN BEAR	0.0
SDCCQ SmileDirectClub Inc Class A	—	-0.0	-72.6	-19.0	-17.5	-23.4	3	LEAN BEAR	0.0
ESVNF Apptly Health Technologies Corp.	—	-2.5	-22.3	-40.4	—	—	2	LEAN BEAR	-22.5
ESVNF Apptly Health Technologies Corp.	—	-2.5	-22.3	-40.4	—	—	2	LEAN BEAR	-22.5
BVS Bioventus Inc.	$890M	16.3	28.0	21.3	21.8	3.1	7	LEAN BEAR	95.7
BVS Bioventus Inc.	$890M	16.3	28.0	21.3	21.8	3.1	7	LEAN BEAR	95.7
BBNX Beta Bionics, Inc.	$850M	-11.3	-26.2	-79.6	-73.1	191.1	3	LEAN BEAR	-6.2
BBNX Beta Bionics, Inc.	$850M	-11.3	-26.2	-79.6	-73.1	191.1	3	LEAN BEAR	-6.2
LDXHF Lumos Diagnostics Holdings Ltd.	$70M	-10.7	-81.7	-123.2	-1.0	19.5	4	LEAN BEAR	-39.1
LDXHF Lumos Diagnostics Holdings Ltd.	$70M	-10.7	-81.7	-123.2	-1.0	19.5	4	LEAN BEAR	-39.1
NSYS Nortech Systems Incorporated	$30M	31.5	3.0	3.2	0.9	6.0	7	LEAN BEAR	20.4
NSYS Nortech Systems Incorporated	$30M	31.5	3.0	3.2	0.9	6.0	7	LEAN BEAR	20.4
CPHI China Pharma Holdings, Inc.	$30M	-0.7	-21.0	-8.7	-153.8	-11.0	4	LEAN BEAR	-67.0
CPHI China Pharma Holdings, Inc.	$30M	-0.7	-21.0	-8.7	-153.8	-11.0	4	LEAN BEAR	-67.0
SKYE Skye Bioscience, Inc.	$10M	-0.2	-233.9	389.5	—	—	3	LEAN BEAR	-60.6
SKYE Skye Bioscience, Inc.	$10M	-0.2	-233.9	389.5	—	—	3	LEAN BEAR	-60.6
LSTA Lisata Therapeutics, Inc.	$10M	-0.9	-99.9	590.1	—	-90.7	2	LEAN BEAR	-40.0
LSTA Lisata Therapeutics, Inc.	$10M	-0.9	-99.9	590.1	—	-90.7	2	LEAN BEAR	-40.0
RGNT Regentis Biomaterials Ltd.	$10M	—	—	—	—	—	—	LEAN BEAR	—
RGNT Regentis Biomaterials Ltd.	$10M	—	—	—	—	—	—	LEAN BEAR	—
PFSA Profusa, Inc. Common Stock	—	-0.0	158.4	181.7	—	—	2	LEAN BEAR	448.0
PFSA Profusa, Inc. Common Stock	—	-0.0	158.4	181.7	—	—	2	LEAN BEAR	448.0
NUGS Cannabis Strategic Ventures	—	-0.3	115.4	-142.7	-3106.7	-29.3	2	LEAN BEAR	7000.0
NUGS Cannabis Strategic Ventures	—	-0.3	115.4	-142.7	-3106.7	-29.3	2	LEAN BEAR	7000.0
PTPI Petros Pharmaceuticals, Inc.	—	0.0	-124.4	96.3	—	-100.0	1	LEAN BEAR	-85.0
PTPI Petros Pharmaceuticals, Inc.	—	0.0	-124.4	96.3	—	-100.0	1	LEAN BEAR	-85.0
BGMS Bio Green Med Solution, Inc.	—	-0.2	-30.7	-64.2	-120.5	—	2	LEAN BEAR	-82.2
BGMS Bio Green Med Solution, Inc.	—	-0.2	-30.7	-64.2	-120.5	—	2	LEAN BEAR	-82.2
ITOC iTonic Holdings Ltd.	—	—	—	—	—	—	—	LEAN BEAR	—
ITOC iTonic Holdings Ltd.	—	—	—	—	—	—	—	LEAN BEAR	—
CBLL CeriBell, Inc.	$900M	-13.5	-43.9	-263.7	-68.6	69.3	3	LEAN BEAR	104.9
CBLL CeriBell, Inc.	$900M	-13.5	-43.9	-263.7	-68.6	69.3	3	LEAN BEAR	104.9
PYPD PolyPid Ltd.	$100M	-3.5	-1913.8	231.6	—	—	3	LEAN BEAR	54.0
PYPD PolyPid Ltd.	$100M	-3.5	-1913.8	231.6	—	—	3	LEAN BEAR	54.0
BIIO Bionovate Technologies Corp	—	-0.0	47.5	16.6	—	—	3	LEAN BEAR	0.0
BIIO Bionovate Technologies Corp	—	-0.0	47.5	16.6	—	—	3	LEAN BEAR	0.0
NWCI NewCardio, Inc.	—	-0.0	258.3	352.6	-23059.8	40.9	2	LEAN BEAR	0.0
NWCI NewCardio, Inc.	—	-0.0	258.3	352.6	-23059.8	40.9	2	LEAN BEAR	0.0
PARD Poniard Pharmaceuticals, Inc.	—	-0.0	-210.4	-442.5	—	—	3	LEAN BEAR	0.0
PARD Poniard Pharmaceuticals, Inc.	—	-0.0	-210.4	-442.5	—	—	3	LEAN BEAR	0.0
ABMT Advanced BioMedical Technologies Inc.	—	-0.1	6.0	9.6	3842.6	264.3	3	LEAN BEAR	400.0
ABMT Advanced BioMedical Technologies Inc.	—	-0.1	6.0	9.6	3842.6	264.3	3	LEAN BEAR	400.0
TVGN Tevogen Bio Holdings Inc.	$30M	-1.2	235.3	244.1	—	—	5	LEAN BEAR	710.5
TVGN Tevogen Bio Holdings Inc.	$30M	-1.2	235.3	244.1	—	—	5	LEAN BEAR	710.5
ALZN Alzamend Neuro Inc	$10M	-0.6	-373.2	-30751.3	—	—	1	LEAN BEAR	-44.1
ALZN Alzamend Neuro Inc	$10M	-0.6	-373.2	-30751.3	—	—	1	LEAN BEAR	-44.1
EGRX Eagle Pharmaceuticals, Inc.	—	0.1	6.4	3.6	8.0	-5.4	3	LEAN BEAR	-92.2
EGRX Eagle Pharmaceuticals, Inc.	—	0.1	6.4	3.6	8.0	-5.4	3	LEAN BEAR	-92.2
ODYY Odyssey Health, Inc.	—	-0.2	43.4	10.0	—	-100.0	4	LEAN BEAR	-81.2
ODYY Odyssey Health, Inc.	—	-0.2	43.4	10.0	—	-100.0	4	LEAN BEAR	-81.2
BPMUF Basilea Pharmaceutica AG	$940M	15.7	140.1	185.7	23.5	49.5	9	LEAN BEAR	12.6
BPMUF Basilea Pharmaceutica AG	$940M	15.7	140.1	185.7	23.5	49.5	9	LEAN BEAR	12.6
AVHHL AVITA Medical, Inc.	$270M	-8.8	211.5	-292.6	-35.3	1.0	4	LEAN BEAR	56.8
AVHHL AVITA Medical, Inc.	$270M	-8.8	211.5	-292.6	-35.3	1.0	4	LEAN BEAR	56.8
QUCY Quantum Cyber N.V.	$30M	—	—	—	—	—	—	LEAN BEAR	—
QUCY Quantum Cyber N.V.	$30M	—	—	—	—	—	—	LEAN BEAR	—
PLSM Pulsenmore Ltd. Ordinary Shares	$10M	—	—	—	—	—	—	LEAN BEAR	—
PLSM Pulsenmore Ltd. Ordinary Shares	$10M	—	—	—	—	—	—	LEAN BEAR	—
EOCN Eocene Ltd.	—	—	—	—	—	—	—	LEAN BEAR	—
EOCN Eocene Ltd.	—	—	—	—	—	—	—	LEAN BEAR	—
RKAGY RHÃN-KLINIKUM Aktiengesellschaft	$1.1B	22.5	2.8	3.1	2.1	2.5	6	BEARISH	10.7
RKAGY RHÃN-KLINIKUM Aktiengesellschaft	$1.1B	22.5	2.8	3.1	2.1	2.5	6	BEARISH	10.7
SHIEF Shield Therapeutics plc	$90M	-8.0	262.0	1974.0	-7.4	547.4	5	BEARISH	-15.8
SHIEF Shield Therapeutics plc	$90M	-8.0	262.0	1974.0	-7.4	547.4	5	BEARISH	-15.8
ANNX Annexon, Inc.	$690M	-3.6	-105.3	-11323.3	—	—	2	BEARISH	38.3
ANNX Annexon, Inc.	$690M	-3.6	-105.3	-11323.3	—	—	2	BEARISH	38.3
SNTI Senti Biosciences, Inc.	$10M	-0.2	-466.5	-430.9	-75000.0	—	2	BEARISH	-77.6
SNTI Senti Biosciences, Inc.	$10M	-0.2	-466.5	-430.9	-75000.0	—	2	BEARISH	-77.6
CODX Co-Diagnostics, Inc.	$10M	-0.0	-174.8	-218.8	-3782.4	-28.1	3	BEARISH	-89.8
CODX Co-Diagnostics, Inc.	$10M	-0.0	-174.8	-218.8	-3782.4	-28.1	3	BEARISH	-89.8
BBRRF Blueberries Medical Corp.	$10M	-7.1	-218.7	-2675.7	-588.1	-36.9	4	BEARISH	8.2
BBRRF Blueberries Medical Corp.	$10M	-7.1	-218.7	-2675.7	-588.1	-36.9	4	BEARISH	8.2
ARTL Artelo Biosciences, Inc.	—	-0.0	-705.7	-1031.2	—	—	5	BEARISH	-91.4
ARTL Artelo Biosciences, Inc.	—	-0.0	-705.7	-1031.2	—	—	5	BEARISH	-91.4
OGEN Oragenics, Inc.	—	-0.1	-1307.1	4273.7	—	—	3	BEARISH	-64.8
OGEN Oragenics, Inc.	—	-0.1	-1307.1	4273.7	—	—	3	BEARISH	-64.8
IMCC IM Cannabis Corp.	—	-1062.5	1556.1	-129.3	-57.5	-21.1	1	BEARISH	-96.4
IMCC IM Cannabis Corp.	—	-1062.5	1556.1	-129.3	-57.5	-21.1	1	BEARISH	-96.4
SLXN Silexion Therapeutics Ltd.	—	-0.0	-17022.0	-931.4	—	—	3	BEARISH	-93.1
SLXN Silexion Therapeutics Ltd.	—	-0.0	-17022.0	-931.4	—	—	3	BEARISH	-93.1
IPIX Innovation Pharmaceuticals Inc.	—	-0.0	-115.7	-377.9	—	-133.3	3	BEARISH	-93.3
IPIX Innovation Pharmaceuticals Inc.	—	-0.0	-115.7	-377.9	—	-133.3	3	BEARISH	-93.3
USAQ QHSLab, Inc.	—	6.8	114.6	6.2	4.5	24.6	6	BEARISH	60.0
USAQ QHSLab, Inc.	—	6.8	114.6	6.2	4.5	24.6	6	BEARISH	60.0
PRFX PRF Technologies Ltd.	—	-0.1	-57.8	-88.3	-19978.6	137249010644668.4	6	BEARISH	-33.3
PRFX PRF Technologies Ltd.	—	-0.1	-57.8	-88.3	-19978.6	137249010644668.4	6	BEARISH	-33.3
BIOAF Bioasis Technologies Inc.	—	-0.1	135.1	538.8	-661.8	614.1	2	BEARISH	-50.0
BIOAF Bioasis Technologies Inc.	—	-0.1	135.1	538.8	-661.8	614.1	2	BEARISH	-50.0
GGBXF Green Growth Brands Inc.	—	—	—	—	—	—	—	BEARISH	0.0
GGBXF Green Growth Brands Inc.	—	—	—	—	—	—	—	BEARISH	0.0
NSTM NovelStem International Corp.	—	-1.5	15.3	31.5	—	-100.0	3	BEARISH	-66.7
NSTM NovelStem International Corp.	—	-1.5	15.3	31.5	—	-100.0	3	BEARISH	-66.7
PKBFF PeakBirch Commerce Inc.	$540M	-0.0	-16609.0	16544.6	-58.8	-69.1	3	BEARISH	0.0
PKBFF PeakBirch Commerce Inc.	$540M	-0.0	-16609.0	16544.6	-58.8	-69.1	3	BEARISH	0.0
CHHHF CareRx Corporation	$150M	7.6	27.3	40.1	0.4	3.0	6	BEARISH	-8.8
CHHHF CareRx Corporation	$150M	7.6	27.3	40.1	0.4	3.0	6	BEARISH	-8.8
CSBR Champions Oncology, Inc.	$70M	-62.5	-30.5	-25.2	-5.3	4.4	4	BEARISH	-22.8
CSBR Champions Oncology, Inc.	$70M	-62.5	-30.5	-25.2	-5.3	4.4	4	BEARISH	-22.8
ONMD OneMedNet Corporation	$30M	-3.2	231.2	252.1	-743.8	216.5	3	BEARISH	-47.7
ONMD OneMedNet Corporation	$30M	-3.2	231.2	252.1	-743.8	216.5	3	BEARISH	-47.7
ELUT Elutia Inc	$30M	0.6	-397.0	-290.2	-315.0	-48.8	6	BEARISH	-12.0
ELUT Elutia Inc	$30M	0.6	-397.0	-290.2	-315.0	-48.8	6	BEARISH	-12.0
LONA LeonaBio, Inc.	$20M	—	—	—	—	—	—	BEARISH	—
LONA LeonaBio, Inc.	$20M	—	—	—	—	—	—	BEARISH	—
LUFFF Herbal Dispatch Inc.	$10M	-1.6	-124.8	-42.8	-26.7	4.6	6	BEARISH	134.3
PTKFY PT Kalbe Farma Tbk	$10M	9.1	15.5	17.8	9.1	13.6	6	BEARISH	-42.4
PTKFY PT Kalbe Farma Tbk	$10M	9.1	15.5	17.8	9.1	13.6	6	BEARISH	-42.4
LUFFF Herbal Dispatch Inc.	$10M	-1.6	-124.8	-42.8	-26.7	4.6	6	BEARISH	134.3
BICX BioCorRx Inc.	$10M	-1.6	25.4	84.3	-1096.7	151.2	3	BEARISH	-5.2
BICX BioCorRx Inc.	$10M	-1.6	25.4	84.3	-1096.7	151.2	3	BEARISH	-5.2
SHOM Southern Home Medical, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
SHOM Southern Home Medical, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
UAHC United American Healthcare Corporation	—	180.0	4.6	-10.0	—	-100.0	6	BEARISH	-14.3
UAHC United American Healthcare Corporation	—	180.0	4.6	-10.0	—	-100.0	6	BEARISH	-14.3
APVO Aptevo Therapeutics Inc.	—	-0.0	-420.3	-4688.7	—	—	1	BEARISH	-92.9
APVO Aptevo Therapeutics Inc.	—	-0.0	-420.3	-4688.7	—	—	1	BEARISH	-92.9
MCET MultiCell Technologies, Inc.	—	-0.1	101.2	99.1	-81.8	1532.7	5	BEARISH	0.0
MCET MultiCell Technologies, Inc.	—	-0.1	101.2	99.1	-81.8	1532.7	5	BEARISH	0.0
MRDH Meridian Holdings, Inc.	—	-0.9	29.2	-2410.8	—	-100.0	1	BEARISH	9.1
MRDH Meridian Holdings, Inc.	—	-0.9	29.2	-2410.8	—	-100.0	1	BEARISH	9.1
RQHTF Reliq Health Technologies Inc.	—	-5.4	-4.5	-8.2	15.4	119.4	5	BEARISH	0.0
RQHTF Reliq Health Technologies Inc.	—	-5.4	-4.5	-8.2	15.4	119.4	5	BEARISH	0.0
GRST Ethema Health Corporation	—	-0.5	18.3	0.0	1.2	171.7	6	BEARISH	-66.7
GRST Ethema Health Corporation	—	-0.5	18.3	0.0	1.2	171.7	6	BEARISH	-66.7
VNRX VolitionRX Ltd	—	-0.1	80.1	66.5	-1837.7	86.3	3	BEARISH	-62.2
VNRX VolitionRX Ltd	—	-0.1	80.1	66.5	-1837.7	86.3	3	BEARISH	-62.2
ISOLF Isodiol International Inc.	—	-0.0	-220.6	-602.3	-73.2	-17.7	4	BEARISH	900.0
ISOLF Isodiol International Inc.	—	-0.0	-220.6	-602.3	-73.2	-17.7	4	BEARISH	900.0
NNLX NanoLogix, Inc.	—	—	—	—	—	—	—	BEARISH	-20.0
NNLX NanoLogix, Inc.	—	—	—	—	—	—	—	BEARISH	-20.0
PAOG PAO Group, Inc.	—	-3.9	-20.2	11.2	—	—	4	BEARISH	0.0
PAOG PAO Group, Inc.	—	-3.9	-20.2	11.2	—	—	4	BEARISH	0.0
WHSI Wearable Health Solutions, Inc.	—	-0.1	37.4	155.3	98.4	-29.7	2	BEARISH	0.0
WHSI Wearable Health Solutions, Inc.	—	-0.1	37.4	155.3	98.4	-29.7	2	BEARISH	0.0
AOXG Aoxing Pharmaceutical Company, Inc.	—	-35.9	-0.2	-13.9	-405.2	-99.8	1	BEARISH	-68.6
AOXG Aoxing Pharmaceutical Company, Inc.	—	-35.9	-0.2	-13.9	-405.2	-99.8	1	BEARISH	-68.6
SNBIF SanBio Company Limited	$1.3B	-19.7	-50.0	1250.3	—	—	4	BEARISH	0.0
SNBIF SanBio Company Limited	$1.3B	-19.7	-50.0	1250.3	—	—	4	BEARISH	0.0
REPL Replimune Group, Inc.	$1.1B	-4.1	-107.9	-2853.5	—	—	1	BEARISH	210.4
REPL Replimune Group, Inc.	$1.1B	-4.1	-107.9	-2853.5	—	—	1	BEARISH	210.4
IRMD IRadimed Corporation	$1.1B	46.9	23.5	50.1	25.5	11.2	6	BEARISH	22.2
IRMD IRadimed Corporation	$1.1B	46.9	23.5	50.1	25.5	11.2	6	BEARISH	22.2
BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited	$540M	10.0	20.8	23.4	32.9	697.9	9	BEARISH	0.0
BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited	$540M	10.0	20.8	23.4	32.9	697.9	9	BEARISH	0.0
TSNLF Tristel PLC	$280M	24.9	43.3	53.7	15.4	25.1	6	BEARISH	8.5
TSNLF Tristel PLC	$280M	24.9	43.3	53.7	15.4	25.1	6	BEARISH	8.5
GALT Galectin Therapeutics Inc.	$260M	-9.1	21.9	99.4	—	—	2	BEARISH	-6.7
GALT Galectin Therapeutics Inc.	$260M	-9.1	21.9	99.4	—	—	2	BEARISH	-6.7
KJFI Comjoyful International Company	$210M	-98.4	56.8	51.4	-1397.6	—	2	BEARISH	441.1
KJFI Comjoyful International Company	$210M	-98.4	56.8	51.4	-1397.6	—	2	BEARISH	441.1
SCNLF Scancell Holdings plc	$150M	-17.9	254.8	3518.0	—	-10.6	1	BEARISH	5.9
SCNLF Scancell Holdings plc	$150M	-17.9	254.8	3518.0	—	-10.6	1	BEARISH	5.9
RANI Rani Therapeutics Holdings, Inc.	$50M	-3.0	-179.1	245.5	-432.7	306.4	5	BEARISH	59.3
RANI Rani Therapeutics Holdings, Inc.	$50M	-3.0	-179.1	245.5	-432.7	306.4	5	BEARISH	59.3
RAPH Raphael Pharmaceutical Inc.	$30M	-28.5	59.9	47.0	—	—	2	BEARISH	536.4
RAPH Raphael Pharmaceutical Inc.	$30M	-28.5	59.9	47.0	—	—	2	BEARISH	536.4
PROT Proteonomix, Inc.	—	-0.0	77.5	-1239.4	—	-63.1	4	BEARISH	0.0
PROT Proteonomix, Inc.	—	-0.0	77.5	-1239.4	—	-63.1	4	BEARISH	0.0
PLSH Panacea Life Sciences Holdings, Inc.	—	-0.8	128.5	-48.4	-1581.6	-90.2	5	BEARISH	14.9
PLSH Panacea Life Sciences Holdings, Inc.	—	-0.8	128.5	-48.4	-1581.6	-90.2	5	BEARISH	14.9
SSKN STRATA Skin Sciences, Inc.	—	-0.0	-164.6	-42.5	0.6	-8.5	4	BEARISH	-99.7
SSKN STRATA Skin Sciences, Inc.	—	-0.0	-164.6	-42.5	0.6	-8.5	4	BEARISH	-99.7
JUNS Jupiter Neurosciences, Inc.	—	-0.1	-1888.7	5586.0	-9380.9	—	3	BEARISH	-98.0
JUNS Jupiter Neurosciences, Inc.	—	-0.1	-1888.7	5586.0	-9380.9	—	3	BEARISH	-98.0
REPCF RepliCel Life Sciences Inc.	—	-9.4	-248.8	-13.9	-80.9	200.0	6	BEARISH	0.0
REPCF RepliCel Life Sciences Inc.	—	-9.4	-248.8	-13.9	-80.9	200.0	6	BEARISH	0.0
KSPHF Kissei Pharmaceutical Co., Ltd.	$1.0B	11.0	6.3	-1.4	11.2	10.9	6	BEARISH	-19.1
KSPHF Kissei Pharmaceutical Co., Ltd.	$1.0B	11.0	6.3	-1.4	11.2	10.9	6	BEARISH	-19.1
BOIRF Boiron S.A.	$550M	13.3	7.2	7.8	2.0	-5.4	4	BEARISH	10.5
BOIRF Boiron S.A.	$550M	13.3	7.2	7.8	2.0	-5.4	4	BEARISH	10.5
AUNA Auna S.A.	$370M	-17.9	0.8	4.5	2.4	9.2	7	BEARISH	-25.0
AUNA Auna S.A.	$370M	-17.9	0.8	4.5	2.4	9.2	7	BEARISH	-25.0
FATE Fate Therapeutics, Inc.	$270M	-2.2	-60.7	-140.1	-1448.6	-23.4	2	BEARISH	109.0
FATE Fate Therapeutics, Inc.	$270M	-2.2	-60.7	-140.1	-1448.6	-23.4	2	BEARISH	109.0
ALEC Alector, Inc.	$200M	-1.6	-385.1	66.8	-692.5	-82.9	1	BEARISH	-39.7
ALEC Alector, Inc.	$200M	-1.6	-385.1	66.8	-692.5	-82.9	1	BEARISH	-39.7
PARK Park Dental Partners, Inc. Common Stock	$90M	-23.9	-16.0	0.0	2.0	—	3	BEARISH	—
PARK Park Dental Partners, Inc. Common Stock	$90M	-23.9	-16.0	0.0	2.0	—	3	BEARISH	—
TELO Telomir Pharmaceuticals, Inc. Common Stock	$80M	-0.8	-213.1	3515.1	—	—	4	BEARISH	-15.1
TELO Telomir Pharmaceuticals, Inc. Common Stock	$80M	-0.8	-213.1	3515.1	—	—	4	BEARISH	-15.1
XTNT Xtant Medical Holdings, Inc.	$50M	-4.1	-25.2	-14.8	-40.9	-14.3	4	BEARISH	-45.5
XTNT Xtant Medical Holdings, Inc.	$50M	-4.1	-25.2	-14.8	-40.9	-14.3	4	BEARISH	-45.5
ELOX Eloxx Pharmaceuticals, Inc.	$50M	-10.2	-107.5	81.5	—	—	4	BEARISH	15509900.5
ELOX Eloxx Pharmaceuticals, Inc.	$50M	-10.2	-107.5	81.5	—	—	4	BEARISH	15509900.5
ABVC ABVC BioPharma, Inc.	$30M	-3.4	-82.2	-43.0	—	-100.0	2	BEARISH	-66.2
ABVC ABVC BioPharma, Inc.	$30M	-3.4	-82.2	-43.0	—	-100.0	2	BEARISH	-66.2
NRXBF NurExone Biologic Inc.	$30M	—	—	—	—	—	—	BEARISH	—
NRXBF NurExone Biologic Inc.	$30M	—	—	—	—	—	—	BEARISH	—
CABR Caring Brands, Inc.	$10M	—	—	—	—	—	—	BEARISH	-69.1
CABR Caring Brands, Inc.	$10M	—	—	—	—	—	—	BEARISH	-69.1
CGNH CardioGenics Holdings Inc	—	-0.0	58.8	40.3	—	—	3	BEARISH	0.0
CGNH CardioGenics Holdings Inc	—	-0.0	58.8	40.3	—	—	3	BEARISH	0.0
EMMA Emmaus Life Sciences, Inc.	—	-0.4	9.9	-9.3	21.2	11.0	4	BEARISH	423.8
EMMA Emmaus Life Sciences, Inc.	—	-0.4	9.9	-9.3	21.2	11.0	4	BEARISH	423.8
BIOCQ Biocept, Inc.	—	-0.0	-13593.8	-631.8	-616.5	—	2	BEARISH	100.0
BIOCQ Biocept, Inc.	—	-0.0	-13593.8	-631.8	-616.5	—	2	BEARISH	100.0
MILC Millennium Sustainable Ventures Corp.	—	-0.0	763.2	-36.7	—	584982.1	2	BEARISH	100.0
MILC Millennium Sustainable Ventures Corp.	—	-0.0	763.2	-36.7	—	584982.1	2	BEARISH	100.0
GNMLF Genomma Lab Internacional, S.A.B. de C.V.	$710M	7.8	14.1	14.1	8.5	18.2	5	BEARISH	-37.6
GNMLF Genomma Lab Internacional, S.A.B. de C.V.	$710M	7.8	14.1	14.1	8.5	18.2	5	BEARISH	-37.6
CTNM Contineum Therapeutics, Inc.	$490M	-7.6	-28.0	-541.6	—	—	4	BEARISH	19.2
CTNM Contineum Therapeutics, Inc.	$490M	-7.6	-28.0	-541.6	—	—	4	BEARISH	19.2
ANVS Annovis Bio, Inc.	$50M	-0.7	-703.7	170.2	—	—	1	BEARISH	-44.6
ANVS Annovis Bio, Inc.	$50M	-0.7	-703.7	170.2	—	—	1	BEARISH	-44.6
SYUP Anbc, Inc.	—	—	—	—	—	—	—	BEARISH	200.0
SYUP Anbc, Inc.	—	—	—	—	—	—	—	BEARISH	200.0
ICBU iMD Companies, Inc.	—	-16.3	27.7	30.0	—	-100.0	3	BEARISH	-62.1
ICBU iMD Companies, Inc.	—	-16.3	27.7	30.0	—	-100.0	3	BEARISH	-62.1
IGEX Indo Global Exchange(s) PTE, Ltd.	—	-20.1	-12.1	-3.5	—	-100.0	5	BEARISH	25.0
IGEX Indo Global Exchange(s) PTE, Ltd.	—	-20.1	-12.1	-3.5	—	-100.0	5	BEARISH	25.0
TSMRF Tsumura & Co.	$1.7B	9.1	9.1	7.0	10.5	6.9	3	BEARISH	inf
TSMRF Tsumura & Co.	$1.7B	9.1	9.1	7.0	10.5	6.9	3	BEARISH	inf
STSEY Stratec SE	$1.7B	-542.5	-0.2	-0.2	7.0	-4.8	4	BEARISH	-17.8
STSEY Stratec SE	$1.7B	-542.5	-0.2	-0.2	7.0	-4.8	4	BEARISH	-17.8
MDCLF MedinCell S.A.	$1.2B	-24.4	264.0	116.8	-152.1	129.2	6	BEARISH	392.7
MDCLF MedinCell S.A.	$1.2B	-24.4	264.0	116.8	-152.1	129.2	6	BEARISH	392.7
AGYTF Allergy Therapeutics plc	$760M	-4.8	-550.7	-218.7	-54.9	4.4	2	BEARISH	76.5
AGYTF Allergy Therapeutics plc	$760M	-4.8	-550.7	-218.7	-54.9	4.4	2	BEARISH	76.5
CLHLF COLTENE Holding AG	$370M	18.9	30.1	25.6	3.6	-5.4	4	BEARISH	0.0
CLHLF COLTENE Holding AG	$370M	18.9	30.1	25.6	3.6	-5.4	4	BEARISH	0.0
JMDMF Japan Medical Dynamic Marketing, Inc.	$130M	—	—	—	—	—	—	BEARISH	49.7
JMDMF Japan Medical Dynamic Marketing, Inc.	$130M	—	—	—	—	—	—	BEARISH	49.7
PLYX Polaryx Therapeutics, Inc. Common Stock	$100M	-17.1	-35.9	437.3	—	—	2	BEARISH	—
PLYX Polaryx Therapeutics, Inc. Common Stock	$100M	-17.1	-35.9	437.3	—	—	2	BEARISH	—
POLBF Poolbeg Pharma PLC	$70M	-9.2	-117.0	-516.5	—	—	1	BEARISH	125.4
POLBF Poolbeg Pharma PLC	$70M	-9.2	-117.0	-516.5	—	—	1	BEARISH	125.4
POCI Precision Optics Corporation, Inc.	$50M	-9.6	-22.3	-19.0	-1.2	65.2	5	BEARISH	2.8
POCI Precision Optics Corporation, Inc.	$50M	-9.6	-22.3	-19.0	-1.2	65.2	5	BEARISH	2.8
CLIFF Cordlife Group Limited	$40M	-2.9	-9.9	-15.8	-11.3	11.3	5	BEARISH	20.3
CLIFF Cordlife Group Limited	$40M	-2.9	-9.9	-15.8	-11.3	11.3	5	BEARISH	20.3
BTAIQ BioXcel Therapeutics, Inc.	—	—	—	—	—	—	—	BEARISH	—
BTAIQ BioXcel Therapeutics, Inc.	—	—	—	—	—	—	—	BEARISH	—
NASC Nascent Pharma Holdings, Inc.	—	—	—	—	—	—	—	BEARISH	—
NASC Nascent Pharma Holdings, Inc.	—	—	—	—	—	—	—	BEARISH	—
PAIOF Paion AG	—	-4.4	-385.3	-130.5	-98.8	-18.0	1	BEARISH	600.0
PAIOF Paion AG	—	-4.4	-385.3	-130.5	-98.8	-18.0	1	BEARISH	600.0
YUKA Yuka Group, Inc.	—	-2.4	24.0	81.8	-50.7	-8.2	5	BEARISH	192.4
YUKA Yuka Group, Inc.	—	-2.4	24.0	81.8	-50.7	-8.2	5	BEARISH	192.4
RBII Rising Biosciences, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
RBII Rising Biosciences, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
MRRCF Wayland Group Corp.	—	—	—	—	—	—	—	BEARISH	0.0
MRRCF Wayland Group Corp.	—	—	—	—	—	—	—	BEARISH	0.0
SHEZF Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	$690M	70.6	2.8	2.7	7.0	-0.3	6	BEARISH	0.0
SHEZF Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	$690M	70.6	2.8	2.7	7.0	-0.3	6	BEARISH	0.0
KMDA Kamada Ltd.	$480M	21.7	8.4	11.0	16.9	13.2	7	BEARISH	21.5
KMDA Kamada Ltd.	$480M	21.7	8.4	11.0	16.9	13.2	7	BEARISH	21.5
CBSC Cardiac Biotech Solutions Inc.	$10M	-8.0	87.3	51.1	-341.6	78.5	3	BEARISH	-30.0
CBSC Cardiac Biotech Solutions Inc.	$10M	-8.0	87.3	51.1	-341.6	78.5	3	BEARISH	-30.0
RVPH Reviva Pharmaceuticals Holdings, Inc.	$10M	-0.1	-32.2	45.6	—	—	4	BEARISH	38.5
RVPH Reviva Pharmaceuticals Holdings, Inc.	$10M	-0.1	-32.2	45.6	—	—	4	BEARISH	38.5
SKTO SK3 Group, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
SKTO SK3 Group, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
FSPM FusionPharm, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
FSPM FusionPharm, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
ARDS Aridis Pharmaceuticals, Inc.	—	-0.0	4.8	10.0	-19.9	2227.6	4	BEARISH	-92.3
ARDS Aridis Pharmaceuticals, Inc.	—	-0.0	4.8	10.0	-19.9	2227.6	4	BEARISH	-92.3
EVRRF Molecule Holdings Inc.	—	-0.1	97.7	-3110.1	-110.2	11.6	4	BEARISH	0.0
EVRRF Molecule Holdings Inc.	—	-0.1	97.7	-3110.1	-110.2	11.6	4	BEARISH	0.0
ALID Allied Corp.	—	-0.0	266.4	484.7	-207842.5	-53.9	2	BEARISH	-95.5
ALID Allied Corp.	—	-0.0	266.4	484.7	-207842.5	-53.9	2	BEARISH	-95.5
DXBRF BellRock Brands Inc.	—	—	—	—	—	—	—	BEARISH	-50.0
DXBRF BellRock Brands Inc.	—	—	—	—	—	—	—	BEARISH	-50.0
EHOS Ehouse Global, Inc.	—	-0.0	161.0	52.5	—	—	1	BEARISH	900.0
EHOS Ehouse Global, Inc.	—	-0.0	161.0	52.5	—	—	1	BEARISH	900.0
JUVAF Juva Life Inc.	—	-0.0	-105.0	-21.4	-24.6	43.5	4	BEARISH	0.0
JUVAF Juva Life Inc.	—	-0.0	-105.0	-21.4	-24.6	43.5	4	BEARISH	0.0
VRTHF Indigenous Bloom Hemp Corp.	—	-0.3	77.3	21.2	—	—	3	BEARISH	0.0
VRTHF Indigenous Bloom Hemp Corp.	—	-0.3	77.3	21.2	—	—	3	BEARISH	0.0
MDIN MedGen, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
MDIN MedGen, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
CNNXF CannAmerica Brands Corp.	—	-0.0	53.3	23.6	-127.3	-16.8	4	BEARISH	0.0
CNNXF CannAmerica Brands Corp.	—	-0.0	53.3	23.6	-127.3	-16.8	4	BEARISH	0.0
IGRW Interactive Health Network	—	0.2	1090.1	947.6	-29882.2	—	2	BEARISH	900.0
IGRW Interactive Health Network	—	0.2	1090.1	947.6	-29882.2	—	2	BEARISH	900.0
WLDFF Wildflower Brands Inc.	—	-0.0	-27.7	-4.7	1.9	319.8	7	BEARISH	0.0
WLDFF Wildflower Brands Inc.	—	-0.0	-27.7	-4.7	1.9	319.8	7	BEARISH	0.0
PUMD ProUroCare Medical Inc.	—	—	—	—	—	—	—	BEARISH	-50.0
PUMD ProUroCare Medical Inc.	—	—	—	—	—	—	—	BEARISH	-50.0
CBDHF Hempfusion Wellness Inc.	—	0.0	-82.5	-84.6	-190.5	—	1	BEARISH	0.0
CBDHF Hempfusion Wellness Inc.	—	0.0	-82.5	-84.6	-190.5	—	1	BEARISH	0.0
ASFX American Scientific Resources, Incorporated	—	—	—	—	—	—	—	BEARISH	-25.0
ASFX American Scientific Resources, Incorporated	—	—	—	—	—	—	—	BEARISH	-25.0
CLVR Clever Leaves Holdings Inc.	—	-0.0	-55.4	-63.3	-109.6	3.6	4	BEARISH	-0.0
CLVR Clever Leaves Holdings Inc.	—	-0.0	-55.4	-63.3	-109.6	3.6	4	BEARISH	-0.0
RCAR RenovaCare, Inc.	—	-0.0	-436.6	812.3	—	—	2	BEARISH	0.0
RCAR RenovaCare, Inc.	—	-0.0	-436.6	812.3	—	—	2	BEARISH	0.0
CSDX CS Diagnostics Corp.	—	—	—	—	—	—	—	BEARISH	—
CSDX CS Diagnostics Corp.	—	—	—	—	—	—	—	BEARISH	—
CAAOF INDVR Brands Inc.	—	-0.0	-111.6	-22.0	-159.3	22.0	4	BEARISH	0.0
CAAOF INDVR Brands Inc.	—	-0.0	-111.6	-22.0	-159.3	22.0	4	BEARISH	0.0
NNBP Nanobac Pharmaceuticals, Incorporated	—	0.0	358.0	221.2	-26718.6	-92.2	3	BEARISH	0.0
NNBP Nanobac Pharmaceuticals, Incorporated	—	0.0	358.0	221.2	-26718.6	-92.2	3	BEARISH	0.0
PRPH ProPhase Labs, Inc.	—	-0.0	-544.0	-207.6	-301.8	-5.5	3	BEARISH	-99.7
PRPH ProPhase Labs, Inc.	—	-0.0	-544.0	-207.6	-301.8	-5.5	3	BEARISH	-99.7
IMVIF IMV Inc.	—	-0.2	-503.3	-2870.5	—	—	1	BEARISH	1900.0
IMVIF IMV Inc.	—	-0.2	-503.3	-2870.5	—	—	1	BEARISH	1900.0
FIORF Fiore Cannabis Ltd.	—	-0.0	-417.3	-33.3	-383.4	-6.2	2	BEARISH	0.0
FIORF Fiore Cannabis Ltd.	—	-0.0	-417.3	-33.3	-383.4	-6.2	2	BEARISH	0.0
MCIC Multicorp International, Inc.	—	-31.5	-1.1	-0.2	—	—	3	BEARISH	100.0
AUSAF Australis Capital Inc.	—	-0.0	-52.8	-42.1	-1022.3	1388076.3	3	BEARISH	-90.0
AUSAF Australis Capital Inc.	—	-0.0	-52.8	-42.1	-1022.3	1388076.3	3	BEARISH	-90.0
MCIC Multicorp International, Inc.	—	-31.5	-1.1	-0.2	—	—	3	BEARISH	100.0
WIBFF West Island Brands Inc.	—	-0.3	-99.5	-95.1	-40.3	165.1	4	BEARISH	0.0
WIBFF West Island Brands Inc.	—	-0.3	-99.5	-95.1	-40.3	165.1	4	BEARISH	0.0
AVTI Avitar, Inc.	—	-0.0	26.0	-62.7	-263.1	-47.4	2	BEARISH	0.0
AVTI Avitar, Inc.	—	-0.0	26.0	-62.7	-263.1	-47.4	2	BEARISH	0.0
LITH BioELife Corp.	—	-0.0	-598.1	467.7	—	—	2	BEARISH	0.0
LITH BioELife Corp.	—	-0.0	-598.1	467.7	—	—	2	BEARISH	0.0
NPHC Nutra Pharma Corp.	—	-0.1	23.1	4.7	-11458.0	55.8	3	BEARISH	0.0
NPHC Nutra Pharma Corp.	—	-0.1	23.1	4.7	-11458.0	55.8	3	BEARISH	0.0
TCNAF TransCanna Holdings Inc.	—	-0.0	-246.6	-38.8	-338.7	90.3	3	BEARISH	0.0
GELS Gelteq Limited Ordinary Shares	—	—	—	—	—	—	—	BEARISH	-59.6
GELS Gelteq Limited Ordinary Shares	—	—	—	—	—	—	—	BEARISH	-59.6
TCNAF TransCanna Holdings Inc.	—	-0.0	-246.6	-38.8	-338.7	90.3	3	BEARISH	0.0
HTGMQ HTG Molecular Diagnostics, Inc.	—	-0.0	-343.2	734.2	-489.6	-28.2	2	BEARISH	0.0
HTGMQ HTG Molecular Diagnostics, Inc.	—	-0.0	-343.2	734.2	-489.6	-28.2	2	BEARISH	0.0
ROTH PharmaRoth Labs, Inc.	—	—	—	—	—	—	—	BEARISH	-90.0
ROTH PharmaRoth Labs, Inc.	—	—	—	—	—	—	—	BEARISH	-90.0
PXYN Praxsyn Corporation	—	-0.0	159.9	101.7	14.5	14.7	4	BEARISH	0.0
PXYN Praxsyn Corporation	—	-0.0	159.9	101.7	14.5	14.7	4	BEARISH	0.0
SNNVF Sunniva Inc.	—	-0.2	-85.4	-22.5	-381.7	126.7	3	BEARISH	900.0
SNNVF Sunniva Inc.	—	-0.2	-85.4	-22.5	-381.7	126.7	3	BEARISH	900.0
IONM Assure Holdings Corp.	—	-0.0	237.0	462.9	-25500.0	-64.6	1	BEARISH	-99.0
IONM Assure Holdings Corp.	—	-0.0	237.0	462.9	-25500.0	-64.6	1	BEARISH	-99.0
MIRA MIRA Pharmaceuticals, Inc.	$30M	-0.5	-710.9	-15187.8	—	—	3	BEARISH	-44.7
MIRA MIRA Pharmaceuticals, Inc.	$30M	-0.5	-710.9	-15187.8	—	—	3	BEARISH	-44.7
SNANF Sona Nanotech Inc.	$30M	-15.4	526.4	236.5	—	—	1	BEARISH	-47.3
SNANF Sona Nanotech Inc.	$30M	-15.4	526.4	236.5	—	—	1	BEARISH	-47.3
RDGL Vivos Inc.	$20M	-5.9	-132.5	-427.2	-2280.7	91.5	3	BEARISH	-49.0
RDGL Vivos Inc.	$20M	-5.9	-132.5	-427.2	-2280.7	91.5	3	BEARISH	-49.0
AIMD Ainos, Inc.	$10M	-0.5	-196.3	-69.4	-3022849.3	-87.7	1	BEARISH	-61.2
AIMD Ainos, Inc.	$10M	-0.5	-196.3	-69.4	-3022849.3	-87.7	1	BEARISH	-61.2
CNBX CNBX Pharmaceuticals Inc.	—	-0.5	17.8	13.3	—	100.0	3	BEARISH	-71.4
CNBX CNBX Pharmaceuticals Inc.	—	-0.5	17.8	13.3	—	100.0	3	BEARISH	-71.4
SKYI Sky Century Investment, Inc.	—	-2.5	26.2	21.6	-11.3	180.9	4	BEARISH	3448.8
SKYI Sky Century Investment, Inc.	—	-2.5	26.2	21.6	-11.3	180.9	4	BEARISH	3448.8
SNNC Sibannac, Inc.	—	-1.7	44.4	105.9	—	-14.2	3	BEARISH	-72.4
SNNC Sibannac, Inc.	—	-1.7	44.4	105.9	—	-14.2	3	BEARISH	-72.4
CBDL CBD Life Sciences Inc.	—	75.9	-92.8	-98.4	-234.9	-30.0	2	BEARISH	-83.3
CBDL CBD Life Sciences Inc.	—	75.9	-92.8	-98.4	-234.9	-30.0	2	BEARISH	-83.3
ACUR Acura Pharmaceuticals, Inc.	—	-0.0	30.8	-306.4	80.6	-56.2	4	BEARISH	-75.0
ACUR Acura Pharmaceuticals, Inc.	—	-0.0	30.8	-306.4	80.6	-56.2	4	BEARISH	-75.0
IVRO InVitro International	—	17.1	3.7	4.6	4.8	-14.0	5	BEARISH	0.0
IVRO InVitro International	—	17.1	3.7	4.6	4.8	-14.0	5	BEARISH	0.0
FUNI Hypha Labs, Inc.	—	-0.4	26.8	31.4	—	—	2	BEARISH	—
FUNI Hypha Labs, Inc.	—	-0.4	26.8	31.4	—	—	2	BEARISH	—
STME Stimcell Energetics, Inc.	—	-6.2	17.7	20.7	—	—	2	BEARISH	—
STME Stimcell Energetics, Inc.	—	-6.2	17.7	20.7	—	—	2	BEARISH	—
AFFY Affymax, Inc.	—	-0.0	98.1	-302.0	17164.3	-99.9	5	BEARISH	77.8
AFFY Affymax, Inc.	—	-0.0	98.1	-302.0	17164.3	-99.9	5	BEARISH	77.8
CARM Carisma Therapeutics, Inc.	—	0.0	-134.1	-376.4	98.8	159.7	3	BEARISH	-99.8
CARM Carisma Therapeutics, Inc.	—	0.0	-134.1	-376.4	98.8	159.7	3	BEARISH	-99.8
NURPF Neuren Pharmaceuticals Limited	$1.8B	128.1	61.3	282.5	14.6	7.2	5	BEARISH	19.0
NURPF Neuren Pharmaceuticals Limited	$1.8B	128.1	61.3	282.5	14.6	7.2	5	BEARISH	19.0
AVBP ArriVent BioPharma, Inc.	$1.3B	-7.7	-53.1	2345.1	—	—	3	BEARISH	53.1
AVBP ArriVent BioPharma, Inc.	$1.3B	-7.7	-53.1	2345.1	—	—	3	BEARISH	53.1
OMDA Omada Health	$1.2B	300.0	1.8	-1.5	6.0	404.7	7	BEARISH	-9.2
OMDA Omada Health	$1.2B	300.0	1.8	-1.5	6.0	404.7	7	BEARISH	-9.2
SLNCF Silence Therapeutics plc	$570M	-2.8	-90.4	137.0	—	-97.6	1	BEARISH	175.9
SLNCF Silence Therapeutics plc	$570M	-2.8	-90.4	137.0	—	-97.6	1	BEARISH	175.9
ZRSEF DocMorris AG	$500M	-8.1	-65.3	-43.0	-8.9	-0.4	4	BEARISH	0.0
ZRSEF DocMorris AG	$500M	-8.1	-65.3	-43.0	-8.9	-0.4	4	BEARISH	0.0
AVIR Atea Pharmaceuticals, Inc.	$410M	-2.5	-58.1	974.6	—	—	3	BEARISH	78.1
AVIR Atea Pharmaceuticals, Inc.	$410M	-2.5	-58.1	974.6	—	—	3	BEARISH	78.1
CARL Carlsmed, Inc.	$390M	-10.5	-43.8	-122.7	-55.5	—	2	BEARISH	7.1
CARL Carlsmed, Inc.	$390M	-10.5	-43.8	-122.7	-55.5	—	2	BEARISH	7.1
BHCCF Benchmark Holdings plc	$230M	-4.1	16.4	-17.9	377.4	-62.6	6	BEARISH	0.0
BHCCF Benchmark Holdings plc	$230M	-4.1	16.4	-17.9	377.4	-62.6	6	BEARISH	0.0
WHWK Whitehawk Therapeutics Inc	$210M	-3.3	-45.0	963.4	—	-100.0	1	BEARISH	93.7
WHWK Whitehawk Therapeutics Inc	$210M	-3.3	-45.0	963.4	—	-100.0	1	BEARISH	93.7
CLLKF BICO Group AB (publ)	$150M	-1.9	-41.7	-8.4	-11.1	-16.1	7	BEARISH	-6.1
CLLKF BICO Group AB (publ)	$150M	-1.9	-41.7	-8.4	-11.1	-16.1	7	BEARISH	-6.1
VTVT vTv Therapeutics Inc.	$80M	-277.9	-11.7	91.2	—	216600.0	4	BEARISH	27.4
VTVT vTv Therapeutics Inc.	$80M	-277.9	-11.7	91.2	—	216600.0	4	BEARISH	27.4
CNTB Connect Biopharma Holdings Limited	$60M	-1.1	-128.0	1785.6	-1249.0	-79.7	2	BEARISH	-38.2
CNTB Connect Biopharma Holdings Limited	$60M	-1.1	-128.0	1785.6	-1249.0	-79.7	2	BEARISH	-38.2
QTI QT Imaging Holdings, Inc.	$40M	-2.3	-1915.2	88.4	-148.9	-99.4	5	BEARISH	372.6
QTI QT Imaging Holdings, Inc.	$40M	-2.3	-1915.2	88.4	-148.9	-99.4	5	BEARISH	372.6
FNCHQ Finch Therapeutics Group, Inc.	$20M	—	—	—	—	—	—	BEARISH	—
AYTU Aytu BioPharma, Inc.	$20M	-1.5	-52.6	-24.3	-0.1	-13.3	4	BEARISH	10.7
AYTU Aytu BioPharma, Inc.	$20M	-1.5	-52.6	-24.3	-0.1	-13.3	4	BEARISH	10.7
FNCHQ Finch Therapeutics Group, Inc.	$20M	—	—	—	—	—	—	BEARISH	—
IMUC EOM Pharmaceuticals Holdings, Inc.	$20M	-10.5	64.4	131.0	—	—	4	BEARISH	269.5
IMUC EOM Pharmaceuticals Holdings, Inc.	$20M	-10.5	64.4	131.0	—	—	4	BEARISH	269.5
HYEX Healthy Extracts Inc.	$20M	-6.6	-7.7	-2.8	-6.3	84.1	5	BEARISH	-38.6
HYEX Healthy Extracts Inc.	$20M	-6.6	-7.7	-2.8	-6.3	84.1	5	BEARISH	-38.6
VYYRF Voyageur Pharmaceuticals Ltd.	$20M	-6.5	-527.9	-47345.4	-6124.5	—	3	BEARISH	-16.7
VYYRF Voyageur Pharmaceuticals Ltd.	$20M	-6.5	-527.9	-47345.4	-6124.5	—	3	BEARISH	-16.7
ASAPF Aurora Spine Corporation	$10M	-6.4	-35.3	-14.8	-22.8	-4.5	5	BEARISH	-51.2
ASAPF Aurora Spine Corporation	$10M	-6.4	-35.3	-14.8	-22.8	-4.5	5	BEARISH	-51.2
INM InMed Pharmaceuticals Inc.	$10M	-0.4	-129.6	732.1	-0.2	37942.8	3	BEARISH	-40.1
INM InMed Pharmaceuticals Inc.	$10M	-0.4	-129.6	732.1	-0.2	37942.8	3	BEARISH	-40.1
TDSGF Telo Genomics Corp.	—	-2.4	-2858.5	258.3	—	—	2	BEARISH	-37.3
TDSGF Telo Genomics Corp.	—	-2.4	-2858.5	258.3	—	—	2	BEARISH	-37.3
AEGY Alternative Energy Partners, Inc.	—	-0.0	190.5	67.0	—	-165.0	4	BEARISH	-80.0
AEGY Alternative Energy Partners, Inc.	—	-0.0	190.5	67.0	—	-165.0	4	BEARISH	-80.0
EMYSF Easy Technologies Inc.	—	-0.3	192.7	227.8	—	-100.0	1	BEARISH	0.0
EMYSF Easy Technologies Inc.	—	-0.3	192.7	227.8	—	-100.0	1	BEARISH	0.0
NUWE Nuwellis, Inc.	—	-0.0	202.0	173.3	-245.2	8.4	5	BEARISH	-78.4
NUWE Nuwellis, Inc.	—	-0.0	202.0	173.3	-245.2	8.4	5	BEARISH	-78.4
MLECW Moolec Science S.A.	—	-0.0	-174.7	-31.5	-91.8	170.4	3	BEARISH	10.8
MLECW Moolec Science S.A.	—	-0.0	-174.7	-31.5	-91.8	170.4	3	BEARISH	10.8
TUTH Standard Dental Labs Inc.	—	-4.5	26.7	318.1	-228.2	-27.6	2	BEARISH	-48.8
TUTH Standard Dental Labs Inc.	—	-4.5	26.7	318.1	-228.2	-27.6	2	BEARISH	-48.8
AZFL Amazonas Florestal, Ltd	—	3.3	19.8	13.9	13.6	—	5	BEARISH	0.0
AZFL Amazonas Florestal, Ltd	—	3.3	19.8	13.9	13.6	—	5	BEARISH	0.0
SCNI Scinai Immunotherapeutics Ltd.	—	-0.0	-19.2	-53.3	-435.4	162.7	2	BEARISH	-4.3
SCNI Scinai Immunotherapeutics Ltd.	—	-0.0	-19.2	-53.3	-435.4	162.7	2	BEARISH	-4.3
ATXI Avenue Therapeutics, Inc.	—	-0.5	-120.0	178.4	—	-100.0	2	BEARISH	-43.4
ATXI Avenue Therapeutics, Inc.	—	-0.5	-120.0	178.4	—	-100.0	2	BEARISH	-43.4
PANHF Ping An Healthcare and Technology Company Limited	$1.7B	23.9	5.3	6.9	8.8	4.4	7	BEARISH	-56.5
PANHF Ping An Healthcare and Technology Company Limited	$1.7B	23.9	5.3	6.9	8.8	4.4	7	BEARISH	-56.5
ARDT Ardent Health Inc.	$1.5B	18.8	6.0	13.5	1.0	3.3	5	BEARISH	-20.9
ARDT Ardent Health Inc.	$1.5B	18.8	6.0	13.5	1.0	3.3	5	BEARISH	-20.9
ORIC ORIC Pharmaceuticals, Inc.	$1.3B	-9.0	-39.8	-102.9	—	—	3	BEARISH	4.3
ORIC ORIC Pharmaceuticals, Inc.	$1.3B	-9.0	-39.8	-102.9	—	—	3	BEARISH	4.3
ANGO AngioDynamics, Inc.	$620M	-17.2	-20.8	-27.0	-13.2	9.5	4	BEARISH	36.5
ANGO AngioDynamics, Inc.	$620M	-17.2	-20.8	-27.0	-13.2	9.5	4	BEARISH	36.5
DCTH Delcath Systems, Inc.	$520M	1375.5	0.5	-2.7	9.2	35.8	6	BEARISH	40.7
DCTH Delcath Systems, Inc.	$520M	1375.5	0.5	-2.7	9.2	35.8	6	BEARISH	40.7
IVVD Invivyd, Inc.	$240M	-2.1	-95.9	-302.5	-310.8	26.3	2	BEARISH	-31.8
IVVD Invivyd, Inc.	$240M	-2.1	-95.9	-302.5	-310.8	26.3	2	BEARISH	-31.8
PDEX Pro-Dex, Inc.	$200M	15.2	32.4	17.5	14.0	16.4	8	BEARISH	89.6
PDEX Pro-Dex, Inc.	$200M	15.2	32.4	17.5	14.0	16.4	8	BEARISH	89.6
LFPI LifePoint, Inc.	—	-0.0	-288.4	-229.2	-52133.6	161.6	3	BEARISH	1400.0
LFPI LifePoint, Inc.	—	-0.0	-288.4	-229.2	-52133.6	161.6	3	BEARISH	1400.0
ONSS Onassis Holdings Corp.	—	-0.2	202.8	38.2	—	-100.0	2	BEARISH	200.0
ONSS Onassis Holdings Corp.	—	-0.2	202.8	38.2	—	-100.0	2	BEARISH	200.0
BRSF Brain Scientific Inc.	—	-0.0	-633.9	-94.8	-77714.6	-19.3	3	BEARISH	-99.9
BRSF Brain Scientific Inc.	—	-0.0	-633.9	-94.8	-77714.6	-19.3	3	BEARISH	-99.9
SNNAQ Sienna Biopharmaceuticals, Inc.	—	-0.0	-140.9	-331.4	—	—	2	BEARISH	9900.0
SNNAQ Sienna Biopharmaceuticals, Inc.	—	-0.0	-140.9	-331.4	—	—	2	BEARISH	9900.0
BLMS Bloomios, Inc.	—	-0.0	221.4	58.3	-3817.0	46.5	2	BEARISH	200.0
BLMS Bloomios, Inc.	—	-0.0	221.4	58.3	-3817.0	46.5	2	BEARISH	200.0
BTAX Biostax Corp.	—	-0.0	7.3	5.8	—	—	2	BEARISH	100.0
BTAX Biostax Corp.	—	-0.0	7.3	5.8	—	—	2	BEARISH	100.0
ALST AllStar Health Brands Inc	—	-0.4	12.9	2.5	—	—	4	BEARISH	-20.0
ALST AllStar Health Brands Inc	—	-0.4	12.9	2.5	—	—	4	BEARISH	-20.0
ALPS Alps Group Inc	$70M	—	—	—	—	—	—	BEARISH	—
ALPS Alps Group Inc	$70M	—	—	—	—	—	—	BEARISH	—
ANEB Anebulo Pharmaceuticals, Inc.	$10M	-2.1	-69.7	650.7	—	—	1	BEARISH	-86.7
ANEB Anebulo Pharmaceuticals, Inc.	$10M	-2.1	-69.7	650.7	—	—	1	BEARISH	-86.7
MDRSF Medartis Holding AG	$1.4B	68.4	5.2	3.9	3.2	29.8	7	BEARISH	72.5
MDRSF Medartis Holding AG	$1.4B	68.4	5.2	3.9	3.2	29.8	7	BEARISH	72.5
KKPCF Kaken Pharmaceutical Co., Ltd.	$980M	13.9	1.4	-0.8	3.9	-17.8	5	BEARISH	-7.5
KKPCF Kaken Pharmaceutical Co., Ltd.	$980M	13.9	1.4	-0.8	3.9	-17.8	5	BEARISH	-7.5
IRD Opus Genetics, Inc.	$380M	-3.6	-4796.5	59.8	-1072.6	-36.1	3	BEARISH	154.4
IRD Opus Genetics, Inc.	$380M	-3.6	-4796.5	59.8	-1072.6	-36.1	3	BEARISH	154.4
VMTHF Venus Medtech (Hangzhou), Inc. Class H	$190M	-1.0	-51.9	-31.5	-141.2	-25.9	4	BEARISH	-18.8
VMTHF Venus Medtech (Hangzhou), Inc. Class H	$190M	-1.0	-51.9	-31.5	-141.2	-25.9	4	BEARISH	-18.8
TCLIF Theraclion S.A.	$40M	-6.4	-342.1	1171.9	-543.9	7.1	2	BEARISH	312841.2
TCLIF Theraclion S.A.	$40M	-6.4	-342.1	1171.9	-543.9	7.1	2	BEARISH	312841.2
ETST Earth Science Tech, Inc.	$30M	6.8	66.8	212.2	8.0	8.0	6	BEARISH	-47.9
ETST Earth Science Tech, Inc.	$30M	6.8	66.8	212.2	8.0	8.0	6	BEARISH	-47.9
LANZ Lancer Orthodontics, Inc.	—	4.0	3.3	2.5	-4.3	4.5	4	BEARISH	2566.7
LANZ Lancer Orthodontics, Inc.	—	4.0	3.3	2.5	-4.3	4.5	4	BEARISH	2566.7
HDRPF Epsilon Healthcare Limited	—	86.7	-33.3	-22.6	-9.6	161.1	5	BEARISH	614.3
HDRPF Epsilon Healthcare Limited	—	86.7	-33.3	-22.6	-9.6	161.1	5	BEARISH	614.3
NDATF nDatalyze Corp.	—	-16.7	-49.3	2580.1	—	-100.0	3	BEARISH	633.9
NDATF nDatalyze Corp.	—	-16.7	-49.3	2580.1	—	-100.0	3	BEARISH	633.9
AOBI American Oriental Bioengineering, Inc.	—	-0.0	-28.2	-16.5	-118.1	-10.2	3	BEARISH	1081.8
AOBI American Oriental Bioengineering, Inc.	—	-0.0	-28.2	-16.5	-118.1	-10.2	3	BEARISH	1081.8
DYAI Dyadic International, Inc.	$20M	-2.1	522.6	1288.0	-221.0	1.5	3	BEARISH	-64.1
DYAI Dyadic International, Inc.	$20M	-2.1	522.6	1288.0	-221.0	1.5	3	BEARISH	-64.1
BMRA Biomerica, Inc.	$10M	-1.7	-112.1	-113.5	-130.9	-16.2	4	BEARISH	-21.3
BMRA Biomerica, Inc.	$10M	-1.7	-112.1	-113.5	-130.9	-16.2	4	BEARISH	-21.3
TOVX Theriva Biologics, Inc.	$10M	-0.3	-101.9	-213.5	—	—	2	BEARISH	-40.8
TOVX Theriva Biologics, Inc.	$10M	-0.3	-101.9	-213.5	—	—	2	BEARISH	-40.8
KALY Kali, Inc.	—	-8.6	32.3	47.0	20.9	28.1	4	BEARISH	100.0
KALY Kali, Inc.	—	-8.6	32.3	47.0	20.9	28.1	4	BEARISH	100.0
MAHN Mid-Atlantic Home Health Network, Inc.	—	—	—	—	—	—	—	BEARISH	-88.0
MAHN Mid-Atlantic Home Health Network, Inc.	—	—	—	—	—	—	—	BEARISH	-88.0
CHALF Chalice Brands Ltd	—	0.0	-51.3	-9.0	9.4	36.2	5	BEARISH	0.0
CHALF Chalice Brands Ltd	—	0.0	-51.3	-9.0	9.4	36.2	5	BEARISH	0.0
PZOO Pazoo, Inc.	—	-0.0	49.0	21.1	-972321.6	-100.0	4	BEARISH	0.0
PZOO Pazoo, Inc.	—	-0.0	49.0	21.1	-972321.6	-100.0	4	BEARISH	0.0
KGET CaliPharms, Inc.	—	-0.4	72.6	7.6	-6979.1	—	2	BEARISH	3900.0
KGET CaliPharms, Inc.	—	-0.4	72.6	7.6	-6979.1	—	2	BEARISH	3900.0
FITX Creative Edge Nutrition, Inc.	—	-0.0	242.9	120.2	-98.6	—	3	BEARISH	0.0
FITX Creative Edge Nutrition, Inc.	—	-0.0	242.9	120.2	-98.6	—	3	BEARISH	0.0
CATV Opus Holdings, Inc.	—	-16.9	-0.8	-1.4	91.7	47.8	5	BEARISH	-50.0
CATV Opus Holdings, Inc.	—	-16.9	-0.8	-1.4	91.7	47.8	5	BEARISH	-50.0
AFIB Acutus Medical, Inc.	—	-0.0	153.1	-0.4	-19.7	375.7	2	BEARISH	-88.9
AFIB Acutus Medical, Inc.	—	-0.0	153.1	-0.4	-19.7	375.7	2	BEARISH	-88.9
OXBOF Oxford BioDynamics Plc	—	-0.3	-920.3	-356.4	-649.8	131.0	4	BEARISH	-85.1
OXBOF Oxford BioDynamics Plc	—	-0.3	-920.3	-356.4	-649.8	131.0	4	BEARISH	-85.1
TOMDF Todos Medical Ltd.	—	-0.0	89.6	-253.6	-355.9	-37.1	3	BEARISH	0.0
TOMDF Todos Medical Ltd.	—	-0.0	89.6	-253.6	-355.9	-37.1	3	BEARISH	0.0
KLYG Kelyniam Global, Inc.	—	-30.2	-26.9	10.0	-16.7	2.0	5	BEARISH	62.6
KLYG Kelyniam Global, Inc.	—	-30.2	-26.9	10.0	-16.7	2.0	5	BEARISH	62.6
WLSI Wellstar International, Inc.	—	-0.0	24.2	35.0	—	—	3	BEARISH	0.0
WLSI Wellstar International, Inc.	—	-0.0	24.2	35.0	—	—	3	BEARISH	0.0
CVSGF CVS Group plc	$1.1B	45.6	16.0	17.2	2.7	49.6	6	BEARISH	1.8
CVSGF CVS Group plc	$1.1B	45.6	16.0	17.2	2.7	49.6	6	BEARISH	1.8
PHGUF Pharming Group N.V.	$780M	66.6	3.7	5.8	1.7	7.8	7	BEARISH	-26.0
PHGUF Pharming Group N.V.	$780M	66.6	3.7	5.8	1.7	7.8	7	BEARISH	-26.0
OFIX Orthofix Medical Inc.	$370M	-5.9	-13.9	-3.6	-7.5	3.0	6	BEARISH	-36.6
OFIX Orthofix Medical Inc.	$370M	-5.9	-13.9	-3.6	-7.5	3.0	6	BEARISH	-36.6
VHIBF Vitalhub Corp.	$340M	63.2	3.3	10.7	6.1	53.9	7	BEARISH	-32.0
VHIBF Vitalhub Corp.	$340M	63.2	3.3	10.7	6.1	53.9	7	BEARISH	-32.0
CATX Perspective Therapeutics, Inc.	$310M	-1.8	-39.5	-108.8	-33069.1	-35.3	3	BEARISH	-19.8
CATX Perspective Therapeutics, Inc.	$310M	-1.8	-39.5	-108.8	-33069.1	-35.3	3	BEARISH	-19.8
PROF Profound Medical Corp.	$210M	-6.1	-73.1	-148.0	-384.2	35.5	3	BEARISH	18.2
PROF Profound Medical Corp.	$210M	-6.1	-73.1	-148.0	-384.2	35.5	3	BEARISH	18.2
CDXS Codexis, Inc.	$150M	-4.0	-69.4	-37.8	-80.5	35.9	3	BEARISH	-45.6
CDXS Codexis, Inc.	$150M	-4.0	-69.4	-37.8	-80.5	35.9	3	BEARISH	-45.6
GTHP Guided Therapeutics, Inc.	$20M	-5.5	66.3	57.9	—	450.8	3	BEARISH	-18.5
GTHP Guided Therapeutics, Inc.	$20M	-5.5	66.3	57.9	—	450.8	3	BEARISH	-18.5
LFCOF Lift & Co. Corp.	—	-0.0	149.0	-666.2	-170.0	—	2	BEARISH	0.0
LFCOF Lift & Co. Corp.	—	-0.0	149.0	-666.2	-170.0	—	2	BEARISH	0.0
LRSV Link Reservations Inc.	—	-7.6	103.3	152.0	-20.7	73995.4	5	BEARISH	-50.0
LRSV Link Reservations Inc.	—	-7.6	103.3	152.0	-20.7	73995.4	5	BEARISH	-50.0
CGNSF Cognetivity Neurosciences Ltd.	—	-0.1	78.7	25.2	-6985.2	—	2	BEARISH	0.0
CGNSF Cognetivity Neurosciences Ltd.	—	-0.1	78.7	25.2	-6985.2	—	2	BEARISH	0.0
DGEN Deltagen Inc.	—	0.0	19.8	182.7	-27.2	-65.8	4	BEARISH	0.0
DGEN Deltagen Inc.	—	0.0	19.8	182.7	-27.2	-65.8	4	BEARISH	0.0
VRSEF Verisante Technology Inc.	—	0.7	124.9	102.2	—	—	3	BEARISH	-88.0
VRSEF Verisante Technology Inc.	—	0.7	124.9	102.2	—	—	3	BEARISH	-88.0
CRRVF CVR Medical Corp.	—	-0.0	49.0	11.5	—	—	1	BEARISH	0.0
CRRVF CVR Medical Corp.	—	-0.0	49.0	11.5	—	—	1	BEARISH	0.0
PSYBF PsyBio Therapeutics Corp	—	-0.0	344.6	135.0	—	—	2	BEARISH	-90.0
PSYBF PsyBio Therapeutics Corp	—	-0.0	344.6	135.0	—	—	2	BEARISH	-90.0
PEMTF Thoughtful Brands Inc.	—	—	—	—	—	—	—	BEARISH	0.0
PEMTF Thoughtful Brands Inc.	—	—	—	—	—	—	—	BEARISH	0.0
MJARF MJardin Group, Inc.	—	-0.0	59.5	-11.0	-1614.6	-42.3	3	BEARISH	0.0
MJARF MJardin Group, Inc.	—	-0.0	59.5	-11.0	-1614.6	-42.3	3	BEARISH	0.0
ROSGQ Rosetta Genomics Ltd.	—	-0.0	-44.3	-306.4	136.0	—	1	BEARISH	0.0
OTRKQ Ontrak, Inc.	—	-0.0	-215.7	-149.5	-341.6	-21.0	1	BEARISH	-99.8
OTRKQ Ontrak, Inc.	—	-0.0	-215.7	-149.5	-341.6	-21.0	1	BEARISH	-99.8
ROSGQ Rosetta Genomics Ltd.	—	-0.0	-44.3	-306.4	136.0	—	1	BEARISH	0.0
SPPH Spencer Pharmaceutical Inc.	—	—	—	—	—	—	—	BEARISH	0.0
SPPH Spencer Pharmaceutical Inc.	—	—	—	—	—	—	—	BEARISH	0.0
IBXG iBX Group, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
IBXG iBX Group, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
LPTI Longport, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
LPTI Longport, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
BMGP Biomagnetics Diagnostics Corp.	—	—	—	—	—	—	—	BEARISH	-28.6
BMGP Biomagnetics Diagnostics Corp.	—	—	—	—	—	—	—	BEARISH	-28.6
RSCI Redwood Scientific Technologies, Inc.	—	-0.0	2488.8	821.0	—	—	2	BEARISH	-99.9
RSCI Redwood Scientific Technologies, Inc.	—	-0.0	2488.8	821.0	—	—	2	BEARISH	-99.9
LIFS Life Stem Genetics Inc.	—	-2.5	-126.7	-111.5	—	—	2	BEARISH	0.0
LIFS Life Stem Genetics Inc.	—	-2.5	-126.7	-111.5	—	—	2	BEARISH	0.0
OMDD Ormand Industries Inc	—	—	—	—	—	—	—	BEARISH	0.0
OMDD Ormand Industries Inc	—	—	—	—	—	—	—	BEARISH	0.0
LLBO Lifeline Biotechnologies, Inc.	—	—	—	—	—	—	—	BEARISH	-60.0
LLBO Lifeline Biotechnologies, Inc.	—	—	—	—	—	—	—	BEARISH	-60.0
HLUN HEALTHeUNIVERSE, Inc.	—	—	—	—	—	—	—	BEARISH	900.0
HLUN HEALTHeUNIVERSE, Inc.	—	—	—	—	—	—	—	BEARISH	900.0
JWCAF James E. Wagner Cultivation Corporation	—	-0.0	-50.3	-16.2	-493.1	315.1	2	BEARISH	9900.0
JWCAF James E. Wagner Cultivation Corporation	—	-0.0	-50.3	-16.2	-493.1	315.1	2	BEARISH	9900.0
PZRXQ PhaseRx, Inc.	—	-0.0	-228.2	8803.4	—	—	2	BEARISH	0.0
PZRXQ PhaseRx, Inc.	—	-0.0	-228.2	8803.4	—	—	2	BEARISH	0.0
NTII Neurobiological Technologies, Inc.	—	0.0	48.7	441.6	89.7	99.7	4	BEARISH	0.0
NTII Neurobiological Technologies, Inc.	—	0.0	48.7	441.6	89.7	99.7	4	BEARISH	0.0
GEATF Radiko Holdings Corp	—	-0.0	178.7	-374.3	-40.1	-30.5	3	BEARISH	0.0
GEATF Radiko Holdings Corp	—	-0.0	178.7	-374.3	-40.1	-30.5	3	BEARISH	0.0
THCBF THC Biomed Intl Ltd.	—	-1.1	-56.5	-34.0	-196.4	-17.5	2	BEARISH	0.0
THCBF THC Biomed Intl Ltd.	—	-1.1	-56.5	-34.0	-196.4	-17.5	2	BEARISH	0.0
CBGL Cannabis Global Inc.	—	-0.5	5.4	17.3	—	520.3	3	BEARISH	900.0
CBGL Cannabis Global Inc.	—	-0.5	5.4	17.3	—	520.3	3	BEARISH	900.0
MDVLQ MedAvail Holdings, Inc.	—	-0.0	-164.8	-243.8	-1429.9	-28.6	4	BEARISH	0.0
MDVLQ MedAvail Holdings, Inc.	—	-0.0	-164.8	-243.8	-1429.9	-28.6	4	BEARISH	0.0
ACNV Accelera Innovations, Inc	—	-0.0	197.1	28.9	—	-97.0	1	BEARISH	0.0
ACNV Accelera Innovations, Inc	—	-0.0	197.1	28.9	—	-97.0	1	BEARISH	0.0
BMCS BioTech Medics, Inc.	—	-13.9	-0.0	-0.0	—	—	5	BEARISH	-97.7
BMCS BioTech Medics, Inc.	—	-13.9	-0.0	-0.0	—	—	5	BEARISH	-97.7
NSVGF Nass Valley Gateway Ltd.	—	-3.7	12.1	2.9	—	-95.8	1	BEARISH	0.0
NSVGF Nass Valley Gateway Ltd.	—	-3.7	12.1	2.9	—	-95.8	1	BEARISH	0.0
INSD Instadose Pharma Corp.	—	-0.0	-9.7	-3.7	—	—	4	BEARISH	-90.9
INSD Instadose Pharma Corp.	—	-0.0	-9.7	-3.7	—	—	4	BEARISH	-90.9
SCRCQ ScripsAmerica, Inc.	—	-0.0	168.2	144.2	-17.6	3510.5	5	BEARISH	0.0
SCRCQ ScripsAmerica, Inc.	—	-0.0	168.2	144.2	-17.6	3510.5	5	BEARISH	0.0
WCUI Wellness Center USA, Inc.	—	-0.0	44.8	1728.1	-86.5	140.9	5	BEARISH	0.0
WCUI Wellness Center USA, Inc.	—	-0.0	44.8	1728.1	-86.5	140.9	5	BEARISH	0.0
AMPE Ampio Pharmaceuticals, Inc.	—	-0.0	-114.0	1652.6	-838.4	—	4	BEARISH	6681.5
AMPE Ampio Pharmaceuticals, Inc.	—	-0.0	-114.0	1652.6	-838.4	—	4	BEARISH	6681.5
MRZM Marizyme, Inc.	—	-0.0	117.5	-190.1	—	-69.0	3	BEARISH	29900.0
MRZM Marizyme, Inc.	—	-0.0	117.5	-190.1	—	-69.0	3	BEARISH	29900.0
MRPI Mera Pharmaceuticals, Inc.	—	-10000.0	24.3	18.3	-159.9	4.8	5	BEARISH	0.0
MRPI Mera Pharmaceuticals, Inc.	—	-10000.0	24.3	18.3	-159.9	4.8	5	BEARISH	0.0
UPPR Upper Street Marketing Inc.	—	-0.0	228.5	-53.9	-715.0	—	1	BEARISH	42.9
UPPR Upper Street Marketing Inc.	—	-0.0	228.5	-53.9	-715.0	—	1	BEARISH	42.9
BHNGF Bhang Inc.	—	-0.0	782.7	270.1	-248.2	78.7	3	BEARISH	0.0
BHNGF Bhang Inc.	—	-0.0	782.7	270.1	-248.2	78.7	3	BEARISH	0.0
DSOL Drug Free Solution, Inc.	—	-16.9	255.8	197.9	—	—	2	BEARISH	-63.6
DSOL Drug Free Solution, Inc.	—	-16.9	255.8	197.9	—	—	2	BEARISH	-63.6
BSPK Bespoke Extracts, Inc.	—	-0.0	37.1	45.4	-16.7	284.5	4	BEARISH	-99.4
BSPK Bespoke Extracts, Inc.	—	-0.0	37.1	45.4	-16.7	284.5	4	BEARISH	-99.4
THER Theralink Technologies, Inc.	—	-0.0	6.0	-69.7	5363.6	32.8	2	BEARISH	0.0
THER Theralink Technologies, Inc.	—	-0.0	6.0	-69.7	5363.6	32.8	2	BEARISH	0.0
BNVIF Binovi Technologies Corp.	—	-0.0	-433.7	182.0	17056.9	-74.4	1	BEARISH	400.0
BNVIF Binovi Technologies Corp.	—	-0.0	-433.7	182.0	17056.9	-74.4	1	BEARISH	400.0
DMSI Dermisonics, Inc.	—	-0.0	-392.2	1105.0	—	—	1	BEARISH	0.0
DMSI Dermisonics, Inc.	—	-0.0	-392.2	1105.0	—	—	1	BEARISH	0.0
EWPI Emerging World Pharma, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
EWPI Emerging World Pharma, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
IMEXF Imagin Medical Inc.	—	-0.0	31.8	185.9	—	—	3	BEARISH	0.0
IMEXF Imagin Medical Inc.	—	-0.0	31.8	185.9	—	—	3	BEARISH	0.0
RGDXQ Response Genetics, Inc	—	-0.0	1186.4	-243.6	-110.9	-8.1	3	BEARISH	0.0
RGDXQ Response Genetics, Inc	—	-0.0	1186.4	-243.6	-110.9	-8.1	3	BEARISH	0.0
ZBIO Zenas BioPharma, Inc.	$1.8B	-2.9	-199.0	5842.1	-11145.6	-93.3	2	BEARISH	27.9
ZBIO Zenas BioPharma, Inc.	$1.8B	-2.9	-199.0	5842.1	-11145.6	-93.3	2	BEARISH	27.9
ETON Eton Pharmaceuticals, Inc.	$1.5B	119.1	36.0	33.3	30.8	81.5	7	BEARISH	173.2
ETON Eton Pharmaceuticals, Inc.	$1.5B	119.1	36.0	33.3	30.8	81.5	7	BEARISH	173.2
HCSG Healthcare Services Group, Inc.	$1.4B	12.1	24.7	31.7	4.8	5.2	8	BEARISH	28.4
HCSG Healthcare Services Group, Inc.	$1.4B	12.1	24.7	31.7	4.8	5.2	8	BEARISH	28.4
SGP SpyGlass Pharma, Inc. Common Stock	$830M	—	—	—	—	—	—	BEARISH	—
SGP SpyGlass Pharma, Inc. Common Stock	$830M	—	—	—	—	—	—	BEARISH	—
ACHV Achieve Life Sciences, Inc.	$740M	-4.7	-845.0	24.6	—	—	2	BEARISH	133.6
ACHV Achieve Life Sciences, Inc.	$740M	-4.7	-845.0	24.6	—	—	2	BEARISH	133.6
TLSI TriSalus Life Sciences, Inc.	$270M	-3.3	438.3	453.7	-80.5	25.2	4	BEARISH	-5.3
TLSI TriSalus Life Sciences, Inc.	$270M	-3.3	438.3	453.7	-80.5	25.2	4	BEARISH	-5.3
ORMP Oramed Pharmaceuticals Inc.	$180M	1.1	74.1	-4.3	—	-100.0	4	BEARISH	76.1
ORMP Oramed Pharmaceuticals Inc.	$180M	1.1	74.1	-4.3	—	-100.0	4	BEARISH	76.1
ENTX Entera Bio Ltd.	$140M	-8.2	-138.9	314.4	—	-100.0	1	BEARISH	54.6
ENTX Entera Bio Ltd.	$140M	-8.2	-138.9	314.4	—	-100.0	1	BEARISH	54.6
ADCT ADC Therapeutics S.A.	$140M	-1.7	45.3	260.9	-86.1	2.0	2	BEARISH	-72.0
ADCT ADC Therapeutics S.A.	$140M	-1.7	45.3	260.9	-86.1	2.0	2	BEARISH	-72.0
OTLK Outlook Therapeutics, Inc.	$110M	-0.3	256.9	1372.0	-225766.7	-169.4	4	BEARISH	-43.0
OTLK Outlook Therapeutics, Inc.	$110M	-0.3	256.9	1372.0	-225766.7	-169.4	4	BEARISH	-43.0
ICCC ImmuCell Corporation	$90M	115.2	2.6	10.2	25.5	8.5	6	BEARISH	47.7
ICCC ImmuCell Corporation	$90M	115.2	2.6	10.2	25.5	8.5	6	BEARISH	47.7
LUNG Pulmonx Corporation	$80M	-1.6	-88.9	-92.5	-44.3	-3.4	4	BEARISH	10.2
LUNG Pulmonx Corporation	$80M	-1.6	-88.9	-92.5	-44.3	-3.4	4	BEARISH	10.2
DRIO DarioHealth Corp.	$50M	9.4	113.8	-93.8	-153.1	-22.6	3	BEARISH	-62.4
DRIO DarioHealth Corp.	$50M	9.4	113.8	-93.8	-153.1	-22.6	3	BEARISH	-62.4
ABDXF Abingdon Health Plc	$40M	-13.1	-143.7	-145.6	-55.4	212.2	6	BEARISH	105.0
ABDXF Abingdon Health Plc	$40M	-13.1	-143.7	-145.6	-55.4	212.2	6	BEARISH	105.0
YI 111, Inc.	$30M	-1.8	30.0	15.9	-1.7	-20.9	2	BEARISH	-29.6
YI 111, Inc.	$30M	-1.8	30.0	15.9	-1.7	-20.9	2	BEARISH	-29.6
RHEPB Regional Health Properties, Inc.	$10M	0.5	-328.8	-0.6	-3.2	200.4	6	BEARISH	-0.8
AIMV AI Maverick Intel, Inc.	$10M	—	—	—	—	—	—	BEARISH	—
AIMV AI Maverick Intel, Inc.	$10M	—	—	—	—	—	—	BEARISH	—
ADVB Advanced Biomed Inc. Common Stock	$10M	-31.6	-10.2	-11.8	—	—	3	BEARISH	-24.9
ADVB Advanced Biomed Inc. Common Stock	$10M	-31.6	-10.2	-11.8	—	—	3	BEARISH	-24.9
RHEPB Regional Health Properties, Inc.	$10M	0.5	-328.8	-0.6	-3.2	200.4	6	BEARISH	-0.8
LOBEF Lobe Sciences Ltd.	$10M	-2.7	359.0	181.6	—	—	2	BEARISH	9.5
LOBEF Lobe Sciences Ltd.	$10M	-2.7	359.0	181.6	—	—	2	BEARISH	9.5
TPST Tempest Therapeutics, Inc.	$10M	-0.2	-931.1	-564.2	—	—	1	BEARISH	-92.0
MTVA MetaVia Inc.	$10M	-0.4	-175.7	209.3	—	—	0	BEARISH	-86.4
MTVA MetaVia Inc.	$10M	-0.4	-175.7	209.3	—	—	0	BEARISH	-86.4
TPST Tempest Therapeutics, Inc.	$10M	-0.2	-931.1	-564.2	—	—	1	BEARISH	-92.0
HCWB HCW Biologics Inc.	—	-0.0	-133.5	-36.8	-3849.9	707.0	3	BEARISH	-92.6
HCWB HCW Biologics Inc.	—	-0.0	-133.5	-36.8	-3849.9	707.0	3	BEARISH	-92.6
NBIO Nascent Biotech, Inc.	—	-0.0	230.6	328.8	—	—	5	BEARISH	-97.1
NBIO Nascent Biotech, Inc.	—	-0.0	230.6	328.8	—	—	5	BEARISH	-97.1
UDOCF Unidoc Health Corp.	—	-1.9	-399.0	358.8	-256.4	—	3	BEARISH	-66.7
UDOCF Unidoc Health Corp.	—	-1.9	-399.0	358.8	-256.4	—	3	BEARISH	-66.7
MDRM Modern Mobility Aids, Inc.	—	-63.9	146.1	120.5	—	—	2	BEARISH	42.9
MDRM Modern Mobility Aids, Inc.	—	-63.9	146.1	120.5	—	—	2	BEARISH	42.9
PMHS Polomar Health Services, Inc.	—	—	—	—	—	—	—	BEARISH	—
PMHS Polomar Health Services, Inc.	—	—	—	—	—	—	—	BEARISH	—
INFIQ Infinity Pharmaceuticals, Inc.	—	-0.0	109.5	60.9	-1707.7	—	2	BEARISH	-98.0
INFIQ Infinity Pharmaceuticals, Inc.	—	-0.0	109.5	60.9	-1707.7	—	2	BEARISH	-98.0
MDCN Medican Enterprises, Inc.	—	-3.4	40.4	-2.1	—	-38.5	3	BEARISH	0.0
MDCN Medican Enterprises, Inc.	—	-3.4	40.4	-2.1	—	-38.5	3	BEARISH	0.0
LVVV LiveWire Ergogenics, Inc.	—	-0.6	-188.5	-4.0	-2585.3	-89.5	3	BEARISH	-0.0
LVVV LiveWire Ergogenics, Inc.	—	-0.6	-188.5	-4.0	-2585.3	-89.5	3	BEARISH	-0.0
SPRC SciSparc Ltd.	—	-0.0	-311.5	-90652.5	-721.8	-48.8	3	BEARISH	-25.2
SPRC SciSparc Ltd.	—	-0.0	-311.5	-90652.5	-721.8	-48.8	3	BEARISH	-25.2
BSSP Baseline Productions, Inc.	—	-0.0	167.7	64.9	—	—	2	BEARISH	-99.0
BSSP Baseline Productions, Inc.	—	-0.0	167.7	64.9	—	—	2	BEARISH	-99.0
ZYBT Zhengye Biotechnology Holding Limited	$60M	—	—	—	—	—	—	BEARISH	-49.8
ZYBT Zhengye Biotechnology Holding Limited	$60M	—	—	—	—	—	—	BEARISH	-49.8
EXOZ eXoZymes, Inc.	$50M	-4.8	-187.2	913.0	—	—	2	BEARISH	-58.8
EXOZ eXoZymes, Inc.	$50M	-4.8	-187.2	913.0	—	—	2	BEARISH	-58.8
NIKI Niki BioSolutions, Inc.	—	—	—	—	—	—	—	BEARISH	—
NIKI Niki BioSolutions, Inc.	—	—	—	—	—	—	—	BEARISH	—
JXFGF Jinxin Fertility Group Limited	$740M	25.5	-8.2	3.3	7.8	-2.0	5	BEARISH	3.6
JXFGF Jinxin Fertility Group Limited	$740M	25.5	-8.2	3.3	7.8	-2.0	5	BEARISH	3.6
VBIZF Viva Biotech Holdings	$400M	15.4	9.0	8.9	8.0	-15.5	5	BEARISH	-31.6
VBIZF Viva Biotech Holdings	$400M	15.4	9.0	8.9	8.0	-15.5	5	BEARISH	-31.6
AMWL American Well Corporation	$210M	-2.6	-31.0	-215.3	-19.1	-19.0	4	BEARISH	100.7
AMWL American Well Corporation	$210M	-2.6	-31.0	-215.3	-19.1	-19.0	4	BEARISH	100.7
OPORF hVIVO plc	$80M	-3.3	-20.1	-21.3	-39.7	-28.1	2	BEARISH	-54.3
OPORF hVIVO plc	$80M	-3.3	-20.1	-21.3	-39.7	-28.1	2	BEARISH	-54.3
BBIXF Bonus Biogroup Ltd.	$50M	-17.8	3245.0	2543.1	—	—	2	BEARISH	-42.9
BBIXF Bonus Biogroup Ltd.	$50M	-17.8	3245.0	2543.1	—	—	2	BEARISH	-42.9
HSTI High Sierra Technologies, Inc.	$30M	-22.8	225.7	189.7	—	—	4	BEARISH	0.0
HSTI High Sierra Technologies, Inc.	$30M	-22.8	225.7	189.7	—	—	4	BEARISH	0.0
NICXF Nicox S.A.	$30M	-7.0	-243.6	-114.4	-302.5	—	2	BEARISH	0.0
NICXF Nicox S.A.	$30M	-7.0	-243.6	-114.4	-302.5	—	2	BEARISH	0.0
HOPHF Hemogenyx Pharmaceuticals Plc	$20M	-3.6	-647.5	-822.2	—	—	2	BEARISH	0.0
HOPHF Hemogenyx Pharmaceuticals Plc	$20M	-3.6	-647.5	-822.2	—	—	2	BEARISH	0.0
LVCLF Algorae Pharmaceuticals Limited	$20M	-4.7	-83.9	-39069.8	—	451.3	3	BEARISH	51.6
LVCLF Algorae Pharmaceuticals Limited	$20M	-4.7	-83.9	-39069.8	—	451.3	3	BEARISH	51.6
ANPCF Cellbxhealth PLC	$20M	—	-239.7	-609.1	-452.4	-32.8	2	BEARISH	-58.3
ANPCF Cellbxhealth PLC	$20M	—	-239.7	-609.1	-452.4	-32.8	2	BEARISH	-58.3
PLLWF Polarean Imaging plc	$10M	-0.1	-181.7	-1444.2	-852.0	157.0	3	BEARISH	-40.0
PLLWF Polarean Imaging plc	$10M	-0.1	-181.7	-1444.2	-852.0	157.0	3	BEARISH	-40.0
BIVI BioVie Inc.	$10M	-0.5	-0.0	-0.0	—	—	3	BEARISH	-26.6
BIVI BioVie Inc.	$10M	-0.5	-0.0	-0.0	—	—	3	BEARISH	-26.6
AOLS Aeolus Pharmaceuticals, Inc.	—	-0.0	-186.4	1650.1	-7300.0	-68.7	1	BEARISH	0.0
AOLS Aeolus Pharmaceuticals, Inc.	—	-0.0	-186.4	1650.1	-7300.0	-68.7	1	BEARISH	0.0
OMWS Omnia Wellness Inc.	—	-0.0	91.7	-520.4	-2231.0	-14.0	1	BEARISH	100.0
OMWS Omnia Wellness Inc.	—	-0.0	91.7	-520.4	-2231.0	-14.0	1	BEARISH	100.0
NMSCA Nutrition Management Services Company	—	0.0	4.0	6.5	-0.5	-7.8	5	BEARISH	200.0
NMSCA Nutrition Management Services Company	—	0.0	4.0	6.5	-0.5	-7.8	5	BEARISH	200.0
LXGTF Registered Plan Private Investments Inc.	—	-0.0	7.6	5.5	—	—	1	BEARISH	0.0
LXGTF Registered Plan Private Investments Inc.	—	-0.0	7.6	5.5	—	—	1	BEARISH	0.0
ELIXF Elixxer Ltd.	—	-0.2	27.1	280.4	—	—	2	BEARISH	-55.4
ELIXF Elixxer Ltd.	—	-0.2	27.1	280.4	—	—	2	BEARISH	-55.4
XSNX NovAccess Global Inc.	—	-0.0	27.7	18.0	—	—	3	BEARISH	-33.3
XSNX NovAccess Global Inc.	—	-0.0	27.7	18.0	—	—	3	BEARISH	-33.3
BGMD BG Medicine, Inc.	—	-0.0	747.3	104.5	-311.0	-43.8	5	BEARISH	0.0
BGMD BG Medicine, Inc.	—	-0.0	747.3	104.5	-311.0	-43.8	5	BEARISH	0.0
CHNXF ChitogenX Inc.	—	-0.2	23.2	36.2	—	—	2	BEARISH	48.0
CHNXF ChitogenX Inc.	—	-0.2	23.2	36.2	—	—	2	BEARISH	48.0
FORU ForU Holdings, Inc.	—	-0.0	759.2	-476.4	—	-100.0	2	BEARISH	100.0
FORU ForU Holdings, Inc.	—	-0.0	759.2	-476.4	—	-100.0	2	BEARISH	100.0
ELXMF Nova Eye Medical Limited	—	-8.6	-75.3	-44.7	-5.3	58.9	4	BEARISH	-85.7
ELXMF Nova Eye Medical Limited	—	-8.6	-75.3	-44.7	-5.3	58.9	4	BEARISH	-85.7
PSIQ Profile Solutions, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
PSIQ Profile Solutions, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
IAGX Imagenetix, Inc.	—	-0.2	-88.3	-8.5	-12.9	-69.1	4	BEARISH	100.0
IAGX Imagenetix, Inc.	—	-0.2	-88.3	-8.5	-12.9	-69.1	4	BEARISH	100.0
RTSL Rapid Therapeutic Science Laboratories, Inc.	—	-0.0	-3.4	35.5	—	-100.0	2	BEARISH	-86.7
RTSL Rapid Therapeutic Science Laboratories, Inc.	—	-0.0	-3.4	35.5	—	-100.0	2	BEARISH	-86.7
NSHSF NanoSphere Health Sciences Inc.	—	-1.8	4.6	11.1	—	—	1	BEARISH	-50.0
NSHSF NanoSphere Health Sciences Inc.	—	-1.8	4.6	11.1	—	—	1	BEARISH	-50.0
AIDA Aida Pharmaceuticals, Inc.	—	0.0	-20.7	25.4	19.3	40.9	6	BEARISH	50.0
AIDA Aida Pharmaceuticals, Inc.	—	0.0	-20.7	25.4	19.3	40.9	6	BEARISH	50.0
CANQF CanaQuest Medical Corp.	—	-0.0	177.1	159.9	-1515.1	102.7	4	BEARISH	-99.3
CANQF CanaQuest Medical Corp.	—	-0.0	177.1	159.9	-1515.1	102.7	4	BEARISH	-99.3
EXETF Extendicare Inc.	$1.9B	21.4	43.8	14.1	5.0	31.2	3	BEARISH	84.2
EXETF Extendicare Inc.	$1.9B	21.4	43.8	14.1	5.0	31.2	3	BEARISH	84.2
MRCHF H.U. Group Holdings, Inc.	$1.2B	20.0	5.0	2.3	2.0	2.3	9	BEARISH	-11.6
MRCHF H.U. Group Holdings, Inc.	$1.2B	20.0	5.0	2.3	2.0	2.3	9	BEARISH	-11.6
CSBTF Kuros Biosciences AG	$950M	102.9	2.4	3.5	4.8	236.5	4	BEARISH	-15.2
CSBTF Kuros Biosciences AG	$950M	102.9	2.4	3.5	4.8	236.5	4	BEARISH	-15.2
AVCTF Avacta Group Plc	$440M	-7.9	-553.3	-1587.8	-33970.3	-65.3	2	BEARISH	25.6
AVCTF Avacta Group Plc	$440M	-7.9	-553.3	-1587.8	-33970.3	-65.3	2	BEARISH	25.6
HNSBF Hansa Biopharma AB	$330M	-4.2	159.8	1182.7	-541.7	-3.7	2	BEARISH	9.7
HNSBF Hansa Biopharma AB	$330M	-4.2	159.8	1182.7	-541.7	-3.7	2	BEARISH	9.7
PFGTF Pacific Edge Limited	$170M	-6.5	-201.2	-1550.5	-299.7	-21.3	2	BEARISH	36.9
PFGTF Pacific Edge Limited	$170M	-6.5	-201.2	-1550.5	-299.7	-21.3	2	BEARISH	36.9
FBIOP Fortress Biotech, Inc.	$130M	0.6	107.5	-87.8	-2.5	15.5	6	BEARISH	124.5
FBIOP Fortress Biotech, Inc.	$130M	0.6	107.5	-87.8	-2.5	15.5	6	BEARISH	124.5
FHTX Foghorn Therapeutics Inc.	$120M	-2.0	81.9	26.3	-44.7	52.0	4	BEARISH	-59.0
FHTX Foghorn Therapeutics Inc.	$120M	-2.0	81.9	26.3	-44.7	52.0	4	BEARISH	-59.0
CWBHF Charlotte's Web Holdings, Inc.	$70M	-1.3	-97.1	-27.9	-38.0	-6.9	5	BEARISH	70.9
CWBHF Charlotte's Web Holdings, Inc.	$70M	-1.3	-97.1	-27.9	-38.0	-6.9	5	BEARISH	70.9
GWLL Goldenwell Biotech, Inc.	$70M	-255.4	31.8	137.0	—	319257.9	5	BEARISH	244.8
GWLL Goldenwell Biotech, Inc.	$70M	-255.4	31.8	137.0	—	319257.9	5	BEARISH	244.8
SNZZF Senzime AB (publ)	$40M	-3.7	-35.1	-36.2	-86.6	27.1	3	BEARISH	-59.3
SNZZF Senzime AB (publ)	$40M	-3.7	-35.1	-36.2	-86.6	27.1	3	BEARISH	-59.3
VICP Vicapsys Life Sciences, Inc.	$20M	-80.2	31.3	17.6	—	—	5	BEARISH	-63.3
VICP Vicapsys Life Sciences, Inc.	$20M	-80.2	31.3	17.6	—	—	5	BEARISH	-63.3
IZOZF Izotropic Corporation	$10M	-5.8	41.7	41.4	—	—	2	BEARISH	-54.1
IZOZF Izotropic Corporation	$10M	-5.8	41.7	41.4	—	—	2	BEARISH	-54.1
PCLOF PharmaCielo Ltd.	$10M	-2.9	39.6	-31.4	-103.5	11.2	4	BEARISH	51.1
PCLOF PharmaCielo Ltd.	$10M	-2.9	39.6	-31.4	-103.5	11.2	4	BEARISH	51.1
BIOE Bio Essence Corporation	$10M	4.9	-392.9	38.8	34.0	416.6	5	BEARISH	114.1
BIOE Bio Essence Corporation	$10M	4.9	-392.9	38.8	34.0	416.6	5	BEARISH	114.1
MJNA Medical Marijuana, Inc.	—	-1.3	-1.3	-2.2	-0.9	-22.1	2	BEARISH	-66.7
MJNA Medical Marijuana, Inc.	—	-1.3	-1.3	-2.2	-0.9	-22.1	2	BEARISH	-66.7
RLFTY MindMaze Therapeutics Holding S.A.	—	-2.1	-66.6	-70.4	-1182.3	-71.4	3	BEARISH	-94.0
RLFTY MindMaze Therapeutics Holding S.A.	—	-2.1	-66.6	-70.4	-1182.3	-71.4	3	BEARISH	-94.0
ERBB American Green, Inc.	—	0.1	33.3	-15.0	-629.5	17.7	3	BEARISH	-33.3
ERBB American Green, Inc.	—	0.1	33.3	-15.0	-629.5	17.7	3	BEARISH	-33.3
SONX Sonendo, Inc.	—	-0.3	-166.8	-185.6	-76.7	-27.7	5	BEARISH	183.3
SONX Sonendo, Inc.	—	-0.3	-166.8	-185.6	-76.7	-27.7	5	BEARISH	183.3
LYPHF Luye Pharma Group Ltd.	$1.1B	9.1	7.6	13.0	13.0	-1.2	4	BEARISH	0.8
LYPHF Luye Pharma Group Ltd.	$1.1B	9.1	7.6	13.0	13.0	-1.2	4	BEARISH	0.8
ELTX Elicio Therapeutics, Inc.	$40M	-0.9	-774.6	2147.3	—	—	4	BEARISH	-82.5
ELTX Elicio Therapeutics, Inc.	$40M	-0.9	-774.6	2147.3	—	—	4	BEARISH	-82.5
SEOVF Sernova Corp.	$30M	-3.6	57.0	76.3	—	—	3	BEARISH	-34.1
SEOVF Sernova Corp.	$30M	-3.6	57.0	76.3	—	—	3	BEARISH	-34.1
INBP Integrated BioPharma, Inc.	$10M	-2.0	-15.0	-13.1	-13.9	-19.3	2	BEARISH	-37.2
INBP Integrated BioPharma, Inc.	$10M	-2.0	-15.0	-13.1	-13.9	-19.3	2	BEARISH	-37.2
IDCN Indocan Resources Inc.	—	—	—	—	—	—	—	BEARISH	100.0
IDCN Indocan Resources Inc.	—	—	—	—	—	—	—	BEARISH	100.0
PJET Priority Aviation, Inc.	—	-0.1	19.5	31.9	—	-83.3	2	BEARISH	0.0
PJET Priority Aviation, Inc.	—	-0.1	19.5	31.9	—	-83.3	2	BEARISH	0.0
RDGT Ridgetech, Inc.	—	-0.0	27.5	-1.8	-1.7	—	2	BEARISH	-32.3
RDGT Ridgetech, Inc.	—	-0.0	27.5	-1.8	-1.7	—	2	BEARISH	-32.3
USRM U.S. Stem Cell, Inc.	—	-0.0	20.8	23.4	-2836.8	-59.1	5	BEARISH	0.0
USRM U.S. Stem Cell, Inc.	—	-0.0	20.8	23.4	-2836.8	-59.1	5	BEARISH	0.0
INND InnerScope Hearing Technologies, Inc.	—	-0.0	-1.4	-0.4	—	-56.8	4	BEARISH	-96.0
INND InnerScope Hearing Technologies, Inc.	—	-0.0	-1.4	-0.4	—	-56.8	4	BEARISH	-96.0
YOURF YourWay Cannabis Brands Inc.	—	-0.0	19.0	18.4	3.3	253.3	8	BEARISH	0.0
YOURF YourWay Cannabis Brands Inc.	—	-0.0	19.0	18.4	3.3	253.3	8	BEARISH	0.0
PHRX Pharmagen, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
PHRX Pharmagen, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
LMAT LeMaitre Vascular, Inc.	$1.8B	27.2	16.8	25.6	24.2	11.8	8	BEARISH	-8.7
LMAT LeMaitre Vascular, Inc.	$1.8B	27.2	16.8	25.6	24.2	11.8	8	BEARISH	-8.7
CNMD CONMED Corporation	$1.4B	25.0	5.5	5.2	6.7	3.4	7	BEARISH	-1.8
CNMD CONMED Corporation	$1.4B	25.0	5.5	5.2	6.7	3.4	7	BEARISH	-1.8
RAFLF Raffles Medical Group Ltd	$1.2B	22.4	5.8	7.3	8.2	-2.8	7	BEARISH	-20.0
RAFLF Raffles Medical Group Ltd	$1.2B	22.4	5.8	7.3	8.2	-2.8	7	BEARISH	-20.0
TNDM Tandem Diabetes Care, Inc.	$1.1B	-17.8	-48.0	-8.2	-8.3	-7.1	4	BEARISH	33.0
TNDM Tandem Diabetes Care, Inc.	$1.1B	-17.8	-48.0	-8.2	-8.3	-7.1	4	BEARISH	33.0
JANX Janux Therapeutics, Inc.	$1.0B	-10.3	-10.7	516.9	-214.0	7162.0	4	BEARISH	-28.6
JANX Janux Therapeutics, Inc.	$1.0B	-10.3	-10.7	516.9	-214.0	7162.0	4	BEARISH	-28.6
IUSDF AS ONE Corporation	$1.0B	18.0	12.2	13.4	8.1	5.7	6	BEARISH	-40.4
IUSDF AS ONE Corporation	$1.0B	18.0	12.2	13.4	8.1	5.7	6	BEARISH	-40.4
TDVXF Tobii Dynavox AB (publ)	$790M	36.5	37.3	16.1	11.0	12.6	8	BEARISH	-41.6
TDVXF Tobii Dynavox AB (publ)	$790M	36.5	37.3	16.1	11.0	12.6	8	BEARISH	-41.6
COLL Collegium Pharmaceutical, Inc.	$710M	14.4	17.6	9.4	-7.5	14.3	6	BEARISH	-37.4
COLL Collegium Pharmaceutical, Inc.	$710M	14.4	17.6	9.4	-7.5	14.3	6	BEARISH	-37.4
SMSZF SMS Co., Ltd.	$700M	-14.6	-38.9	25.5	-109.1	6.8	4	BEARISH	0.0
SMSZF SMS Co., Ltd.	$700M	-14.6	-38.9	25.5	-109.1	6.8	4	BEARISH	0.0
TGRNF Tong Ren Tang Technologies Co. Ltd.	$510M	11.1	10.2	30.0	8.2	-8.5	6	BEARISH	-43.0
TGRNF Tong Ren Tang Technologies Co. Ltd.	$510M	11.1	10.2	30.0	8.2	-8.5	6	BEARISH	-43.0
ELTP Elite Pharmaceuticals, Inc.	$250M	4.6	58.9	-0.1	45.3	77.1	6	BEARISH	-65.6
ELTP Elite Pharmaceuticals, Inc.	$250M	4.6	58.9	-0.1	45.3	77.1	6	BEARISH	-65.6
NNNN Anbio Biotechnology Class A Ordinary Shares	$240M	—	—	—	—	—	—	BEARISH	-84.1
NNNN Anbio Biotechnology Class A Ordinary Shares	$240M	—	—	—	—	—	—	BEARISH	-84.1
FOCL EDAP TMS S.A. American Depositary Shares	$160M	—	—	—	—	—	—	BEARISH	—
FOCL EDAP TMS S.A. American Depositary Shares	$160M	—	—	—	—	—	—	BEARISH	—
STRO Sutro Biopharma, Inc.	$150M	-0.9	266.8	43.6	-391.6	-56.3	4	BEARISH	70.0
STRO Sutro Biopharma, Inc.	$150M	-0.9	266.8	43.6	-391.6	-56.3	4	BEARISH	70.0
KRMD KORU Medical Systems, Inc.	$140M	-75.5	-10.5	-8.8	2.1	22.4	6	BEARISH	-22.3
KRMD KORU Medical Systems, Inc.	$140M	-75.5	-10.5	-8.8	2.1	22.4	6	BEARISH	-22.3
IMDX Insight Molecular Diagnostics Inc.	$110M	-2.3	488.7	92.7	-4711.3	-60.8	2	BEARISH	4.6
IMDX Insight Molecular Diagnostics Inc.	$110M	-2.3	488.7	92.7	-4711.3	-60.8	2	BEARISH	4.6
UNHLF EC Healthcare	$100M	-1.7	-34.1	6.2	-21.3	-2.2	5	BEARISH	0.0
UNHLF EC Healthcare	$100M	-1.7	-34.1	6.2	-21.3	-2.2	5	BEARISH	0.0
IBIO iBio, Inc.	$70M	-3.5	-65.7	21688.6	—	-75.0	4	BEARISH	37.2
IBIO iBio, Inc.	$70M	-3.5	-65.7	21688.6	—	-75.0	4	BEARISH	37.2
TIL Instil Bio, Inc.	$50M	-1.6	-25.3	-69.1	—	—	4	BEARISH	-62.2
TIL Instil Bio, Inc.	$50M	-1.6	-25.3	-69.1	—	—	4	BEARISH	-62.2
AIRDF Rocket Doctor AI Inc.	$40M	-2.2	-6105.0	-2497.4	-909.1	—	2	BEARISH	-13.3
AIRDF Rocket Doctor AI Inc.	$40M	-2.2	-6105.0	-2497.4	-909.1	—	2	BEARISH	-13.3
ZHYBF Zhong Yuan Bio-Technology Holdings Limited	$40M	118.8	228.3	11.8	-21.1	6.2	3	BEARISH	0.0
ZHYBF Zhong Yuan Bio-Technology Holdings Limited	$40M	118.8	228.3	11.8	-21.1	6.2	3	BEARISH	0.0
IGC IGC Pharma, Inc.	$30M	-3.3	-105.2	-118.3	-757.7	-6.7	2	BEARISH	-33.2
IGC IGC Pharma, Inc.	$30M	-3.3	-105.2	-118.3	-757.7	-6.7	2	BEARISH	-33.2
ACTU Actuate Therapeutics Inc	$20M	-0.9	2457.6	541.3	—	—	3	BEARISH	-88.2
ACTU Actuate Therapeutics Inc	$20M	-0.9	2457.6	541.3	—	—	3	BEARISH	-88.2
TCRX TScan Therapeutics, Inc.	$20M	-0.4	-95.8	-159.4	-2888.6	2.2	2	BEARISH	-84.7
TCRX TScan Therapeutics, Inc.	$20M	-0.4	-95.8	-159.4	-2888.6	2.2	2	BEARISH	-84.7
PVCT Provectus Biopharmaceuticals, Inc.	$20M	-4.8	78.1	83.4	—	-100.0	5	BEARISH	-38.4
PVCT Provectus Biopharmaceuticals, Inc.	$20M	-4.8	78.1	83.4	—	-100.0	5	BEARISH	-38.4
NCNA NuCana plc	$10M	-0.3	-70.7	-739.9	—	—	4	BEARISH	-77.6
NCNA NuCana plc	$10M	-0.3	-70.7	-739.9	—	—	4	BEARISH	-77.6
GDTC CytoMed Therapeutics Limited	$10M	-2.6	-90.6	-106.7	-1125.6	62.6	1	BEARISH	-56.2
GDTC CytoMed Therapeutics Limited	$10M	-2.6	-90.6	-106.7	-1125.6	62.6	1	BEARISH	-56.2
ALGWF Alliance Growers Corp.	—	—	—	—	—	—	—	BEARISH	0.0
ALGWF Alliance Growers Corp.	—	—	—	—	—	—	—	BEARISH	0.0
ADLI American Medical Technologies Inc.	—	-0.0	-34.0	1108.3	-19.7	-21.7	3	BEARISH	0.0
ADLI American Medical Technologies Inc.	—	-0.0	-34.0	1108.3	-19.7	-21.7	3	BEARISH	0.0
NOBDF North Bud Farms Inc.	—	-0.0	-30.5	-29.8	—	—	2	BEARISH	0.0
NOBDF North Bud Farms Inc.	—	-0.0	-30.5	-29.8	—	—	2	BEARISH	0.0
BZYR Burzynski Research Institute, Inc.	—	-0.3	2902.9	1462.7	—	—	4	BEARISH	-94.9
BZYR Burzynski Research Institute, Inc.	—	-0.3	2902.9	1462.7	—	—	4	BEARISH	-94.9
VIAP VIA Pharmaceuticals, Inc.	—	-0.0	64.7	103.9	—	—	2	BEARISH	0.0
VIAP VIA Pharmaceuticals, Inc.	—	-0.0	64.7	103.9	—	—	2	BEARISH	0.0
SPDE Speedus Corp.	—	—	—	—	—	—	—	BEARISH	0.0
SPDE Speedus Corp.	—	—	—	—	—	—	—	BEARISH	0.0
MBCI MabCure Inc.	—	-0.0	-127.0	-14.0	-2239.0	—	3	BEARISH	-80.0
MBCI MabCure Inc.	—	-0.0	-127.0	-14.0	-2239.0	—	3	BEARISH	-80.0
NIVF NewGenIvf Group Limited	—	0.0	50.6	-147.7	-8.5	—	2	BEARISH	-93.3
NIVF NewGenIvf Group Limited	—	0.0	50.6	-147.7	-8.5	—	2	BEARISH	-93.3
RNUGF ReNeuron Group plc	—	-0.0	-153.3	532.8	-1809.6	194.9	3	BEARISH	0.0
RNUGF ReNeuron Group plc	—	-0.0	-153.3	532.8	-1809.6	194.9	3	BEARISH	0.0
SPBBF Speakeasy Cannabis Club Ltd.	—	-0.0	-55.1	-4.0	-803.2	16129.5	3	BEARISH	0.0
SPBBF Speakeasy Cannabis Club Ltd.	—	-0.0	-55.1	-4.0	-803.2	16129.5	3	BEARISH	0.0
HCANF Halo Collective Inc.	—	-0.0	-132.7	-43.7	-192.0	-43.0	2	BEARISH	0.0
BSPM Biostar Pharmaceuticals, Inc.	—	-0.0	2.7	1.9	—	-91.9	5	BEARISH	0.0
BSPM Biostar Pharmaceuticals, Inc.	—	-0.0	2.7	1.9	—	-91.9	5	BEARISH	0.0
HCANF Halo Collective Inc.	—	-0.0	-132.7	-43.7	-192.0	-43.0	2	BEARISH	0.0
BVAXF BioVaxys Technology Corp.	—	-0.9	310.6	48.4	—	—	1	BEARISH	-61.2
BVAXF BioVaxys Technology Corp.	—	-0.9	310.6	48.4	—	—	1	BEARISH	-61.2
ARPC Arem Pacific Corporation	—	-9.0	-104.2	50.1	-12.7	-7.6	5	BEARISH	0.0
ARPC Arem Pacific Corporation	—	-9.0	-104.2	50.1	-12.7	-7.6	5	BEARISH	0.0
SOFE SOAFEE, Inc.	—	0.1	12.0	-337.1	21.4	1539.1	4	BEARISH	45.5
SOFE SOAFEE, Inc.	—	0.1	12.0	-337.1	21.4	1539.1	4	BEARISH	45.5
ENCW Enchanted World Inc.	—	—	—	—	—	—	—	BEARISH	-99.8
ENCW Enchanted World Inc.	—	—	—	—	—	—	—	BEARISH	-99.8
EVARF Lombard Medical, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
EVARF Lombard Medical, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
KNBIF Kane Biotech Inc.	—	-2.1	439.7	-2166.6	-10238.1	-97.9	2	BEARISH	-43.7
KNBIF Kane Biotech Inc.	—	-2.1	439.7	-2166.6	-10238.1	-97.9	2	BEARISH	-43.7
PMCB PharmaCyte Biotech, Inc.	—	-0.2	-45.6	142.9	—	—	2	BEARISH	-59.2
PMCB PharmaCyte Biotech, Inc.	—	-0.2	-45.6	142.9	—	—	2	BEARISH	-59.2
BIOIF Biome Grow Inc.	—	-0.0	56.7	86.9	—	—	3	BEARISH	0.0
BIOIF Biome Grow Inc.	—	-0.0	56.7	86.9	—	—	3	BEARISH	0.0
BBLNF Babylon Holdings Limited	—	-0.0	348.4	-1412.2	-20.3	198.9	3	BEARISH	0.0
BBLNF Babylon Holdings Limited	—	-0.0	348.4	-1412.2	-20.3	198.9	3	BEARISH	0.0
SECI Sector 10, Inc.	—	0.0	0.5	0.3	—	—	3	BEARISH	0.0
SECI Sector 10, Inc.	—	0.0	0.5	0.3	—	—	3	BEARISH	0.0
CBDY Target Group Inc.	—	-0.2	23.2	-10.4	-17.4	-30.4	2	BEARISH	-58.8
NVOS Novo Integrated Sciences, Inc.	—	-0.0	-81.4	-35.0	162.4	5.7	3	BEARISH	-88.0
NVOS Novo Integrated Sciences, Inc.	—	-0.0	-81.4	-35.0	162.4	5.7	3	BEARISH	-88.0
CBDY Target Group Inc.	—	-0.2	23.2	-10.4	-17.4	-30.4	2	BEARISH	-58.8
CDXI Cardax, Inc.	—	-0.0	81.1	38.5	-1740.8	-27.3	2	BEARISH	0.0
CDXI Cardax, Inc.	—	-0.0	81.1	38.5	-1740.8	-27.3	2	BEARISH	0.0
RLLVF Relevium Technologies Inc.	—	-0.3	969.5	2839.9	-218.6	—	1	BEARISH	0.0
RLLVF Relevium Technologies Inc.	—	-0.3	969.5	2839.9	-218.6	—	1	BEARISH	0.0
ZMSPF Zecotek Photonics Inc.	—	-0.0	21.5	53.8	1884.0	2081.2	3	BEARISH	0.0
ZMSPF Zecotek Photonics Inc.	—	-0.0	21.5	53.8	1884.0	2081.2	3	BEARISH	0.0
HLTHQ Cue Health Inc.	—	-0.0	-90.3	-100.6	-789.6	-85.3	1	BEARISH	0.0
HLTHQ Cue Health Inc.	—	-0.0	-90.3	-100.6	-789.6	-85.3	1	BEARISH	0.0
CNFHF CanaFarma Hemp Products Corp.	—	—	—	—	—	—	—	BEARISH	0.0
CNFHF CanaFarma Hemp Products Corp.	—	—	—	—	—	—	—	BEARISH	0.0
AHGIF Alternate Health Corp.	—	-0.0	-611.4	-2862.3	-21.3	171.0	4	BEARISH	0.0
AHGIF Alternate Health Corp.	—	-0.0	-611.4	-2862.3	-21.3	171.0	4	BEARISH	0.0
EVGN Evogene Ltd.	—	-0.4	265.3	101.3	-509.5	-80.4	3	BEARISH	-63.0
EVGN Evogene Ltd.	—	-0.4	265.3	101.3	-509.5	-80.4	3	BEARISH	-63.0
NXGLW NEXGEL, Inc.	—	-0.2	-128.6	-35.8	-98.6	3.4	1	BEARISH	-95.4
NXGLW NEXGEL, Inc.	—	-0.2	-128.6	-35.8	-98.6	3.4	1	BEARISH	-95.4
CVHIF Ventura Cannabis & Wellness Corporation	—	-0.0	-24592.2	-12731.6	-112.6	-64.0	4	BEARISH	0.0
CVHIF Ventura Cannabis & Wellness Corporation	—	-0.0	-24592.2	-12731.6	-112.6	-64.0	4	BEARISH	0.0
SYVC Synovics Pharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
SYVC Synovics Pharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
SHMN SOHM, Inc.	—	9.0	-15.3	-2.9	-130.8	-3.6	4	BEARISH	-18.2
SHMN SOHM, Inc.	—	9.0	-15.3	-2.9	-130.8	-3.6	4	BEARISH	-18.2
ADYX Adynxx, Inc.	—	-0.0	1148.3	259.7	—	-95.1	2	BEARISH	0.0
ADYX Adynxx, Inc.	—	-0.0	1148.3	259.7	—	-95.1	2	BEARISH	0.0
CASIF CASI Pharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	—
CASIF CASI Pharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	—
IYXI Inyx, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
IYXI Inyx, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
XCRP Xcorporeal, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
XCRP Xcorporeal, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
VIVXF Avivagen Inc.	—	-0.1	63.9	92.2	-2302.1	-7.9	3	BEARISH	0.0
VIVXF Avivagen Inc.	—	-0.1	63.9	92.2	-2302.1	-7.9	3	BEARISH	0.0
CFRXQ ContraFect Corp.	—	-0.0	544.7	276.9	—	—	1	BEARISH	-98.0
CFRXQ ContraFect Corp.	—	-0.0	544.7	276.9	—	—	1	BEARISH	-98.0
ARNI Arno Therapeutics, Inc.	—	-0.0	250.7	111.6	—	—	3	BEARISH	0.0
ARNI Arno Therapeutics, Inc.	—	-0.0	250.7	111.6	—	—	3	BEARISH	0.0
GRPS Trans American Aquaculture, Inc.	—	-0.5	114.2	17.8	—	-96.0	3	BEARISH	-66.7
GRPS Trans American Aquaculture, Inc.	—	-0.5	114.2	17.8	—	-96.0	3	BEARISH	-66.7
KONEF Wellbeing Digital Sciences Inc.	—	—	10994.4	-1249.0	-349.5	—	2	BEARISH	0.0
KONEF Wellbeing Digital Sciences Inc.	—	—	10994.4	-1249.0	-349.5	—	2	BEARISH	0.0
LBLTF Lattice Biologics Ltd.	—	-0.0	27.4	-482.6	—	-28.9	4	BEARISH	0.0
LBLTF Lattice Biologics Ltd.	—	-0.0	27.4	-482.6	—	-28.9	4	BEARISH	0.0
LIPO Lipella Pharmaceuticals Inc.	—	-0.0	-361.8	4105.8	—	-64.1	1	BEARISH	-99.9
LIPO Lipella Pharmaceuticals Inc.	—	-0.0	-361.8	4105.8	—	-64.1	1	BEARISH	-99.9
PLWY Peoplesway.com Inc.	—	-0.0	-6.5	-4001.9	-1.4	-22.7	5	BEARISH	0.0
PLWY Peoplesway.com Inc.	—	-0.0	-6.5	-4001.9	-1.4	-22.7	5	BEARISH	0.0
PFND Pathfinder Cell Therapy, Inc.	—	-0.0	22.4	46.3	—	—	2	BEARISH	0.0
PFND Pathfinder Cell Therapy, Inc.	—	-0.0	22.4	46.3	—	—	2	BEARISH	0.0
GSRX GSRX Industries Inc.	—	-0.0	-119.6	-84.3	-81.5	-5.5	5	BEARISH	0.0
GSRX GSRX Industries Inc.	—	-0.0	-119.6	-84.3	-81.5	-5.5	5	BEARISH	0.0
BNKL Bionik Laboratories Corp.	—	-0.0	-787.6	-1107.0	-282.5	41.7	3	BEARISH	0.0
BNKL Bionik Laboratories Corp.	—	-0.0	-787.6	-1107.0	-282.5	41.7	3	BEARISH	0.0
UPHL UpHealth, Inc.	—	-0.0	-84.2	-4.7	—	-46.7	3	BEARISH	-50.0
UPHL UpHealth, Inc.	—	-0.0	-84.2	-4.7	—	-46.7	3	BEARISH	-50.0
CTVEF Certive Solutions Inc.	—	-0.2	13.8	16.9	-129.9	8.5	4	BEARISH	159900.0
CTVEF Certive Solutions Inc.	—	-0.2	13.8	16.9	-129.9	8.5	4	BEARISH	159900.0
GBHPF Global Hemp Group Inc.	—	-0.1	61.0	8.0	—	—	2	BEARISH	-98.6
GBHPF Global Hemp Group Inc.	—	-0.1	61.0	8.0	—	—	2	BEARISH	-98.6
PANC Panacos Pharmaceuticals, Inc.	—	-0.0	-168.8	-792.8	-33966.7	-45.9	1	BEARISH	0.0
PANC Panacos Pharmaceuticals, Inc.	—	-0.0	-168.8	-792.8	-33966.7	-45.9	1	BEARISH	0.0
ELLXF Elixinol Wellness Limited	—	-0.7	-80.4	-69.0	-14.9	63.8	4	BEARISH	-69.5
ELLXF Elixinol Wellness Limited	—	-0.7	-80.4	-69.0	-14.9	63.8	4	BEARISH	-69.5
PROCF Sofgen Pharma S.A.	—	—	—	—	—	—	—	BEARISH	—
PROCF Sofgen Pharma S.A.	—	—	—	—	—	—	—	BEARISH	—
SNDA Sonida Senior Living, Inc.	$1.8B	-5.4	-25.2	-2.9	-11.8	49.4	4	BEARISH	36.5
SNDA Sonida Senior Living, Inc.	$1.8B	-5.4	-25.2	-2.9	-11.8	49.4	4	BEARISH	36.5
SGRY Surgery Partners, Inc.	$1.7B	-19.3	-5.2	5.9	-1.8	4.0	5	BEARISH	-37.1
SGRY Surgery Partners, Inc.	$1.7B	-19.3	-5.2	5.9	-1.8	4.0	5	BEARISH	-37.1
GDRX GoodRx Holdings, Inc.	$1.1B	62.4	2.5	3.5	4.3	-1.8	6	BEARISH	-34.8
GDRX GoodRx Holdings, Inc.	$1.1B	62.4	2.5	3.5	4.3	-1.8	6	BEARISH	-34.8
IART Integra LifeSciences Holdings Corporation	$990M	-137.5	-0.7	18.4	1.1	1.6	6	BEARISH	-13.9
IART Integra LifeSciences Holdings Corporation	$990M	-137.5	-0.7	18.4	1.1	1.6	6	BEARISH	-13.9
CBIO Crescent Biopharma, Inc.	$530M	-1.9	-107.7	1928.6	—	—	5	BEARISH	20.3
CBIO Crescent Biopharma, Inc.	$530M	-1.9	-107.7	1928.6	—	—	5	BEARISH	20.3
NRC NRC Health	$460M	77.5	42.0	9.9	-9.3	-0.2	6	BEARISH	33.4
NRC NRC Health	$460M	77.5	42.0	9.9	-9.3	-0.2	6	BEARISH	33.4
CERS Cerus Corporation	$460M	-63.0	-10.8	-7.4	-5.1	15.1	5	BEARISH	50.0
CERS Cerus Corporation	$460M	-63.0	-10.8	-7.4	-5.1	15.1	5	BEARISH	50.0
NIKA Nika Pharmaceuticals Inc.	$430M	-5519.3	26.8	18.5	—	100.0	3	BEARISH	40.6
NIKA Nika Pharmaceuticals Inc.	$430M	-5519.3	26.8	18.5	—	100.0	3	BEARISH	40.6
EDIT Editas Medicine, Inc.	$400M	-3.5	-118.8	71.4	-153.3	20.8	4	BEARISH	-26.2
EDIT Editas Medicine, Inc.	$400M	-3.5	-118.8	71.4	-153.3	20.8	4	BEARISH	-26.2
MGNX MacroGenics, Inc.	$230M	-16.3	-32.6	33.8	59.4	2.3	2	BEARISH	110.6
MGNX MacroGenics, Inc.	$230M	-16.3	-32.6	33.8	59.4	2.3	2	BEARISH	110.6
NYXH Nyxoah S.A.	$140M	-0.6	-125.8	-181.3	-429.5	359.2	2	BEARISH	-72.5
NYXH Nyxoah S.A.	$140M	-0.6	-125.8	-181.3	-429.5	359.2	2	BEARISH	-72.5
VANI Vivani Medical, Inc.	$110M	-3.5	-220.4	-127.1	—	—	4	BEARISH	-14.6
VANI Vivani Medical, Inc.	$110M	-3.5	-220.4	-127.1	—	—	4	BEARISH	-14.6
TLPH Talphera, Inc.	$60M	-3.5	-143.4	436.3	—	-96.3	2	BEARISH	21.1
TLPH Talphera, Inc.	$60M	-3.5	-143.4	436.3	—	-96.3	2	BEARISH	21.1
PRPO Precipio, Inc.	$40M	-35.6	-9.0	-8.1	-3.1	33.5	6	BEARISH	12.8
PRPO Precipio, Inc.	$40M	-35.6	-9.0	-8.1	-3.1	33.5	6	BEARISH	12.8
ACHFF Arch Biopartners Inc.	$40M	-19.5	73.5	165.4	—	100.0	2	BEARISH	-33.2
ACHFF Arch Biopartners Inc.	$40M	-19.5	73.5	165.4	—	100.0	2	BEARISH	-33.2
NEPH Nephros, Inc.	$40M	22.8	16.1	20.0	19.9	24.2	5	BEARISH	-20.1
NEPH Nephros, Inc.	$40M	22.8	16.1	20.0	19.9	24.2	5	BEARISH	-20.1
RVP Retractable Technologies, Inc.	$20M	-5.8	-4.5	-53.2	39.3	-11.2	4	BEARISH	-16.9
RVP Retractable Technologies, Inc.	$20M	-5.8	-4.5	-53.2	39.3	-11.2	4	BEARISH	-16.9
ZJYL Jin Medical International Ltd.	$20M	13.3	10.5	9.5	-1.2	40.1	5	BEARISH	250.3
ZJYL Jin Medical International Ltd.	$20M	13.3	10.5	9.5	-1.2	40.1	5	BEARISH	250.3
COCP Cocrystal Pharma, Inc.	$20M	-1.5	-311.7	-3697.6	-3013.3	—	2	BEARISH	-8.7
COCP Cocrystal Pharma, Inc.	$20M	-1.5	-311.7	-3697.6	-3013.3	—	2	BEARISH	-8.7
IMRN Immuron Limited	$10M	-3.1	-74.6	-356.5	-54.4	28.7	5	BEARISH	-42.9
IMRN Immuron Limited	$10M	-3.1	-74.6	-356.5	-54.4	28.7	5	BEARISH	-42.9
SNOA Sonoma Pharmaceuticals, Inc.	$10M	-1.0	-84.6	-126.4	-10.4	36.7	2	BEARISH	-67.9
SNOA Sonoma Pharmaceuticals, Inc.	$10M	-1.0	-84.6	-126.4	-10.4	36.7	2	BEARISH	-67.9
SYBX Synlogic, Inc.	$10M	-20.7	-5.3	306.3	—	—	2	BEARISH	-33.5
SYBX Synlogic, Inc.	$10M	-20.7	-5.3	306.3	—	—	2	BEARISH	-33.5
QNCX Quince Therapeutics, Inc.	$10M	-0.4	-153.8	1282.0	—	—	4	BEARISH	1702.5
QNCX Quince Therapeutics, Inc.	$10M	-0.4	-153.8	1282.0	—	—	4	BEARISH	1702.5
CMPD CompuMed, Inc.	$10M	-29.7	-8.7	-11.2	1.1	22.4	6	BEARISH	59.8
CMPD CompuMed, Inc.	$10M	-29.7	-8.7	-11.2	1.1	22.4	6	BEARISH	59.8
AAGH America Great Health	—	2.0	-12.2	22.4	-635.8	-5.1	4	BEARISH	-66.7
AAGH America Great Health	—	2.0	-12.2	22.4	-635.8	-5.1	4	BEARISH	-66.7
BUDZ WEED, Inc.	—	-3.6	176.9	220.9	—	-100.0	1	BEARISH	-38.5
BUDZ WEED, Inc.	—	-3.6	176.9	220.9	—	-100.0	1	BEARISH	-38.5
RGBPP Regen BioPharma, Inc.	—	-0.0	20.3	12.8	-1079.8	0.0	4	BEARISH	-98.3
RGBPP Regen BioPharma, Inc.	—	-0.0	20.3	12.8	-1079.8	0.0	4	BEARISH	-98.3
RAFA Rafarma Pharmaceuticals, Inc.	—	13.9	2.9	3.4	26.6	-66.0	3	BEARISH	-33.3
RAFA Rafarma Pharmaceuticals, Inc.	—	13.9	2.9	3.4	26.6	-66.0	3	BEARISH	-33.3
NCEL NewcelX Ltd.	—	8.6	-48.0	-39.1	—	—	2	BEARISH	—
NCEL NewcelX Ltd.	—	8.6	-48.0	-39.1	—	—	2	BEARISH	—
PPCB Propanc Biopharma, Inc.	—	-0.0	-161.9	-166.7	—	—	4	BEARISH	-70.2
PPCB Propanc Biopharma, Inc.	—	-0.0	-161.9	-166.7	—	—	4	BEARISH	-70.2
ISCO International Stem Cell Corporation	—	-4.6	30.4	-10.8	-2.7	3.4	6	BEARISH	123.1
ISCO International Stem Cell Corporation	—	-4.6	30.4	-10.8	-2.7	3.4	6	BEARISH	123.1
FGHQF Frontage Holdings Corporation	$350M	28.9	4.2	4.5	4.6	2.1	6	BEARISH	16.8
FGHQF Frontage Holdings Corporation	$350M	28.9	4.2	4.5	4.6	2.1	6	BEARISH	16.8
SGMT Sagimet Biosciences Inc.	$300M	-7.1	-24.4	-231.4	—	—	3	BEARISH	30.9
SGMT Sagimet Biosciences Inc.	$300M	-7.1	-24.4	-231.4	—	—	3	BEARISH	30.9
IMPZY Implanet S.A.	$230M	-5.3	-1018.0	-250.0	-30.0	60.8	6	BEARISH	0.2
IMPZY Implanet S.A.	$230M	-5.3	-1018.0	-250.0	-30.0	60.8	6	BEARISH	0.2
BRIBF Brii Biosciences Limited	$90M	-3.1	-16.9	-94.3	—	-81.5	4	BEARISH	-46.0
BRIBF Brii Biosciences Limited	$90M	-3.1	-16.9	-94.3	—	-81.5	4	BEARISH	-46.0
NUMIF Numinus Wellness Inc.	$10M	-0.8	57.6	40.6	-18.7	429.3	5	BEARISH	-36.6
NUMIF Numinus Wellness Inc.	$10M	-0.8	57.6	40.6	-18.7	429.3	5	BEARISH	-36.6
ANTCF Aion Therapeutic Inc.	—	-0.2	365.1	64.7	-53.7	563.3	3	BEARISH	17.6
ANTCF Aion Therapeutic Inc.	—	-0.2	365.1	64.7	-53.7	563.3	3	BEARISH	17.6
SYGGF Synairgen plc	—	-0.2	-114.6	-853.1	—	—	2	BEARISH	-50.0
SYGGF Synairgen plc	—	-0.2	-114.6	-853.1	—	—	2	BEARISH	-50.0
MSIU Medical Supply International USA, Inc.	—	—	—	—	—	—	—	BEARISH	300.0
MSIU Medical Supply International USA, Inc.	—	—	—	—	—	—	—	BEARISH	300.0
OLMM OneLife Technologies Corp.	—	-0.0	454.4	-594.1	—	—	3	BEARISH	900.0
OLMM OneLife Technologies Corp.	—	-0.0	454.4	-594.1	—	—	3	BEARISH	900.0
SYDRF Delota Corp.	—	-3.8	-52.9	-6.1	-4.8	7.8	6	BEARISH	25.0
SYDRF Delota Corp.	—	-3.8	-52.9	-6.1	-4.8	7.8	6	BEARISH	25.0
EPGNF Epigenomics AG	—	-0.0	-414.0	-186.5	2801.6	-30.1	3	BEARISH	0.0
EPGNF Epigenomics AG	—	-0.0	-414.0	-186.5	2801.6	-30.1	3	BEARISH	0.0
SDNI Scandia, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
SDNI Scandia, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
IDYLF Imaging Dynamics Company Ltd.	—	-0.3	18.7	39.1	-2277.3	-65.6	4	BEARISH	152.7
IDYLF Imaging Dynamics Company Ltd.	—	-0.3	18.7	39.1	-2277.3	-65.6	4	BEARISH	152.7
ACBM Acro Biomedical Co., Ltd.	—	-10.8	36.8	262.2	—	100.0	3	BEARISH	3614.3
ACBM Acro Biomedical Co., Ltd.	—	-10.8	36.8	262.2	—	100.0	3	BEARISH	3614.3
CHYPF Health Logic Interactive Inc.	—	-3.5	20.0	14.2	—	—	1	BEARISH	-45.2
CHYPF Health Logic Interactive Inc.	—	-3.5	20.0	14.2	—	—	1	BEARISH	-45.2
GHRS GH Research PLC	$1.6B	-22.9	-18.8	2015.5	—	—	2	BEARISH	69.0
GHRS GH Research PLC	$1.6B	-22.9	-18.8	2015.5	—	—	2	BEARISH	69.0
LXRX Lexicon Pharmaceuticals, Inc.	$810M	-12.1	-40.2	-99.7	-4591.8	-29.0	3	BEARISH	59.6
LXRX Lexicon Pharmaceuticals, Inc.	$810M	-12.1	-40.2	-99.7	-4591.8	-29.0	3	BEARISH	59.6
ACRS Aclaris Therapeutics, Inc.	$610M	-7.6	-59.1	-206.5	-1320.1	-51.0	3	BEARISH	134.8
ACRS Aclaris Therapeutics, Inc.	$610M	-7.6	-59.1	-206.5	-1320.1	-51.0	3	BEARISH	134.8
NVLPF Nova Leap Health Corp.	$30M	23.1	7.0	5.6	6.9	20.3	5	BEARISH	49.1
NVLPF Nova Leap Health Corp.	$30M	23.1	7.0	5.6	6.9	20.3	5	BEARISH	49.1
MDBIF TrivarX Limited	$10M	-0.0	-75.0	-48.2	—	23.6	3	BEARISH	-66.7
MDBIF TrivarX Limited	$10M	-0.0	-75.0	-48.2	—	23.6	3	BEARISH	-66.7
XBIO Xenetic Biosciences, Inc.	$10M	-1.9	-47.0	523.4	-140.7	33.3	4	BEARISH	-29.0
XBIO Xenetic Biosciences, Inc.	$10M	-1.9	-47.0	523.4	-140.7	33.3	4	BEARISH	-29.0
CANN Trees Corporation	—	-3.1	284.2	-3.9	-15.1	-24.7	4	BEARISH	-67.0
CANN Trees Corporation	—	-3.1	284.2	-3.9	-15.1	-24.7	4	BEARISH	-67.0
CPMD CannaPharmaRX, Inc.	—	-0.1	42.4	22.4	-691.1	24.8	3	BEARISH	-33.3
CPMD CannaPharmaRX, Inc.	—	-0.1	42.4	22.4	-691.1	24.8	3	BEARISH	-33.3
DCGO DocGo Inc.	$40M	-0.2	-92.4	-73.3	-21.5	-32.4	3	BEARISH	-71.8
DCGO DocGo Inc.	$40M	-0.2	-92.4	-73.3	-21.5	-32.4	3	BEARISH	-71.8
OBX Obsidian Therapeutics Inc.	$10M	—	—	—	—	—	—	BEARISH	—
OBX Obsidian Therapeutics Inc.	$10M	—	—	—	—	—	—	BEARISH	—
IRIX IRIDEX Corporation	$10M	-3.2	-73.1	-73.9	-10.1	3.7	5	BEARISH	-43.1
IRIX IRIDEX Corporation	$10M	-3.2	-73.1	-73.9	-10.1	3.7	5	BEARISH	-43.1
VTAK Catheter Precision, Inc.	—	-0.0	-103.3	-50.5	-323.4	219.2	4	BEARISH	-94.3
VTAK Catheter Precision, Inc.	—	-0.0	-103.3	-50.5	-323.4	219.2	4	BEARISH	-94.3
BACK IMAC Holdings, Inc.	—	-0.0	109.1	67.3	-14505.6	100.5	2	BEARISH	-99.1
BACK IMAC Holdings, Inc.	—	-0.0	109.1	67.3	-14505.6	100.5	2	BEARISH	-99.1
IVF INVO Fertility, Inc.	—	-0.0	-55.3	-28.1	40.9	13.8	4	BEARISH	-97.2
IVF INVO Fertility, Inc.	—	-0.0	-55.3	-28.1	40.9	13.8	4	BEARISH	-97.2
VICA Rafina Innovations Inc.	—	-0.1	-51.0	-15.7	—	873.6	3	BEARISH	900.0
VICA Rafina Innovations Inc.	—	-0.1	-51.0	-15.7	—	873.6	3	BEARISH	900.0
EMED Electromedical Technologies, Inc.	—	-0.2	44.6	29.8	-8153.1	-66.6	2	BEARISH	-50.0
EMED Electromedical Technologies, Inc.	—	-0.2	44.6	29.8	-8153.1	-66.6	2	BEARISH	-50.0
SWNM Southwestern Medical Solutions, Inc.	—	—	—	—	—	—	—	BEARISH	-70.0
SWNM Southwestern Medical Solutions, Inc.	—	—	—	—	—	—	—	BEARISH	-70.0
SQZB SQZ Biotechnologies Company	—	-0.0	-203.4	-410.2	—	-44.6	0	BEARISH	-14.3
SQZB SQZ Biotechnologies Company	—	-0.0	-203.4	-410.2	—	-44.6	0	BEARISH	-14.3
SYBE SYBLEU Inc	—	-3.1	71.5	-202.2	-685.7	—	2	BEARISH	0.0
SYBE SYBLEU Inc	—	-3.1	71.5	-202.2	-685.7	—	2	BEARISH	0.0
STOK Stoke Therapeutics, Inc.	$1.6B	-7.6	-61.1	-318.5	-660.8	-86.2	2	BEARISH	8.6
STOK Stoke Therapeutics, Inc.	$1.6B	-7.6	-61.1	-318.5	-660.8	-86.2	2	BEARISH	8.6
LFTSF LifeTech Scientific Corporation	$1.0B	88.0	7.3	6.9	-5.7	9.2	4	BEARISH	0.0
LFTSF LifeTech Scientific Corporation	$1.0B	88.0	7.3	6.9	-5.7	9.2	4	BEARISH	0.0
ENOV Enovis Corporation	$1.0B	-0.9	-54.3	-13.5	-0.2	4.9	4	BEARISH	-41.7
ENOV Enovis Corporation	$1.0B	-0.9	-54.3	-13.5	-0.2	4.9	4	BEARISH	-41.7
IMTX Immatics N.V.	$1.0B	-4.2	-47.8	-858.3	-683.4	-68.0	2	BEARISH	-15.7
IMTX Immatics N.V.	$1.0B	-4.2	-47.8	-858.3	-683.4	-68.0	2	BEARISH	-15.7
ODTX Odyssey Therapeutics, Inc.	$1.0B	—	—	—	—	—	—	BEARISH	—
ODTX Odyssey Therapeutics, Inc.	$1.0B	—	—	—	—	—	—	BEARISH	—
SVRA Savara Inc.	$990M	-8.3	-105.5	-15438.9	—	—	2	BEARISH	35.9
SVRA Savara Inc.	$990M	-8.3	-105.5	-15438.9	—	—	2	BEARISH	35.9
DSGN Design Therapeutics, Inc.	$770M	-10.5	-34.1	1787.8	—	—	1	BEARISH	81.7
DSGN Design Therapeutics, Inc.	$770M	-10.5	-34.1	1787.8	—	—	1	BEARISH	81.7
MTLZF Metall Zug AG	$680M	-36.4	-5.8	-4.7	-5.6	-60.7	4	BEARISH	0.0
MTLZF Metall Zug AG	$680M	-36.4	-5.8	-4.7	-5.6	-60.7	4	BEARISH	0.0
CRWRF Craneware plc	$620M	24.1	11.2	12.9	9.7	8.7	7	BEARISH	-47.1
CRWRF Craneware plc	$620M	24.1	11.2	12.9	9.7	8.7	7	BEARISH	-47.1
RZLT Rezolute, Inc.	$390M	-5.3	-59.0	1060.6	—	—	2	BEARISH	-57.5
RZLT Rezolute, Inc.	$390M	-5.3	-59.0	1060.6	—	—	2	BEARISH	-57.5
OCGN Ocugen, Inc.	$350M	-4.0	1211.7	190.2	-1671.8	-3.7	2	BEARISH	-39.3
OCGN Ocugen, Inc.	$350M	-4.0	1211.7	190.2	-1671.8	-3.7	2	BEARISH	-39.3
CAMP CAMP4 Therapeutics Corporation	$250M	-1.8	-545.9	48.4	-1884.8	40.2	2	BEARISH	35.6
CAMP CAMP4 Therapeutics Corporation	$250M	-1.8	-545.9	48.4	-1884.8	40.2	2	BEARISH	35.6
RNAC Cartesian Therapeutics, Inc.	$220M	-1.2	241.0	37.3	—	44.0	2	BEARISH	-28.1
RNAC Cartesian Therapeutics, Inc.	$220M	-1.2	241.0	37.3	—	44.0	2	BEARISH	-28.1
APLMW Apollomics, Inc.	$160M	-3.0	-4655.8	1929.8	1188.0	—	2	BEARISH	-59.6
APLMW Apollomics, Inc.	$160M	-3.0	-4655.8	1929.8	1188.0	—	2	BEARISH	-59.6
ARMP Armata Pharmaceuticals, Inc.	$130M	-0.7	127.8	-54.7	2953.8	-35.1	2	BEARISH	18.9
ARMP Armata Pharmaceuticals, Inc.	$130M	-0.7	127.8	-54.7	2953.8	-35.1	2	BEARISH	18.9
BDTX Black Diamond Therapeutics, Inc.	$110M	-2.6	-37.2	-1604.9	—	-100.0	1	BEARISH	-49.2
BDTX Black Diamond Therapeutics, Inc.	$110M	-2.6	-37.2	-1604.9	—	-100.0	1	BEARISH	-49.2
SKIN SkinHealth Systems Inc.	$80M	-2.8	-43.8	-1.6	-3.7	-6.5	4	BEARISH	-64.6
SKIN SkinHealth Systems Inc.	$80M	-2.8	-43.8	-1.6	-3.7	-6.5	4	BEARISH	-64.6
OSTX OS Therapies Incorporated	$70M	-1.5	1924.5	268.9	—	—	1	BEARISH	-18.5
OSTX OS Therapies Incorporated	$70M	-1.5	1924.5	268.9	—	—	1	BEARISH	-18.5
GOSS Gossamer Bio, Inc.	$70M	-0.2	178.7	117.2	182.9	32.4	3	BEARISH	-94.6
GOSS Gossamer Bio, Inc.	$70M	-0.2	178.7	117.2	182.9	32.4	3	BEARISH	-94.6
TDMMF Mach7 Technologies Limited	$40M	-6.1	-35.0	-38.2	-22.3	4.2	4	BEARISH	-67.9
TDMMF Mach7 Technologies Limited	$40M	-6.1	-35.0	-38.2	-22.3	4.2	4	BEARISH	-67.9
INNMF Amplia Therapeutics Limited	$40M	-6.6	-55.4	-129.9	—	-32.9	3	BEARISH	-20.0
INNMF Amplia Therapeutics Limited	$40M	-6.6	-55.4	-129.9	—	-32.9	3	BEARISH	-20.0
TLTFF Theralase Technologies Inc.	$40M	-12.3	-93.5	-173.9	-646.5	-24.8	4	BEARISH	-8.2
TLTFF Theralase Technologies Inc.	$40M	-12.3	-93.5	-173.9	-646.5	-24.8	4	BEARISH	-8.2
RVXCF Resverlogix Corp.	$20M	-1.8	11.5	25.3	—	—	4	BEARISH	-11.2
RVXCF Resverlogix Corp.	$20M	-1.8	11.5	25.3	—	—	4	BEARISH	-11.2
OTCFF Ocumetics Technology Corp.	$20M	-6.9	174.3	2137.7	—	—	1	BEARISH	-67.5
IPDQF ImpediMed Limited	$20M	-0.5	-189.0	712.6	-177.9	26.1	3	BEARISH	-83.3
IPDQF ImpediMed Limited	$20M	-0.5	-189.0	712.6	-177.9	26.1	3	BEARISH	-83.3
OTCFF Ocumetics Technology Corp.	$20M	-6.9	174.3	2137.7	—	—	1	BEARISH	-67.5
AIM AIM ImmunoTech Inc.	$10M	-0.0	-2382.3	-513.5	-14569.2	-21.5	5	BEARISH	-92.8
AIM AIM ImmunoTech Inc.	$10M	-0.0	-2382.3	-513.5	-14569.2	-21.5	5	BEARISH	-92.8
MVMDF The More Life Company Corp.	$10M	-6.2	-190.3	2590.3	-2792.5	-82.4	1	BEARISH	177.6
OPTH Optimi Health Corp.	$10M	—	—	—	—	—	—	BEARISH	—
OPTH Optimi Health Corp.	$10M	—	—	—	—	—	—	BEARISH	—
NSCIF Nanalysis Scientific Corp.	$10M	-3.5	-33.5	-6.2	-6.9	-6.2	5	BEARISH	-41.0
NSCIF Nanalysis Scientific Corp.	$10M	-3.5	-33.5	-6.2	-6.9	-6.2	5	BEARISH	-41.0
MVMDF The More Life Company Corp.	$10M	-6.2	-190.3	2590.3	-2792.5	-82.4	1	BEARISH	177.6
PFHO Pacific Health Care Organization, Inc.	$10M	12.3	7.5	60.8	18.4	-2.6	4	BEARISH	-19.7
PFHO Pacific Health Care Organization, Inc.	$10M	12.3	7.5	60.8	18.4	-2.6	4	BEARISH	-19.7
VPTDF VentriPoint Diagnostics Ltd.	$10M	-6.5	58.8	122.3	-3487.7	8.8	4	BEARISH	-13.3
VPTDF VentriPoint Diagnostics Ltd.	$10M	-6.5	58.8	122.3	-3487.7	8.8	4	BEARISH	-13.3
TRUFF Rhelion Life Sciences Corp.	$10M	-2.1	-41.6	-142.7	-288.8	-15.2	4	BEARISH	-18.0
TRUFF Rhelion Life Sciences Corp.	$10M	-2.1	-41.6	-142.7	-288.8	-15.2	4	BEARISH	-18.0
KALA KALA BIO, Inc.	$10M	-0.0	-345.3	-913.5	—	-100.0	4	BEARISH	-99.4
KALA KALA BIO, Inc.	$10M	-0.0	-345.3	-913.5	—	-100.0	4	BEARISH	-99.4
CNTMF Fluent Corp.	$10M	-0.2	119.7	-49.4	-65.1	-34.7	4	BEARISH	-57.4
CNTMF Fluent Corp.	$10M	-0.2	119.7	-49.4	-65.1	-34.7	4	BEARISH	-57.4
HIND Vyome Holdings, Inc.	$10M	-0.1	-193.1	516.3	-2543.3	-98.0	4	BEARISH	-65.3
HIND Vyome Holdings, Inc.	$10M	-0.1	-193.1	516.3	-2543.3	-98.0	4	BEARISH	-65.3
BMGL Basel Medical Group Ltd Ordinary Shares	$10M	—	—	—	—	—	—	BEARISH	-84.2
BMGL Basel Medical Group Ltd Ordinary Shares	$10M	—	—	—	—	—	—	BEARISH	-84.2
DECN Decision Diagnostics Corp.	—	-0.0	-8643.1	-51.3	-107.0	-2.7	4	BEARISH	-99.0
DECN Decision Diagnostics Corp.	—	-0.0	-8643.1	-51.3	-107.0	-2.7	4	BEARISH	-99.0
ULGX Urologix, Inc.	—	-0.0	80.8	96.5	-12.5	-19.4	3	BEARISH	0.0
ULGX Urologix, Inc.	—	-0.0	80.8	96.5	-12.5	-19.4	3	BEARISH	0.0
GNPX Genprex, Inc.	—	-0.0	-203.9	3484.8	—	—	4	BEARISH	-98.7
GNPX Genprex, Inc.	—	-0.0	-203.9	3484.8	—	—	4	BEARISH	-98.7
AKAN Akanda Corp.	—	-0.0	679.7	-257.3	-17342.7	-77.1	3	BEARISH	-97.1
AKAN Akanda Corp.	—	-0.0	679.7	-257.3	-17342.7	-77.1	3	BEARISH	-97.1
GPFT Grapefruit USA, Inc.	—	-0.2	11.4	5.9	—	—	2	BEARISH	-80.0
GPFT Grapefruit USA, Inc.	—	-0.2	11.4	5.9	—	—	2	BEARISH	-80.0
VLXC Veltex Corporation	—	-2.6	49.0	-433.9	-89.4	3.2	3	BEARISH	-37.1
VLXC Veltex Corporation	—	-2.6	49.0	-433.9	-89.4	3.2	3	BEARISH	-37.1
STHZF StateHouse Holdings Inc.	—	-0.1	36.1	3.8	0.8	-2.6	4	BEARISH	-100.0
STHZF StateHouse Holdings Inc.	—	-0.1	36.1	3.8	0.8	-2.6	4	BEARISH	-100.0
HPMM Hemp Naturals, Inc.	—	-0.0	-141.5	-78.5	—	17757.1	3	BEARISH	-99.0
HPMM Hemp Naturals, Inc.	—	-0.0	-141.5	-78.5	—	17757.1	3	BEARISH	-99.0
EMGE Emergent Health Corp	—	-0.0	23.7	51.7	—	-80.0	1	BEARISH	0.0
EMGE Emergent Health Corp	—	-0.0	23.7	51.7	—	-80.0	1	BEARISH	0.0
SFWJ Software Effective Solutions Corp.	—	-0.9	-21.8	-12.6	-51.5	26679.3	6	BEARISH	-33.3
SFWJ Software Effective Solutions Corp.	—	-0.9	-21.8	-12.6	-51.5	26679.3	6	BEARISH	-33.3
VRSYF VMS Rehab Systems, Inc.	—	—	—	—	—	—	—	BEARISH	-99.0
VRSYF VMS Rehab Systems, Inc.	—	—	—	—	—	—	—	BEARISH	-99.0
ABTI Alterola Biotech, Inc.	—	-0.1	-27.4	216.7	—	—	3	BEARISH	0.0
ABTI Alterola Biotech, Inc.	—	-0.1	-27.4	216.7	—	—	3	BEARISH	0.0
APLIF Appili Therapeutics Inc	—	-0.1	27.5	94.3	-2486.7	159.8	2	BEARISH	-50.0
APLIF Appili Therapeutics Inc	—	-0.1	27.5	94.3	-2486.7	159.8	2	BEARISH	-50.0
CMND Clearmind Medicine Inc.	—	-0.1	-104.0	593.4	—	—	2	BEARISH	-99.8
CMND Clearmind Medicine Inc.	—	-0.1	-104.0	593.4	—	—	2	BEARISH	-99.8
BIGG Big Tree Group, Inc.	—	0.0	0.4	-0.6	-0.6	55.4	5	BEARISH	0.0
BIGG Big Tree Group, Inc.	—	0.0	0.4	-0.6	-0.6	55.4	5	BEARISH	0.0
MDCE Medical Care Technologies Inc.	—	1.0	28.0	28.7	23.9	0.6	7	BEARISH	-75.0
MDCE Medical Care Technologies Inc.	—	1.0	28.0	28.7	23.9	0.6	7	BEARISH	-75.0
NEXI NexImmune, Inc.	—	-0.0	-230.1	1048.5	—	—	4	BEARISH	-50.0
NEXI NexImmune, Inc.	—	-0.0	-230.1	1048.5	—	—	4	BEARISH	-50.0
PDMI Paradigm Medical Industries, Inc.	—	-0.0	47.4	-40.4	-184.3	-30.7	4	BEARISH	-99.0
PDMI Paradigm Medical Industries, Inc.	—	-0.0	47.4	-40.4	-184.3	-30.7	4	BEARISH	-99.0
HKPD Cellyan Biotechnology Co., Ltd	—	-5.0	-20.8	-14.1	-20.5	—	2	BEARISH	-92.4
HKPD Cellyan Biotechnology Co., Ltd	—	-5.0	-20.8	-14.1	-20.5	—	2	BEARISH	-92.4
WPHM Winston Pharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	-66.7
WPHM Winston Pharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	-66.7
CRYM Cryomass Technologies Inc.	—	-0.0	137.2	57.9	-22040.0	-96.0	2	BEARISH	-99.8
CRYM Cryomass Technologies Inc.	—	-0.0	137.2	57.9	-22040.0	-96.0	2	BEARISH	-99.8
CEROW CERo Therapeutics Holdings, Inc.	—	-0.0	101.5	60.5	—	-100.0	1	BEARISH	-88.0
CEROW CERo Therapeutics Holdings, Inc.	—	-0.0	101.5	60.5	—	-100.0	1	BEARISH	-88.0
MCDA KMA Holding, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
MCDA KMA Holding, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
BMMJ Body and Mind Inc.	—	-0.1	267.1	411.6	-58.9	-48.9	2	BEARISH	-98.0
BMMJ Body and Mind Inc.	—	-0.1	267.1	411.6	-58.9	-48.9	2	BEARISH	-98.0
DOGP Dogecoin Cash, Inc.	—	-1.9	30.1	16.3	-76.3	0.2	3	BEARISH	-77.3
DOGP Dogecoin Cash, Inc.	—	-1.9	30.1	16.3	-76.3	0.2	3	BEARISH	-77.3
CDXQ China De Xiao Quan Care Group Co., Ltd	—	0.0	-136.1	-277.5	—	—	4	BEARISH	300.0
CDXQ China De Xiao Quan Care Group Co., Ltd	—	0.0	-136.1	-277.5	—	—	4	BEARISH	300.0
SIGO Sunset Island Group, Inc.	—	-0.0	185.8	85.4	—	—	4	BEARISH	0.0
SIGO Sunset Island Group, Inc.	—	-0.0	185.8	85.4	—	—	4	BEARISH	0.0
HESG Health Sciences Group, Inc.	—	-0.0	69.4	44.6	-19219.1	101.6	3	BEARISH	-90.0
HESG Health Sciences Group, Inc.	—	-0.0	69.4	44.6	-19219.1	101.6	3	BEARISH	-90.0
ECIA Encision Inc.	—	-0.7	-21.4	-7.6	-17.5	-3.0	3	BEARISH	-97.0
ECIA Encision Inc.	—	-0.7	-21.4	-7.6	-17.5	-3.0	3	BEARISH	-97.0
VRAYQ ViewRay, Inc.	—	-0.0	-108.9	-146.1	-128.1	44.1	1	BEARISH	-90.0
VRAYQ ViewRay, Inc.	—	-0.0	-108.9	-146.1	-128.1	44.1	1	BEARISH	-90.0
PNPL Pineapple, Inc.	—	-6.5	63.1	-28.2	-276.2	943.8	7	BEARISH	-99.6
PNPL Pineapple, Inc.	—	-6.5	63.1	-28.2	-276.2	943.8	7	BEARISH	-99.6
TSOI Therapeutic Solutions International, Inc.	—	-0.1	-187.6	-130.3	-5123.0	-99.7	4	BEARISH	0.0
TSOI Therapeutic Solutions International, Inc.	—	-0.1	-187.6	-130.3	-5123.0	-99.7	4	BEARISH	0.0
MRES Institute of Biomedical Research Corp.	—	-4.8	301783.0	-6062.7	—	—	1	BEARISH	-71.8
MRES Institute of Biomedical Research Corp.	—	-4.8	301783.0	-6062.7	—	—	1	BEARISH	-71.8
LOWLF Lowell Farms Inc.	—	-0.0	-146.8	-63.3	-111.9	-35.7	5	BEARISH	-100.0
LOWLF Lowell Farms Inc.	—	-0.0	-146.8	-63.3	-111.9	-35.7	5	BEARISH	-100.0
CANF Can-Fite BioPharma Ltd.	—	-0.3	-184.2	353.7	-2277.7	-40.1	2	BEARISH	-82.1
CANF Can-Fite BioPharma Ltd.	—	-0.3	-184.2	353.7	-2277.7	-40.1	2	BEARISH	-82.1
STAB Statera Biopharma, Inc.	—	-0.0	-298.8	2085.4	-769.5	1459.1	3	BEARISH	-99.0
STAB Statera Biopharma, Inc.	—	-0.0	-298.8	2085.4	-769.5	1459.1	3	BEARISH	-99.0
DHBUF Delivra Health Brands Inc.	—	-2.5	-19.4	-34.1	-82.4	-10.7	2	BEARISH	-67.7
DHBUF Delivra Health Brands Inc.	—	-2.5	-19.4	-34.1	-82.4	-10.7	2	BEARISH	-67.7
GCTK GlucoTrack, Inc.	—	-0.0	-620.6	427.4	—	—	2	BEARISH	-98.7
GCTK GlucoTrack, Inc.	—	-0.0	-620.6	427.4	—	—	2	BEARISH	-98.7
QMDT Quick-Med Technologies, Inc.	—	-0.0	8.3	3.4	-78.6	-6.9	5	BEARISH	400.0
QMDT Quick-Med Technologies, Inc.	—	-0.0	8.3	3.4	-78.6	-6.9	5	BEARISH	400.0
NEPTF Neptune Wellness Solutions Inc.	—	-2.7	606.5	1351.5	-233.6	-24.7	2	BEARISH	-100.0
NEPTF Neptune Wellness Solutions Inc.	—	-2.7	606.5	1351.5	-233.6	-24.7	2	BEARISH	-100.0
SCPX Scorpius Holdings, Inc.	—	-0.0	0.0	0.0	-428.3	-75.5	0	BEARISH	-90.9
SCPX Scorpius Holdings, Inc.	—	-0.0	0.0	0.0	-428.3	-75.5	0	BEARISH	-90.9
MEDVF Medivolve Inc.	—	-0.2	149.7	23.5	-322.7	-93.6	3	BEARISH	-95.0
MEDVF Medivolve Inc.	—	-0.2	149.7	23.5	-322.7	-93.6	3	BEARISH	-95.0
ISPC iSpecimen Inc.	—	-0.0	-968.5	305.3	-896.9	-92.1	4	BEARISH	-97.9
ISPC iSpecimen Inc.	—	-0.0	-968.5	305.3	-896.9	-92.1	4	BEARISH	-97.9
YCBD cbdMD, Inc.	—	-1.5	-40.3	-27.6	-20.3	10.0	2	BEARISH	-60.0
YCBD cbdMD, Inc.	—	-1.5	-40.3	-27.6	-20.3	10.0	2	BEARISH	-60.0
SEPN Septerna Inc	$1.7B	-69.8	-6.3	-93.1	-48.7	17878.5	5	BEARISH	98.5
SEPN Septerna Inc	$1.7B	-69.8	-6.3	-93.1	-48.7	17878.5	5	BEARISH	98.5
CRON Cronos Group Inc.	$1.2B	17.2	6.5	5.3	45.4	86.4	6	BEARISH	21.4
CRON Cronos Group Inc.	$1.2B	17.2	6.5	5.3	45.4	86.4	6	BEARISH	21.4
SIBN SI-BONE, Inc.	$800M	-53.2	-8.3	-32.2	-7.3	15.3	6	BEARISH	26.7
SIBN SI-BONE, Inc.	$800M	-53.2	-8.3	-32.2	-7.3	15.3	6	BEARISH	26.7
FDMT 4D Molecular Therapeutics, Inc.	$710M	-5.0	-43.3	-182.0	-1929.0	278712.1	4	BEARISH	56.6
FDMT 4D Molecular Therapeutics, Inc.	$710M	-5.0	-43.3	-182.0	-1929.0	278712.1	4	BEARISH	56.6
TMCI Treace Medical Concepts, Inc.	$280M	-4.7	-72.0	-44.8	-35.0	-4.0	2	BEARISH	-30.5
TMCI Treace Medical Concepts, Inc.	$280M	-4.7	-72.0	-44.8	-35.0	-4.0	2	BEARISH	-30.5
ANIK Anika Therapeutics, Inc.	$260M	-70.9	-2.7	-3.3	10.1	31.4	7	BEARISH	106.5
ANIK Anika Therapeutics, Inc.	$260M	-70.9	-2.7	-3.3	10.1	31.4	7	BEARISH	106.5
EPRX Eupraxia Pharmaceuticals Inc.	$240M	-7.1	-68.6	8742.2	—	—	3	BEARISH	19.3
EPRX Eupraxia Pharmaceuticals Inc.	$240M	-7.1	-68.6	8742.2	—	—	3	BEARISH	19.3
NKTX Nkarta, Inc.	$180M	-1.6	-38.8	-75.4	—	—	1	BEARISH	16.7
NKTX Nkarta, Inc.	$180M	-1.6	-38.8	-75.4	—	—	1	BEARISH	16.7
COCH Envoy Medical, Inc.	$50M	-1.0	176.2	119.9	-11729.4	-6.8	4	BEARISH	-12.3
COCH Envoy Medical, Inc.	$50M	-1.0	176.2	119.9	-11729.4	-6.8	4	BEARISH	-12.3
IBO Impact BioMedical Inc.	$50M	-4.5	10.8	-30.4	-23300.0	—	5	BEARISH	-34.5
IBO Impact BioMedical Inc.	$50M	-4.5	10.8	-30.4	-23300.0	—	5	BEARISH	-34.5
IXHL Incannex Healthcare Limited	$40M	-2.9	-163.9	14055.6	—	378.7	5	BEARISH	-75.2
IXHL Incannex Healthcare Limited	$40M	-2.9	-163.9	14055.6	—	378.7	5	BEARISH	-75.2
CCEL Cryo-Cell International, Inc.	$30M	-13.6	14.8	0.7	7.1	-2.7	5	BEARISH	-13.9
CCEL Cryo-Cell International, Inc.	$30M	-13.6	14.8	0.7	7.1	-2.7	5	BEARISH	-13.9
ERNAW Ernexa Therapeutics Inc. Warrants	—	—	—	—	—	—	—	BEARISH	—
ERNAW Ernexa Therapeutics Inc. Warrants	—	—	—	—	—	—	—	BEARISH	—
JNDOF JINS HOLDINGS Inc.	$900M	15.6	25.4	27.3	9.4	15.5	4	BEARISH	68.9
JNDOF JINS HOLDINGS Inc.	$900M	15.6	25.4	27.3	9.4	15.5	4	BEARISH	68.9
AMGXF AnGes, Inc.	$140M	-3.7	-160.6	-111.8	-531.3	-16.1	4	BEARISH	0.0
AMGXF AnGes, Inc.	$140M	-3.7	-160.6	-111.8	-531.3	-16.1	4	BEARISH	0.0
VYND Vynleads, Inc.	$10M	-27.0	74.2	89.5	—	—	4	BEARISH	-18.0
VYND Vynleads, Inc.	$10M	-27.0	74.2	89.5	—	—	4	BEARISH	-18.0
MYMX Mymetics Corporation	—	-0.0	16.6	357.9	-3012.0	-62.8	2	BEARISH	0.0
MYMX Mymetics Corporation	—	-0.0	16.6	357.9	-3012.0	-62.8	2	BEARISH	0.0
IMMB Immunotech Laboratories, Inc.	—	—	—	—	—	—	—	BEARISH	100.0
IMMB Immunotech Laboratories, Inc.	—	—	—	—	—	—	—	BEARISH	100.0
SLHPF Skylight Health Group Inc.	—	-0.0	-109.3	-44.8	-21.4	—	2	BEARISH	-90.0
SLHPF Skylight Health Group Inc.	—	-0.0	-109.3	-44.8	-21.4	—	2	BEARISH	-90.0
ATRX Adhera Therapeutics Inc	—	-0.0	18.6	6.5	—	—	1	BEARISH	-99.0
ATRX Adhera Therapeutics Inc	—	-0.0	18.6	6.5	—	—	1	BEARISH	-99.0
IRME IR-Med Inc.	—	-0.1	1793.9	264.1	—	-23.5	2	BEARISH	-95.6
IRME IR-Med Inc.	—	-0.1	1793.9	264.1	—	-23.5	2	BEARISH	-95.6
IHTI Integrative Health Technologies, Inc.	—	0.0	-13.8	-11.8	53.8	263.8	4	BEARISH	-95.0
IHTI Integrative Health Technologies, Inc.	—	0.0	-13.8	-11.8	53.8	263.8	4	BEARISH	-95.0
STLNW Starling Oncology Inc. Wt	—	—	—	—	—	—	—	BEARISH	—
STLNW Starling Oncology Inc. Wt	—	—	—	—	—	—	—	BEARISH	—
NWPHF Newron Pharmaceuticals S.p.A.	$420M	-6.0	83.9	-32.1	-513.4	—	1	BEARISH	—
NWPHF Newron Pharmaceuticals S.p.A.	$420M	-6.0	83.9	-32.1	-513.4	—	1	BEARISH	—
BLEVF Beleave Inc.	—	-0.0	-105.9	-25.1	-653.1	117.7	4	BEARISH	-90.0
BLEVF Beleave Inc.	—	-0.0	-105.9	-25.1	-653.1	117.7	4	BEARISH	-90.0
ARCT Arcturus Therapeutics Holdings Inc.	$370M	-3.9	-46.3	-2501.0	-803.8	-79.1	1	BEARISH	-36.4
ARCT Arcturus Therapeutics Holdings Inc.	$370M	-3.9	-46.3	-2501.0	-803.8	-79.1	1	BEARISH	-36.4
ENSC Ensysce Biosciences, Inc.	$10M	-0.1	-968.3	792.9	-220.8	-77.6	3	BEARISH	-83.7
ENSC Ensysce Biosciences, Inc.	$10M	-0.1	-968.3	792.9	-220.8	-77.6	3	BEARISH	-83.7
APRE Aprea Therapeutics, Inc.	$10M	-0.6	-47.4	378.1	—	-99.8	2	BEARISH	-52.4
APRE Aprea Therapeutics, Inc.	$10M	-0.6	-47.4	378.1	—	-99.8	2	BEARISH	-52.4
VAXX Vaxxinity, Inc.	—	-0.2	-150.6	2534.7	—	—	0	BEARISH	-99.5
VAXX Vaxxinity, Inc.	—	-0.2	-150.6	2534.7	—	—	0	BEARISH	-99.5
SYRS Syros Pharmaceuticals, Inc.	—	-0.0	-777.0	960.6	—	-90.5	0	BEARISH	300.0
SYRS Syros Pharmaceuticals, Inc.	—	-0.0	-777.0	960.6	—	-90.5	0	BEARISH	300.0
QDEL QuidelOrtho Corporation	$730M	-0.7	-45.9	-13.7	-14.7	0.1	4	BEARISH	-65.5
QDEL QuidelOrtho Corporation	$730M	-0.7	-45.9	-13.7	-14.7	0.1	4	BEARISH	-65.5
ROMJF Rubicon Organics Inc.	$20M	-18.5	-4.1	-24.0	2.2	16.7	1	BEARISH	-19.4
ROMJF Rubicon Organics Inc.	$20M	-18.5	-4.1	-24.0	2.2	16.7	1	BEARISH	-19.4
DVHGF Devonian Health Group Inc.	$20M	-3.8	-76.1	-75.1	-1098.1	-91.5	1	BEARISH	37.7
DVHGF Devonian Health Group Inc.	$20M	-3.8	-76.1	-75.1	-1098.1	-91.5	1	BEARISH	37.7
MDCX Medicus Pharma Ltd. Common Stock	$10M	-0.1	-3904.0	-693.1	—	—	2	BEARISH	-92.8
MDCX Medicus Pharma Ltd. Common Stock	$10M	-0.1	-3904.0	-693.1	—	—	2	BEARISH	-92.8
CMHSF Comprehensive Healthcare Systems, Inc.	$10M	-2.0	78.3	144.6	-37.9	-22.6	3	BEARISH	-26.7
CMHSF Comprehensive Healthcare Systems, Inc.	$10M	-2.0	78.3	144.6	-37.9	-22.6	3	BEARISH	-26.7
FAMDF Futura Medical plc	—	-0.3	-203.4	-1029.2	-72.8	1.5	3	BEARISH	-94.4
FAMDF Futura Medical plc	—	-0.3	-203.4	-1029.2	-72.8	1.5	3	BEARISH	-94.4
APPB Applied Biosciences Corp.	—	-0.0	-297.6	-188.8	-798.1	75.3	4	BEARISH	0.0
APPB Applied Biosciences Corp.	—	-0.0	-297.6	-188.8	-798.1	75.3	4	BEARISH	0.0
MNDR Mobile-health Network Solutions Class A Ordinary Shares	—	-0.0	-218.1	-292.1	-21.7	—	2	BEARISH	-99.1
MNDR Mobile-health Network Solutions Class A Ordinary Shares	—	-0.0	-218.1	-292.1	-21.7	—	2	BEARISH	-99.1
OCEA Ocean Biomedical, Inc.	—	-0.0	36.5	0.3	—	—	1	BEARISH	-83.0
OCEA Ocean Biomedical, Inc.	—	-0.0	36.5	0.3	—	—	1	BEARISH	-83.0
NMXS Net Medical Xpress Solutions, Inc.	—	-0.0	-362.8	-352.4	-6733.3	-89.2	2	BEARISH	600.0
NMXS Net Medical Xpress Solutions, Inc.	—	-0.0	-362.8	-352.4	-6733.3	-89.2	2	BEARISH	600.0
BHVN Biohaven Ltd.	$1.9B	-2.8	-799.5	-1083.0	—	—	3	BEARISH	-13.1
BHVN Biohaven Ltd.	$1.9B	-2.8	-799.5	-1083.0	—	—	3	BEARISH	-13.1
RTEZ Rest Ez Inc.	$1.9B	—	—	—	—	—	—	BEARISH	0.0
RTEZ Rest Ez Inc.	$1.9B	—	—	—	—	—	—	BEARISH	0.0
PVLA Palvella Therapeutics, Inc.	$1.9B	-27.4	-46.6	137.5	—	—	3	BEARISH	109.5
PVLA Palvella Therapeutics, Inc.	$1.9B	-27.4	-46.6	137.5	—	—	3	BEARISH	109.5
NVCR Novocure Ltd	$1.7B	-11.5	-43.2	-93.1	-8.5	11.0	6	BEARISH	6.9
NVCR Novocure Ltd	$1.7B	-11.5	-43.2	-93.1	-8.5	11.0	6	BEARISH	6.9
AGL Agilon Health, Inc.	$1.4B	-5.5	-78.9	-273.7	1.2	0.3	6	BEARISH	237.0
AGL Agilon Health, Inc.	$1.4B	-5.5	-78.9	-273.7	1.2	0.3	6	BEARISH	237.0
TYRA Tyra Biosciences, Inc.	$1.2B	-8.5	-45.3	-2390.9	—	—	2	BEARISH	52.2
TYRA Tyra Biosciences, Inc.	$1.2B	-8.5	-45.3	-2390.9	—	—	2	BEARISH	52.2
INNV Innovage Holding Corp.	$1.2B	-432.9	-1.1	-89.6	3.2	16.4	6	BEARISH	72.6
INNV Innovage Holding Corp.	$1.2B	-432.9	-1.1	-89.6	3.2	16.4	6	BEARISH	72.6
VOR Vor Biopharma Inc.	$1.0B	-0.1	-73.6	22.2	—	—	3	BEARISH	-52.4
VOR Vor Biopharma Inc.	$1.0B	-0.1	-73.6	22.2	—	—	3	BEARISH	-52.4
ABUS Arbutus Biopharma Corp	$880M	5.6	89.6	86.7	-507.2	1078.8	4	BEARISH	-3.0
ABUS Arbutus Biopharma Corp	$880M	5.6	89.6	86.7	-507.2	1078.8	4	BEARISH	-3.0
SLBT SL Science Holding Ltd	$880M	—	—	—	—	—	—	BEARISH	—
SLBT SL Science Holding Ltd	$880M	—	—	—	—	—	—	BEARISH	—
AVR Anteris Technologies Global Corp.	$750M	-2.8	-75.1	3136.2	-2884.3	31.1	5	BEARISH	81.4
AVR Anteris Technologies Global Corp.	$750M	-2.8	-75.1	3136.2	-2884.3	31.1	5	BEARISH	81.4
IRWD Ironwood Pharmaceuticals, Inc.	$600M	4.6	-55.3	93.9	45.4	26.2	7	BEARISH	149.3
IRWD Ironwood Pharmaceuticals, Inc.	$600M	4.6	-55.3	93.9	45.4	26.2	7	BEARISH	149.3
RSLBF RaySearch Laboratories AB (publ)	$560M	29.1	26.1	21.8	7.2	1.2	6	BEARISH	-40.2
RSLBF RaySearch Laboratories AB (publ)	$560M	29.1	26.1	21.8	7.2	1.2	6	BEARISH	-40.2
EIKN Eikon Therapeutics, Inc. Common Stock	$400M	—	—	—	—	—	—	BEARISH	—
EIKN Eikon Therapeutics, Inc. Common Stock	$400M	—	—	—	—	—	—	BEARISH	—
VREOF Vireo Growth Inc.	$360M	-4.8	-4.6	-0.7	-0.0	—	3	BEARISH	—
VREOF Vireo Growth Inc.	$360M	-4.8	-4.6	-0.7	-0.0	—	3	BEARISH	—
CLVLF Clinuvel Pharmaceuticals Limited	$290M	11.9	29.5	262.1	41.1	13.1	6	BEARISH	-28.1
CLVLF Clinuvel Pharmaceuticals Limited	$290M	11.9	29.5	262.1	41.1	13.1	6	BEARISH	-28.1
UPB Upstream Bio, Inc.	$270M	-1.7	-46.0	-1266.4	-5136.1	49.2	3	BEARISH	-70.9
UPB Upstream Bio, Inc.	$270M	-1.7	-46.0	-1266.4	-5136.1	49.2	3	BEARISH	-70.9
TRDA Entrada Therapeutics, Inc.	$210M	-1.4	-54.1	-236.6	-4762.0	-94.1	1	BEARISH	-8.5
TRDA Entrada Therapeutics, Inc.	$210M	-1.4	-54.1	-236.6	-4762.0	-94.1	1	BEARISH	-8.5
ELDN Eledon Pharmaceuticals, Inc.	$190M	-2.5	-110.7	411.1	—	—	2	BEARISH	-6.4
ELDN Eledon Pharmaceuticals, Inc.	$190M	-2.5	-110.7	411.1	—	—	2	BEARISH	-6.4
MFCSF Medical Facilities Corporation	$180M	8.3	46.9	50.2	2.5	3.2	7	BEARISH	2.1
MFCSF Medical Facilities Corporation	$180M	8.3	46.9	50.2	2.5	3.2	7	BEARISH	2.1
DERM Journey Medical Corporation	$180M	-29.3	-23.8	-7.4	-1.7	20.9	5	BEARISH	-8.8
DERM Journey Medical Corporation	$180M	-29.3	-23.8	-7.4	-1.7	20.9	5	BEARISH	-8.8
DTIL Precision BioSciences, Inc.	$170M	-2.3	-135.1	203.1	—	3473.0	5	BEARISH	16.0
DTIL Precision BioSciences, Inc.	$170M	-2.3	-135.1	203.1	—	3473.0	5	BEARISH	16.0
BRNHF Broncus Holding Corporation	$160M	-2.5	-19.0	-76.7	-247.3	-20.6	5	BEARISH	0.0
BRNHF Broncus Holding Corporation	$160M	-2.5	-19.0	-76.7	-247.3	-20.6	5	BEARISH	0.0
NRXP NRx Pharmaceuticals, Inc.	$130M	-3.9	131.2	61.3	-1500.5	—	5	BEARISH	-12.9
NRXP NRx Pharmaceuticals, Inc.	$130M	-3.9	131.2	61.3	-1500.5	—	5	BEARISH	-12.9
HURA TuHURA Biosciences, Inc.	$120M	-3.5	-161.4	-137.6	—	—	2	BEARISH	-24.8
HURA TuHURA Biosciences, Inc.	$120M	-3.5	-161.4	-137.6	—	—	2	BEARISH	-24.8
TRIB Trinity Biotech plc	$120M	-0.1	69.8	-14.6	-157.8	-28.8	2	BEARISH	457.8
TRIB Trinity Biotech plc	$120M	-0.1	69.8	-14.6	-157.8	-28.8	2	BEARISH	457.8
AARD Aardvark Therapeutics, Inc. Common Stock	$110M	-1.6	-66.0	-3642.4	—	—	1	BEARISH	-66.1
AARD Aardvark Therapeutics, Inc. Common Stock	$110M	-1.6	-66.0	-3642.4	—	—	1	BEARISH	-66.1
ADAG Adagene Inc.	$110M	-6.0	-72.6	324.2	-1011.1	1054.7	4	BEARISH	42.5
ADAG Adagene Inc.	$110M	-6.0	-72.6	324.2	-1011.1	1054.7	4	BEARISH	42.5
KRRO Korro Bio, Inc.	$100M	-1.0	-97.7	-196.6	—	-62.1	2	BEARISH	-78.0
KRRO Korro Bio, Inc.	$100M	-1.0	-97.7	-196.6	—	-62.1	2	BEARISH	-78.0
HLTRF HLS Therapeutics Inc.	$90M	-10.3	-14.1	-4.2	-7.0	-0.2	5	BEARISH	-27.6
HLTRF HLS Therapeutics Inc.	$90M	-10.3	-14.1	-4.2	-7.0	-0.2	5	BEARISH	-27.6
PXMBF Paxman AB (publ)	$80M	-303.4	-1.2	-1.7	2.4	33.5	3	BEARISH	0.0
PXMBF Paxman AB (publ)	$80M	-303.4	-1.2	-1.7	2.4	33.5	3	BEARISH	0.0
RNXT RenovoRx, Inc.	$70M	-5.0	-125.2	4391.9	-320.2	198.5	3	BEARISH	17.9
RNXT RenovoRx, Inc.	$70M	-5.0	-125.2	4391.9	-320.2	198.5	3	BEARISH	17.9
BOLD Boundless Bio, Inc.	$60M	-0.9	-67.9	807.9	—	—	2	BEARISH	113.0
BOLD Boundless Bio, Inc.	$60M	-0.9	-67.9	807.9	—	—	2	BEARISH	113.0
INMB INmune Bio, Inc.	$50M	-2.8	-74.8	-475.4	—	-100.0	2	BEARISH	-9.4
INMB INmune Bio, Inc.	$50M	-2.8	-74.8	-475.4	—	-100.0	2	BEARISH	-9.4
NNOX Nano-X Imaging Ltd.	$40M	-0.4	-99.0	-164.5	-1335.1	31.5	2	BEARISH	-82.8
NNOX Nano-X Imaging Ltd.	$40M	-0.4	-99.0	-164.5	-1335.1	31.5	2	BEARISH	-82.8
NDTP NDT Pharmaceuticals Inc.	$40M	-50.0	-3.8	-1.5	-458.3	—	4	BEARISH	-78.2
NDTP NDT Pharmaceuticals Inc.	$40M	-50.0	-3.8	-1.5	-458.3	—	4	BEARISH	-78.2
MDXH MDxHealth S.A.	$30M	-1.0	321.7	-43.8	-42.4	34.4	5	BEARISH	-87.8
MDXH MDxHealth S.A.	$30M	-1.0	321.7	-43.8	-42.4	34.4	5	BEARISH	-87.8
TELIF Telescope Innovations Corp.	$20M	-7.2	-229.2	-80.7	-116.8	66.3	2	BEARISH	13.6
NEUP Neuphoria Therapeutics Inc.	$20M	-0.5	-0.2	-0.2	-417.7	-91.9	4	BEARISH	-75.0
NEUP Neuphoria Therapeutics Inc.	$20M	-0.5	-0.2	-0.2	-417.7	-91.9	4	BEARISH	-75.0
TELIF Telescope Innovations Corp.	$20M	-7.2	-229.2	-80.7	-116.8	66.3	2	BEARISH	13.6
MDNAF Medicenna Therapeutics Corp.	$20M	—	—	—	—	—	—	BEARISH	—
MDNAF Medicenna Therapeutics Corp.	$20M	—	—	—	—	—	—	BEARISH	—
KPTI Karyopharm Therapeutics Inc.	$20M	-0.0	79.0	36.3	-200.5	6.8	2	BEARISH	-87.1
KPTI Karyopharm Therapeutics Inc.	$20M	-0.0	79.0	36.3	-200.5	6.8	2	BEARISH	-87.1
ALLR Allarity Therapeutics, Inc.	$20M	-1.3	-157.1	-96.5	—	—	2	BEARISH	-35.8
ALLR Allarity Therapeutics, Inc.	$20M	-1.3	-157.1	-96.5	—	—	2	BEARISH	-35.8
TXMD TherapeuticsMD, Inc.	$20M	-109.0	-0.8	-12.9	17.8	27.8	6	BEARISH	88.7
TXMD TherapeuticsMD, Inc.	$20M	-109.0	-0.8	-12.9	17.8	27.8	6	BEARISH	88.7
AVCNF Avicanna Inc.	$10M	-3.1	-109.4	-64.5	-18.1	-0.2	3	BEARISH	-61.0
PHYOF IXICO plc	$10M	-3.8	-32.4	-40.1	-28.5	-1.5	2	BEARISH	0.0
PHYOF IXICO plc	$10M	-3.8	-32.4	-40.1	-28.5	-1.5	2	BEARISH	0.0
CTXR Citius Pharmaceuticals, Inc.	$10M	-0.3	-70.3	-85.4	-593.3	4456.8	3	BEARISH	-61.2
AVCNF Avicanna Inc.	$10M	-3.1	-109.4	-64.5	-18.1	-0.2	3	BEARISH	-61.0
CTXR Citius Pharmaceuticals, Inc.	$10M	-0.3	-70.3	-85.4	-593.3	4456.8	3	BEARISH	-61.2
GTBP GT Biopharma, Inc.	$10M	-0.1	-798.9	927.8	—	—	2	BEARISH	-62.8
GTBP GT Biopharma, Inc.	$10M	-0.1	-798.9	927.8	—	—	2	BEARISH	-62.8
ADIL Adial Pharmaceuticals, Inc.	$10M	-0.2	-2011.6	159.6	—	—	3	BEARISH	-56.2
ADIL Adial Pharmaceuticals, Inc.	$10M	-0.2	-2011.6	159.6	—	—	3	BEARISH	-56.2
AVTBF Avant Brands Inc.	$10M	-0.5	-47.1	-18.4	-41.2	13.3	4	BEARISH	-37.6
AVTBF Avant Brands Inc.	$10M	-0.5	-47.1	-18.4	-41.2	13.3	4	BEARISH	-37.6
RVLWF Revitalist Lifestyle and Wellness Ltd.	$10M	-0.1	613.5	-129.3	-263.6	—	2	BEARISH	0.0
RVLWF Revitalist Lifestyle and Wellness Ltd.	$10M	-0.1	613.5	-129.3	-263.6	—	2	BEARISH	0.0
SNGX Soligenix, Inc.	$10M	-0.3	-241.7	304.6	—	—	4	BEARISH	-88.4
SNGX Soligenix, Inc.	$10M	-0.3	-241.7	304.6	—	—	4	BEARISH	-88.4
NRSN NeuroSense Therapeutics Ltd.	$10M	-0.4	779.3	571.3	—	—	3	BEARISH	-83.9
NRSN NeuroSense Therapeutics Ltd.	$10M	-0.4	779.3	571.3	—	—	3	BEARISH	-83.9
PLRZ Polyrizon Ltd.	$10M	-2.3	-30.9	-68.2	—	—	1	BEARISH	46.9
PLRZ Polyrizon Ltd.	$10M	-2.3	-30.9	-68.2	—	—	1	BEARISH	46.9
ENGNW enGene Holdings Inc. Warrants	$10M	-6.9	-2.3	134.1	—	-100.0	2	BEARISH	-69.2
ENGNW enGene Holdings Inc. Warrants	$10M	-6.9	-2.3	134.1	—	-100.0	2	BEARISH	-69.2
BRGX BioRegenx, Inc.	—	-2.7	0.6	1.6	-6.2	—	3	BEARISH	—
BRGX BioRegenx, Inc.	—	-2.7	0.6	1.6	-6.2	—	3	BEARISH	—
VRAX Virax Biolabs Group Limited	—	-0.1	-207.4	-812.1	-40439.1	-87.7	4	BEARISH	255.2
VRAX Virax Biolabs Group Limited	—	-0.1	-207.4	-812.1	-40439.1	-87.7	4	BEARISH	255.2
GSAC GelStat Corporation	—	-2.8	25.1	80.4	-124.9	62.9	6	BEARISH	-14.3
GSAC GelStat Corporation	—	-2.8	25.1	80.4	-124.9	62.9	6	BEARISH	-14.3
HTDS Hard to Treat Diseases Inc.	—	—	—	—	—	—	—	BEARISH	-95.0
HTDS Hard to Treat Diseases Inc.	—	—	—	—	—	—	—	BEARISH	-95.0
XENO Xeno Transplants Corporation	—	-0.0	-286.5	78.1	—	—	1	BEARISH	0.0
XENO Xeno Transplants Corporation	—	-0.0	-286.5	78.1	—	—	1	BEARISH	0.0
PHMB PharmaCom BioVet, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
PHMB PharmaCom BioVet, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
AMBD American Mobile Dental Corp.	—	—	—	—	—	—	—	BEARISH	0.0
AMBD American Mobile Dental Corp.	—	—	—	—	—	—	—	BEARISH	0.0
HTPRF HTC Purenergy Inc.	—	-0.1	13.4	-6.6	—	100.0	5	BEARISH	-99.8
HTPRF HTC Purenergy Inc.	—	-0.1	13.4	-6.6	—	100.0	5	BEARISH	-99.8
VSMD Vasamed, Inc.	—	-0.0	54566.1	395.4	-334.5	70.0	4	BEARISH	0.0
VSMD Vasamed, Inc.	—	-0.0	54566.1	395.4	-334.5	70.0	4	BEARISH	0.0
CHME China Medicine Corp.	—	-196.6	9.7	9.7	12.7	-4.3	6	BEARISH	2483.3
CHME China Medicine Corp.	—	-196.6	9.7	9.7	12.7	-4.3	6	BEARISH	2483.3
BTCY Biotricity, Inc.	—	-0.4	7.6	-22.1	-7.6	16.0	4	BEARISH	-88.9
BTCY Biotricity, Inc.	—	-0.4	7.6	-22.1	-7.6	16.0	4	BEARISH	-88.9
CNNC Cannonau Corp.	—	0.0	-96.5	-93.3	—	-100.0	2	BEARISH	-66.7
CNNC Cannonau Corp.	—	0.0	-96.5	-93.3	—	-100.0	2	BEARISH	-66.7
AMIX Autonomix Medical, Inc.	—	-0.1	-238.9	1213.5	—	—	1	BEARISH	-84.6
AMIX Autonomix Medical, Inc.	—	-0.1	-238.9	1213.5	—	—	1	BEARISH	-84.6
EFTR eFFECTOR Therapeutics, Inc.	—	-0.0	1737.6	607.9	—	-91.9	4	BEARISH	0.0
EFTR eFFECTOR Therapeutics, Inc.	—	-0.0	1737.6	607.9	—	-91.9	4	BEARISH	0.0
AQQRF Aquarius Surgical Technologies Inc.	—	-0.2	10.7	-42.8	91.2	0.3	5	BEARISH	0.0
AQQRF Aquarius Surgical Technologies Inc.	—	-0.2	10.7	-42.8	91.2	0.3	5	BEARISH	0.0
MMTC Micro Imaging Technology, Inc.	—	-0.0	83.3	72.6	—	—	1	BEARISH	0.0
MMTC Micro Imaging Technology, Inc.	—	-0.0	83.3	72.6	—	—	1	BEARISH	0.0
CHMMF Chimeric Therapeutics Limited	—	-0.0	1115.1	183.2	—	98.4	3	BEARISH	0.0
CHMMF Chimeric Therapeutics Limited	—	-0.0	1115.1	183.2	—	98.4	3	BEARISH	0.0
NHEL Natural Health Farm Holdings Inc.	—	-0.0	-37.2	-15.8	9.3	6892.6	4	BEARISH	0.0
NHEL Natural Health Farm Holdings Inc.	—	-0.0	-37.2	-15.8	9.3	6892.6	4	BEARISH	0.0
RMTG Regenerative Medical Technology Group Inc.	—	-0.1	9.6	-3.3	-72.2	—	3	BEARISH	—
RMTG Regenerative Medical Technology Group Inc.	—	-0.1	9.6	-3.3	-72.2	—	3	BEARISH	—
NXGT Nexteligent Holdings, Inc.	—	-11.6	2.7	-1.5	5.3	-0.2	3	BEARISH	-35.0
NXGT Nexteligent Holdings, Inc.	—	-11.6	2.7	-1.5	5.3	-0.2	3	BEARISH	-35.0
CRFTF BC Craft Supply Co. Ltd.	—	-0.0	152.6	13.1	—	-82.0	2	BEARISH	-90.0
CRFTF BC Craft Supply Co. Ltd.	—	-0.0	152.6	13.1	—	-82.0	2	BEARISH	-90.0
RDHL RedHill Biopharma Ltd.	—	-0.2	428.1	117.9	-101.3	157.6	6	BEARISH	-80.2
RDHL RedHill Biopharma Ltd.	—	-0.2	428.1	117.9	-101.3	157.6	6	BEARISH	-80.2
OILFF Nextleaf Solutions Ltd.	—	-2.2	-41.0	-53.4	-19.9	-18.2	3	BEARISH	-61.2
OILFF Nextleaf Solutions Ltd.	—	-2.2	-41.0	-53.4	-19.9	-18.2	3	BEARISH	-61.2
RSCF Reflect Scientific, Inc.	—	13.2	12.1	17.0	15.2	76.0	6	BEARISH	-17.6
RSCF Reflect Scientific, Inc.	—	13.2	12.1	17.0	15.2	76.0	6	BEARISH	-17.6
OXIHF Oxford Investments Holdings Inc.	—	-0.2	19.5	9.8	6887.8	-90.6	2	BEARISH	0.0
OXIHF Oxford Investments Holdings Inc.	—	-0.2	19.5	9.8	6887.8	-90.6	2	BEARISH	0.0
EVLO Evelo Biosciences, Inc.	—	-0.0	948.0	605.0	—	—	2	BEARISH	-80.0
EVLO Evelo Biosciences, Inc.	—	-0.0	948.0	605.0	—	—	2	BEARISH	-80.0
MPXOF MPX International Corp.	—	-0.0	-179.4	-42.1	-411.8	14.3	4	BEARISH	-99.0
MPXOF MPX International Corp.	—	-0.0	-179.4	-42.1	-411.8	14.3	4	BEARISH	-99.0
NTRR Neutra Corp.	—	1.0	1.2	-42.9	632.2	1449.2	6	BEARISH	-33.3
NTRR Neutra Corp.	—	1.0	1.2	-42.9	632.2	1449.2	6	BEARISH	-33.3
UNVC Univec, Inc.	—	-3.7	6.9	5.9	-1481.4	78.3	4	BEARISH	-60.0
UNVC Univec, Inc.	—	-3.7	6.9	5.9	-1481.4	78.3	4	BEARISH	-60.0
CALA Calithera Biosciences, Inc.	—	-0.0	-141.5	979.6	—	-100.0	1	BEARISH	0.0
CALA Calithera Biosciences, Inc.	—	-0.0	-141.5	979.6	—	-100.0	1	BEARISH	0.0
CYIO CYIOS Corporation	—	1.6	60.5	46.3	—	-48.3	2	BEARISH	-79.6
CYIO CYIOS Corporation	—	1.6	60.5	46.3	—	-48.3	2	BEARISH	-79.6
PGNY Progyny, Inc.	$2.0B	26.0	16.2	30.2	8.0	5.5	7	BEARISH	18.9
PGNY Progyny, Inc.	$2.0B	26.0	16.2	30.2	8.0	5.5	7	BEARISH	18.9
ESTA Establishment Labs Holdings Inc.	$1.9B	-49.0	-175.3	-6.9	-17.4	38.6	5	BEARISH	56.9
ESTA Establishment Labs Holdings Inc.	$1.9B	-49.0	-175.3	-6.9	-17.4	38.6	5	BEARISH	56.9
ELEAF EL.En. S.p.A.	$1.4B	14.1	13.2	29.1	6.0	25.8	8	BEARISH	39.8
ELEAF EL.En. S.p.A.	$1.4B	14.1	13.2	29.1	6.0	25.8	8	BEARISH	39.8
IDRSF Idorsia Ltd	$1.4B	-3.4	27.1	-344.5	-203.1	-8.1	1	BEARISH	17.0
IDRSF Idorsia Ltd	$1.4B	-3.4	27.1	-344.5	-203.1	-8.1	1	BEARISH	17.0
MEDOF Medios AG	$1.3B	23.5	2.1	2.8	0.6	10.0	6	BEARISH	0.0
MEDOF Medios AG	$1.3B	23.5	2.1	2.8	0.6	10.0	6	BEARISH	0.0
CGEM Cullinan Therapeutics, Inc.	$950M	-4.6	-50.3	1635.6	—	—	1	BEARISH	158.5
CGEM Cullinan Therapeutics, Inc.	$950M	-4.6	-50.3	1635.6	—	—	1	BEARISH	158.5
JBIO Jade Biosciences, Inc.	$860M	-5.1	-47.8	629.9	—	—	3	BEARISH	55.0
JBIO Jade Biosciences, Inc.	$860M	-5.1	-47.8	629.9	—	—	3	BEARISH	55.0
INMD InMode Ltd.	$810M	11.3	12.3	44.5	17.9	-6.7	5	BEARISH	-7.8
INMD InMode Ltd.	$810M	11.3	12.3	44.5	17.9	-6.7	5	BEARISH	-7.8
MNPR Monopar Therapeutics Inc.	$520M	-33.3	-19.5	523.8	—	—	2	BEARISH	-8.0
MNPR Monopar Therapeutics Inc.	$520M	-33.3	-19.5	523.8	—	—	2	BEARISH	-8.0
ASMB Assembly Biosciences, Inc.	$450M	41.0	-0.0	56.2	-28.8	125.1	4	BEARISH	-8.4
ASMB Assembly Biosciences, Inc.	$450M	41.0	-0.0	56.2	-28.8	125.1	4	BEARISH	-8.4
CTEV Claritev Corporation	$400M	-1.4	169.3	0.9	-23.0	110.3	4	BEARISH	-51.2
CTEV Claritev Corporation	$400M	-1.4	169.3	0.9	-23.0	110.3	4	BEARISH	-51.2
ABEO Abeona Therapeutics Inc.	$290M	-4.4	-43.1	-5983.3	-177.4	6280.0	2	BEARISH	-4.7
ABEO Abeona Therapeutics Inc.	$290M	-4.4	-43.1	-5983.3	-177.4	6280.0	2	BEARISH	-4.7
PRQR ProQR Therapeutics N.V.	$170M	-3.7	-57.9	139.7	-99.6	12.7	2	BEARISH	-24.1
PRQR ProQR Therapeutics N.V.	$170M	-3.7	-57.9	139.7	-99.6	12.7	2	BEARISH	-24.1
STIM Neuronetics, Inc.	$150M	-5.0	-135.3	-21.3	-8.3	39.6	4	BEARISH	-20.6
STIM Neuronetics, Inc.	$150M	-5.0	-135.3	-21.3	-8.3	39.6	4	BEARISH	-20.6
IMUX Immunic, Inc.	$110M	-1.7	-138.2	345.6	—	—	5	BEARISH	-17.1
IMUX Immunic, Inc.	$110M	-1.7	-138.2	345.6	—	—	5	BEARISH	-17.1
BMEA Biomea Fusion, Inc.	$90M	-2.6	-164.1	210.3	—	—	2	BEARISH	-39.2
BMEA Biomea Fusion, Inc.	$90M	-2.6	-164.1	210.3	—	—	2	BEARISH	-39.2
RVRC Revium Recovery Inc.	$90M	-6.4	-0.0	0.0	—	—	2	BEARISH	175.0
RVRC Revium Recovery Inc.	$90M	-6.4	-0.0	0.0	—	—	2	BEARISH	175.0
PMN ProMIS Neurosciences, Inc.	$80M	-0.6	-172.3	844.3	—	—	2	BEARISH	-17.5
PMN ProMIS Neurosciences, Inc.	$80M	-0.6	-172.3	844.3	—	—	2	BEARISH	-17.5
AVEFF Avecho Biotechnology Limited	$20M	-13.3	-238.0	200.0	-3227.5	83.1	5	BEARISH	0.0
AVEFF Avecho Biotechnology Limited	$20M	-13.3	-238.0	200.0	-3227.5	83.1	5	BEARISH	0.0
PIII P3 Health Partners Inc.	$20M	-0.2	-168.8	-64.8	1.9	2.8	4	BEARISH	-27.7
PIII P3 Health Partners Inc.	$20M	-0.2	-168.8	-64.8	1.9	2.8	4	BEARISH	-27.7
CMMB Chemomab Therapeutics Ltd.	$10M	-1.4	-82.7	-314.7	—	—	1	BEARISH	-45.8
CMMB Chemomab Therapeutics Ltd.	$10M	-1.4	-82.7	-314.7	—	—	1	BEARISH	-45.8
NVNO enVVeno Medical Corporation	$10M	-0.0	-58.5	4255.8	—	—	4	BEARISH	789.6
NVNO enVVeno Medical Corporation	$10M	-0.0	-58.5	4255.8	—	—	4	BEARISH	789.6
IBXXF Imagion Biosystems Limited	$10M	-0.6	157.2	463.1	-376.2	-53.1	3	BEARISH	-20.0
IBXXF Imagion Biosystems Limited	$10M	-0.6	157.2	463.1	-376.2	-53.1	3	BEARISH	-20.0
ANTH Anthera Pharmaceuticals, Inc.	—	-0.0	-251.4	1107.5	—	—	1	BEARISH	0.0
TBRIF Therma Bright Inc.	—	-0.6	711.8	33.4	-336.3	202.0	3	BEARISH	-62.9
TBRIF Therma Bright Inc.	—	-0.6	711.8	33.4	-336.3	202.0	3	BEARISH	-62.9
ANTH Anthera Pharmaceuticals, Inc.	—	-0.0	-251.4	1107.5	—	—	1	BEARISH	0.0
DPAT Dental Patient Care America, Inc.	—	419.0	117.2	10.7	26.9	-3.7	5	BEARISH	114.9
DPAT Dental Patient Care America, Inc.	—	419.0	117.2	10.7	26.9	-3.7	5	BEARISH	114.9
RXEI RxElite, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
GNLKQ GeneLink, Inc.	—	-0.0	73.0	82.1	-183.0	-33.6	3	BEARISH	0.0
GNLKQ GeneLink, Inc.	—	-0.0	73.0	82.1	-183.0	-33.6	3	BEARISH	0.0
RXEI RxElite, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
GLABF Gemina Laboratories Ltd.	—	-3.0	42.7	32.4	-7838.5	—	5	BEARISH	-85.1
GLABF Gemina Laboratories Ltd.	—	-3.0	42.7	32.4	-7838.5	—	5	BEARISH	-85.1
OZYMF Strategic Partners A/S	—	21.7	0.9	-117.6	1019.0	—	5	BEARISH	0.0
OZYMF Strategic Partners A/S	—	21.7	0.9	-117.6	1019.0	—	5	BEARISH	0.0
IVIXF Invion Limited	—	-0.6	-106.0	-133.1	-537.3	-89.5	1	BEARISH	0.0
IVIXF Invion Limited	—	-0.6	-106.0	-133.1	-537.3	-89.5	1	BEARISH	0.0
SILO Silo Pharma, Inc.	—	-0.3	-91.2	645.1	—	-25.0	3	BEARISH	113.0
SILO Silo Pharma, Inc.	—	-0.3	-91.2	645.1	—	-25.0	3	BEARISH	113.0
HELP Cybin Inc. Common Stock	$730M	-2.8	-38.6	-94.5	—	—	2	BEARISH	—
HELP Cybin Inc. Common Stock	$730M	-2.8	-38.6	-94.5	—	—	2	BEARISH	—
MAJI Nextel Medical Corp.	—	-0.8	-0.6	7.4	—	—	1	BEARISH	—
MAJI Nextel Medical Corp.	—	-0.8	-0.6	7.4	—	—	1	BEARISH	—
SNDX Syndax Pharmaceuticals, Inc.	$1.6B	-7.0	-255.9	-270.9	-67.8	222.3	4	BEARISH	12.2
SNDX Syndax Pharmaceuticals, Inc.	$1.6B	-7.0	-255.9	-270.9	-67.8	222.3	4	BEARISH	12.2
HBMHF HBM Holdings Limited	$1.3B	17.0	58.2	96.1	53.0	133.3	6	BEARISH	-8.8
HBMHF HBM Holdings Limited	$1.3B	17.0	58.2	96.1	53.0	133.3	6	BEARISH	-8.8
ARDX Ardelyx, Inc.	$830M	-14.8	-38.6	-22.7	-13.8	16.8	4	BEARISH	-37.7
ARDX Ardelyx, Inc.	$830M	-14.8	-38.6	-22.7	-13.8	16.8	4	BEARISH	-37.7
PHR Phreesia, Inc.	$620M	58.5	0.8	-1.4	1.0	14.5	4	BEARISH	-55.1
PHR Phreesia, Inc.	$620M	58.5	0.8	-1.4	1.0	14.5	4	BEARISH	-55.1
SWDCF Swedencare AB (publ)	$370M	43.2	1.1	1.6	3.5	4.5	8	BEARISH	-35.8
SWDCF Swedencare AB (publ)	$370M	43.2	1.1	1.6	3.5	4.5	8	BEARISH	-35.8
MOBI Mobia Medical, Inc. Common Stock	$310M	—	—	—	—	—	—	BEARISH	—
MOBI Mobia Medical, Inc. Common Stock	$310M	—	—	—	—	—	—	BEARISH	—
LXEO Lexeo Therapeutics, Inc. Common Stock	$280M	-3.1	-46.8	-249.1	—	—	3	BEARISH	-46.8
LXEO Lexeo Therapeutics, Inc. Common Stock	$280M	-3.1	-46.8	-249.1	—	—	3	BEARISH	-46.8
BOVNF BioInvent International AB (publ)	$220M	-3.0	-88.2	20101.5	-964.0	-87.2	1	BEARISH	0.0
BOVNF BioInvent International AB (publ)	$220M	-3.0	-88.2	20101.5	-964.0	-87.2	1	BEARISH	0.0
EDSA Edesa Biotech, Inc.	$40M	-2.3	-122.9	759.6	—	—	1	BEARISH	50.2
EDSA Edesa Biotech, Inc.	$40M	-2.3	-122.9	759.6	—	—	1	BEARISH	50.2
CLCS Cell Source, Inc.	$30M	-4.0	27.7	34.5	—	—	4	BEARISH	11.9
CLCS Cell Source, Inc.	$30M	-4.0	27.7	34.5	—	—	4	BEARISH	11.9
CNTX Context Therapeutics Inc.	$30M	-0.6	-76.1	841.7	—	—	2	BEARISH	-68.1
CNTX Context Therapeutics Inc.	$30M	-0.6	-76.1	841.7	—	—	2	BEARISH	-68.1
LDDD Longduoduo Company Limited	$20M	-26.6	47.5	-421.7	-13.8	-36.8	5	BEARISH	-62.8
LDDD Longduoduo Company Limited	$20M	-26.6	47.5	-421.7	-13.8	-36.8	5	BEARISH	-62.8
JMPHF Leveljump Healthcare Corp.	$10M	-1.5	-21.1	0.7	-9.7	5.4	3	BEARISH	677.3
JMPHF Leveljump Healthcare Corp.	$10M	-1.5	-21.1	0.7	-9.7	5.4	3	BEARISH	677.3
AIXN AiXin Life International, Inc.	$10M	-3.2	37.6	39.5	-191.9	-61.1	4	BEARISH	-54.9
AIXN AiXin Life International, Inc.	$10M	-3.2	37.6	39.5	-191.9	-61.1	4	BEARISH	-54.9
LTHO Legacy Technology Holdings, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
LTHO Legacy Technology Holdings, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
PPBT Purple Biotech Ltd.	—	-0.0	-111.3	-99.1	—	—	2	BEARISH	157.7
PPBT Purple Biotech Ltd.	—	-0.0	-111.3	-99.1	—	—	2	BEARISH	157.7
RSLT Resilient Healthcare Corp	—	—	—	—	—	—	—	BEARISH	—
RSLT Resilient Healthcare Corp	—	—	—	—	—	—	—	BEARISH	—
HMPQ HempAmericana, Inc	—	-0.5	25.6	14.8	—	184.6	2	BEARISH	0.0
HMPQ HempAmericana, Inc	—	-0.5	25.6	14.8	—	184.6	2	BEARISH	0.0
OMID OMID Holdings, Inc.	—	-10.9	-127.5	-314.5	40.6	57.1	5	BEARISH	-6.0
OMID OMID Holdings, Inc.	—	-10.9	-127.5	-314.5	40.6	57.1	5	BEARISH	-6.0
MSGP MedSmart Group Inc.	—	-0.2	33.6	85.8	—	-100.0	1	BEARISH	500.0
MSGP MedSmart Group Inc.	—	-0.2	33.6	85.8	—	-100.0	1	BEARISH	500.0
NAVBQ Navidea Biopharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	—
NAVBQ Navidea Biopharmaceuticals, Inc.	—	—	—	—	—	—	—	BEARISH	—
CLDI Calidi Biotherapeutics, Inc.	—	-0.0	-713.6	-1404.6	—	—	4	BEARISH	-95.9
CLDI Calidi Biotherapeutics, Inc.	—	-0.0	-713.6	-1404.6	—	—	4	BEARISH	-95.9
RNAZ TransCode Therapeutics, Inc.	—	-0.0	-59.2	-21.0	—	—	1	BEARISH	-85.2
RNAZ TransCode Therapeutics, Inc.	—	-0.0	-59.2	-21.0	—	—	1	BEARISH	-85.2
KOAN Resonate Blends, Inc.	—	-0.0	46.5	-991.9	-399.0	-32.1	4	BEARISH	-97.4
KOAN Resonate Blends, Inc.	—	-0.0	46.5	-991.9	-399.0	-32.1	4	BEARISH	-97.4
ECGS Eco-Growth Strategies Inc.	—	-2.0	19.5	55.1	—	—	2	BEARISH	-76.5
ECGS Eco-Growth Strategies Inc.	—	-2.0	19.5	55.1	—	—	2	BEARISH	-76.5
ARUXF Acrux Limited	—	-7.1	-276.2	-405.6	-26.5	-56.9	3	BEARISH	-93.4
ARUXF Acrux Limited	—	-7.1	-276.2	-405.6	-26.5	-56.9	3	BEARISH	-93.4
PREDQ Predictive Discovery Limited	—	—	—	—	—	—	—	BEARISH	—
PREDQ Predictive Discovery Limited	—	—	—	—	—	—	—	BEARISH	—
RADX Radiopharm Theranostics Limited	—	—	—	—	—	—	—	BEARISH	-74.7
RADX Radiopharm Theranostics Limited	—	—	—	—	—	—	—	BEARISH	-74.7
AYURF Ayurcann Holdings Corp.	—	-0.5	315.5	53.8	-13.0	47.1	4	BEARISH	-99.0
AYURF Ayurcann Holdings Corp.	—	-0.5	315.5	53.8	-13.0	47.1	4	BEARISH	-99.0
ADVT Advantis Corp.	—	-0.4	-8.4	-3.2	-1775.1	—	1	BEARISH	0.0
ADVT Advantis Corp.	—	-0.4	-8.4	-3.2	-1775.1	—	1	BEARISH	0.0
WLSS Welsis Corp.	—	-40.5	6.2	3.3	—	—	1	BEARISH	-82.9
WLSS Welsis Corp.	—	-40.5	6.2	3.3	—	—	1	BEARISH	-82.9
TSTTF TripSitter Clinic Ltd.	—	-19.2	-0.1	30.7	—	100.0	4	BEARISH	-56.2
TSTTF TripSitter Clinic Ltd.	—	-19.2	-0.1	30.7	—	100.0	4	BEARISH	-56.2
MYNDF MYND Life Sciences Inc.	—	-2.2	9.5	34.0	—	—	5	BEARISH	-41.3
MYNDF MYND Life Sciences Inc.	—	-2.2	9.5	34.0	—	—	5	BEARISH	-41.3
SEPSF Asep Medical Holdings Inc	—	-0.4	-36.4	-75.5	-844.8	208.8	5	BEARISH	-97.2
SEPSF Asep Medical Holdings Inc	—	-0.4	-36.4	-75.5	-844.8	208.8	5	BEARISH	-97.2
ENDV Endonovo Therapeutics, Inc.	—	-0.1	9.2	4.5	—	-100.0	3	BEARISH	-50.0
ENDV Endonovo Therapeutics, Inc.	—	-0.1	9.2	4.5	—	-100.0	3	BEARISH	-50.0
LNDZF Evome Medical Technologies Inc.	—	-2.2	-294.8	-10.4	-11.5	-15.9	4	BEARISH	-97.6
LNDZF Evome Medical Technologies Inc.	—	-2.2	-294.8	-10.4	-11.5	-15.9	4	BEARISH	-97.6
ACUT Accustem Sciences Inc.	—	-1.3	49.7	34.0	-256.7	2610.7	4	BEARISH	-91.0
ACUT Accustem Sciences Inc.	—	-1.3	49.7	34.0	-256.7	2610.7	4	BEARISH	-91.0
IPAH Interpharm Holdings, Inc.	—	-0.0	-342.5	-47.0	-67.2	-5.1	1	BEARISH	-99.8
IPAH Interpharm Holdings, Inc.	—	-0.0	-342.5	-47.0	-67.2	-5.1	1	BEARISH	-99.8
MICR Micron Solutions, Inc.	—	-0.0	-32.9	-10.2	-16.0	19.3	3	BEARISH	50.0
MICR Micron Solutions, Inc.	—	-0.0	-32.9	-10.2	-16.0	19.3	3	BEARISH	50.0
HSMD Healthcare Solutions Management Group, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
HSMD Healthcare Solutions Management Group, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
OVIT OncoVista Innovative Therapies, Inc.	—	-0.0	61.2	43.6	—	—	1	BEARISH	0.0
OVIT OncoVista Innovative Therapies, Inc.	—	-0.0	61.2	43.6	—	—	1	BEARISH	0.0
ELAB PMGC Holdings Inc.	—	-0.0	-73.0	-66.6	-225.1	408.6	3	BEARISH	-99.9
POAS Phaos Technology Holdings (Caym	—	—	—	—	—	—	—	BEARISH	—
POAS Phaos Technology Holdings (Caym	—	—	—	—	—	—	—	BEARISH	—
ELAB PMGC Holdings Inc.	—	-0.0	-73.0	-66.6	-225.1	408.6	3	BEARISH	-99.9
ADXN Addex Therapeutics Ltd	—	-0.5	-150.5	-168.4	-17543.0	-48.1	2	BEARISH	-67.3
ADXN Addex Therapeutics Ltd	—	-0.5	-150.5	-168.4	-17543.0	-48.1	2	BEARISH	-67.3
ZLDAF Zelira Therapeutics Limited	—	-1.6	-294.0	349.6	-185107971.7	-94.8	1	BEARISH	-1.4
ZLDAF Zelira Therapeutics Limited	—	-1.6	-294.0	349.6	-185107971.7	-94.8	1	BEARISH	-1.4
NXEN Nexien BioPharma, Inc.	—	-0.0	48.5	112.0	—	—	2	BEARISH	-99.2
NXEN Nexien BioPharma, Inc.	—	-0.0	48.5	112.0	—	—	2	BEARISH	-99.2
CGHC Capital Group Holdings, Inc.	—	-0.0	-44.6	-14.9	-24.2	—	5	BEARISH	0.0
CGHC Capital Group Holdings, Inc.	—	-0.0	-44.6	-14.9	-24.2	—	5	BEARISH	0.0
AGTX Agentix Corp.	—	-1.9	14.5	10.8	—	—	3	BEARISH	-55.6
AGTX Agentix Corp.	—	-1.9	14.5	10.8	—	—	3	BEARISH	-55.6
DOSEF Doseology Sciences Inc.	—	-0.9	-95.4	-103.8	-1609.9	161.1	1	BEARISH	-88.9
DOSEF Doseology Sciences Inc.	—	-0.9	-95.4	-103.8	-1609.9	161.1	1	BEARISH	-88.9
AGIO Agios Pharmaceuticals, Inc.	$1.9B	-4.5	-34.3	-82.5	-225.1	140.6	4	BEARISH	-20.6
AGIO Agios Pharmaceuticals, Inc.	$1.9B	-4.5	-34.3	-82.5	-225.1	140.6	4	BEARISH	-20.6
ZYME Zymeworks Inc.	$1.9B	-12.5	-72.3	-156.9	-980.8	-69.8	2	BEARISH	48.5
ZYME Zymeworks Inc.	$1.9B	-12.5	-72.3	-156.9	-980.8	-69.8	2	BEARISH	48.5
NUVB Nuvation Bio Inc.	$1.8B	-11.8	-47.8	70.2	-198.3	1083.6	4	BEARISH	38.6
NUVB Nuvation Bio Inc.	$1.8B	-11.8	-47.8	70.2	-198.3	1083.6	4	BEARISH	38.6
CMPS COMPASS Pathways plc	$1.6B	-2.1	-319.1	48.8	—	—	2	BEARISH	106.2
CMPS COMPASS Pathways plc	$1.6B	-2.1	-319.1	48.8	—	—	2	BEARISH	106.2
IMCR Immunocore Holdings plc	$1.5B	-164.8	-2.3	-472.0	-0.7	13.4	4	BEARISH	-17.3
IMCR Immunocore Holdings plc	$1.5B	-164.8	-2.3	-472.0	-0.7	13.4	4	BEARISH	-17.3
TSHA Taysha Gene Therapies, Inc.	$1.5B	-11.0	-47.1	961.0	—	-32.3	3	BEARISH	45.6
TSHA Taysha Gene Therapies, Inc.	$1.5B	-11.0	-47.1	961.0	—	-32.3	3	BEARISH	45.6
INBX Inhibrx Biosciences Inc.	$1.4B	-10.9	-1773.6	55.8	—	-100.0	4	BEARISH	185.4
INBX Inhibrx Biosciences Inc.	$1.4B	-10.9	-1773.6	55.8	—	-100.0	4	BEARISH	185.4
NBTX Nanobiotix S.A.	$1.3B	-20.8	380.7	158.8	-941.2	-73.7	3	BEARISH	37.4
NBTX Nanobiotix S.A.	$1.3B	-20.8	380.7	158.8	-941.2	-73.7	3	BEARISH	37.4
TDOC Teladoc Health, Inc.	$1.0B	-5.6	-13.0	-8.7	-6.4	-2.1	5	BEARISH	-29.2
TDOC Teladoc Health, Inc.	$1.0B	-5.6	-13.0	-8.7	-6.4	-2.1	5	BEARISH	-29.2
KURA Kura Oncology, Inc.	$950M	-3.2	-167.7	56.3	-327.3	-7.3	1	BEARISH	15.8
KURA Kura Oncology, Inc.	$950M	-3.2	-167.7	56.3	-327.3	-7.3	1	BEARISH	15.8
CADL Candel Therapeutics, Inc.	$750M	-7.2	-81.8	219.4	—	—	2	BEARISH	83.8
CADL Candel Therapeutics, Inc.	$750M	-7.2	-81.8	219.4	—	—	2	BEARISH	83.8
ZVRA Zevra Therapeutics, Inc.	$590M	10.4	34.8	-1356.4	22.1	119.4	6	BEARISH	5.9
ZVRA Zevra Therapeutics, Inc.	$590M	10.4	34.8	-1356.4	22.1	119.4	6	BEARISH	5.9
AQST Aquestive Therapeutics, Inc.	$570M	-7.0	121.1	43.4	-165.5	22.6	5	BEARISH	-22.6
AQST Aquestive Therapeutics, Inc.	$570M	-7.0	121.1	43.4	-165.5	22.6	5	BEARISH	-22.6
PRME Prime Medicine, Inc.	$540M	-2.7	-373.3	-271.3	-3649.0	-17.9	3	BEARISH	-46.7
PRME Prime Medicine, Inc.	$540M	-2.7	-373.3	-271.3	-3649.0	-17.9	3	BEARISH	-46.7
EOLS Evolus, Inc.	$470M	-13.8	138.6	-20.7	-9.6	13.9	5	BEARISH	16.1
EOLS Evolus, Inc.	$470M	-13.8	138.6	-20.7	-9.6	13.9	5	BEARISH	16.1
AUTL Autolus Therapeutics plc	$470M	-1.7	-132.9	451.5	-85.6	292.0	3	BEARISH	6.6
AUTL Autolus Therapeutics plc	$470M	-1.7	-132.9	451.5	-85.6	292.0	3	BEARISH	6.6
OVID Ovid Therapeutics Inc.	$440M	-5.0	-26.0	-43.7	-2047.6	-76.2	3	BEARISH	73.7
OVID Ovid Therapeutics Inc.	$440M	-5.0	-26.0	-43.7	-2047.6	-76.2	3	BEARISH	73.7
NGNE Neurogene Inc.	$410M	-4.7	-45.3	-111469.0	—	—	2	BEARISH	42.7
NGNE Neurogene Inc.	$410M	-4.7	-45.3	-111469.0	—	—	2	BEARISH	42.7
CLPT ClearPoint Neuro, Inc.	$330M	-9.2	-226.5	-54.1	-104.2	25.9	3	BEARISH	-47.9
CLPT ClearPoint Neuro, Inc.	$330M	-9.2	-226.5	-54.1	-104.2	25.9	3	BEARISH	-47.9
CCCC C4 Therapeutics, Inc.	$330M	-3.0	-48.1	-175.0	-355.9	2.3	4	BEARISH	37.2
CCCC C4 Therapeutics, Inc.	$330M	-3.0	-48.1	-175.0	-355.9	2.3	4	BEARISH	37.2
CYDY CytoDyn Inc.	$270M	-5.8	41.5	21.3	—	100.0	3	BEARISH	-23.0
CYDY CytoDyn Inc.	$270M	-5.8	41.5	21.3	—	100.0	3	BEARISH	-23.0
IFRX InflaRx N.V.	$250M	-3.1	-38.5	251.5	—	-106.2	4	BEARISH	26.5
IFRX InflaRx N.V.	$250M	-3.1	-38.5	251.5	—	-106.2	4	BEARISH	26.5
CGEN Compugen Ltd.	$220M	6.2	49.6	-90.2	-269.3	886.7	5	BEARISH	44.4
CGEN Compugen Ltd.	$220M	6.2	49.6	-90.2	-269.3	886.7	5	BEARISH	44.4
CUE Cue Biopharma, Inc.	$190M	-0.9	-1603.5	1241.9	-1943.2	354.4	3	BEARISH	17.8
CUE Cue Biopharma, Inc.	$190M	-0.9	-1603.5	1241.9	-1943.2	354.4	3	BEARISH	17.8
ABOS Acumen Pharmaceuticals, Inc.	$150M	-1.2	-120.5	389.8	—	—	2	BEARISH	16.6
ABOS Acumen Pharmaceuticals, Inc.	$150M	-1.2	-120.5	389.8	—	—	2	BEARISH	16.6
IPHA Innate Pharma S.A.	$150M	-2.6	1600.0	254.7	-630.0	-91.4	2	BEARISH	-21.2
IPHA Innate Pharma S.A.	$150M	-2.6	1600.0	254.7	-630.0	-91.4	2	BEARISH	-21.2
PYXS Pyxis Oncology, Inc.	$140M	-1.5	-179.1	1953.9	—	291.4	2	BEARISH	-2.3
PYXS Pyxis Oncology, Inc.	$140M	-1.5	-179.1	1953.9	—	291.4	2	BEARISH	-2.3
MEDXF Medexus Pharmaceuticals Inc.	$110M	-43.4	-4.7	7.1	-10.9	-8.3	5	BEARISH	80.5
MEDXF Medexus Pharmaceuticals Inc.	$110M	-43.4	-4.7	7.1	-10.9	-8.3	5	BEARISH	80.5
MXCT MaxCyte, Inc.	$110M	-3.2	-20.4	-38.9	-122.0	-13.2	2	BEARISH	-33.1
MXCT MaxCyte, Inc.	$110M	-3.2	-20.4	-38.9	-122.0	-13.2	2	BEARISH	-33.1
VRCA Verrica Pharmaceuticals Inc.	$80M	-2.5	473.3	437.4	-224.4	106.2	5	BEARISH	-1.4
VRCA Verrica Pharmaceuticals Inc.	$80M	-2.5	473.3	437.4	-224.4	106.2	5	BEARISH	-1.4
PLNH Planet 13 Holdings Inc.	$40M	-0.6	-90.5	-50.0	-24.4	-21.2	2	BEARISH	-54.1
PLNH Planet 13 Holdings Inc.	$40M	-0.6	-90.5	-50.0	-24.4	-21.2	2	BEARISH	-54.1
MLSS Milestone Scientific Inc.	$30M	-7.9	-121.7	-160.5	-37.3	3.7	4	BEARISH	-16.1
MLSS Milestone Scientific Inc.	$30M	-7.9	-121.7	-160.5	-37.3	3.7	4	BEARISH	-16.1
BETRF BetterLife Pharma Inc.	$30M	-12.0	14.6	14.7	—	—	4	BEARISH	252.4
BETRF BetterLife Pharma Inc.	$30M	-12.0	14.6	14.7	—	—	4	BEARISH	252.4
KZIA Kazia Therapeutics Ltd ADR	$20M	-1.3	-196.1	162.7	—	250944.3	5	BEARISH	35.3
KZIA Kazia Therapeutics Ltd ADR	$20M	-1.3	-196.1	162.7	—	250944.3	5	BEARISH	35.3
LPCN Lipocine Inc.	$20M	-1.1	-60.9	662.3	-1379.6	-62.7	2	BEARISH	-31.0
LPCN Lipocine Inc.	$20M	-1.1	-60.9	662.3	-1379.6	-62.7	2	BEARISH	-31.0
ADIA Adia Med Inc.	$10M	-0.1	32.2	-16.3	8.3	—	1	BEARISH	145.7
ADIA Adia Med Inc.	$10M	-0.1	32.2	-16.3	8.3	—	1	BEARISH	145.7
IMNN Imunon, Inc.	$10M	-0.3	-429.7	-226.7	—	—	2	BEARISH	-75.6
IMNN Imunon, Inc.	$10M	-0.3	-429.7	-226.7	—	—	2	BEARISH	-75.6
UEEC United Health Products, Inc.	$10M	-5.5	37.4	34.4	—	—	4	BEARISH	-57.9
UEEC United Health Products, Inc.	$10M	-5.5	37.4	34.4	—	—	4	BEARISH	-57.9
AKTX Akari Therapeutics, Plc	$10M	-0.0	-139.9	-175.8	—	—	3	BEARISH	-77.8
AKTX Akari Therapeutics, Plc	$10M	-0.0	-139.9	-175.8	—	—	3	BEARISH	-77.8
AMS American Shared Hospital Services	$10M	-5.5	-7.5	-5.5	-6.1	4.0	5	BEARISH	-43.5
AMS American Shared Hospital Services	$10M	-5.5	-7.5	-5.5	-6.1	4.0	5	BEARISH	-43.5
EVFM Evofem Biosciences, Inc.	—	-0.1	20.1	26.0	-419.1	4.5	2	BEARISH	-44.8
EVFM Evofem Biosciences, Inc.	—	-0.1	20.1	26.0	-419.1	4.5	2	BEARISH	-44.8
CCM Concord Medical Services Holdings Limited	—	-0.0	7.5	-26.9	-13.5	-22.5	2	BEARISH	-51.0
CCM Concord Medical Services Holdings Limited	—	-0.0	7.5	-26.9	-13.5	-22.5	2	BEARISH	-51.0
PAVS Paranovus Entertainment Technology Ltd.	—	-0.0	-157.0	-4.3	-5.5	-82.4	3	BEARISH	-96.3
PAVS Paranovus Entertainment Technology Ltd.	—	-0.0	-157.0	-4.3	-5.5	-82.4	3	BEARISH	-96.3
EVIO EVIO, Inc.	—	1.7	65.3	33.5	8.3	-26.9	4	BEARISH	0.0
EVIO EVIO, Inc.	—	1.7	65.3	33.5	8.3	-26.9	4	BEARISH	0.0
LMLLF Pharmadrug Inc.	—	-0.9	37.6	446.5	—	—	2	BEARISH	-57.5
LMLLF Pharmadrug Inc.	—	-0.9	37.6	446.5	—	—	2	BEARISH	-57.5
IMNM Immunome, Inc.	$2.0B	-8.2	-64.0	-2208.4	—	-100.0	4	BEARISH	84.3
IMNM Immunome, Inc.	$2.0B	-8.2	-64.0	-2208.4	—	-100.0	4	BEARISH	84.3
TRVI Trevi Therapeutics, Inc.	$2.0B	-41.2	-19.7	-1451.7	—	—	3	BEARISH	48.0
TRVI Trevi Therapeutics, Inc.	$2.0B	-41.2	-19.7	-1451.7	—	—	3	BEARISH	48.0
QURE uniQure N.V.	$1.6B	-5.8	-157.6	37.9	-1387.8	30.2	4	BEARISH	-57.3
QURE uniQure N.V.	$1.6B	-5.8	-157.6	37.9	-1387.8	30.2	4	BEARISH	-57.3
RAPP Rapport Therapeutics, Inc. Common Stock	$1.5B	-10.6	-40.0	3981.5	—	—	4	BEARISH	12.2
RAPP Rapport Therapeutics, Inc. Common Stock	$1.5B	-10.6	-40.0	3981.5	—	—	4	BEARISH	12.2
OCUL Ocular Therapeutix, Inc.	$1.5B	-4.9	-73.0	-31671.3	-584.5	-8.1	3	BEARISH	-37.0
OCUL Ocular Therapeutix, Inc.	$1.5B	-4.9	-73.0	-31671.3	-584.5	-8.1	3	BEARISH	-37.0
ANAB AnaptysBio, Inc.	$1.4B	7.2	-1146.3	466.0	668.9	92.9	5	BEARISH	127.7
ANAB AnaptysBio, Inc.	$1.4B	7.2	-1146.3	466.0	668.9	92.9	5	BEARISH	127.7
TWAPF Towa Pharmaceutical Co., Ltd.	$1.3B	20.8	3.0	2.6	-17.0	6.0	5	BEARISH	inf
TWAPF Towa Pharmaceutical Co., Ltd.	$1.3B	20.8	3.0	2.6	-17.0	6.0	5	BEARISH	inf
NKTR Nektar Therapeutics	$1.2B	-6.5	-35.8	-29.2	-401.0	-27.2	3	BEARISH	-25.9
NKTR Nektar Therapeutics	$1.2B	-6.5	-35.8	-29.2	-401.0	-27.2	3	BEARISH	-25.9
BCAX Bicara Therapeutics Inc. Common Stock	$1.2B	-5.7	-41.0	583.9	—	—	2	BEARISH	6.1
BCAX Bicara Therapeutics Inc. Common Stock	$1.2B	-5.7	-41.0	583.9	—	—	2	BEARISH	6.1
LBRX LB Pharmaceuticals Inc Common Stock	$1.1B	-12.5	-25.8	-768.9	—	—	2	BEARISH	134.7
LBRX LB Pharmaceuticals Inc Common Stock	$1.1B	-12.5	-25.8	-768.9	—	—	2	BEARISH	134.7
MGTX MeiraGTx Holdings plc	$1.0B	14.2	72.3	96.7	50.0	948.3	7	BEARISH	30.5
MGTX MeiraGTx Holdings plc	$1.0B	14.2	72.3	96.7	50.0	948.3	7	BEARISH	30.5
AKTS Aktis Oncology, Inc.	$990M	-17.6	-29.9	276.4	-713.5	-36.1	5	BEARISH	18875.4
AKTS Aktis Oncology, Inc.	$990M	-17.6	-29.9	276.4	-713.5	-36.1	5	BEARISH	18875.4
ANRO Alto Neuroscience, Inc.	$870M	-10.0	-49.2	-201.4	—	—	3	BEARISH	509.6
ANRO Alto Neuroscience, Inc.	$870M	-10.0	-49.2	-201.4	—	—	3	BEARISH	509.6
AVTX Avalo Therapeutics, Inc.	$790M	-3.2	-36.3	-148.4	—	-86.6	4	BEARISH	15.7
AVTX Avalo Therapeutics, Inc.	$790M	-3.2	-36.3	-148.4	—	-86.6	4	BEARISH	15.7
XVIPF Xvivo Perfusion AB (publ)	$690M	76.0	7.6	35.3	6.8	8.3	6	BEARISH	14.4
XVIPF Xvivo Perfusion AB (publ)	$690M	76.0	7.6	35.3	6.8	8.3	6	BEARISH	14.4
SLDB Solid Biosciences Inc.	$670M	-3.6	-65.5	-1012.6	—	—	3	BEARISH	16.7
SLDB Solid Biosciences Inc.	$670M	-3.6	-65.5	-1012.6	—	—	3	BEARISH	16.7
CLYM Climb Bio, Inc.	$630M	-13.2	-27.1	-88.6	—	—	2	BEARISH	455.3
CLYM Climb Bio, Inc.	$630M	-13.2	-27.1	-88.6	—	—	2	BEARISH	455.3
AURA Aura Biosciences, Inc.	$630M	-3.4	-53.5	-1360.0	—	—	4	BEARISH	-1.0
AURA Aura Biosciences, Inc.	$630M	-3.4	-53.5	-1360.0	—	—	4	BEARISH	-1.0
IMMX Immix Biopharma, Inc.	$530M	-11.0	-34.2	1509.2	—	—	4	BEARISH	365.4
IMMX Immix Biopharma, Inc.	$530M	-11.0	-34.2	1509.2	—	—	4	BEARISH	365.4
BRSYF BrainsWay Ltd.	$510M	52.6	12.9	30.9	15.8	31.5	6	BEARISH	129.5
BRSYF BrainsWay Ltd.	$510M	52.6	12.9	30.9	15.8	31.5	6	BEARISH	129.5
TECX Tectonic Therapeutic, Inc.	$430M	-4.9	-33.8	-6371.3	—	—	1	BEARISH	43.9
TECX Tectonic Therapeutic, Inc.	$430M	-4.9	-33.8	-6371.3	—	—	1	BEARISH	43.9
SRTA Strata Critical Medical, Inc.	$410M	9.5	16.0	-6.2	-14.5	0.6	3	BEARISH	-8.1
SRTA Strata Critical Medical, Inc.	$410M	9.5	16.0	-6.2	-14.5	0.6	3	BEARISH	-8.1
EVH Evolent Health, Inc.	$390M	-0.8	-79.0	-1.8	-4.3	-4.5	5	BEARISH	-56.8
EVH Evolent Health, Inc.	$390M	-0.8	-79.0	-1.8	-4.3	-4.5	5	BEARISH	-56.8
FENC Fennec Pharmaceuticals Inc.	$350M	-78.5	-18.6	-76.2	11.0	77.8	6	BEARISH	6.4
FENC Fennec Pharmaceuticals Inc.	$350M	-78.5	-18.6	-76.2	11.0	77.8	6	BEARISH	6.4
ARTV Artiva Biotherapeutics, Inc.	$330M	-2.1	-36.6	-954.6	—	—	3	BEARISH	133.9
ARTV Artiva Biotherapeutics, Inc.	$330M	-2.1	-36.6	-954.6	—	—	3	BEARISH	133.9
SPHDF Santhera Pharmaceuticals Holding AG	$270M	-6.6	-464.2	715.5	-44.5	26.5	3	BEARISH	37.4
SPHDF Santhera Pharmaceuticals Holding AG	$270M	-6.6	-464.2	715.5	-44.5	26.5	3	BEARISH	37.4
IKT Inhibikase Therapeutics, Inc.	$260M	-4.2	-52.0	920.5	—	—	3	BEARISH	24.2
IKT Inhibikase Therapeutics, Inc.	$260M	-4.2	-52.0	920.5	—	—	3	BEARISH	24.2
QTTB Q32 Bio Inc.	$240M	2.9	72.1	435.2	—	—	5	BEARISH	295.7
QTTB Q32 Bio Inc.	$240M	2.9	72.1	435.2	—	—	5	BEARISH	295.7
CRLBF Cresco Labs Inc.	$230M	-2.2	-25.8	5.5	9.7	-4.5	2	BEARISH	-53.6
CRLBF Cresco Labs Inc.	$230M	-2.2	-25.8	5.5	9.7	-4.5	2	BEARISH	-53.6
PRLD Prelude Therapeutics Incorporated	$210M	-4.6	-57.7	14236.3	-244.1	220.3	5	BEARISH	143.1
PRLD Prelude Therapeutics Incorporated	$210M	-4.6	-57.7	14236.3	-244.1	220.3	5	BEARISH	143.1
ZNTL Zentalis Pharmaceuticals, Inc.	$180M	-1.0	-83.7	-2245.4	—	-100.0	2	BEARISH	63.6
ZNTL Zentalis Pharmaceuticals, Inc.	$180M	-1.0	-83.7	-2245.4	—	-100.0	2	BEARISH	63.6
ALXO ALX Oncology Holdings Inc.	$160M	-1.1	-80.6	-851.1	—	—	4	BEARISH	-32.6
ALXO ALX Oncology Holdings Inc.	$160M	-1.1	-80.6	-851.1	—	—	4	BEARISH	-32.6
MAYNF Mayne Pharma Group Limited	$160M	9.2	-16.4	-17.8	23.0	38.4	5	BEARISH	-41.2
MAYNF Mayne Pharma Group Limited	$160M	9.2	-16.4	-17.8	23.0	38.4	5	BEARISH	-41.2
CRDL Cardiol Therapeutics Inc.	$160M	-5.9	-204.6	1592.3	—	—	4	BEARISH	31.8
CRDL Cardiol Therapeutics Inc.	$160M	-5.9	-204.6	1592.3	—	—	4	BEARISH	31.8
CRBP Corbus Pharmaceuticals Holdings, Inc.	$110M	-0.9	-95.6	738.2	—	—	1	BEARISH	-53.0
CRBP Corbus Pharmaceuticals Holdings, Inc.	$110M	-0.9	-95.6	738.2	—	—	1	BEARISH	-53.0
CRDF Cardiff Oncology, Inc.	$90M	-1.9	-94.1	443.4	-8876.9	-7.0	3	BEARISH	-46.1
CRDF Cardiff Oncology, Inc.	$90M	-1.9	-94.1	443.4	-8876.9	-7.0	3	BEARISH	-46.1
RTGN RetinalGenix Technologies Inc.	$80M	-36.0	90.4	-10.3	—	-100.0	4	BEARISH	12.7
RTGN RetinalGenix Technologies Inc.	$80M	-36.0	90.4	-10.3	—	-100.0	4	BEARISH	12.7
ACET Adicet Bio, Inc.	$60M	-0.6	-78.1	-553.5	—	—	4	BEARISH	-50.6
ACET Adicet Bio, Inc.	$60M	-0.6	-78.1	-553.5	—	—	4	BEARISH	-50.6
SER Serina Therapeutics, Inc.	$30M	-1.0	-206.3	1868.6	—	-100.0	3	BEARISH	-62.7
SER Serina Therapeutics, Inc.	$30M	-1.0	-206.3	1868.6	—	-100.0	3	BEARISH	-62.7
BFRI Biofrontera Inc.	$10M	-1.7	-988.4	-39.2	-5.0	17.8	4	BEARISH	-1.0
BFRI Biofrontera Inc.	$10M	-1.7	-988.4	-39.2	-5.0	17.8	4	BEARISH	-1.0
PRMD PrimeMD Inc	—	0.0	42.8	34.3	159.9	—	3	BEARISH	200.0
PRMD PrimeMD Inc	—	0.0	42.8	34.3	159.9	—	3	BEARISH	200.0
XTLB XTL Biopharmaceuticals Ltd.	—	-1.0	-26.8	-38.7	-88.2	—	3	BEARISH	87.8
XTLB XTL Biopharmaceuticals Ltd.	—	-1.0	-26.8	-38.7	-88.2	—	3	BEARISH	87.8
CYDX CYduct Diagnostics, Inc.	—	-11.1	15.8	13.7	-394.2	-16.3	3	BEARISH	112.9
CYDX CYduct Diagnostics, Inc.	—	-11.1	15.8	13.7	-394.2	-16.3	3	BEARISH	112.9
CDT CDT Equity Inc.	—	-0.0	13.1	5.4	9.1	—	7	BEARISH	-82.2
CDT CDT Equity Inc.	—	-0.0	13.1	5.4	9.1	—	7	BEARISH	-82.2
HXBM Helix BioMedix, Inc.	—	—	—	—	—	—	—	BEARISH	-6.0
HXBM Helix BioMedix, Inc.	—	—	—	—	—	—	—	BEARISH	-6.0
ALUR Allurion Technologies Inc.	—	-0.0	45.2	39.3	-206.8	-55.5	3	BEARISH	-80.2
ALUR Allurion Technologies Inc.	—	-0.0	45.2	39.3	-206.8	-55.5	3	BEARISH	-80.2
VIBEF Vibe Growth Corporation	—	-0.1	40.9	-1.4	-8.6	24.4	6	BEARISH	486.7
VIBEF Vibe Growth Corporation	—	-0.1	40.9	-1.4	-8.6	24.4	6	BEARISH	486.7
BRVE Braveheart Bio, Inc.	$1.5B	—	—	—	—	—	—	BEARISH	—
BRVE Braveheart Bio, Inc.	$1.5B	—	—	—	—	—	—	BEARISH	—
APMD Apnimed, Inc.	$860M	—	—	—	—	—	—	BEARISH	—
APMD Apnimed, Inc.	$860M	—	—	—	—	—	—	BEARISH	—
GENSF Genus plc	$1.9B	5.0	45.8	14.4	80.4	28.9	7	BEARISH	-17.7
GENSF Genus plc	$1.9B	5.0	45.8	14.4	80.4	28.9	7	BEARISH	-17.7
ADDLF AddLife AB (publ)	$1.9B	34.7	11.4	7.4	4.8	2.5	7	BEARISH	-62.5
ADDLF AddLife AB (publ)	$1.9B	34.7	11.4	7.4	4.8	2.5	7	BEARISH	-62.5
ALHC Alignment Healthcare, Inc.	$1.6B	39.8	20.0	-54.4	2.7	37.2	8	BEARISH	-52.8
ALHC Alignment Healthcare, Inc.	$1.6B	39.8	20.0	-54.4	2.7	37.2	8	BEARISH	-52.8
MCRPF MicroPort Scientific Corp.	$1.6B	31.2	-19.0	-7.8	21.3	13.2	4	BEARISH	-54.0
MCRPF MicroPort Scientific Corp.	$1.6B	31.2	-19.0	-7.8	21.3	13.2	4	BEARISH	-54.0
VIMGF Vimian Group AB (publ)	$1.5B	44.8	5.2	5.9	6.9	10.8	6	BEARISH	-8.0
VIMGF Vimian Group AB (publ)	$1.5B	44.8	5.2	5.9	6.9	10.8	6	BEARISH	-8.0
COAG Hemab Therapeutics Holdings, Inc. Common Stock	$1.4B	—	—	—	—	—	—	BEARISH	—
COAG Hemab Therapeutics Holdings, Inc. Common Stock	$1.4B	—	—	—	—	—	—	BEARISH	—
LWSCF Sienna Senior Living Inc.	$1.4B	38.5	6.7	3.9	4.4	16.2	7	BEARISH	4.2
LWSCF Sienna Senior Living Inc.	$1.4B	38.5	6.7	3.9	4.4	16.2	7	BEARISH	4.2
KLRA Kailera Therapeutics, Inc.	$1.4B	—	—	—	—	—	—	BEARISH	—
KLRA Kailera Therapeutics, Inc.	$1.4B	—	—	—	—	—	—	BEARISH	—
KARD Kardigan, Inc.	$1.3B	—	—	—	—	—	—	BEARISH	—
KARD Kardigan, Inc.	$1.3B	—	—	—	—	—	—	BEARISH	—
VTRLY Vitrolife AB (publ)	$1.3B	-2.5	-46.5	-42.3	15.1	-4.6	6	BEARISH	-36.7
VTRLY Vitrolife AB (publ)	$1.3B	-2.5	-46.5	-42.3	15.1	-4.6	6	BEARISH	-36.7
AVLN Avalyn Pharma Inc. Common Stock	$1.2B	—	—	—	—	—	—	BEARISH	—
AVLN Avalyn Pharma Inc. Common Stock	$1.2B	—	—	—	—	—	—	BEARISH	—
RYHTY Ryman Healthcare Limited	$1.2B	-11.0	-14.4	-0.6	-30.8	24.7	4	BEARISH	-14.1
RYHTY Ryman Healthcare Limited	$1.2B	-11.0	-14.4	-0.6	-30.8	24.7	4	BEARISH	-14.1
TTALF Terveystalo Oyj	$1.1B	13.7	12.6	7.6	4.7	-7.9	4	BEARISH	-30.9
TTALF Terveystalo Oyj	$1.1B	13.7	12.6	7.6	4.7	-7.9	4	BEARISH	-30.9
SHPHF Sihuan Pharmaceutical Holdings Group Ltd.	$1.1B	18.4	4.2	-0.8	19.4	33.4	7	BEARISH	21.7
SHPHF Sihuan Pharmaceutical Holdings Group Ltd.	$1.1B	18.4	4.2	-0.8	19.4	33.4	7	BEARISH	21.7
CMOPF Cosmo Pharmaceuticals N.V.	$1.1B	-148.1	9.2	10.2	-9.5	-1.7	3	BEARISH	-22.4
CMOPF Cosmo Pharmaceuticals N.V.	$1.1B	-148.1	9.2	10.2	-9.5	-1.7	3	BEARISH	-22.4
LMRI Lumexa Imaging Holdings, Inc. Common Stock	$990M	-27.5	-3.9	0.1	1.0	—	3	BEARISH	—
LMRI Lumexa Imaging Holdings, Inc. Common Stock	$990M	-27.5	-3.9	0.1	1.0	—	3	BEARISH	—
SPTX Seaport Therapeutics, Inc. Common Stock	$990M	—	—	—	—	—	—	BEARISH	—
SPTX Seaport Therapeutics, Inc. Common Stock	$990M	—	—	—	—	—	—	BEARISH	—
MLTX MoonLake Immunotherapeutics	$960M	-3.0	-67.4	2902.7	—	—	1	BEARISH	61.6
MLTX MoonLake Immunotherapeutics	$960M	-3.0	-67.4	2902.7	—	—	1	BEARISH	61.6
CHIZF China Traditional Chinese Medicine Holdings Co. Limited	$820M	-5.1	-5.9	-0.3	-14.3	-30.1	5	BEARISH	-40.7
CHIZF China Traditional Chinese Medicine Holdings Co. Limited	$820M	-5.1	-5.9	-0.3	-14.3	-30.1	5	BEARISH	-40.7
AHCO AdaptHealth Corp.	$760M	-3.3	-15.5	-0.2	-18.1	22.9	6	BEARISH	-38.5
AHCO AdaptHealth Corp.	$760M	-3.3	-15.5	-0.2	-18.1	22.9	6	BEARISH	-38.5
WVE Wave Life Sciences Ltd.	$740M	-3.5	-68.3	-2645.3	-3052.6	-30.4	5	BEARISH	-46.2
WVE Wave Life Sciences Ltd.	$740M	-3.5	-68.3	-2645.3	-3052.6	-30.4	5	BEARISH	-46.2
FTH Faeth Therapeutics, Inc.	$730M	—	—	—	—	—	—	BEARISH	—
FTH Faeth Therapeutics, Inc.	$730M	—	—	—	—	—	—	BEARISH	—
GMRS GMR Solutions Inc.	$530M	—	—	—	—	—	—	BEARISH	—
GMRS GMR Solutions Inc.	$530M	—	—	—	—	—	—	BEARISH	—
TCMD Tactile Systems Technology, Inc.	$500M	20.3	11.9	13.8	9.1	17.2	8	BEARISH	59.8
TCMD Tactile Systems Technology, Inc.	$500M	20.3	11.9	13.8	9.1	17.2	8	BEARISH	59.8
DRUG Bright Minds Biosciences Inc.	$500M	-24.3	-13.7	-105758.3	—	—	3	BEARISH	-12.5
DRUG Bright Minds Biosciences Inc.	$500M	-24.3	-13.7	-105758.3	—	—	3	BEARISH	-12.5
OCS Oculis Holding AG	$500M	-5.2	-44.0	-31.0	—	-6.9	3	BEARISH	-49.8
OCS Oculis Holding AG	$500M	-5.2	-44.0	-31.0	—	-6.9	3	BEARISH	-49.8
KSRBF Kossan Rubber Industries Bhd	$480M	15.4	5.0	8.5	11.3	1.0	5	BEARISH	-43.2
KSRBF Kossan Rubber Industries Bhd	$480M	15.4	5.0	8.5	11.3	1.0	5	BEARISH	-43.2
PRTA Prothena Corporation plc	$440M	-10.1	-14.4	-871.5	-1839.9	427.3	5	BEARISH	-15.7
PRTA Prothena Corporation plc	$440M	-10.1	-14.4	-871.5	-1839.9	427.3	5	BEARISH	-15.7
MPLT MapLight Therapeutics, Inc.	$420M	-1.9	-57.5	-366.6	—	—	2	BEARISH	—
MPLT MapLight Therapeutics, Inc.	$420M	-1.9	-57.5	-366.6	—	—	2	BEARISH	—
ZURA Zura Bio Limited	$390M	-3.6	-54.3	910.3	—	—	2	BEARISH	1.7
ZURA Zura Bio Limited	$390M	-3.6	-54.3	910.3	—	—	2	BEARISH	1.7
CABA Cabaletta Bio, Inc.	$330M	-1.3	-93.2	-1308.0	—	—	3	BEARISH	-13.4
CABA Cabaletta Bio, Inc.	$330M	-1.3	-93.2	-1308.0	—	—	3	BEARISH	-13.4
BBOT BridgeBio Oncology Therapeutics Inc.	$310M	-0.0	-56.4	-157.3	—	—	1	BEARISH	-67.7
BBOT BridgeBio Oncology Therapeutics Inc.	$310M	-0.0	-56.4	-157.3	—	—	1	BEARISH	-67.7
FULC Fulcrum Therapeutics, Inc.	$280M	-3.0	-32.4	2389.1	—	—	4	BEARISH	-60.5
FULC Fulcrum Therapeutics, Inc.	$280M	-3.0	-32.4	2389.1	—	—	4	BEARISH	-60.5
SABS SAB Biotherapeutics, Inc.	$270M	0.8	-11.3	-48.4	—	-100.0	3	BEARISH	50.5
SABS SAB Biotherapeutics, Inc.	$270M	0.8	-11.3	-48.4	—	-100.0	3	BEARISH	50.5
PALI Palisade Bio, Inc.	$250M	-2.7	-51.4	815.6	-2114.8	—	5	BEARISH	9.9
PALI Palisade Bio, Inc.	$250M	-2.7	-51.4	815.6	-2114.8	—	5	BEARISH	9.9
NWBO Northwest Biotherapeutics, Inc.	$250M	-6.0	55.8	-188.7	-1142.6	98.6	3	BEARISH	-39.7
NWBO Northwest Biotherapeutics, Inc.	$250M	-6.0	55.8	-188.7	-1142.6	98.6	3	BEARISH	-39.7
HLOSF Healios K.K.	$240M	57.9	3.7	-129.2	17028.6	-47.1	4	BEARISH	-56.6
HLOSF Healios K.K.	$240M	57.9	3.7	-129.2	17028.6	-47.1	4	BEARISH	-56.6
AKBA Akebia Therapeutics, Inc.	$230M	-8.0	-109.4	15.6	-18.1	7.5	6	BEARISH	-67.7
AKBA Akebia Therapeutics, Inc.	$230M	-8.0	-109.4	15.6	-18.1	7.5	6	BEARISH	-67.7
NAGE Niagen Bioscience Inc	$220M	14.4	21.8	44.7	3.2	11.0	6	BEARISH	-64.6
NAGE Niagen Bioscience Inc	$220M	14.4	21.8	44.7	3.2	11.0	6	BEARISH	-64.6
YARW Yarrow Bioscience Inc	$210M	—	—	—	—	—	—	BEARISH	—
YARW Yarrow Bioscience Inc	$210M	—	—	—	—	—	—	BEARISH	—
NBP NovaBridge Biosciences	$160M	-2.4	-45.7	-617.8	—	—	1	BEARISH	-64.8
NBP NovaBridge Biosciences	$160M	-2.4	-45.7	-617.8	—	—	1	BEARISH	-64.8
VRXA Veraxa Biotech Holding AG	$160M	—	—	—	—	—	—	BEARISH	—
VRXA Veraxa Biotech Holding AG	$160M	—	—	—	—	—	—	BEARISH	—
IMRX Immuneering Corporation	$150M	-3.9	-52.1	-112.8	—	—	4	BEARISH	-36.0
IMRX Immuneering Corporation	$150M	-3.9	-52.1	-112.8	—	—	4	BEARISH	-36.0
CMPX Compass Therapeutics, Inc.	$150M	-2.1	-56.7	1526.3	—	—	4	BEARISH	-74.5
CMPX Compass Therapeutics, Inc.	$150M	-2.1	-56.7	1526.3	—	—	4	BEARISH	-74.5
TNXP Tonix Pharmaceuticals Holding Corp.	$140M	-0.7	-81.8	-276.2	-299.4	196.0	3	BEARISH	-62.8
TNXP Tonix Pharmaceuticals Holding Corp.	$140M	-0.7	-81.8	-276.2	-299.4	196.0	3	BEARISH	-62.8
CLLS Cellectis S.A.	$140M	-2.2	-94.6	118.6	-417.3	0.5	2	BEARISH	-56.5
CLLS Cellectis S.A.	$140M	-2.2	-94.6	118.6	-417.3	0.5	2	BEARISH	-56.5
ONVVF Oneview Healthcare PLC	$120M	-7.5	-404.0	-6454.4	-100.1	40.0	4	BEARISH	-6.2
ONVVF Oneview Healthcare PLC	$120M	-7.5	-404.0	-6454.4	-100.1	40.0	4	BEARISH	-6.2
AIRS AirSculpt Technologies, Inc.	$120M	-9.7	-12.0	-6.0	-2.6	-8.7	5	BEARISH	-78.2
AIRS AirSculpt Technologies, Inc.	$120M	-9.7	-12.0	-6.0	-2.6	-8.7	5	BEARISH	-78.2
ORPOF OSE Immunotherapeutics S.A.	$100M	—	—	—	—	—	—	BEARISH	—
ORPOF OSE Immunotherapeutics S.A.	$100M	—	—	—	—	—	—	BEARISH	—
MIST Milestone Pharmaceuticals Inc.	$100M	-1.2	-35522.6	587.8	-5118.8	—	5	BEARISH	-52.1
MIST Milestone Pharmaceuticals Inc.	$100M	-1.2	-35522.6	587.8	-5118.8	—	5	BEARISH	-52.1
HUMA Humacyte, Inc.	$90M	-1.0	-547.9	-500.7	-9064.5	-73.6	3	BEARISH	-70.4
HUMA Humacyte, Inc.	$90M	-1.0	-547.9	-500.7	-9064.5	-73.6	3	BEARISH	-70.4
ABSCF AB Science S.A.	$80M	-13.8	49.2	32.6	549.3	16.5	5	BEARISH	-11.1
ABSCF AB Science S.A.	$80M	-13.8	49.2	32.6	549.3	16.5	5	BEARISH	-11.1
JWCTF JW (Cayman) Therapeutics Co. Ltd	$80M	-2.9	-98.4	-35.5	-45.3	36.2	4	BEARISH	-58.9
JWCTF JW (Cayman) Therapeutics Co. Ltd	$80M	-2.9	-98.4	-35.5	-45.3	36.2	4	BEARISH	-58.9
INO Inovio Pharmaceuticals, Inc.	$80M	-1.0	-409.9	257.7	—	-100.0	1	BEARISH	-51.0
INO Inovio Pharmaceuticals, Inc.	$80M	-1.0	-409.9	257.7	—	-100.0	1	BEARISH	-51.0
LNSR LENSAR Inc	$80M	5.3	1231.0	-218.4	21.4	3.3	5	BEARISH	-45.0
LNSR LENSAR Inc	$80M	5.3	1231.0	-218.4	21.4	3.3	5	BEARISH	-45.0
THOXF BioPorto A/S	$70M	81.2	12.3	43.6	520.6	3.4	4	BEARISH	-48.3
THOXF BioPorto A/S	$70M	81.2	12.3	43.6	520.6	3.4	4	BEARISH	-48.3
GANX Gain Therapeutics, Inc.	$70M	-3.4	-268.3	1288.8	—	—	4	BEARISH	-6.0
GANX Gain Therapeutics, Inc.	$70M	-3.4	-268.3	1288.8	—	—	4	BEARISH	-6.0
RECEF Recce Pharmaceuticals Ltd	$70M	-6.3	277.4	402.1	—	11.3	2	BEARISH	-63.3
RECEF Recce Pharmaceuticals Ltd	$70M	-6.3	277.4	402.1	—	11.3	2	BEARISH	-63.3
MAIA MAIA Biotechnology, Inc.	$70M	-1.9	-218.7	330.4	—	—	3	BEARISH	-28.3
MAIA MAIA Biotechnology, Inc.	$70M	-1.9	-218.7	330.4	—	—	3	BEARISH	-28.3
KLRS Kalaris Therapeutics Inc	$60M	-1.3	-79.9	109.5	—	—	0	BEARISH	-55.5
KLRS Kalaris Therapeutics Inc	$60M	-1.3	-79.9	109.5	—	—	0	BEARISH	-55.5
IMA ImageneBio Inc	$50M	-0.9	-40.7	-594.7	—	—	3	BEARISH	-46.0
IMA ImageneBio Inc	$50M	-0.9	-40.7	-594.7	—	—	3	BEARISH	-46.0
ORXOF Orexo AB (publ)	$50M	-1.5	-578.7	-5591.3	-2868.6	-78.2	4	BEARISH	-43.5
ORXOF Orexo AB (publ)	$50M	-1.5	-578.7	-5591.3	-2868.6	-78.2	4	BEARISH	-43.5
BSEM BioStem Technologies, Inc.	$50M	-1.6	-74.7	-84.3	-113.6	-119.6	2	BEARISH	-45.3
BSEM BioStem Technologies, Inc.	$50M	-1.6	-74.7	-84.3	-113.6	-119.6	2	BEARISH	-45.3
DWTX Dogwood Therapeutics, Inc.	$50M	-0.2	-47.8	-39.7	—	—	2	BEARISH	-79.3
DWTX Dogwood Therapeutics, Inc.	$50M	-0.2	-47.8	-39.7	—	—	2	BEARISH	-79.3
RPID Rapid Micro Biosystems, Inc.	$40M	-0.8	-141.6	-183.2	-160.5	16.1	2	BEARISH	-73.4
RPID Rapid Micro Biosystems, Inc.	$40M	-0.8	-141.6	-183.2	-160.5	16.1	2	BEARISH	-73.4
MYCOF Noveris Health Sciences Inc.	$40M	-6.6	22.3	49.3	—	—	5	BEARISH	12066.7
MYCOF Noveris Health Sciences Inc.	$40M	-6.6	22.3	49.3	—	—	5	BEARISH	12066.7
SYMQY SymBio Pharmaceuticals Limited	$30M	-0.6	-334.3	639.4	-515.2	-54.2	1	BEARISH	-41.5
SYMQY SymBio Pharmaceuticals Limited	$30M	-0.6	-334.3	639.4	-515.2	-54.2	1	BEARISH	-41.5
GRCE Grace Therapeutics, Inc.	$30M	-1.6	-13.8	-21.9	—	—	1	BEARISH	-32.6
GRCE Grace Therapeutics, Inc.	$30M	-1.6	-13.8	-21.9	—	—	1	BEARISH	-32.6
ESLA Estrella Immunopharma, Inc.	$20M	-1.9	148.1	102.1	—	—	3	BEARISH	-65.1
ESLA Estrella Immunopharma, Inc.	$20M	-1.9	148.1	102.1	—	—	3	BEARISH	-65.1
DTCFF Defence Therapeutics Inc.	$20M	-3.5	-237.8	-86.8	—	—	4	BEARISH	-45.0
DTCFF Defence Therapeutics Inc.	$20M	-3.5	-237.8	-86.8	—	—	4	BEARISH	-45.0
PYNKF Perimeter Medical Imaging AI, Inc.	$20M	-2.1	-234.4	-475.2	-504.1	36.6	3	BEARISH	12.8
MRKR Marker Therapeutics, Inc.	$20M	-2.2	-76.9	-1014.3	—	-77.1	2	BEARISH	15.6
MRKR Marker Therapeutics, Inc.	$20M	-2.2	-76.9	-1014.3	—	-77.1	2	BEARISH	15.6
MODD Modular Medical, Inc.	$20M	-0.2	-188.1	-339.7	—	—	2	BEARISH	-90.3
PYNKF Perimeter Medical Imaging AI, Inc.	$20M	-2.1	-234.4	-475.2	-504.1	36.6	3	BEARISH	12.8
MODD Modular Medical, Inc.	$20M	-0.2	-188.1	-339.7	—	—	2	BEARISH	-90.3
CRVW CareView Communications, Inc.	$20M	-6.4	6.4	-1.4	-10.0	8.5	7	BEARISH	71.0
CRVW CareView Communications, Inc.	$20M	-6.4	6.4	-1.4	-10.0	8.5	7	BEARISH	71.0
NXTC NextCure, Inc.	$20M	-0.5	-195.2	949.7	—	—	2	BEARISH	-10.5
NXTC NextCure, Inc.	$20M	-0.5	-195.2	949.7	—	—	2	BEARISH	-10.5
CKDXF Ceryvyn Therapeutics Limited	$10M	0.2	-234.2	64023.3	—	-92.0	4	BEARISH	-97.7
CKDXF Ceryvyn Therapeutics Limited	$10M	0.2	-234.2	64023.3	—	-92.0	4	BEARISH	-97.7
LGVN Longeveron Inc.	$10M	-0.3	-203.6	-2062.6	-2116.0	-42.7	4	BEARISH	-65.2
LGVN Longeveron Inc.	$10M	-0.3	-203.6	-2062.6	-2116.0	-42.7	4	BEARISH	-65.2
MDXHF MedX Health Corp	$10M	-1.9	63.5	166.6	-1353.4	19.2	3	BEARISH	-49.0
NMTC NeuroOne Medical Technologies Corporation	$10M	-1.2	-119.7	-335.0	-101.7	50.8	5	BEARISH	29.3
NMTC NeuroOne Medical Technologies Corporation	$10M	-1.2	-119.7	-335.0	-101.7	50.8	5	BEARISH	29.3
IUGNF Imugene Limited	$10M	-0.1	-273.9	-901.2	—	-73.7	1	BEARISH	-87.2
MDXHF MedX Health Corp	$10M	-1.9	63.5	166.6	-1353.4	19.2	3	BEARISH	-49.0
XCUR Exicure, Inc.	$10M	-0.9	-168.4	779.8	—	—	2	BEARISH	-72.0
XCUR Exicure, Inc.	$10M	-0.9	-168.4	779.8	—	—	2	BEARISH	-72.0
IUGNF Imugene Limited	$10M	-0.1	-273.9	-901.2	—	-73.7	1	BEARISH	-87.2
LNAI Lunai Bioworks Inc.	$10M	-0.0	-21.6	30.2	—	—	2	BEARISH	-87.0
VRCDF Verici Dx plc	$10M	-0.6	-252.0	-302.5	-219.5	1257.8	5	BEARISH	-60.5
VRCDF Verici Dx plc	$10M	-0.6	-252.0	-302.5	-219.5	1257.8	5	BEARISH	-60.5
LNAI Lunai Bioworks Inc.	$10M	-0.0	-21.6	30.2	—	—	2	BEARISH	-87.0
INBS Intelligent Bio Solutions Inc.	$10M	-0.2	-292.3	-304.3	-341.0	38.1	4	BEARISH	-84.0
INBS Intelligent Bio Solutions Inc.	$10M	-0.2	-292.3	-304.3	-341.0	38.1	4	BEARISH	-84.0
QNRX Quoin Pharmaceuticals, Ltd.	$10M	-0.3	-578.6	221.3	—	—	1	BEARISH	-38.2
QNRX Quoin Pharmaceuticals, Ltd.	$10M	-0.3	-578.6	221.3	—	—	1	BEARISH	-38.2
CNSY Cerenome, Inc.	$10M	—	—	—	—	—	—	BEARISH	—
CNSY Cerenome, Inc.	$10M	—	—	—	—	—	—	BEARISH	—
FEMY Femasys Inc.	$10M	-0.4	-443.7	-188.1	-1346.8	21.9	5	BEARISH	-72.3
FEMY Femasys Inc.	$10M	-0.4	-443.7	-188.1	-1346.8	21.9	5	BEARISH	-72.3
BLRX BioLineRx Ltd.	$10M	-1.4	-63.5	-113.0	-1029.3	-94.3	3	BEARISH	-38.8
BLRX BioLineRx Ltd.	$10M	-1.4	-63.5	-113.0	-1029.3	-94.3	3	BEARISH	-38.8
LFWD Lifeward Ltd.	$10M	-0.3	-225.6	-129.9	-173.9	-10.7	4	BEARISH	-31.3
PDRX PD-Rx Pharmaceuticals, Inc.	$10M	—	—	—	—	—	—	BEARISH	8.8
PDRX PD-Rx Pharmaceuticals, Inc.	$10M	—	—	—	—	—	—	BEARISH	8.8
ENLV Enlivex Therapeutics Ltd.	$10M	0.0	209.7	-0.4	—	—	5	BEARISH	-97.4
ENLV Enlivex Therapeutics Ltd.	$10M	0.0	209.7	-0.4	—	—	5	BEARISH	-97.4
CTSO Cytosorbents Corporation	$10M	-0.7	-336.2	-46.3	-45.9	3.1	4	BEARISH	-79.4
CTSO Cytosorbents Corporation	$10M	-0.7	-336.2	-46.3	-45.9	3.1	4	BEARISH	-79.4
LFWD Lifeward Ltd.	$10M	-0.3	-225.6	-129.9	-173.9	-10.7	4	BEARISH	-31.3
PLUR Pluri Inc.	$10M	-0.4	163.6	-483.9	-1755.2	-24.0	2	BEARISH	-76.8
PLUR Pluri Inc.	$10M	-0.4	163.6	-483.9	-1755.2	-24.0	2	BEARISH	-76.8
PXXLF Poxel S.A.	$10M	-0.4	222.8	275.8	-624.6	-73.2	2	BEARISH	-12.0
PXXLF Poxel S.A.	$10M	-0.4	222.8	275.8	-624.6	-73.2	2	BEARISH	-12.0
ZEOX Zeo ScientifiX, Inc.	$10M	-2.2	-140.0	105.8	-5.6	—	2	BEARISH	—
ZEOX Zeo ScientifiX, Inc.	$10M	-2.2	-140.0	105.8	-5.6	—	2	BEARISH	—
INTS Intensity Therapeutics, Inc.	$10M	-0.7	-195.9	4123.4	—	—	5	BEARISH	-46.6
INTS Intensity Therapeutics, Inc.	$10M	-0.7	-195.9	4123.4	—	—	5	BEARISH	-46.6
CALC CalciMedica, Inc.	$10M	-0.2	-365.7	118.3	—	—	4	BEARISH	-89.5
CALC CalciMedica, Inc.	$10M	-0.2	-365.7	118.3	—	—	4	BEARISH	-89.5
OPTBF OptiBiotix Health PLC	$10M	-1.4	-102.1	-102.1	-231.5	-12.9	4	BEARISH	109900.0
OPTBF OptiBiotix Health PLC	$10M	-1.4	-102.1	-102.1	-231.5	-12.9	4	BEARISH	109900.0
GSGTF GenSight Biologics S.A.	$10M	-1.1	104.0	107.2	848.8	-139.6	2	BEARISH	-57.9
GSGTF GenSight Biologics S.A.	$10M	-1.1	104.0	107.2	848.8	-139.6	2	BEARISH	-57.9
SUVZ Suvanza Pharma, LLC	—	—	—	—	—	—	—	BEARISH	0.0
SUVZ Suvanza Pharma, LLC	—	—	—	—	—	—	—	BEARISH	0.0
IHGP Jun An Kang Group Inc.	—	2.0	0.5	0.5	1.0	64.0	6	BEARISH	-98.2
IHGP Jun An Kang Group Inc.	—	2.0	0.5	0.5	1.0	64.0	6	BEARISH	-98.2
VSBC VitaSpring Biomedical Co. Ltd.	—	-4.8	35.7	8.9	—	-100.0	3	BEARISH	-98.9
VSBC VitaSpring Biomedical Co. Ltd.	—	-4.8	35.7	8.9	—	-100.0	3	BEARISH	-98.9
PXMD PaxMedica, Inc. Common Stock	—	-0.0	-7716.2	572.1	—	—	2	BEARISH	400.0
PXMD PaxMedica, Inc. Common Stock	—	-0.0	-7716.2	572.1	—	—	2	BEARISH	400.0
OWPC One World Products, Inc.	—	0.0	-124.8	-16.4	10538.7	1987.1	5	BEARISH	-99.6
OWPC One World Products, Inc.	—	0.0	-124.8	-16.4	10538.7	1987.1	5	BEARISH	-99.6
ICCO InterCare DX, Inc.	—	-0.0	16.1	3053.3	—	—	5	BEARISH	-98.0
ICCO InterCare DX, Inc.	—	-0.0	16.1	3053.3	—	—	5	BEARISH	-98.0
CBDX Curative Biosciences, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
CBDX Curative Biosciences, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
BKUH Bakhu Holdings, Corp.	—	-0.0	-7.1	-30.3	—	-200.0	3	BEARISH	-95.0
BKUH Bakhu Holdings, Corp.	—	-0.0	-7.1	-30.3	—	-200.0	3	BEARISH	-95.0
ACUS Acusphere, Inc.	—	-0.0	-363.3	-4565.0	-3033.3	-5.2	2	BEARISH	0.0
ACUS Acusphere, Inc.	—	-0.0	-363.3	-4565.0	-3033.3	-5.2	2	BEARISH	0.0
FNAM Evolutionary Genomics, Inc.	—	-0.0	62.2	-99.6	—	—	2	BEARISH	0.0
FNAM Evolutionary Genomics, Inc.	—	-0.0	62.2	-99.6	—	—	2	BEARISH	0.0
KAPA Kairos Pharma, Ltd.	—	-0.8	-114.0	-301.0	—	—	3	BEARISH	-80.3
KAPA Kairos Pharma, Ltd.	—	-0.8	-114.0	-301.0	—	—	3	BEARISH	-80.3
ISHI Islet Holdings, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
ISHI Islet Holdings, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
WOWU WOWI, Inc.	—	0.0	51.5	49.7	-38.1	—	4	BEARISH	-50.0
WOWU WOWI, Inc.	—	0.0	51.5	49.7	-38.1	—	4	BEARISH	-50.0
STMH Stem Holdings, Inc.	—	-0.0	-274.8	873.4	98.5	-100.0	3	BEARISH	-90.0
STMH Stem Holdings, Inc.	—	-0.0	-274.8	873.4	98.5	-100.0	3	BEARISH	-90.0
AJOY Ayujoy Herbals Ltd.	—	-1.0	-54.8	142.7	—	-100.0	3	BEARISH	-70.7
AJOY Ayujoy Herbals Ltd.	—	-1.0	-54.8	142.7	—	-100.0	3	BEARISH	-70.7
AGFAF Digicann Ventures Inc.	—	-0.0	30.8	63.6	—	—	2	BEARISH	-76.8
AGFAF Digicann Ventures Inc.	—	-0.0	30.8	63.6	—	—	2	BEARISH	-76.8
GENX Genex Pharmaceutical, Inc.	—	0.0	7.8	5.1	-8.1	32.8	5	BEARISH	0.0
GENX Genex Pharmaceutical, Inc.	—	0.0	7.8	5.1	-8.1	32.8	5	BEARISH	0.0
MDIT Medite Cancer Diagnostics, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
MDIT Medite Cancer Diagnostics, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
TBIO Telesis Bio, Inc.	—	-0.0	-180.9	-154.3	-424.1	-54.9	3	BEARISH	-99.2
TBIO Telesis Bio, Inc.	—	-0.0	-180.9	-154.3	-424.1	-54.9	3	BEARISH	-99.2
PAIYY Aesthetic Medical International Holdings Group Limited	—	—	—	—	—	—	—	BEARISH	-93.2
PAIYY Aesthetic Medical International Holdings Group Limited	—	—	—	—	—	—	—	BEARISH	-93.2
CPYT CarePayment Technologies, Inc.	—	-0.0	1607.0	-66.2	-585.5	—	2	BEARISH	0.0
CPYT CarePayment Technologies, Inc.	—	-0.0	1607.0	-66.2	-585.5	—	2	BEARISH	0.0
BPTSY Biophytis S.A.	—	-0.0	376.0	1163.5	—	—	2	BEARISH	-87.5
BPTSY Biophytis S.A.	—	-0.0	376.0	1163.5	—	—	2	BEARISH	-87.5
PERCF Percheron Therapeutics Limited	—	—	—	—	—	—	—	BEARISH	—
PERCF Percheron Therapeutics Limited	—	—	—	—	—	—	—	BEARISH	—
ITMC Itoco Inc.	—	-0.0	303.4	96.7	—	—	2	BEARISH	0.0
ITMC Itoco Inc.	—	-0.0	303.4	96.7	—	—	2	BEARISH	0.0
APYI Aspyra Inc.	—	-0.0	-102.5	49.8	-82.7	-15.6	1	BEARISH	0.0
BICTF Biocure Technology Inc.	—	-0.1	-889.9	60.0	—	—	1	BEARISH	0.0
BICTF Biocure Technology Inc.	—	-0.1	-889.9	60.0	—	—	1	BEARISH	0.0
APYI Aspyra Inc.	—	-0.0	-102.5	49.8	-82.7	-15.6	1	BEARISH	0.0
FBLG FibroBiologics, Inc. Common Stock	—	-0.2	-660.1	-511.6	—	—	4	BEARISH	-88.2
FBLG FibroBiologics, Inc. Common Stock	—	-0.2	-660.1	-511.6	—	—	4	BEARISH	-88.2
PMSNF Proteome Sciences plc	—	-2.0	75.0	-73.3	-74.6	-100.0	1	BEARISH	-80.0
PMSNF Proteome Sciences plc	—	-2.0	75.0	-73.3	-74.6	-100.0	1	BEARISH	-80.0
AREVF AREV Life Sciences Global Corp	—	-1.9	23.9	15.1	—	-96.1	2	BEARISH	-95.0
AREVF AREV Life Sciences Global Corp	—	-1.9	23.9	15.1	—	-96.1	2	BEARISH	-95.0
ADGM Adagio Medical Holdings, Inc.	—	-0.1	-657.8	-87.8	—	-100.0	2	BEARISH	-92.3
ADGM Adagio Medical Holdings, Inc.	—	-0.1	-657.8	-87.8	—	-100.0	2	BEARISH	-92.3
IBOGF Universal Ibogaine Inc.	—	-0.5	-94.8	5.5	-9.4	208.2	4	BEARISH	-98.8
IBOGF Universal Ibogaine Inc.	—	-0.5	-94.8	5.5	-9.4	208.2	4	BEARISH	-98.8
HRTT Heart Tronics, Inc.	—	-0.0	-1320.1	-1322.8	—	—	1	BEARISH	0.0
HRTT Heart Tronics, Inc.	—	-0.0	-1320.1	-1322.8	—	—	1	BEARISH	0.0
PPRG Patient Portal Technologies, Inc.	—	-0.0	-4.5	-0.3	-3.5	-23.2	2	BEARISH	0.0
PPRG Patient Portal Technologies, Inc.	—	-0.0	-4.5	-0.3	-3.5	-23.2	2	BEARISH	0.0
AVCRF Avricore Health Inc.	—	-3.4	-131.4	-548.9	-354.9	-93.8	2	BEARISH	-98.3
AVCRF Avricore Health Inc.	—	-3.4	-131.4	-548.9	-354.9	-93.8	2	BEARISH	-98.3
SMAS Somatic Systems, Inc.	—	—	—	—	—	—	—	BEARISH	-99.0
SMAS Somatic Systems, Inc.	—	—	—	—	—	—	—	BEARISH	-99.0
AXRX Amexdrug Corporation	—	—	—	—	—	—	—	BEARISH	0.0
AXRX Amexdrug Corporation	—	—	—	—	—	—	—	BEARISH	0.0
HMGN Hemagen Diagnostics, Inc.	—	-0.0	29.1	-24.6	-18.6	-21.4	2	BEARISH	100.0
HMGN Hemagen Diagnostics, Inc.	—	-0.0	29.1	-24.6	-18.6	-21.4	2	BEARISH	100.0
RPGLF Regent Pacific Group Limited	—	-16.1	119.2	-279.5	10.3	1351.3	6	BEARISH	-94.1
RPGLF Regent Pacific Group Limited	—	-16.1	119.2	-279.5	10.3	1351.3	6	BEARISH	-94.1
USMJ North American Cannabis Holdings, Inc.	—	-3.5	40.1	1.5	—	14.2	2	BEARISH	0.0
USMJ North American Cannabis Holdings, Inc.	—	-3.5	40.1	1.5	—	14.2	2	BEARISH	0.0
RASP Actavia Life Sciences, Inc.	—	-0.1	20.1	14.5	—	—	2	BEARISH	-87.5
RASP Actavia Life Sciences, Inc.	—	-0.1	20.1	14.5	—	—	2	BEARISH	-87.5
ADTX Aditxt, Inc.	—	-0.0	622.6	49.4	-131159.8	-74.1	1	BEARISH	-100.0
ADTX Aditxt, Inc.	—	-0.0	622.6	49.4	-131159.8	-74.1	1	BEARISH	-100.0
TCRT Alaunos Therapeutics, Inc.	—	-0.4	-185.9	-607.2	—	-50.0	1	BEARISH	-66.9
TCRT Alaunos Therapeutics, Inc.	—	-0.4	-185.9	-607.2	—	-50.0	1	BEARISH	-66.9
NUNZ Nunzia Pharmaceutical Company	—	-0.0	69398.6	176728.6	—	—	2	BEARISH	0.0
NUNZ Nunzia Pharmaceutical Company	—	-0.0	69398.6	176728.6	—	—	2	BEARISH	0.0
OVATF Ovation Science Inc.	—	-1.7	44.0	34.6	-690.6	-27.1	3	BEARISH	-70.9
OVATF Ovation Science Inc.	—	-1.7	44.0	34.6	-690.6	-27.1	3	BEARISH	-70.9
RVVQF RavenQuest BioMed Inc.	—	-0.0	-112.5	-40.6	-440.2	93.6	2	BEARISH	0.0
RVVQF RavenQuest BioMed Inc.	—	-0.0	-112.5	-40.6	-440.2	93.6	2	BEARISH	0.0
MCOA Marijuana Company of America, Inc.	—	-0.1	295.5	51.6	—	-72.4	1	BEARISH	0.0
MCOA Marijuana Company of America, Inc.	—	-0.1	295.5	51.6	—	-72.4	1	BEARISH	0.0
PTLF Petlife Pharmaceuticals, Inc.	—	-0.0	257.0	178.4	—	—	2	BEARISH	0.0
PTLF Petlife Pharmaceuticals, Inc.	—	-0.0	257.0	178.4	—	—	2	BEARISH	0.0
BBAL New York Health Care, Inc.	—	-0.0	-9.2	-21.4	-1.7	3.5	6	BEARISH	0.0
BBAL New York Health Care, Inc.	—	-0.0	-9.2	-21.4	-1.7	3.5	6	BEARISH	0.0
TTOO T2 Biosystems, Inc.	—	-0.0	277.6	-638.9	-509.7	-30.2	3	BEARISH	-95.1
TTOO T2 Biosystems, Inc.	—	-0.0	277.6	-638.9	-509.7	-30.2	3	BEARISH	-95.1
PPII Coenzyme-A Inc.	—	—	—	—	—	—	—	BEARISH	0.0
PPII Coenzyme-A Inc.	—	—	—	—	—	—	—	BEARISH	0.0
OJSY OJsys, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
OJSY OJsys, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
BBLG Bone Biologics Corporation	—	-0.3	-55.0	2257.6	—	—	2	BEARISH	-83.0
BBLG Bone Biologics Corporation	—	-0.3	-55.0	2257.6	—	—	2	BEARISH	-83.0
RSHN RushNet, Inc.	—	-1.0	-1202.9	-22.5	—	-43.0	2	BEARISH	-98.0
RSHN RushNet, Inc.	—	-1.0	-1202.9	-22.5	—	-43.0	2	BEARISH	-98.0
SCAL Stem Cell Authority, Ltd.	—	—	—	—	—	—	—	BEARISH	0.0
SCAL Stem Cell Authority, Ltd.	—	—	—	—	—	—	—	BEARISH	0.0
FCGD First Colombia Gold Corp.	—	-95.6	23.1	122.7	—	-93.9	2	BEARISH	0.0
CEVE Ceres Ventures, Inc.	—	-0.0	175.9	280.3	—	—	3	BEARISH	0.0
CEVE Ceres Ventures, Inc.	—	-0.0	175.9	280.3	—	—	3	BEARISH	0.0
FCGD First Colombia Gold Corp.	—	-95.6	23.1	122.7	—	-93.9	2	BEARISH	0.0
RGRX RegeneRx Biopharmaceuticals, Inc.	—	-0.0	53.5	45.8	-2006.3	-0.0	3	BEARISH	450.0
RGRX RegeneRx Biopharmaceuticals, Inc.	—	-0.0	53.5	45.8	-2006.3	-0.0	3	BEARISH	450.0
SRUTF Sproutly Canada Inc.	—	-0.0	7045.7	-519.2	-1194.7	28.2	4	BEARISH	0.0
SRUTF Sproutly Canada Inc.	—	-0.0	7045.7	-519.2	-1194.7	28.2	4	BEARISH	0.0
USPS Ultimate Sports, Inc.	—	-10.6	14.7	11.0	—	—	1	BEARISH	4650.0
USPS Ultimate Sports, Inc.	—	-10.6	14.7	11.0	—	—	1	BEARISH	4650.0
OMHE OMNI Health, Inc.	—	0.0	30.4	-8.8	-6.1	2046.4	4	BEARISH	-95.0
GRCU Global Roundtable Corporation	—	-2.9	28.1	25.5	-673.8	35.7	7	BEARISH	-99.0
GRCU Global Roundtable Corporation	—	-2.9	28.1	25.5	-673.8	35.7	7	BEARISH	-99.0
OMHE OMNI Health, Inc.	—	0.0	30.4	-8.8	-6.1	2046.4	4	BEARISH	-95.0
GRPI Grupo International Inc.	—	—	—	—	—	—	—	BEARISH	0.0
GRPI Grupo International Inc.	—	—	—	—	—	—	—	BEARISH	0.0
OHCS Optimus Healthcare Services, Inc.	—	-0.0	99.2	130.3	-469.4	43.7	4	BEARISH	-98.6
OHCS Optimus Healthcare Services, Inc.	—	-0.0	99.2	130.3	-469.4	43.7	4	BEARISH	-98.6
VIVS VivoSim Labs, Inc.	—	-0.0	1259.6	159.9	-14410.0	—	2	BEARISH	-93.9
VIVS VivoSim Labs, Inc.	—	-0.0	1259.6	159.9	-14410.0	—	2	BEARISH	-93.9
TNGNQ Tengion, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
TNGNQ Tengion, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
TWSI Tristar Wellness Solutions Inc.	—	-2.0	61.9	93.6	-80.6	-29.1	3	BEARISH	-99.6
TWSI Tristar Wellness Solutions Inc.	—	-2.0	61.9	93.6	-80.6	-29.1	3	BEARISH	-99.6
WEQL WellQuest Medical & Wellness Corporation	—	-0.0	16.1	-19.9	-36.3	126.5	3	BEARISH	100.0
WEQL WellQuest Medical & Wellness Corporation	—	-0.0	16.1	-19.9	-36.3	126.5	3	BEARISH	100.0
EVGRF China Evergrande New Energy Vehicle Group Limited	—	-13.0	110.9	47.6	-766929.9	-74.0	2	BEARISH	-71.4
EVGRF China Evergrande New Energy Vehicle Group Limited	—	-13.0	110.9	47.6	-766929.9	-74.0	2	BEARISH	-71.4
TRGM Targeted Medical Pharma, Inc.	—	-0.0	26.6	20.9	-45.1	-26.0	4	BEARISH	-90.0
EXMT Anything Technologies Media, Inc.	—	-7.0	27.0	-24.5	—	-100.0	2	BEARISH	-28.6
EXMT Anything Technologies Media, Inc.	—	-7.0	27.0	-24.5	—	-100.0	2	BEARISH	-28.6
TRGM Targeted Medical Pharma, Inc.	—	-0.0	26.6	20.9	-45.1	-26.0	4	BEARISH	-90.0
WOK WORK Medical Technology Group Ltd. Class A	—	-0.0	-27.2	-22.6	-63.0	—	2	BEARISH	-78.1
WOK WORK Medical Technology Group Ltd. Class A	—	-0.0	-27.2	-22.6	-63.0	—	2	BEARISH	-78.1
NEUN Neurogenesis, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
NEUN Neurogenesis, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
DROR Dror Ortho-Design, Inc.	—	-0.0	15.8	36.4	—	—	1	BEARISH	—
DROR Dror Ortho-Design, Inc.	—	-0.0	15.8	36.4	—	—	1	BEARISH	—
VPRO Viropro Inc.	—	-0.0	-19.7	-4.8	-269.7	155.0	2	BEARISH	0.0
VPRO Viropro Inc.	—	-0.0	-19.7	-4.8	-269.7	155.0	2	BEARISH	0.0
EAPH Parallel Industries Inc.	—	-0.2	26.8	19.0	—	0.0	4	BEARISH	-90.0
EAPH Parallel Industries Inc.	—	-0.2	26.8	19.0	—	0.0	4	BEARISH	-90.0
DRMA Dermata Therapeutics, Inc.	—	-0.3	-183.9	734.5	—	—	2	BEARISH	-78.4
DRMA Dermata Therapeutics, Inc.	—	-0.3	-183.9	734.5	—	—	2	BEARISH	-78.4
REFG Medical Cannabis Payment Solutions	—	-3.0	1.2	1.5	—	—	2	BEARISH	0.0
REFG Medical Cannabis Payment Solutions	—	-3.0	1.2	1.5	—	—	2	BEARISH	0.0
ONCSQ OncoSec Medical Incorporated	—	-0.0	-410.2	452.1	—	—	2	BEARISH	-90.0
ONCSQ OncoSec Medical Incorporated	—	-0.0	-410.2	452.1	—	—	2	BEARISH	-90.0
AMHD HLK Biotech Holding Group, Inc.	—	—	—	—	—	—	—	BEARISH	-0.0
AMHD HLK Biotech Holding Group, Inc.	—	—	—	—	—	—	—	BEARISH	-0.0
XTXXF Adastra Holdings Ltd.	—	-0.7	-227.3	-93.3	-9.6	-33.9	2	BEARISH	-44.9
XTXXF Adastra Holdings Ltd.	—	-0.7	-227.3	-93.3	-9.6	-33.9	2	BEARISH	-44.9
ENZC Enzolytics Inc.	—	-9.3	105.9	1.4	—	—	7	BEARISH	100.0
ENZC Enzolytics Inc.	—	-9.3	105.9	1.4	—	—	7	BEARISH	100.0
FWDG FutureWorld Corp.	—	-0.1	-1.2	-0.5	-507.1	153.6	5	BEARISH	0.0
FWDG FutureWorld Corp.	—	-0.1	-1.2	-0.5	-507.1	153.6	5	BEARISH	0.0
WSNAF Wesana Health Holdings Inc.	—	-0.1	1113.6	90.8	—	—	3	BEARISH	-87.1
WSNAF Wesana Health Holdings Inc.	—	-0.1	1113.6	90.8	—	—	3	BEARISH	-87.1
LEXX Lexaria Bioscience Corp.	—	-0.5	-150.3	-504.2	—	-68.5	4	BEARISH	-80.9
LEXX Lexaria Bioscience Corp.	—	-0.5	-150.3	-504.2	—	-68.5	4	BEARISH	-80.9
VRXAW Veraxa Biotech AG	—	—	—	—	—	—	—	BEARISH	—
ETAOF Etao International Co., Ltd.	—	-0.0	-1369.5	4843.5	-1544.0	—	5	BEARISH	-66.7
ETAOF Etao International Co., Ltd.	—	-0.0	-1369.5	4843.5	-1544.0	—	5	BEARISH	-66.7
VRXAW Veraxa Biotech AG	—	—	—	—	—	—	—	BEARISH	—
EKGGF CardioComm Solutions, Inc.	—	-4.2	92.7	515.6	-152.3	-41.9	2	BEARISH	150.0
EKGGF CardioComm Solutions, Inc.	—	-4.2	92.7	515.6	-152.3	-41.9	2	BEARISH	150.0
PCSA Processa Pharmaceuticals, Inc.	—	-0.3	-464.2	1977.5	—	—	2	BEARISH	-67.5
PCSA Processa Pharmaceuticals, Inc.	—	-0.3	-464.2	1977.5	—	—	2	BEARISH	-67.5
IMMVF Immunovia AB	—	-0.5	-425.5	808.2	-5991.9	31.4	3	BEARISH	-80.8
IMMVF Immunovia AB	—	-0.5	-425.5	808.2	-5991.9	31.4	3	BEARISH	-80.8
NGMDF NuGen Medical Devices Inc.	—	-0.3	81.2	-448.2	-19565.6	-86.3	2	BEARISH	-76.2
MSTH Mystic Holdings, Inc.	—	-0.0	-35.2	-19.8	-27.1	24.7	5	BEARISH	-97.7
MSTH Mystic Holdings, Inc.	—	-0.0	-35.2	-19.8	-27.1	24.7	5	BEARISH	-97.7
NGMDF NuGen Medical Devices Inc.	—	-0.3	81.2	-448.2	-19565.6	-86.3	2	BEARISH	-76.2
AIDX 20/20 Biolabs Inc.	—	—	—	—	—	—	—	BEARISH	—
AIDX 20/20 Biolabs Inc.	—	—	—	—	—	—	—	BEARISH	—
ICCM IceCure Medical Ltd	—	-0.2	-228.3	36140.9	-496.3	41.6	7	BEARISH	-94.7
ICCM IceCure Medical Ltd	—	-0.2	-228.3	36140.9	-496.3	41.6	7	BEARISH	-94.7
LUDG Ludwig Enterprises, Inc.	—	-0.4	43.5	103.5	—	100.0	4	BEARISH	-94.3
LUDG Ludwig Enterprises, Inc.	—	-0.4	43.5	103.5	—	100.0	4	BEARISH	-94.3
MBAI MBody AI Ltd.	—	—	—	—	—	—	—	BEARISH	—
MBGNF Many Bright Ideas Technologies Inc.	—	-2.2	20.4	126.7	—	—	2	BEARISH	0.0
MBGNF Many Bright Ideas Technologies Inc.	—	-2.2	20.4	126.7	—	—	2	BEARISH	0.0
MBAI MBody AI Ltd.	—	—	—	—	—	—	—	BEARISH	—
NBRVF Nabriva Therapeutics plc	—	—	—	—	—	—	—	BEARISH	-0.0
NBRVF Nabriva Therapeutics plc	—	—	—	—	—	—	—	BEARISH	-0.0
GENPF Genix Pharmaceuticals Corporation	—	-5.2	19.6	11.6	—	-100.0	2	BEARISH	0.0
GENPF Genix Pharmaceuticals Corporation	—	-5.2	19.6	11.6	—	-100.0	2	BEARISH	0.0
NEWUF Newtopia Inc.	—	-0.1	75.4	107.5	-166.7	-36.4	2	BEARISH	-58.3
CHHE China Health Industries Holdings, Inc.	—	-0.0	-6.9	-35.0	-164082.8	77.5	2	BEARISH	-100.0
CHHE China Health Industries Holdings, Inc.	—	-0.0	-6.9	-35.0	-164082.8	77.5	2	BEARISH	-100.0
NEWUF Newtopia Inc.	—	-0.1	75.4	107.5	-166.7	-36.4	2	BEARISH	-58.3
JNHMF Jack Nathan Medical Corp.	—	-0.7	-152.9	25.0	-471.3	-108.0	4	BEARISH	-75.0
JNHMF Jack Nathan Medical Corp.	—	-0.7	-152.9	25.0	-471.3	-108.0	4	BEARISH	-75.0
CVKD Cadrenal Therapeutics, Inc. Common Stock	—	-0.2	-275.2	-540.4	—	—	3	BEARISH	-93.1
CVKD Cadrenal Therapeutics, Inc. Common Stock	—	-0.2	-275.2	-540.4	—	—	3	BEARISH	-93.1
FITY Fifty 1 Labs, Inc.	—	-4.2	132.4	345.2	-58137.6	-75.6	4	BEARISH	-92.9
FITY Fifty 1 Labs, Inc.	—	-4.2	132.4	345.2	-58137.6	-75.6	4	BEARISH	-92.9
PMEDF Qscreen Ai Inc.	—	-13.1	145.2	82.8	—	—	3	BEARISH	-47.3
PMEDF Qscreen Ai Inc.	—	-13.1	145.2	82.8	—	—	3	BEARISH	-47.3
SZLSF StageZero Life Sciences Ltd.	—	-0.0	23.1	18.6	-79.9	-29.3	2	BEARISH	-80.4
SZLSF StageZero Life Sciences Ltd.	—	-0.0	23.1	18.6	-79.9	-29.3	2	BEARISH	-80.4
BNIGF Beroni Group Limited	—	-0.1	-1153.4	-274.8	-15945.7	-40.4	4	BEARISH	0.0
BNIGF Beroni Group Limited	—	-0.1	-1153.4	-274.8	-15945.7	-40.4	4	BEARISH	0.0
PNDHF Pond Technologies Holdings Inc.	—	-0.4	43.2	90.7	-114.9	-47.3	2	BEARISH	23.1
PNDHF Pond Technologies Holdings Inc.	—	-0.4	43.2	90.7	-114.9	-47.3	2	BEARISH	23.1
LVCE LiveCare, Inc.	—	—	—	—	—	—	—	BEARISH	-76.8
LVCE LiveCare, Inc.	—	—	—	—	—	—	—	BEARISH	-76.8
THCT THC Therapeutics, Inc.	—	-0.0	16.8	16.9	—	—	2	BEARISH	-40.0
THCT THC Therapeutics, Inc.	—	-0.0	16.8	16.9	—	—	2	BEARISH	-40.0
SRPT Sarepta Therapeutics, Inc.	$1.9B	-12.2	-9.5	-6.3	-1.2	-20.4	4	BEARISH	-9.4
SRPT Sarepta Therapeutics, Inc.	$1.9B	-12.2	-9.5	-6.3	-1.2	-20.4	4	BEARISH	-9.4
MESO Mesoblast Limited	$1.8B	-32.0	-9.9	-6.3	-25.2	599.2	5	BEARISH	-13.5
MESO Mesoblast Limited	$1.8B	-32.0	-9.9	-6.3	-25.2	599.2	5	BEARISH	-13.5
GENB Generate Biomedicines, Inc.	$1.8B	-12.9	-28.2	-175.0	-1065.2	—	1	BEARISH	—
GENB Generate Biomedicines, Inc.	$1.8B	-12.9	-28.2	-175.0	-1065.2	—	1	BEARISH	—
XRAY DENTSPLY SIRONA Inc.	$1.7B	-3.2	-33.0	9.9	4.1	-0.8	5	BEARISH	-33.0
XRAY DENTSPLY SIRONA Inc.	$1.7B	-3.2	-33.0	9.9	4.1	-0.8	5	BEARISH	-33.0
GPCR Structure Therapeutics Inc.	$1.6B	-9.1	-20.2	-1134.3	—	—	3	BEARISH	6.3
GPCR Structure Therapeutics Inc.	$1.6B	-9.1	-20.2	-1134.3	—	—	3	BEARISH	6.3
NPNKF Nippon Shinyaku Co., Ltd.	$1.6B	7.2	11.1	12.2	8.9	7.1	3	BEARISH	inf
NPNKF Nippon Shinyaku Co., Ltd.	$1.6B	7.2	11.1	12.2	8.9	7.1	3	BEARISH	inf
INVA Innoviva, Inc.	$1.5B	4.2	36.7	15.0	-69.8	19.8	7	BEARISH	12.8
INVA Innoviva, Inc.	$1.5B	4.2	36.7	15.0	-69.8	19.8	7	BEARISH	12.8
GTBIF Green Thumb Industries Inc.	$1.4B	12.3	7.0	2.5	1.6	4.8	7	BEARISH	-21.6
GTBIF Green Thumb Industries Inc.	$1.4B	12.3	7.0	2.5	1.6	4.8	7	BEARISH	-21.6
ASPHF Ascentage Pharma Group International	$1.4B	-6.4	-316.9	-211.0	-270.2	-29.1	1	BEARISH	-58.3
ASPHF Ascentage Pharma Group International	$1.4B	-6.4	-316.9	-211.0	-270.2	-29.1	1	BEARISH	-58.3
SWGHF Sawai Group Holdings Co., Ltd.	$1.3B	21.1	5.9	6.5	-0.7	7.2	6	BEARISH	-1.6
SWGHF Sawai Group Holdings Co., Ltd.	$1.3B	21.1	5.9	6.5	-0.7	7.2	6	BEARISH	-1.6
DMRA Damora Therapeutics, Inc.	$1.3B	—	—	—	—	—	—	BEARISH	—
DMRA Damora Therapeutics, Inc.	$1.3B	—	—	—	—	—	—	BEARISH	—
TRAX First Tracks Biotherapeutics Inc	$1.2B	—	—	—	—	—	—	BEARISH	—
TRAX First Tracks Biotherapeutics Inc	$1.2B	—	—	—	—	—	—	BEARISH	—
TGLVY Top Glove Corporation Bhd.	$1.2B	32.3	4.0	4.2	7.4	12.8	7	BEARISH	24.7
TGLVY Top Glove Corporation Bhd.	$1.2B	32.3	4.0	4.2	7.4	12.8	7	BEARISH	24.7
HROW Harrow Health, Inc.	$1.1B	-30.7	-114.8	1.9	-24.4	21.1	5	BEARISH	-37.0
HROW Harrow Health, Inc.	$1.1B	-30.7	-114.8	1.9	-24.4	21.1	5	BEARISH	-37.0
ASCLF Ascletis Pharma Inc.	$1.1B	-11.7	-38.0	-12387.1	—	-95.5	2	BEARISH	-14.8
ASCLF Ascletis Pharma Inc.	$1.1B	-11.7	-38.0	-12387.1	—	-95.5	2	BEARISH	-14.8
AORT Artivion, Inc.	$1.1B	-374.3	-0.7	-3.4	-10.7	16.4	4	BEARISH	-45.7
AORT Artivion, Inc.	$1.1B	-374.3	-0.7	-3.4	-10.7	16.4	4	BEARISH	-45.7
EBOSY EBOS Group Limited	$1.0B	14.2	11.3	9.3	1.7	3.6	4	BEARISH	-53.6
EBOSY EBOS Group Limited	$1.0B	14.2	11.3	9.3	1.7	3.6	4	BEARISH	-53.6
GRRMF Gerresheimer AG	$1.0B	-2.4	1.6	2.2	-2.3	11.8	4	BEARISH	-43.5
GRRMF Gerresheimer AG	$1.0B	-2.4	1.6	2.2	-2.3	11.8	4	BEARISH	-43.5
PRCT PROCEPT BioRobotics Corporation	$980M	-8.8	-30.2	-47.6	-28.4	22.7	2	BEARISH	-50.6
PRCT PROCEPT BioRobotics Corporation	$980M	-8.8	-30.2	-47.6	-28.4	22.7	2	BEARISH	-50.6
LTGO Latigo Biotherapeutics Inc.	$960M	—	—	—	—	—	—	BEARISH	—
LTGO Latigo Biotherapeutics Inc.	$960M	—	—	—	—	—	—	BEARISH	—
CRVS Corvus Pharmaceuticals, Inc.	$920M	-17.0	-35.4	-415.6	—	—	4	BEARISH	50.1
CRVS Corvus Pharmaceuticals, Inc.	$920M	-17.0	-35.4	-415.6	—	—	4	BEARISH	50.1
GLUE Monte Rosa Therapeutics, Inc.	$890M	-4.8	-42.7	149.9	-483.9	-83.9	3	BEARISH	40.0
GLUE Monte Rosa Therapeutics, Inc.	$890M	-4.8	-42.7	149.9	-483.9	-83.9	3	BEARISH	40.0
ALMS Alumis Inc.	$850M	-1.8	-93.6	2645.2	-8557.2	-63.1	2	BEARISH	68.7
ALMS Alumis Inc.	$850M	-1.8	-93.6	2645.2	-8557.2	-63.1	2	BEARISH	68.7
SANA Sana Biotechnology, Inc.	$800M	-3.8	-152.9	-242.3	—	—	3	BEARISH	-21.9
SANA Sana Biotechnology, Inc.	$800M	-3.8	-152.9	-242.3	—	—	3	BEARISH	-21.9
GERN Geron Corporation	$770M	-12.0	-29.2	-74.1	-29.0	24.4	2	BEARISH	-14.9
GERN Geron Corporation	$770M	-12.0	-29.2	-74.1	-29.0	24.4	2	BEARISH	-14.9
IVEVF Inventiva S.A.	$760M	-5.9	5541.6	502.1	-347346.6	-57.3	4	BEARISH	41.2
IVEVF Inventiva S.A.	$760M	-5.9	5541.6	502.1	-347346.6	-57.3	4	BEARISH	41.2
ATTO Attovia Therapeutics, Inc.	$740M	-18.5	-294.4	-1137.2	-4597.1	-50.5	4	BEARISH	308.8
ATTO Attovia Therapeutics, Inc.	$740M	-18.5	-294.4	-1137.2	-4597.1	-50.5	4	BEARISH	308.8
OLMA Olema Pharmaceuticals, Inc.	$720M	-3.9	-52.7	585.3	—	—	2	BEARISH	-25.4
OLMA Olema Pharmaceuticals, Inc.	$720M	-3.9	-52.7	585.3	—	—	2	BEARISH	-25.4
BLSM BlossomHill Therapeutics, Inc.	$570M	—	—	—	—	—	—	BEARISH	—
BLSM BlossomHill Therapeutics, Inc.	$570M	—	—	—	—	—	—	BEARISH	—
CTMX CytomX Therapeutics, Inc.	$560M	-5.7	-37.8	305.9	-1457.4	-87.0	2	BEARISH	-23.6
CTMX CytomX Therapeutics, Inc.	$560M	-5.7	-37.8	305.9	-1457.4	-87.0	2	BEARISH	-23.6
CRMD CorMedix Inc.	$560M	3.0	54.9	57.2	25.5	280.5	5	BEARISH	-34.9
CRMD CorMedix Inc.	$560M	3.0	54.9	57.2	25.5	280.5	5	BEARISH	-34.9
PHAT Phathom Pharmaceuticals, Inc.	$560M	-5.4	26.4	8.9	-23.7	110.2	4	BEARISH	-43.7
PHAT Phathom Pharmaceuticals, Inc.	$560M	-5.4	26.4	8.9	-23.7	110.2	4	BEARISH	-43.7
ALT Altimmune, Inc.	$530M	-3.5	-28.9	-43.1	—	55.0	4	BEARISH	-20.4
ALT Altimmune, Inc.	$530M	-3.5	-28.9	-43.1	—	55.0	4	BEARISH	-20.4
SSII SS Innovations International, Inc.	$530M	-41.0	-26.1	-15.6	-19.1	108.5	3	BEARISH	-62.4
SSII SS Innovations International, Inc.	$530M	-41.0	-26.1	-15.6	-19.1	108.5	3	BEARISH	-62.4
ALLO Allogene Therapeutics, Inc.	$520M	-2.2	-42.4	-81.9	-919.8	—	5	BEARISH	21.0
ALLO Allogene Therapeutics, Inc.	$520M	-2.2	-42.4	-81.9	-919.8	—	5	BEARISH	21.0
ARVN Arvinas, Inc.	$480M	39.0	1.6	-519.3	67.8	-15.0	4	BEARISH	-18.8
ARVN Arvinas, Inc.	$480M	39.0	1.6	-519.3	67.8	-15.0	4	BEARISH	-18.8
CALZF Polynovo Limited	$430M	85.4	25.3	19.0	10.0	60.8	7	BEARISH	-34.7
CALZF Polynovo Limited	$430M	85.4	25.3	19.0	10.0	60.8	7	BEARISH	-34.7
NPCE NeuroPace, Inc.	$430M	-22.2	-122.1	-39.6	-27.2	11.6	4	BEARISH	25.2
NPCE NeuroPace, Inc.	$430M	-22.2	-122.1	-39.6	-27.2	11.6	4	BEARISH	25.2
GLAS Glass House Brands Inc	$420M	—	—	—	—	—	—	BEARISH	—
GLAS Glass House Brands Inc	$420M	—	—	—	—	—	—	BEARISH	—
AGMB AgomAb Therapeutics N.V. American Depositary Shares	$420M	—	—	—	—	—	—	BEARISH	—
AGMB AgomAb Therapeutics N.V. American Depositary Shares	$420M	—	—	—	—	—	—	BEARISH	—
SPRY ARS Pharmaceuticals, Inc.	$400M	-1.9	-210.3	-424.3	-185.2	4.1	2	BEARISH	-59.7
SPRY ARS Pharmaceuticals, Inc.	$400M	-1.9	-210.3	-424.3	-185.2	4.1	2	BEARISH	-59.7
TLRY Tilray Brands, Inc.	$400M	-2.7	-8.1	-2.7	-17.6	1.2	3	BEARISH	-78.2
TLRY Tilray Brands, Inc.	$400M	-2.7	-8.1	-2.7	-17.6	1.2	3	BEARISH	-78.2
VRNO Verano Holdings Corp	$390M	-1.5	-4.5	1.5	-6.2	—	3	BEARISH	—
VRNO Verano Holdings Corp	$390M	-1.5	-4.5	1.5	-6.2	—	3	BEARISH	—
PTCHF PureTech Health plc	$380M	8.2	14.7	-97.5	1890.6	-3.3	5	BEARISH	-0.7
PTCHF PureTech Health plc	$380M	8.2	14.7	-97.5	1890.6	-3.3	5	BEARISH	-0.7
RGNX REGENXBIO Inc.	$380M	-2.0	-137.6	-368.4	21.0	12.0	2	BEARISH	-23.9
KYTX Kyverna Therapeutics, Inc.	$380M	-2.1	-87.2	14267.8	—	—	2	BEARISH	4.2
KYTX Kyverna Therapeutics, Inc.	$380M	-2.1	-87.2	14267.8	—	—	2	BEARISH	4.2
RGNX REGENXBIO Inc.	$380M	-2.0	-137.6	-368.4	21.0	12.0	2	BEARISH	-23.9
CYH Community Health Systems, Inc.	$380M	-1.2	19.9	-79.1	1.7	77.2	5	BEARISH	-13.1
CYH Community Health Systems, Inc.	$380M	-1.2	19.9	-79.1	1.7	77.2	5	BEARISH	-13.1
RLMD Relmada Therapeutics, Inc.	$380M	-3.9	-55.7	460.5	—	—	3	BEARISH	66.7
RLMD Relmada Therapeutics, Inc.	$380M	-3.9	-55.7	460.5	—	—	3	BEARISH	66.7
CGC Canopy Growth Corporation	$370M	-1.9	-53.8	-16.5	-220.5	27.6	2	BEARISH	-36.6
CGC Canopy Growth Corporation	$370M	-1.9	-53.8	-16.5	-220.5	27.6	2	BEARISH	-36.6
BNTC Benitec Biopharma Inc.	$310M	-9.2	-33.2	1840.8	—	—	3	BEARISH	-29.6
BNTC Benitec Biopharma Inc.	$310M	-9.2	-33.2	1840.8	—	—	3	BEARISH	-29.6
IDGXF Integrated Diagnostics Holdings plc	$310M	11.0	41.4	38.4	13.8	46.8	8	BEARISH	11.2
IDGXF Integrated Diagnostics Holdings plc	$310M	11.0	41.4	38.4	13.8	46.8	8	BEARISH	11.2
LRMR Larimar Therapeutics, Inc.	$310M	-1.5	-139.6	590.9	—	—	2	BEARISH	-28.7
LRMR Larimar Therapeutics, Inc.	$310M	-1.5	-139.6	590.9	—	—	2	BEARISH	-28.7
CUVL Clinuvel Pharmaceuticals Ltd.	$300M	—	—	—	—	—	—	BEARISH	—
CUVL Clinuvel Pharmaceuticals Ltd.	$300M	—	—	—	—	—	—	BEARISH	—
HUMDF Hua Medicine (Shanghai) Ltd.	$290M	-19.6	202.2	-122.6	-8.0	415.7	4	BEARISH	-28.5
HUMDF Hua Medicine (Shanghai) Ltd.	$290M	-19.6	202.2	-122.6	-8.0	415.7	4	BEARISH	-28.5
VNDA Vanda Pharmaceuticals Inc.	$280M	-1.0	-77.8	-201.0	-123.7	6.0	3	BEARISH	-9.2
VNDA Vanda Pharmaceuticals Inc.	$280M	-1.0	-77.8	-201.0	-123.7	6.0	3	BEARISH	-9.2
RCKT Rocket Pharmaceuticals, Inc.	$280M	-16.0	-4.8	-137.8	—	—	3	BEARISH	-19.0
RCKT Rocket Pharmaceuticals, Inc.	$280M	-16.0	-4.8	-137.8	—	—	3	BEARISH	-19.0
IPSC Century Therapeutics, Inc.	$280M	-1.5	-49.7	-60.0	—	-100.0	2	BEARISH	206.1
IPSC Century Therapeutics, Inc.	$280M	-1.5	-49.7	-60.0	—	-100.0	2	BEARISH	206.1
SCTX Scribe Therapeutics Inc.	$270M	—	—	—	—	—	—	BEARISH	—
SCTX Scribe Therapeutics Inc.	$270M	—	—	—	—	—	—	BEARISH	—
XFOR X4 Pharmaceuticals, Inc.	$270M	-2.4	-113.1	-281.1	-183.5	-51.6	4	BEARISH	-21.8
XFOR X4 Pharmaceuticals, Inc.	$270M	-2.4	-113.1	-281.1	-183.5	-51.6	4	BEARISH	-21.8
EYPT EyePoint Pharmaceuticals, Inc.	$270M	-0.9	-148.7	-3014.8	-18633.1	-94.6	2	BEARISH	-74.8
EYPT EyePoint Pharmaceuticals, Inc.	$270M	-0.9	-148.7	-3014.8	-18633.1	-94.6	2	BEARISH	-74.8
AMRN Amarin Corporation plc	$260M	-8.6	-6.0	-19.6	-18.1	-15.1	6	BEARISH	-25.8
AMRN Amarin Corporation plc	$260M	-8.6	-6.0	-19.6	-18.1	-15.1	6	BEARISH	-25.8
VOGX Vogenx Inc.	$250M	—	—	—	—	—	—	BEARISH	—
ORYZF Oryzon Genomics S.A.	$250M	-87.6	-3.0	-7.2	-1.6	12.6	4	BEARISH	-8.3
ORYZF Oryzon Genomics S.A.	$250M	-87.6	-3.0	-7.2	-1.6	12.6	4	BEARISH	-8.3
DBVT DBV Technologies S.A.	$250M	-2.7	-142.6	-2201.5	—	-100.0	2	BEARISH	4.8
DBVT DBV Technologies S.A.	$250M	-2.7	-142.6	-2201.5	—	-100.0	2	BEARISH	4.8
VOGX Vogenx Inc.	$250M	—	—	—	—	—	—	BEARISH	—
BIOA BioAge Labs Inc.	$250M	-2.8	-28.2	-142.3	-1064.7	168.1	4	BEARISH	11.7
BIOA BioAge Labs Inc.	$250M	-2.8	-28.2	-142.3	-1064.7	168.1	4	BEARISH	11.7
EVMN Evommune, Inc.	$250M	-2.4	-29.6	-82.4	—	—	2	BEARISH	—
EVMN Evommune, Inc.	$250M	-2.4	-29.6	-82.4	—	—	2	BEARISH	—
CPHRF Cipher Pharmaceuticals Inc.	$240M	8.4	23.5	24.9	33.3	3.7	6	BEARISH	-14.2
CPHRF Cipher Pharmaceuticals Inc.	$240M	8.4	23.5	24.9	33.3	3.7	6	BEARISH	-14.2
LYEL Lyell Immunopharma, Inc.	$230M	-0.6	-93.3	-227.7	-1118875.0	-55.0	3	BEARISH	-44.0
LYEL Lyell Immunopharma, Inc.	$230M	-0.6	-93.3	-227.7	-1118875.0	-55.0	3	BEARISH	-44.0
BCYC Bicycle Therapeutics plc	$230M	-1.2	-32.3	-1197.0	-8002.1	217.4	4	BEARISH	-59.4
BCYC Bicycle Therapeutics plc	$230M	-1.2	-32.3	-1197.0	-8002.1	217.4	4	BEARISH	-59.4
LCTX Lineage Cell Therapeutics, Inc.	$230M	-6.6	-59.0	-171.3	138.6	19.9	5	BEARISH	-45.0
LCTX Lineage Cell Therapeutics, Inc.	$230M	-6.6	-59.0	-171.3	138.6	19.9	5	BEARISH	-45.0
SION Sionna Therapeutics, Inc.	$220M	-2.3	-32.3	-137.7	—	—	0	BEARISH	-82.8
SION Sionna Therapeutics, Inc.	$220M	-2.3	-32.3	-137.7	—	—	0	BEARISH	-82.8
TSNDF TerrAscend Corp.	$190M	-4.1	-22.6	-28.1	-13.6	—	3	BEARISH	—
TSNDF TerrAscend Corp.	$190M	-4.1	-22.6	-28.1	-13.6	—	3	BEARISH	—
RXST RxSight, Inc.	$190M	-4.1	-17.3	-66.9	-35.9	-18.8	3	BEARISH	-48.1
RXST RxSight, Inc.	$190M	-4.1	-17.3	-66.9	-35.9	-18.8	3	BEARISH	-48.1
CHRS Coherus Oncology, Inc.	$180M	-1.1	-145.4	1854.0	-144.2	-64.3	2	BEARISH	-28.4
CHRS Coherus Oncology, Inc.	$180M	-1.1	-145.4	1854.0	-144.2	-64.3	2	BEARISH	-28.4
ORGO Organogenesis Holdings Inc.	$170M	-1.6	-27.8	-7.7	-227.0	6.4	3	BEARISH	-69.0
ORGO Organogenesis Holdings Inc.	$170M	-1.6	-27.8	-7.7	-227.0	6.4	3	BEARISH	-69.0
AVXL Anavex Life Sciences Corp.	$170M	-7.0	-23.6	411.7	—	—	2	BEARISH	-79.8
AVXL Anavex Life Sciences Corp.	$170M	-7.0	-23.6	411.7	—	—	2	BEARISH	-79.8
PEPG PepGen Inc.	$160M	-1.5	-75.5	-327.5	—	—	4	BEARISH	-51.6
PEPG PepGen Inc.	$160M	-1.5	-75.5	-327.5	—	—	4	BEARISH	-51.6
VYGR Voyager Therapeutics, Inc.	$150M	-1.4	-54.1	-131.1	-773.2	-19.1	2	BEARISH	-47.6
PHCUF Photocure ASA	$150M	16.5	14.5	37.4	-0.5	29.5	5	BEARISH	-3.8
PHCUF Photocure ASA	$150M	16.5	14.5	37.4	-0.5	29.5	5	BEARISH	-3.8
VYGR Voyager Therapeutics, Inc.	$150M	-1.4	-54.1	-131.1	-773.2	-19.1	2	BEARISH	-47.6
NGEN NervGen Pharma Corp. Common stock	$150M	—	—	—	—	—	—	BEARISH	—
NGEN NervGen Pharma Corp. Common stock	$150M	—	—	—	—	—	—	BEARISH	—
TARA Protara Therapeutics, Inc.	$150M	-2.0	-45.8	-41.3	—	—	2	BEARISH	-38.8
TARA Protara Therapeutics, Inc.	$150M	-2.0	-45.8	-41.3	—	—	2	BEARISH	-38.8
NERV Minerva Neurosciences, Inc.	$150M	-0.1	337.5	10.0	—	—	1	BEARISH	56.2
NERV Minerva Neurosciences, Inc.	$150M	-0.1	337.5	10.0	—	—	1	BEARISH	56.2
OGI Organigram Global Inc.	$130M	2.1	18.4	-1.3	99.8	38.1	5	BEARISH	-50.1
SPRB Spruce Biosciences, Inc.	$130M	-1.1	-106.0	772.2	—	-100.0	4	BEARISH	413.6
SPRB Spruce Biosciences, Inc.	$130M	-1.1	-106.0	772.2	—	-100.0	4	BEARISH	413.6
OGI Organigram Global Inc.	$130M	2.1	18.4	-1.3	99.8	38.1	5	BEARISH	-50.1
RNA Atrium Therapeutics, Inc.	$130M	-2.0	-36.9	455.9	-672.0	235.3	5	BEARISH	-82.0
RNA Atrium Therapeutics, Inc.	$130M	-2.0	-36.9	455.9	-672.0	235.3	5	BEARISH	-82.0
LUCD Lucid Diagnostics Inc.	$120M	-1.3	-556.3	-1646.4	-792.9	24.9	6	BEARISH	-38.5
LUCD Lucid Diagnostics Inc.	$120M	-1.3	-556.3	-1646.4	-792.9	24.9	6	BEARISH	-38.5
TNYA Tenaya Therapeutics, Inc.	$120M	-1.1	-121.9	1769.3	-3909.3	—	3	BEARISH	-66.4
TNYA Tenaya Therapeutics, Inc.	$120M	-1.1	-121.9	1769.3	-3909.3	—	3	BEARISH	-66.4
CRBU Caribou Biosciences, Inc.	$120M	-1.1	-78.3	-695.0	-1619.9	10.0	3	BEARISH	-46.0
CRBU Caribou Biosciences, Inc.	$120M	-1.1	-78.3	-695.0	-1619.9	10.0	3	BEARISH	-46.0
STXS Stereotaxis, Inc.	$120M	-4.8	-184.3	-142.6	-58.3	-5.5	5	BEARISH	-62.4
STXS Stereotaxis, Inc.	$120M	-4.8	-184.3	-142.6	-58.3	-5.5	5	BEARISH	-62.4
UNCY Unicycive Therapeutics, Inc.	$110M	-2.5	-101.1	349.9	—	—	4	BEARISH	-5.4
UNCY Unicycive Therapeutics, Inc.	$110M	-2.5	-101.1	349.9	—	—	4	BEARISH	-5.4
VXRT Vaxart, Inc.	$110M	2.9	67.0	149.6	-49.6	201.1	6	BEARISH	15.0
VXRT Vaxart, Inc.	$110M	2.9	67.0	149.6	-49.6	201.1	6	BEARISH	15.0
LENZ LENZ Therapeutics, Inc.	$110M	-0.9	-59.2	17313.3	-581.8	329.5	3	BEARISH	-92.7
LENZ LENZ Therapeutics, Inc.	$110M	-0.9	-59.2	17313.3	-581.8	329.5	3	BEARISH	-92.7
APYX Apyx Medical Corporation	$110M	-12.3	-96.4	-12.3	-23.4	25.6	5	BEARISH	18.6
APYX Apyx Medical Corporation	$110M	-12.3	-96.4	-12.3	-23.4	25.6	5	BEARISH	18.6
JYNT The Joint Corp.	$100M	27.4	19.4	-33.1	4.3	220.6	8	BEARISH	-21.5
JYNT The Joint Corp.	$100M	27.4	19.4	-33.1	4.3	220.6	8	BEARISH	-21.5
OKUR OnKure Therapeutics, Inc.	$100M	-0.7	-46.9	1464.5	—	—	4	BEARISH	-4.1
OKUR OnKure Therapeutics, Inc.	$100M	-0.7	-46.9	1464.5	—	—	4	BEARISH	-4.1
CCLD CareCloud, Inc.	$90M	28.9	21.8	15.7	3.5	15.1	4	BEARISH	-39.7
NMRA Neumora Therapeutics, Inc. Common Stock	$90M	-0.4	-187.1	231.9	—	—	2	BEARISH	-71.3
NMRA Neumora Therapeutics, Inc. Common Stock	$90M	-0.4	-187.1	231.9	—	—	2	BEARISH	-71.3
CCLD CareCloud, Inc.	$90M	28.9	21.8	15.7	3.5	15.1	4	BEARISH	-39.7
CNXU Conexeu Sciences Inc.	$80M	—	—	—	—	—	—	BEARISH	—
CNXU Conexeu Sciences Inc.	$80M	—	—	—	—	—	—	BEARISH	—
CGTX Cognition Therapeutics, Inc.	$80M	-4.8	-83.8	6061.8	—	—	3	BEARISH	-38.7
CGTX Cognition Therapeutics, Inc.	$80M	-4.8	-83.8	6061.8	—	—	3	BEARISH	-38.7
NTHI Neonc Technologies Holdings, Inc.	$80M	—	—	—	—	—	—	BEARISH	-69.7
NTHI Neonc Technologies Holdings, Inc.	$80M	—	—	—	—	—	—	BEARISH	-69.7
EAPIF Euroapi S.A.	$80M	-0.2	-57.5	-10.4	-39.7	-14.7	6	BEARISH	-72.7
EAPIF Euroapi S.A.	$80M	-0.2	-57.5	-10.4	-39.7	-14.7	6	BEARISH	-72.7
PTHS Pelthos Therapeutics Inc.	$70M	-0.5	4767.3	-97.0	-150.1	—	2	BEARISH	-23.7
PTHS Pelthos Therapeutics Inc.	$70M	-0.5	4767.3	-97.0	-150.1	—	2	BEARISH	-23.7
ALDX Aldeyra The	$70M	-3.0	-49.5	269.3	—	—	4	BEARISH	-77.7
ALDX Aldeyra The	$70M	-3.0	-49.5	269.3	—	—	4	BEARISH	-77.7
PLRX Pliant Therapeutics, Inc.	$60M	-0.7	-50.3	-438.3	—	—	3	BEARISH	-29.0
PLRX Pliant Therapeutics, Inc.	$60M	-0.7	-50.3	-438.3	—	—	3	BEARISH	-29.0
GUTS Fractyl Health, Inc.	$60M	-0.4	1063.0	-568.7	—	-100.0	4	BEARISH	-72.3
GUTS Fractyl Health, Inc.	$60M	-0.4	1063.0	-568.7	—	-100.0	4	BEARISH	-72.3
ONCY Oncolytics Biotech Inc.	$60M	-2.6	90135.4	285.1	—	—	1	BEARISH	-56.1
ONCY Oncolytics Biotech Inc.	$60M	-2.6	90135.4	285.1	—	—	1	BEARISH	-56.1
HBPCF Helix BioPharma Corp.	$60M	-22.3	-50.8	-21.5	—	—	3	BEARISH	28.3
HBPCF Helix BioPharma Corp.	$60M	-22.3	-50.8	-21.5	—	—	3	BEARISH	28.3
CING Cingulate Inc.	$60M	-1.0	-198.7	-1452.8	—	—	4	BEARISH	13.6
CING Cingulate Inc.	$60M	-1.0	-198.7	-1452.8	—	—	4	BEARISH	13.6
BTMD biote Corp.	$50M	6.8	-7.8	19.7	-14.8	-7.8	5	BEARISH	-61.4
BTMD biote Corp.	$50M	6.8	-7.8	19.7	-14.8	-7.8	5	BEARISH	-61.4
SOMNF SomnoMed Limited	$50M	-24.0	-13.2	10.2	-6.4	28.9	6	BEARISH	-45.5
SOMNF SomnoMed Limited	$50M	-24.0	-13.2	10.2	-6.4	28.9	6	BEARISH	-45.5
MBOT Microbot Medical Inc.	$50M	-4.4	-32.9	-600.2	-2334.9	—	3	BEARISH	-63.3
MBOT Microbot Medical Inc.	$50M	-4.4	-32.9	-600.2	-2334.9	—	3	BEARISH	-63.3
SRTS Sensus Healthcare, Inc.	$50M	-3.2	-34.8	-47.6	-382.1	-53.4	3	BEARISH	-5.7
SRTS Sensus Healthcare, Inc.	$50M	-3.2	-34.8	-47.6	-382.1	-53.4	3	BEARISH	-5.7
MDDVF Medical Developments International Limited	$40M	75.9	1.4	12.3	4.1	24.6	8	BEARISH	-1.0
MDDVF Medical Developments International Limited	$40M	75.9	1.4	12.3	4.1	24.6	8	BEARISH	-1.0
MGX Metagenomi, Inc. Common Stock	$40M	-0.4	-60.6	-268.2	10693.4	-59.8	1	BEARISH	-57.3
MGX Metagenomi, Inc. Common Stock	$40M	-0.4	-60.6	-268.2	10693.4	-59.8	1	BEARISH	-57.3
ACH Accendra Health, Inc.	$40M	-0.1	-1.1	4.3	-14.5	-99.1	3	BEARISH	-95.6
ACH Accendra Health, Inc.	$40M	-0.1	-1.1	4.3	-14.5	-99.1	3	BEARISH	-95.6
CVRX CVRx, Inc.	$40M	-0.8	-133.4	-260.4	-89.4	12.0	3	BEARISH	-80.5
CVRX CVRx, Inc.	$40M	-0.8	-133.4	-260.4	-89.4	12.0	3	BEARISH	-80.5
VEXTF Vext Science, Inc.	$40M	-2.1	-23.2	-8.7	-2.6	14.2	5	BEARISH	-41.4
VEXTF Vext Science, Inc.	$40M	-2.1	-23.2	-8.7	-2.6	14.2	5	BEARISH	-41.4
PRRUF Immutep Ltd	$40M	-0.6	-96.5	2212.5	-328.8	153.6	3	BEARISH	-84.2
PRRUF Immutep Ltd	$40M	-0.6	-96.5	2212.5	-328.8	153.6	3	BEARISH	-84.2
BDMD Baird Medical Investment Holdings Limited	$30M	-1.4	-51.7	-23.6	0.1	26.4	3	BEARISH	-64.9
IDXG Interpace Biosciences, Inc.	$30M	0.2	221.9	123.7	1.7	-20.3	6	BEARISH	46.3
IDXG Interpace Biosciences, Inc.	$30M	0.2	221.9	123.7	1.7	-20.3	6	BEARISH	46.3
BDMD Baird Medical Investment Holdings Limited	$30M	-1.4	-51.7	-23.6	0.1	26.4	3	BEARISH	-64.9
KYNB Kyntra Bio, Inc.	$30M	0.1	-115.2	29.6	-812.3	—	2	BEARISH	—
KYNB Kyntra Bio, Inc.	$30M	0.1	-115.2	29.6	-812.3	—	2	BEARISH	—
MCRB Seres Therapeutics, Inc.	$30M	-1.2	-66.6	-87.8	622.4	—	3	BEARISH	-85.7
MCRB Seres Therapeutics, Inc.	$30M	-1.2	-66.6	-87.8	622.4	—	3	BEARISH	-85.7
NSPR InspireMD, Inc.	$30M	-1.3	-148.8	-1383.2	-808.8	53.4	4	BEARISH	-74.1
NSPR InspireMD, Inc.	$30M	-1.3	-148.8	-1383.2	-808.8	53.4	4	BEARISH	-74.1
IMMP Immutep Limited	$30M	-0.6	-112.5	2661.4	-328.8	195.3	4	BEARISH	-88.0
IMMP Immutep Limited	$30M	-0.6	-112.5	2661.4	-328.8	195.3	4	BEARISH	-88.0
SCLX Scilex Holding Company	$30M	-0.1	160.5	105.7	-1485.2	-28.5	3	BEARISH	-80.4
SCLX Scilex Holding Company	$30M	-0.1	160.5	105.7	-1485.2	-28.5	3	BEARISH	-80.4
ATYR aTyr Pharma, Inc.	$30M	-0.5	-98.4	-1890.1	—	—	2	BEARISH	-58.4
ATYR aTyr Pharma, Inc.	$30M	-0.5	-98.4	-1890.1	—	—	2	BEARISH	-58.4
BCDA BioCardia, Inc.	$20M	-1.4	-1803.2	519.4	—	—	3	BEARISH	-21.8
BCDA BioCardia, Inc.	$20M	-1.4	-1803.2	519.4	—	—	3	BEARISH	-21.8
PAVM PAVmed Inc.	$20M	-0.2	-31.9	-43.6	-16315.2	-89.0	3	BEARISH	552.3
PAVM PAVmed Inc.	$20M	-0.2	-31.9	-43.6	-16315.2	-89.0	3	BEARISH	552.3
RDTCF Rapid Dose Therapeutics Corp.	$10M	-4.2	54.7	78.9	-106.0	33.0	3	BEARISH	-49.1
ACXP Acurx Pharmaceuticals, Inc.	$10M	-0.4	-128.1	241.9	—	—	3	BEARISH	-72.4
ACXP Acurx Pharmaceuticals, Inc.	$10M	-0.4	-128.1	241.9	—	—	3	BEARISH	-72.4
RDTCF Rapid Dose Therapeutics Corp.	$10M	-4.2	54.7	78.9	-106.0	33.0	3	BEARISH	-49.1
OTLC Oncotelic Therapeutics, Inc.	$10M	0.0	0.0	-0.0	155.3	—	5	BEARISH	-69.5
OTLC Oncotelic Therapeutics, Inc.	$10M	0.0	0.0	-0.0	155.3	—	5	BEARISH	-69.5
SCNX Scienture Holdings, Inc.	$10M	-0.1	-53.5	-15.4	-821.3	540.6	3	BEARISH	-82.5
CLRB Cellectar Biosciences, Inc.	$10M	-0.4	-119.6	717.6	—	—	3	BEARISH	-69.2
CLRB Cellectar Biosciences, Inc.	$10M	-0.4	-119.6	717.6	—	—	3	BEARISH	-69.2
MSLE Satellos Bioscience Inc.	$10M	—	—	—	—	—	—	BEARISH	—
MSLE Satellos Bioscience Inc.	$10M	—	—	—	—	—	—	BEARISH	—
SCNX Scienture Holdings, Inc.	$10M	-0.1	-53.5	-15.4	-821.3	540.6	3	BEARISH	-82.5
LTRN Lantern Pharma Inc.	$10M	-0.5	-400.9	115.9	—	—	2	BEARISH	-78.5
IGPK Integrated Cannabis Solutions, Inc.	$10M	9.2	-3.2	-5.2	0.6	2762.5	5	BEARISH	-72.4
IGPK Integrated Cannabis Solutions, Inc.	$10M	9.2	-3.2	-5.2	0.6	2762.5	5	BEARISH	-72.4
LTRN Lantern Pharma Inc.	$10M	-0.5	-400.9	115.9	—	—	2	BEARISH	-78.5
TVRD Tvardi Therapeutics, Inc.	$10M	-0.4	-126.2	296.9	—	—	1	BEARISH	-97.0
TVRD Tvardi Therapeutics, Inc.	$10M	-0.4	-126.2	296.9	—	—	1	BEARISH	-97.0
PHIO Phio Pharmaceuticals Corp.	$10M	-0.7	-113.7	2701.6	—	—	2	BEARISH	-59.3
PHIO Phio Pharmaceuticals Corp.	$10M	-0.7	-113.7	2701.6	—	—	2	BEARISH	-59.3
JSPR Jasper Therapeutics, Inc.	$10M	-0.4	-255.0	773.9	—	—	2	BEARISH	-76.5
JSPR Jasper Therapeutics, Inc.	$10M	-0.4	-255.0	773.9	—	—	2	BEARISH	-76.5
PRVCF PreveCeutical Medical Inc.	$10M	-16.7	9.9	96.4	—	—	3	BEARISH	-56.2
PRVCF PreveCeutical Medical Inc.	$10M	-16.7	9.9	96.4	—	—	3	BEARISH	-56.2
HMTXF Hemostemix Inc	$10M	-2.4	69.9	190.1	—	—	1	BEARISH	-38.1
HMTXF Hemostemix Inc	$10M	-2.4	69.9	190.1	—	—	1	BEARISH	-38.1
INNPF INNOCAN PHARMA Corp	$10M	-7.4	-21.0	-13488.5	-0.6	-19.2	3	BEARISH	-80.8
INNPF INNOCAN PHARMA Corp	$10M	-7.4	-21.0	-13488.5	-0.6	-19.2	3	BEARISH	-80.8
PASG Passage Bio, Inc.	$10M	-0.4	-169.1	159.0	—	—	3	BEARISH	-49.3
PASG Passage Bio, Inc.	$10M	-0.4	-169.1	159.0	—	—	3	BEARISH	-49.3
CVSI CV Sciences, Inc.	—	-1.0	-118.9	-46.0	-26.0	-14.9	1	BEARISH	-74.5
CVSI CV Sciences, Inc.	—	-1.0	-118.9	-46.0	-26.0	-14.9	1	BEARISH	-74.5
LABT Lakewood-Amedex Biotherapeutics, Inc.	—	—	—	—	—	—	—	BEARISH	—
LABT Lakewood-Amedex Biotherapeutics, Inc.	—	—	—	—	—	—	—	BEARISH	—
ERNA Ernexa Therapeutics Inc.	—	-0.2	-320.7	626.9	—	-100.0	5	BEARISH	-89.6
ERNA Ernexa Therapeutics Inc.	—	-0.2	-320.7	626.9	—	-100.0	5	BEARISH	-89.6
PBIGF Paradigm Biopharmaceuticals Limited	—	-1.6	-550.4	1492.1	-60158.9	17.4	3	BEARISH	-99.2
PBIGF Paradigm Biopharmaceuticals Limited	—	-1.6	-550.4	1492.1	-60158.9	17.4	3	BEARISH	-99.2
MHTX Manhattan Scientifics, Inc.	—	-0.0	45.1	23.3	—	104.9	3	BEARISH	-90.0
MHTX Manhattan Scientifics, Inc.	—	-0.0	45.1	23.3	—	104.9	3	BEARISH	-90.0
EDNEF Eden Empire Inc.	—	—	64.3	-88.8	-1382.1	—	2	BEARISH	-90.9
EDNEF Eden Empire Inc.	—	—	64.3	-88.8	-1382.1	—	2	BEARISH	-90.9
BNYN Banyan Corp.	—	-0.0	719.9	-36.9	-121.9	-37.7	3	BEARISH	-99.5
BNYN Banyan Corp.	—	-0.0	719.9	-36.9	-121.9	-37.7	3	BEARISH	-99.5
NLVVF New Leaf Ventures Inc	—	-0.2	-2466.1	-179.6	-152.9	-39.2	1	BEARISH	-99.0
NLVVF New Leaf Ventures Inc	—	-0.2	-2466.1	-179.6	-152.9	-39.2	1	BEARISH	-99.0
GREH Green Rain Energy Holdings Inc.	—	0.2	28.6	-43.9	-94.2	—	3	BEARISH	-56.4
GREH Green Rain Energy Holdings Inc.	—	0.2	28.6	-43.9	-94.2	—	3	BEARISH	-56.4
PPJE PPJ Healthcare Enterprises, Inc.	—	56.8	-0.0	-0.0	0.0	-1.2	4	BEARISH	-99.0
PPJE PPJ Healthcare Enterprises, Inc.	—	56.8	-0.0	-0.0	0.0	-1.2	4	BEARISH	-99.0
STJO St. Joseph, Inc.	—	1.1	9.1	6.7	89.6	-23.9	7	BEARISH	-43.1
STJO St. Joseph, Inc.	—	1.1	9.1	6.7	89.6	-23.9	7	BEARISH	-43.1
MBIO Mustang Bio, Inc.	—	-1.0	-58.1	36.6	—	—	2	BEARISH	-70.0
MBIO Mustang Bio, Inc.	—	-1.0	-58.1	36.6	—	—	2	BEARISH	-70.0
EDVA Endovia Health Sciences, Inc.	—	—	—	—	—	—	—	BEARISH	—
EDVA Endovia Health Sciences, Inc.	—	—	—	—	—	—	—	BEARISH	—
ZVSA ZyVersa Therapeutics, Inc.	—	-0.0	817.1	242.0	—	-100.0	1	BEARISH	-44.1
ZVSA ZyVersa Therapeutics, Inc.	—	-0.0	817.1	242.0	—	-100.0	1	BEARISH	-44.1
BLFE BioLife Sciences Inc.	—	-0.0	318059.1	-92210.0	—	—	2	BEARISH	0.0
BLFE BioLife Sciences Inc.	—	-0.0	318059.1	-92210.0	—	—	2	BEARISH	0.0
BIMI BIMI International Medical Inc.	—	-0.0	-159.5	-56.3	-124.0	-65.7	4	BEARISH	0.0
BIMI BIMI International Medical Inc.	—	-0.0	-159.5	-56.3	-124.0	-65.7	4	BEARISH	0.0
IGNT Ingen Technologies, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
IGNT Ingen Technologies, Inc.	—	—	—	—	—	—	—	BEARISH	0.0
REVB Revelation Biosciences, Inc.	—	-0.1	-154.8	1317.2	—	—	3	BEARISH	-47.9
MBRX Moleculin Biotech, Inc.	—	-0.0	-1371.6	-494.1	—	—	2	BEARISH	-96.4
MBRX Moleculin Biotech, Inc.	—	-0.0	-1371.6	-494.1	—	—	2	BEARISH	-96.4
REVB Revelation Biosciences, Inc.	—	-0.1	-154.8	1317.2	—	—	3	BEARISH	-47.9
SBFM Sunshine Biopharma, Inc.	—	-0.1	-21.9	-31.4	-16.9	-2.7	4	BEARISH	-56.7
SBFM Sunshine Biopharma, Inc.	—	-0.1	-21.9	-31.4	-16.9	-2.7	4	BEARISH	-56.7
CRIS Curis, Inc.	—	-0.1	455.3	-23281.0	—	-62.2	3	BEARISH	-97.6
CRIS Curis, Inc.	—	-0.1	455.3	-23281.0	—	-62.2	3	BEARISH	-97.6
NUMD Nu-Med Plus, Inc.	—	-48.7	8.1	29.2	—	-100.0	4	BEARISH	-53.2
NUMD Nu-Med Plus, Inc.	—	-48.7	8.1	29.2	—	-100.0	4	BEARISH	-53.2
MEDD Medical Imaging Corp.	—	—	—	—	—	—	—	BEARISH	100.0
MEDD Medical Imaging Corp.	—	—	—	—	—	—	—	BEARISH	100.0
SCPS Scopus BioPharma Inc.	—	-0.0	132.3	53.6	—	—	2	BEARISH	33.3
SCPS Scopus BioPharma Inc.	—	-0.0	132.3	53.6	—	—	2	BEARISH	33.3
CNHC China Health Management Corp.	—	16.1	3.2	3.3	29.8	-1.0	6	BEARISH	100.8
CNHC China Health Management Corp.	—	16.1	3.2	3.3	29.8	-1.0	6	BEARISH	100.8
BRTX BioRestorative Therapies, Inc.	—	-0.1	-241.1	2112.9	-9298.3	-8.5	3	BEARISH	-92.3
BRTX BioRestorative Therapies, Inc.	—	-0.1	-241.1	2112.9	-9298.3	-8.5	3	BEARISH	-92.3
HEWA HealthWarehouse.com, Inc.	—	-3.3	24.7	44.2	-6.8	-42.5	3	BEARISH	-36.4
HEWA HealthWarehouse.com, Inc.	—	-3.3	24.7	44.2	-6.8	-42.5	3	BEARISH	-36.4
CYYNF Cynata Therapeutics Limited	—	-0.3	-542.5	1354.9	—	-40.0	2	BEARISH	-98.8
CYYNF Cynata Therapeutics Limited	—	-0.3	-542.5	1354.9	—	-40.0	2	BEARISH	-98.8
XAGE Longevity Health Holdings Inc.	—	-0.0	109.8	56.6	-475.6	60.3	3	BEARISH	-79.8
XAGE Longevity Health Holdings Inc.	—	-0.0	109.8	56.6	-475.6	60.3	3	BEARISH	-79.8
CLAZF Claritas Pharmaceuticals, Inc.	—	0.0	-170.1	15.9	—	—	3	BEARISH	-99.0
CLAZF Claritas Pharmaceuticals, Inc.	—	0.0	-170.1	15.9	—	—	3	BEARISH	-99.0
AXIM AXIM Biotechnologies, Inc.	—	-1.6	3.0	24.9	-90.9	2142.6	5	BEARISH	-38.2
AXIM AXIM Biotechnologies, Inc.	—	-1.6	3.0	24.9	-90.9	2142.6	5	BEARISH	-38.2
PKTX ProtoKinetix, Incorporated	—	-0.7	-117.2	-115.0	—	—	2	BEARISH	-96.4
PKTX ProtoKinetix, Incorporated	—	-0.7	-117.2	-115.0	—	—	2	BEARISH	-96.4
BXRXQ Baudax Bio, Inc.	—	—	—	—	—	—	—	BEARISH	-90.0
BXRXQ Baudax Bio, Inc.	—	—	—	—	—	—	—	BEARISH	-90.0
MHUAF Meihua International Medical Technologies Co., Ltd.	—	—	—	—	—	—	—	BEARISH	—
MHUAF Meihua International Medical Technologies Co., Ltd.	—	—	—	—	—	—	—	BEARISH	—
CDIX Cardiff Lexington Corporation	—	-0.1	-481.3	-3.3	-114.8	0.3	2	BEARISH	-99.3
CDIX Cardiff Lexington Corporation	—	-0.1	-481.3	-3.3	-114.8	0.3	2	BEARISH	-99.3
HEMP Hemp, Inc	—	-0.2	-38.7	-6.0	-4131.8	333.7	4	BEARISH	0.0
HEMP Hemp, Inc	—	-0.2	-38.7	-6.0	-4131.8	333.7	4	BEARISH	0.0
AZTR Azitra, Inc.	—	-0.1	-256.7	-959.6	—	—	4	BEARISH	-81.7
JRSS JRSIS Health Care Corporation	—	-7.4	-10.1	-10.3	4.5	-94.6	6	BEARISH	7.7
JRSS JRSIS Health Care Corporation	—	-7.4	-10.1	-10.3	4.5	-94.6	6	BEARISH	7.7
AZTR Azitra, Inc.	—	-0.1	-256.7	-959.6	—	—	4	BEARISH	-81.7
ATTBF Abattis Bioceuticals Corp.	—	-0.0	-27.0	-30.2	-400.9	4163.2	4	BEARISH	-96.7
ATTBF Abattis Bioceuticals Corp.	—	-0.0	-27.0	-30.2	-400.9	4163.2	4	BEARISH	-96.7
INLB Item 9 Labs Corp.	—	-0.0	-47.3	-18.4	-117.7	-17.4	2	BEARISH	-99.0
INLB Item 9 Labs Corp.	—	-0.0	-47.3	-18.4	-117.7	-17.4	2	BEARISH	-99.0
GBLX GB Sciences, Inc.	—	-0.0	19.5	17.2	-103.2	—	3	BEARISH	-50.0
GBLX GB Sciences, Inc.	—	-0.0	19.5	17.2	-103.2	—	3	BEARISH	-50.0
LCDX Caliber Imaging & Diagnostics, Inc.	—	-0.0	54.6	46.8	-212.5	20.6	3	BEARISH	0.0
LCDX Caliber Imaging & Diagnostics, Inc.	—	-0.0	54.6	46.8	-212.5	20.6	3	BEARISH	0.0
GOVX GeoVax Labs, Inc.	—	-0.0	-891.6	1530.7	—	-100.0	3	BEARISH	-97.6
GOVX GeoVax Labs, Inc.	—	-0.0	-891.6	1530.7	—	-100.0	3	BEARISH	-97.6
WUHN Wuhan General Group (China), Inc.	—	-0.0	106.5	1.0	-155074.0	—	2	BEARISH	100.0
WUHN Wuhan General Group (China), Inc.	—	-0.0	106.5	1.0	-155074.0	—	2	BEARISH	100.0
GXXY Galexxy Holdings, Inc.	—	-0.0	370.1	271.5	-385.0	-88.8	2	BEARISH	-98.3
GXXY Galexxy Holdings, Inc.	—	-0.0	370.1	271.5	-385.0	-88.8	2	BEARISH	-98.3
DHAI DIH Holding US, Inc.	—	-0.0	24.9	14.2	-34.8	262.3	3	BEARISH	-100.0
DHAI DIH Holding US, Inc.	—	-0.0	24.9	14.2	-34.8	262.3	3	BEARISH	-100.0
EVAHF EGF Theramed Health Corp.	—	-0.2	102.2	4.7	—	—	2	BEARISH	-65.1
EVAHF EGF Theramed Health Corp.	—	-0.2	102.2	4.7	—	—	2	BEARISH	-65.1
BLEG Branded Legacy, Inc.	—	-0.0	2011.7	147.0	—	-29.4	2	BEARISH	-98.6
BLEG Branded Legacy, Inc.	—	-0.0	2011.7	147.0	—	-29.4	2	BEARISH	-98.6
AGNPF Grey Matters Health Inc.	—	—	-140.9	-64.7	—	—	3	BEARISH	-50.0
AGNPF Grey Matters Health Inc.	—	—	-140.9	-64.7	—	—	3	BEARISH	-50.0
MDXL Medixall Group, Inc.	—	-0.1	48.8	48.2	678.9	29.4	6	BEARISH	3200.0
MDXL Medixall Group, Inc.	—	-0.1	48.8	48.2	678.9	29.4	6	BEARISH	3200.0

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

YECO vs Benchmarks

ROIC

YECO

15.0

Industry

11.2

Gross Margin

YECO

0.0

Industry

84.0

Op Margin

YECO

18.6

Industry

-207.4

Net Margin

YECO

18.6

Industry

-213.8

Sector

-157.4

Revenue Growth

YECO

347.3

Sector

0.8

P/E Ratio

YECO

-0.0

Sector

17.0

ROE

YECO

4.7

Sector

-70.3

Piotroski F

YECO

6.0

Sector

3.0

YECO OTC

Technical Signal Map

Peer Comparison

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

YECO vs Benchmarks

Sign in to InsiderStreet